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Zussamenfassung  
Genomweite Transkriptomstudien haben unterschiedliche Klassen von Nicht-Protein-
kodierenden (nk) RNS offenbart und Fragen nach der Komplexität und Regulation 
des Genoms aufgeworfen. Genomische Prägung, ein epigenetisches Phänomen das 
die Exprimierung eines Gens in diploiden Zellen auf ein von zwei elterlichen 
Chromosomen beschränkt, ist ein Modellsystem um die Funktion der makro oder 
langen nkRNAs zu studieren. Sechs gut erforschte geprägte Gen- Cluster enthalten 
jeweils eine makro nkRNS die zwischen Maus und Mensch konserviert ist. Weiters 
wurde gezeigt, dass die zwei murinen makro nkRNAs Airn und Kcnq1ot1 die 
Exprimierung aller Protein-kodierenden Gene in den jeweiligen Gen-Clustern Igf2r 
und Kcnq1 unterdrücken. Beim Menschen exprimieren 8 von 27 bekannten 
geprägten Gen-Regionen geprägte makro nkRNAs. Um herauszufinden ob makro 
nkRNAs ein universelles Merkmal von allen menschlichen geprägten Gen-Regionen 
sind, habe ich individuell entwickelte Human Imprinted Tiling Arrays (HIRTA) und 
RNA-Sequenzierungstechnologien verwendet. Durch Hybridisierung von cDNA von 
menschlichen Geweben (20 normale und 23 Krebsgewebe) habe ich 
gewebespezifische Exprimierungsprofile von menschlichen geprägten Regionen 
erhalten. Dadurch konnte ich 101 neue Transkripte kartieren von denen 95% durch 
einen bioinformatische Analyse als macro nkRNS bestätigt werden konnten. Die 
RNA-Sequenzierung von nicht-ribosomaler RNA einer Fibroblasten Zelllinie ergab 
26,2 Millionen einmalig zugeordnete Sequenzfragmente. Damit konnte ich sowohl die 
Exprimierung bereits bekannter geprägter makro nkRNAs erfolgreich detektieren als 
auch die Exprimierung von 22/23 neuen makro nkRNAs bestätigen die ich mittels 
HIRTA gefunden habe. Sieben neue makro nkRNAs sind entwicklungsspezifisch 
reguliert wie ich mittels eines Differenzierungssystems in embryonalen Stammzellen 
zeigen konnte. Die weitere Charakterisierung von zehn makro nkRNAs hat gezeigt, 
dass 4/10 ausschliesslich im Zellkern vorliegen, 6/10 monoallelisch oder bevorzugt 
monoallelisch exprimiert werden und 2/10 einen CpG Insel Promoter haben der 
unterschiedlich stark auf den beiden elterlichen Chromosomen methyliert ist (DMR). 
Zusammengenommen habe ich Beweise für sechs neue geprägte makro nkRNAs. 
Weiters sind 22 der 101 neu kartierten Transkripte nur in Krebsgeweben exprimiert. 
Diese könnten einen wertvollen Startpunkt für weiterführende Biomarker Forschung 
darstellen. Weiters konnte ich zeigen, dass alle menschlichen geprägten Gen-
Regionen zumindest je eine makro nkRNA exprimieren welche geprägt sein könnte 
und diese daher möglicherweise eine Rolle in der Genregulation unter normalen als 
auch krankhaften Zuständen beim Menschen spielt. 
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Abstract 
 
Recent genome-wide transcriptome studies revealed diverse classes of non-protein-
coding (nc)RNAs and raised questions about the complexity and regulation of the 
genome. Genomic imprinting (an epigenetic phenomenon that restricts gene 
expression to one of two parental alleles in diploid cells) is a model system to study 
the function of an unusual class of macro or long ncRNAs. Six well-studied imprinted 
gene clusters contain a macro ncRNA that are mainly conserved between mouse 
and human. Furthermore, the mouse Airn and Kcnq1ot1 macro ncRNAs have been 
shown to repress all protein-coding genes, respectively in the Igf2r and Kcnq1 
imprinted gene clusters. In humans, 8 out of 27 known imprinted gene regions 
express imprinted macro ncRNAs. To determine if macro ncRNAs are universal 
features of all human imprinted gene regions I used a custom Human Imprinting 
Region Tilling Array (HIRTA) and RNA-seq technologies. By applying 20 normal and 
23 cancer human samples to HIRTA, I obtained the tissue-specific expression 
profiles of human imprinted gene regions and based on these profiles I mapped 101 
novel transcripts of which about 95% were confirmed as macro ncRNA using a 
bioinformatics approach. Using ribosomal RNA depleted RNA-seq in a fibroblast cell 
line, I obtained 26.2 million uniquely mapped reads, successfully detected the known 
imprinted macro ncRNAs and validated expression of 22/23 novel macro ncRNA 
transcripts detected by HIRTA. 7 novel macro ncRNAs were developmentally 
regulated in the human embryonic stem cells differentiation system. Characterization 
of 10 macro ncRNAs showed that 4/10 were exclusively nuclear localized, 6/10 had 
monoallelic or expression biased towards one parental allele and 2/10 had CpG 
island promoters that are differentially methylated regions (DMRs). Thus, I have 
partial evidence for 6 novel imprinted macro ncRNAs. Furthermore, 22 out of the 101 
mapped transcripts were expressed exclusively in cancer samples and may 
represent a valuable starting point for biomarkers research. In summary, all human 
imprinted gene regions express at least one macro ncRNA that may be imprinted and 
potentially play a role in gene regulation in normal or disease conditions in human.  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1. Introduction 
 
1. 1. Epigenetics and non-protein coding RNAs 
 
1. 1. 1. Definition of epigenetics 
Epigenetics has been defined many times through history. Aristotle (384-322 BC) 
used the term epigenesis in order to define gradual development of individual organic 
form from unformed in his book “Generation of Animals”. The term epigenetics (epi-
greek: above-genetics) was for the first time defined by Conrad Waddington, 1942, 
as “the branch of biology which studies the causal interactions between genes and 
their products, which bring the phenotype into being” (Waddington, 1942). One of the 
phenomena explained as epigenetic by Waddingtons’ work is cellular differentiation. 
In 1957, he modeled the cellular differentiation process through his epigenetic 
landscape concept where a ball representing the cell is able to take different 
permitted trajectories leading to different cell fates (Figure 1).  
 
                   
Figure 1. Waddingtons’ epigenetics landscape. Taken unmodified from (Waddington, 
1957). 
 
One of the most accepted definitions of epigenetics, given by Arthur D. Riggs in 
1996, is: “the study of mitotically and/or meiotically heritable changes in genes 
function that cannot be explained by changes in DNA sequence”. Epigenetics today 
is a fast growing field. The epigenetic community took a collective effort to define and 
discuss epigenetics at a meeting hosted by the Banbury Conference Center and Cold 
Spring Harbor Laboratory which resulted in an operational definition of epigenetics 
being given by Ali Shilatifard and colleagues in 2009: “An epigenetic trait is a stably 
heritable phenotype resulting from changes in a chromosome without alterations in 
the DNA sequence” (Berger et al., 2009). The operational definition will further be 
discussed in the next section where the epigenetic pathway and its set of operational 
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steps will be dissected. Epigenetics can be defined in different ways but as a 
conclusion I would point to recent Denise Barlows’ quotation: ”Epigenetics has 
always been all the weird and wonderful things that cannot be explained by genetics” 
(http://epigenome.eu/en/1,1,0).  
 
1. 1. 2. The epigenetic pathway 
A recent conference and discussion including a number of leading scientists in the 
field led to an operational definition of epigenetics based on three categories of 
signals leading to a stably heritable epigenetic state (Berger et al., 2009). Signals 
named: “Epigenator”, “Epigenetic Initiator” and “Epigenetic Maintainer” are proposed 
to be parts of the epigenetic pathway (Figure 2). 
 
 
Figure 2. The epigenetic pathway. Includes epigenator that comes from enviroment and 
“activate” locus specific epigenetic initiator (e.g. ncRNA) leading to establishment of specific 
chromatin enviroment by action of epigenetic maintainer signals. 
 
The “Epigenator” comes from environment and “activates” the “Epigenetic Initiator”. 
This epigenator signal is transient and could be for example changes in temperature 
that affect paramutation in plants, where paramutation is a phenomenon in which one 
allele causes heritable expression change of the homologous allele. The “Epigenetic 
Initiator” is locus specific. By action of Initiators, such as non- protein coding RNAs 
(ncRNAs) and DNA binding proteins, a specific chromatin environment is established 
at a particular location in the genome. The Initiator is not necessarily transient as the 
“Epigenator” but may persist together with “Epigenetic Maintainer”. The “Epigenetic 
Maintainer” is not locus specific and could operate at any location where it is 
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recruited by an Initiator. Maintainers include a variety of epigenetic signals like DNA 
methylation, histone modifications, variants of histones and nucleosome positioning. 
The division of epigenetic pathways into three classes of signals provides a basis for 
understanding epigenetic pathways and their role in gene regulation through cellular 
generations. Further investigation of epigenetic pathways, signals and their 
interconnection is necessary and will provide a better understanding of a whole layer 
of information “above the genome” implicated in normal development and disease. 
 
1. 1. 3. Epigenetic roles of DNA methylation 
DNA methylation is a covalent modification of DNA, in mammals restricted to 
cytosine residues and almost exclusively found on CpG dinucleotides (Figure 3). 
 
Figure 3. Cytosine methylation. Modified from (Bernstein et al., 2007). 
 
CpG dinucleotides in the human genome are present at low density (93%) or 
concentrated in CpG islands (7%) (Fazzari and Greally, 2004). CpG islands were 
originally defined as regions of DNA of at least: 200bp length, 55% GC content and 
0.6 ratio of observed to expected CpG frequency. Today the CpG island length is 
usually set to more than 500bp since this lowers the number of false positives 
(Gardiner-Garden and Frommer, 1987; Takai and Jones, 2002). CpG island 
promoters are a feature of around 56% of genes in the human genome (Antequera 
and Bird, 1993). Large-scale studies of cytosine methylation in human showed that 
global DNA methylation is found throughout the genome: in gene bodies, 
transposons and intergenic DNA, while CpG islands are mostly unmethylated. No 
correlation between unmethylated CpG island promoters and expression state of the 
gene could be found. Exceptionally, methylated CpG islands are involved in X 
chromosome inactivation and genomic imprinting while their involvement in tissue 
specific gene silencing is starting to emerge (reviewed in (Suzuki and Bird, 2008)).  
 
DNA methylation is clearly an epigenetic modification as it provides heritable 
information not encoded by nucleotide sequence. Mouse embryogenesis research 
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has provided insights into the DNA methylation “cycle”. In the preimplantation embryo 
genome-wide loss of DNA methylation is observed (Monk et al., 1987). In the 
germline, DNA methylation patterns are set by de novo methyltransferases DNMT3A 
and DNMT3B (Okano et al., 1999). DNMT3A2 isoform and its cofactor DNMT3-like 
(DNMT3L) introduce DNA methylation to female gametes imprint control elements 
(ICEs) which are one of the key features of imprinted gene regions (Hata et al., 
2002). DNMT3L is not necessary for DNMT3A2 establishment of DNA methylation 
imprints in sperm (Kaneda et al., 2004). DNMT3B is shown to be required for 
methylation of pericentromeric repetitive DNA and CpG islands of the inactive X 
chromosome (Bird, 2002). Propagation of methylation patterns through cell divisions 
is achieved by involvement of the “maintenance” methyltransferase DNMT1. 
Specifically hemi- methylated CpG dinucleotides are targeted by this enzyme to 
methylate newly synthesized DNA strand based on complementary strand 
methylation (Bird, 2002). However, it was shown that DNMT1 is inefficient at 
maintaining methylation at some CpG dense regions (Liang et al., 2002), therefore 
current opinion is that DNMT3A and DNMT3B are also taking part in maintenance of 
the methylation (Miranda and Jones, 2007). 
 
One of the best-documented roles of DNA methylation is a role in transcriptional 
gene silencing. Reduction of DNA methylation has been shown to lead to 
derepression of LINE (Long Interspersed Nuclear Elements) and SINE (Short 
Interspersed Nuclear Elements) promoters in the human genome (Liu et al., 1994; 
Woodcock et al., 1997). For example artificial demethylation of promoters of Alu 
family elements stimulates their expression (Liu et al., 1994). Silencing of repetitive 
elements by DNA methylation gives support to the genome defense model (Yoder et 
al., 1997). According to this model DNA methylation has a biological role in silencing 
repetitive elements and thereby preventing DNA damage due to their transposition 
(Robertson and Wolffe, 2000).  
 
Long term silencing of transcription by DNA methylation of CpG islands is well 
established in two forms of non-Mendelian inheritance: X chromosome inactivation 
and genomic imprinting. During X-inactivation, one female X chromosome is 
inactivated. CpG island promoters are methylated within the inactive X chromosome 
by DNA methylation which stabilizes the repressed state of the corresponding genes 
(Chang et al., 2006). Interestingly, gene-body DNA methylation is two times more 
abundant on the active X than on the inactive X chromosome, which has been 
showed by allele-specific DNA methylation of more than 1000 informative loci on the 
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human X chromosome (Hellman and Chess, 2007). Thus, X-inactivation provides 
evidence of gene-body methylation association with transcriptional activity.  
 
In imprinted gene clusters DNA methylation is present in the form of DMRs 
(Differentially Methylated Regions) representing CpG islands methylated on one 
parental allele. DMRs have function as imprint control elements (ICE) if acquired in 
the primordial germline. The retention of the imprinted gene state through cellular 
generations is achieved by DNA methylation silencing of ICE that is a cis-acting 
repressor on one parental allele (Koerner and Barlow, 2010).  
 
Different models suggest mechanisms by which DNA methylation could be involved 
in transcriptional gene silencing. Two common views are that DNA methylation could 
impede the binding of transcription factors (e.g. CTCF (Bell and Felsenfeld, 2000)) or 
it could promote binding of MBPs (Methyl-Binding Proteins (Kass et al., 1997)) which 
by binding to repressors and histone deacetylases could lead to inactive chromatin 
formation (Harikrishnan et al., 2005).  
 
The epigenetic role of DNA methylation in development and differentiation is still not 
fully understood. Weber et al. (2007) found systematic methylation of germline-
specific gene promoters in somatic cells (fibroblasts) while this methylation was 
absent from mature sperm. This finding implicates DNA methylation as having a role 
in the silencing of germline specific genes that could contribute to cell differentiation. 
Homeobox (HOX) and paired box (PAX) genes play important roles in development. 
DNA methylation has been found on the CpG island promoters of these genes in 
human somatic tissues implying a role in development (Illingworth et al., 2008). 
Further, Lister et al. (2009) compared human stem cells and fetal fibroblasts at base 
resolution and identified hundreds of DMRs proximal to genes playing a role in 
pluripotency and differentiation. Several studies examined DNA methylation in 
human and showed that DNA methylation of CpG island promoters is more spread in 
somatic tissues than thought. For example, one group mapped DNA methylation 
genome-wide profiles in 13 human somatic tissues and proposed that promoter 
methylation could play role in the context of cell and tissue specific transcriptional 
programs (Rakyan et al., 2008). Tissue-specific differentially methylated regions 
(tDMR) are found in both gene-coding and intergenic regions. tDMRs, outside of 
annotated genes, could potentially play a role as cis- regulatory elements involved in 
gene expression control or as promoters of not yet annotated non-protein coding 
RNAs (Suzuki and Bird, 2008). The roles of DNA methylation in transcriptional gene 
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silencing, development and differentiation, together with the interplay with other 
“epigenetic maintainers” such as histone modifications and “epigenetic initiators” 
such as ncRNAs remain to be fully understood.  
 
1. 1. 4. Epigenetic roles of histone modifications 
DNA is wrapped around the histone octamer (two times of each H3, H4, H2A, H2B 
histone) forming the nucleosome, the basic unit of chromatin. Postranslational 
modifications can be found on the N-terminal tails or globular domains of histones. 
There is a debate in the field if histone modifications are epigenetic since it is not 
clear how and if chromatin modifications are heritable. Still, their roles in epigenetic 
processes are evident and recently they are recognized as potential “Epigenetic 
maintainers”. Histone modifications have roles in transcription regulation, repair, 
replication and condensation. Different classes of histone modifications in mammals 
are shown in Table 1. 
 
Histone modification 
classes 
Residues modified Histone modifications 
Acethylation K H3K9, H3K14, H3K18, H3K56, H4K5, H4K8, 
H4K12, H4K16, H2AK5, H2BK12, H2BK15 
Methylation  K, R H3K4, H3K9, H3K27, H3K36, H3K79, H4K20, 
H2BK5, H3R2, H3R8, H3R17, H3R26, H4R3 
Phosphorylation S, T H3S10, H3S28, H4S1, H2BS14, H3T3 
Ubiquitylation K H2AK119, H2BK120 
Sumoylation K H4 (Shiio and Eisenman, 2003) 
ADP ribosylation E H3, H4, H2A, H2B (Burzio et al., 1979) 
Deimination R>C H3, H2A, H4 (Hagiwara et al., 2002) 
Proline Isomerization P-cis>P-trans H3P30, H3P38 
Table 1. Eight classes of histone modifications are overviewed. Histone amino acid 
residues modified by different chemical reactions are: K(lysine), R(arginine), S(serine), 
T(threonine), E(glutamic acid), C(cysteine) and P(proline). Histone modifications found on 
specific positions of histones are shown (reviewed in (Kouzarides, 2007), (Barski et al., 
2007)). Lysine methylation and arginine methylation can show an even higher diversity as 
mono(me1), di(me2) and tri(me3) methylations are found (where one, two or three 
methylation groups are subsequently bound) on lysine and mono(me1) or two kinds of 
di(me2a, me2s) methylations are found on arginine.  
 
Genome wide approaches such as ChIP-chip and ChIP-Seq made it possible map 
histone modifications in different cell lines and tissues where different modification 
patterns can be correlated with transcription of the genes. An overview of 
modifications mapped on specific locations of active/inactive genes, specific 
regulatory regions and other genetic/epigenetic elements is shown in Table 2 
(reviewed in (Wang et al., 2009b)). Use of chromatin maps to map novel genes and 
regulatory regions is accepted on the basis of the strong correlation between certain 
histone modifications or their combinations with specific genomic regions. For 
example H3K4me3 is associated with promoters of expressed genes.  
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Specific 
genetic/epigenetic 
regions  
Histone modifications 
Promoters of active 
genes 
H3K4me3 (H3K4me2/me1 spreads towards transcribed regions of genes), 
H3K9ac, H3K14ac, H3K23ac, H2BK5me1, H3K9me1, H3K27me1, H4K20me1, 
H3K79me1 (H3K79me2/me3 spreads towards the transcribed regions of 
genes), H4K5/8/12/16ac (spreading through gene body), reviewed in (Wang et 
al., 2009b) 
Active genes body H3K36me3, H3K79, H3K9me1, H3K27me1, H4K20me1, H3K23ac (decreasing 
through the gene body), H2BK5me1, H3K9me1, H3K27me1, H3K36me3, 
H4K5/8/12/16ac, reviewed in (Wang et al., 2009b) 
Inactive genes body H3K9me2/me3, H3K27me2/me3, H4K20me3 reviewed in (Wang et al., 2009b) 
Repeats (e. g. LTRs 
(Long Terminal 
Repeats)) 
H3K9me3 + H4K20me3 (Mikkelsen et al., 2007) 
Enhancers H3K4me1 (absence H3K4me3) (Heintzman et al., 2007) 
H2A.Z  + H3K4me3 + H3K4me1 (Barski et al., 2007) 
Imprint control 
elements 
(ICE) 
Modifications depend on the differential methylation status: 
Methylated ICE: H3K9me3, H4K20me3; Unmethylated ICE: H3K4me3, 
H3K4me2, H3K9Ac (Regha et al., 2007) 
Methylated allele: H3K9me3, H4K20me3; Unmethylated allele: H3K4me2, H3ac 
(Delaval et al., 2007) 
H3K4me3 + H3K9me3 in ES cells (Mikkelsen et al., 2007) 
Table 2. Specific genomic regions enriched by characteristic histone modifications are 
listed. +; Histone modifications on the same locus on two parental chromosomes. 
 
Histone modifications are dynamic and set or reversed (except methylation of 
arginine for which demethylating enzyme is still not found) by a number of histone 
modifying enzymes (reviewed in (Kouzarides, 2007)). The role of histone 
modifications in DNA condensation and possibly change in higher order chromatin 
structure is expected and partially shown for acetylation and phosphorylation via their 
influence on charge changes. For example, Shogren-Knaak at al. (Shogren-Knaak et 
al., 2006) showed that H4-K16Ac controls chromatin structure. H4 that was 
homogenously acetylated on K16 by a native chemical ligation strategy after 
incorporation into nucleosomal arrays impedes formation of one of the levels of 
chromatin compaction (30-nanometar like fibers). Histone modifications are 
regulating transcription, repair and replication by recruiting number of other proteins 
on histones. For example Guccione at al. (Guccione et al., 2006) found that tethering 
of Myc transcription factor in human is restricted to a stretch of chromatin carrying H3 
K4/K79 and H3Ac. This is just one of the examples of proteins recruited by histone 
modifications functioning in the activation or repression of transcription (reviewed in 
(Li et al., 2007)). The question about inheritance of histone modifications remains to 
be answered. One of the models how the memory of specific chromatin states could 
be transmitted involves RNA as a molecule “carrying” the memory while histone 
modifications could be the executers of the epigenetic phenomena (Kouzarides, 
2007). This model is in agreement with already discussed “Epigenator-Initiator-
Maintainer” model of epigenetic pathway.  
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1. 1. 5. Epigenetic roles of ncRNAs 
The central dogma of molecular biology (Francis Crick, 1958, 1970) has been to see 
RNA as an intermediary molecule into which genomic information from DNA is 
transcribed and which is further translated into proteins. This dogma is based on the 
assumption that one gene is coding for one protein has been challenged by the 
finding that most of the genome is transcribed into non-protein coding RNAs, adding 
a new layer of complexity (Birney et al., 2007) (Figure 4). 
 
                                                  
Figure 4. New layer of complexity has been added to Cricks’ central dogma of 
molecular biology. Black; Original figure representing interconnections between DNA, RNA 
and protein, Orange; Solid arrow shows transcription of ncRNA from DNA, curved arrows 
represent impact of ncRNAs on DNA, RNA and proteins through different functions of 
ncRNAs. Modified from Crick (Crick, 1970). 
 
Non-protein coding RNAs (ncRNAs) are not translated into proteins but they are 
functional RNAs. ncRNAs could be grouped depending on their length (small<200bp 
and long or macro ncRNAs>200bp), location (nuclear enriched and cytoplasmic 
RNAs), orientation to protein coding genes (sense or antisense) and function (RNAs 
functioning in cis or in trans; housekeeping RNAs and regulatory RNAs). Already in 
1961, Jacob and Monod proposed potential interaction of sequence-specific ncRNAs 
with promoters, which could regulate genes (Jacob and Monod, 1961).  
 
Today it has been shown that a number of long/macro regulatory ncRNAs are gene 
regulators implicated in wide range of complex epigenetic phenomena such as X-
inactivation and genomic imprinting and that they are involved in development. Xist 
(X-Inactive-Specific-Transcript) ncRNA mediates whole chromosome transcriptional 
silencing during the dose compensation process in mammals. Dosage compensation 
involves inactivation of n-1 X chromosome in females, where n is the number of X 
chromosomes. Upregulation and coating of X chromosome by Xist ncRNA are the 
first signs of X-chromosome inactivation (XIC). After the coating numerous changes 
in chromatin modifications and enrichment in histone variant macroH2A are 
observed. Observed chromatin modifications on the inactive X chromosome include: 
loss of “active” modifications such as H3K9Ac and H3K4me3, H4 hypoacetylation 
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and H3K27 hypermethylation, H3K9 hypermethylation, H4K20 monomethylation as 
well as H2A K119 monoubiquitylation. The modifications lead to establishment of 
silent chromatin, which keeps X chromosome inactivated throughout the cell cycle 
(Prasanth and Spector, 2007). Xist deletion and transgene analyses showed that Xist 
ncRNA is essential for X-inactivation (Penny et al., 1996; Wutz and Jaenisch, 2000). 
Beside Xist ncRNA, Tsix, Xite (X-inactivation Intergenic Transcription Elements) and 
Jpx/Enox ncRNAs are involved in mouse dosage compensation. In mice Tsix and 
Xite together with part of the Xist 3’ region are regulating Xist ncRNA expression 
(Heard and Disteche, 2006). The exact mechanism of these RNAs involvement in X-
chromosome dosage compensation remains to be understood.  
 
The epigenetic roles of numerous macro ncRNAs involved in genomic imprinting 
show that imprinting is a valuable model in ncRNA research. An example of a long, 
non-imprinted RNA that has an epigenetic role and regulates development by 
transcriptional repression is the HOTAIR ncRNA. Human HOX genes are organized 
in 4 clusters (HOXA-D) localized on different chromosomes. HOX proteins are 
transcription factors regulating correct body axis development. Among 231 ncRNAs 
mapped in human HOX clusters in 11 fibroblast cell lines from distinct positions along 
the body axes, HOTAIR ncRNA was found in the HOXC cluster (Rinn et al., 2007). 
Knockdown of HOTAIR showed a loss of transcriptional repression, lost of 
H3K27me3 repressive histone modification and lost of PRC2 (Polycomb Repressor 
Complex 2) in a 40kb region of the HOXD cluster while expression of the HOXC 
cluster was not influenced. These findings by Rinn et al. (2007) and an experiment 
where PRC2 pull-down showed a specific interaction with HOTAIR, are suggesting 
the epigenetic pathway of the HOTAIR ncRNA action in development (Woo and 
Kingston, 2007).  
 
An example of a ncRNA that regulates development by transcription activation is Evf-
2. This 3.8kb long ncRNA is found in mouse to form a stable complex with Dlx-2 
(homeodomain protein important for development of neural system) that stabilizes an 
interaction between the Dlx-2 and Dlx5/6 enhancer leading to activation of 
transcription of target genes (Feng et al., 2006). 
 
Epigenetic roles have also been described for four small regulatory RNAs classes 
(small nucleolar RNAs (snoRNAs), micro RNAs (miRNAs), short interfering RNAs 
(siRNAs) and piwi- interacting RNAs (piRNAs)). SnoRNAs guide 2’-O-ribose 
methylation and pseudouridylation to nucleotides of ribosomal RNAs (rRNAs), 
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transfer RNAs (tRNAs), spliceosomal snRNAs and possiblly mRNAs (Bachellerie et 
al., 2002). SNORD115 (HBII-52) is a snoRNA with a different function: regulating 
alternative splicing of the serotonin receptor 2C (Kishore and Stamm, 2006). 
SnoRNAs can also be processed to small RNAs that can function as miRNAs as for 
example with the ACA45 snoRNA (Ender et al., 2008).  
 
MiRNAs have roles in post-transcriptional gene regulation, reviewed in (Malone and 
Hannon, 2009; Mattick and Makunin, 2005). MiRNAs are 21-25bp in length. They are 
transcribed by RNA Polymerase II (Borchert et al., 2006; Lee et al., 2004) or RNA 
Polymerase III (Borchert et al., 2006) as primary RNA (pri-miRNAs) and processed 
by a complex containing Drosha (RNaseIII) to pre-miRNAs (hairpin structured) and 
further transported to the cytoplasm where Dicer (RNaseIII) generate a short dsRNA 
that is unwound leading to a single stranded mature miRNA. MiRNAs are 
incorporated into miRNPs (micro ribonuclear particles) which in mammals usually 
target complementary or partially complementary 3’UTRs of protein coding genes 
mRNAs and can in most cases suppress translation (imperfect match) or cleave 
target mRNAs (perfect match). Alterations in their activities are associated with 
cancer and numerous diseases.  
 
SiRNAs are 20-25 nucleotides in length and processed similarly to miRNAs. 
Precursors of siRNAs are endogenous or exogenous double-stranded RNAs (e.g. 
viral). Dicer directly cuts these precursors and produces short RNAs that together 
with Argonaute (AGO) proteins form RISC (RNA-induced silencing complex) where 
just one strand of the short RNAs is retained (reviewed in (Mattick and Makunin, 
2005)). Endogenous siRNAs were found in mammals for the first time in 2008 when 
Tam et al. (Tam et al., 2008), as well as Watanabe et al. (Watanabe et al., 2008) 
showed their presence in mouse oocytes. Interestingly, Tam et al., found that 
endogenous siRNAs are processed from double-stranded RNAs formed when 
protein-coding transcripts are hybridized to their homologous pseudogene 
transcripts, or from inverted pseudogene transcripts alone. They showed regulatory 
activity of these siRNAs in repression of mobile genetic elements. Further, Watanabe 
et al., found that numerous 21bp endogenous siRNAs found in mouse oocytes 
correspond to mRNAs or retrotransposons and function in the regulation of gene 
expression. Synthetic siRNAs are used as an important tool in removal of targeted 
mRNAs and have potential to be used as therapeutic agents.  
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PiRNAs were discovered in 2006 (Aravin et al., 2006; Girard et al., 2006; Grivna et 
al., 2006; Watanabe et al., 2006). These small ncRNAs are associated with germline 
specific Piwi proteins (Argonaute protein family). Two classes of Piwi proteins (MIWI 
and MILI) have been found to associate with piRNAs. MIWI associated piRNAs are 
30-31 bp long while MILI associated are 26-28bp in length (reviewed in (Thomson 
and Lin, 2009)). The epigenetic roles of these small RNAs are still unclear. Xu at al. 
(2008) showed the potential role of piRNAs in repression of transposons since 
deletion of piRNA cluster in mice leads to increased transposon activity (Xu et al., 
2008). Evidence that piRNAs are involved in directing de novo DNA methylation by 
an as yet unknown mechanism are reviewed by Aravin and Bourc’his (Aravin and 
Bourc'his, 2008).  
 
Current understanding of epigenetic roles of long and small regulatory RNAs has 
been described. Regulatory RNAs are recently recognized as “Epigenetic Initiators” 
whose known role in epigenetic pathways are predicted to be the “tip of the iceberg” 
that remain to be uncovered.  
 
1. 2. Genomic imprinting as a model in ncRNA research 
 
1. 2. 1. Genomic imprinting is an epigenetic phenomenon 
Genomic imprinting is an epigenetic phenomenon that restricts expression of a gene 
to one of two parental chromosomes. While most genes are expressed from both 
parental alleles in diploid cells, imprinted genes show paternal or maternal 
monoallelic expression. Different epigenetic mechanisms involving DNA methylation, 
chromatin modifications and ncRNAs lead to monoallelic expression of imprinted 
genes from just one of two identical DNA copies. The imprinted status of genes is 
clearly a heritable epigenetic phenomenon that is passed through cell divisions.   
 
1. 2. 2. Discovery of genomic imprinting 
The discovery that the genomes of sperm and egg are different originates from the 
mid 1970’s. For example, Linder et al. (Linder et al., 1975) showed that the 
developmental potential of human oocytes depends on the parental genome driving 
that development. While normal ovarian germ cells have both the mothers’ and 
fathers’ set of chromosomes, Linder showed that they can give rise to two kinds of 
tumors: teratomas that are gynogenetic (two mothers’ chromosome sets) and 
hydatidiform mole that are androgenetic (two fathers’ chromosome sets). The 
observation that these two tumors are histopathologically very different: teratomas 
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are consisting of all three germinative layers while hydatiform mole contains only 
trophoblast elements, indicated a difference between the parental genomes. The 
development of nuclear transfer technology used in experiments examining mouse 
parthenogenesis in 1980’ directly showed that both parental genomes are required 
for the embryo to develop (McGrath and Solter, 1984; Surani et al., 1984). After 
removing the male or female pronucleus from one fertilized egg and adding one of 
two parental pronuclei to the same egg three kinds of diploid embryos were obtained: 
wildtype with one maternal and one paternal nucleus, gynogenetic with two maternal 
genomes and androgenetic with two paternal genomes. Both gynogenetic and 
androgenetic embryos were lethal, whereas the wild type survived. This explained 
why there is no parthenogenesis in mammals and posed the question of the 
difference between the parental genomes indicating that this difference could be in 
the parental specific expression of developmentally important genes. The first 
imprinted genes were found in 1991, when Igf2r (Insulin-like growth factor type 2 
receptor) was shown to be maternally expressed (Barlow et al., 1991), Igf2 was 
found to be paternally expressed (Insulin-like growth factor type 2) (DeChiara et al., 
1991; Ferguson-Smith et al., 1991) and H19 (Hepatic library clone 19) non-coding 
RNA was shown to be a maternally expressed imprinted gene in mouse (Bartolomei 
et al., 1991). These findings led to the discoveries of more imprinted genes and to 
the establishment of the genomic imprinting field. 
 
1. 2. 3. Evolution of genomic imprinting 
Genomic imprinting evolved independently at least three times. This phenomenon is 
present in angiospermic plants (e.g. Arabidopsis), in some Insecta (e.g. Sciara, 
Coccidae) and in Therian Mammals (Das et al., 2009). In plants a small subset of 
genes is imprinted in endosperm by a mechanism involving targeted demethylation 
leading to activation of the expressed allele (Scott and Spielman, 2006), while in 
Insecta the whole paternal genome heterochromatization is named genomic 
imprinting (Khosla et al., 2006).  
 
Genomic imprinting in Therian mammals is complex and a number of hypotheses 
have attempted to describe: 1) how the imprinting mechanism arose and 2) the 
evolutionary driving force that could explain why imprinting arose around 125 million 
years ago and is still present in Therian Mammals. “The host defense” hypothesis is 
one of the rare hypotheses addressing directly the mechanism of how imprinting 
arose (Barlow, 1993). This hypothesis raises the possibility that in order to defend the 
host genome retrotransposons and foreign DNA were DNA methylated and 
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repressed, and this system also methylated imprinted genes. The existence of 
retrotransposed imprinted genes e.g. PEG10 could support this theory.  
 
Theories about the potential adaptive advantage gained by imprinting in mammals 
are specially addressed in order to explain the obvious disadvantage resulting from 
the nature of imprinting: monoallelic expression of genes cause functional haploidy, 
thus all mutations of imprinted genes are dominant (imprinted expression leads to 
increased risk of genetic diseases and cancer). The “Parental conflict” hypothesis 
(Moore and Haig, 1991) proposes that paternally expressed imprinted genes 
increase growth leading to the enhancement of fitness of the offspring carrying the 
paternal genome while maternally expressed imprinted genes suppress fetal growth 
maximizing reproductive fitness of mother thus enhancing transmission of maternal 
genome to more offsprings with the potentially different paternal genomes. Imprinting 
has evolved in response to viviparity and polygamy according to this hypothesis.  
 
“Trophoblast defense” or “ovarian time bomb” hypothesis (Varmuza and Mann, 1994; 
Weisstein et al., 2002) propose that imprinting evolved in order to protect oocytes 
and thus female mammals from ovarian teratomas. Imprinted genes “defend” mother 
from potential malignant trophoblast formation that could arose from 
partenogenetically activated oocytes developing into ovarian teratomas. Thus 
selective pressure through evolution would favor females with imprinted genes not 
developing lethal trophoblast disease. Trophoblast is an invading part of the placenta 
that mediates implantation of fetus to the mothers’ uterus. Thus silencing of the 
genes functioning to promote placental development and activation of the genes 
limiting placental development by imprinting is expected to “defend” the mother from 
cancer development.  
 
Further, Kono hypothesized that imprinting may evolve as a defense against 
parthenogenesis to select for sexual reproduction (Kono, 2006). The hypothesis that 
imprinted expression has evolved in order to regulate development (the 
complementation hypothesis) is proposed by Kaneko-Ishino (Kaneko-Ishino et al., 
2006). Imprinting is proposed to evolve on the basis of dosage compensation 
required for duplicated genes by Walter and Paulsen (Walter and Paulsen, 2003). 
Recently, the theory of “coadaptation” links evolution of imprinting with its role in 
regulation of embryonic development and reproductive behavior (Keverne and 
Curley, 2008).  
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As described, theories deciphering the mechanism how imprinting arose and the 
evolution of imprinting are proposed and are more or less supported with novel 
findings in imprinting research. Potentially, imprinting could have evolved by different 
mechanisms at different loci (Renfree et al., 2009), but further analysis of the 
imprinting mechanism in different species and mammalian lineages is needed to fulfill 
our understanding of imprinting.  
 
1. 2. 4. Key features of genomic imprinting  
Genomic imprinting involves a cis-acting mechanism affecting one parental 
chromosome and leading to differences between paternal and maternal alleles. 
Genes affected by genomic imprinting are usually clustered. Imprinted gene clusters 
consists of protein-coding gene mRNAs and often include of macro ncRNAs that 
show reciprocical imprinted expression. Each set of imprinted genes residing in one 
cluster has a common regulator known as imprinting control element (ICE). Imprinted 
gene clusters are of different lengths that are up to 4Mb for the human PWS cluster 
(UCSC genome browser). Some imprinted genes are “orphans” and belong to micro-
imprinted gene clusters (e.g. Nap1l5 (Evans et al., 2001)).  
 
The presence of an imprint control element (ICE) is one of the key features of 
genomic imprinting. ICEs are defined by deletion experiments as DNA elements 
whose epigenetic state controls expression of all imprinted genes in their clusters 
(Koerner and Barlow, 2010). The ICE is DNA methylated on one allele where its 
function is repressed and is unmethylated on another allele where it can function as a 
repressor in three potential ways (Kaneda et al., 2004; Koerner and Barlow, 2010). In 
the mouse Igf2 (insulin growth factor 2) imprinted gene cluster, the unmethylated ICE 
binds the CTCF protein and acts as an insulator since its’ binding blocks influence of 
enhancers on the Igf2 gene leading to the absence of Igf2 expression from the 
chromosome with the unmethylated ICE (Hark et al., 2000). In mouse the Igf2r and 
Kcnq1 imprinted gene regions unmethylated ICEs contain promoters for Airn and 
Kcnq1ot1 macro ncRNAs respectively. These ncRNAs are expressed from 
unmethylated ICE and are repressing protein-coding genes in cis. A third possibility 
for the function of unmethylated ICE is shown in the mouse H13 imprinted gene 
cluster where the unmethylated ICE contains active promoter of the Mcts2 retrogene 
causing expression of truncated H13 transcripts (Wood et al., 2008).  
 
Gametic DMRs (Differentially Methylated Regions) are methylated on only one 
parental allele, are set in parental gametes (mechanism described in 1.1.3.) and 
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have a function as an ICE. After fertilization, genome-wide reprogramming of DNA 
methylation takes place, but gametic imprints are not reprogrammed and are 
maintained on the same parental chromosome in all cells up to the adult stage. Germ 
cells of embryonic gonads are the only cells where gametic imprints are erased at a 
stage before the sex of the embryo is determined. With the development of mature 
gonads parent specific imprints are again established in gametes (Barlow, 2007). 16 
gametic DMRs are found in mice and have been shown to be maternally (13) or 
paternally (3) methylated (Table 3, Table 4, section 1.2.5.). In human 6 gametic 
DMRs have been identified to be maternally (4) or paternally (2) mathylated (Table 3, 
Table 4, section 1.2.5.). The low number of known human gametic DMRs may be 
due to of difficulties in obtaining human oocytes.  
 
Gametic DMRs often contain a series of tandem direct repeats (Hutter et al., 2006; 
Neumann et al., 1995; Paoloni-Giacobino et al., 2007; Sleutels et al., 2002). The role 
of tandem direct repeats has been examined for Snurf/Snrpn, Kcnq1 and Igf2r DMRs 
using transgenic mice. Authors proposed that tandem repeats could have a role in 
the establishment and maintenance of parental specific methylation (Reinhart et al., 
2002; Reinhart et al., 2006).  
 
DMRs show common histone modification signatures named DHMs (Differential 
Histone Modifications). For example our lab showed that the DNA methylated alleles 
of DMRs are enriched in H3K9me3 and H4K20me3, whereas the unmethylated 
alleles have H3K4me3, H3K4me2 and H3K9Ac marks (Regha et al., 2007). Genome-
wide chromatin maps in mouse ES cells showed that overlapping H3K4m3 and 
H3K9me3 are common signatures of an ICE (Mikkelsen et al., 2007) (described in 
Table 2, 1.1.4). 
 
Second class of DMRs are somatic DMRs that are erased during post-fertilization 
reprogramming of DNA methylation marks and are set in somatic cells of post-
implantation embryos. Numerous human DMRs have been found, yet if they are 
somatic or gametic remains to be tested.  
 
One of the key features of genomic imprinting is cis-regulation of imprinted genes 
over long genomic distances leading to their parental specific monoallelic expression. 
Genes showing imprinted expression can be maternally or paternally expressed, 
from the mother or father’s chromosome respectively. Tissue and developmental 
stage specific differences in parent-of-origin specific imprinted expression are 
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proposed to exist due different “readers” of imprints. For example, specific 
transcription factors could influence imprinting expression and lead to expression 
variation of imprinted genes in tissues and in development. Both protein coding 
genes and non-protein coding RNAs can be imprinted and show parental specific 
imprinted expression.  
 
1. 2. 5. Human and mouse imprinted gene regions 
Imprinted gene regions could be defined as genomic regions where at least one gene 
showing imprinted expression has been located, although most regions contain more 
genes (between 2-15) that form an imprinted gene cluster. 26 imprinted gene regions 
exist in mouse according to the Harwell web site 
(http://www.mousebook.org/catalog.php?catalog=imprinting) while 27 imprinted gene 
regions are found in human (Figure 5). Although, the epigenetic initiator responsible 
for silencing has been identified in some clusters, the mechanisms of silencing are 
not so well defined and the borders of many imprinted gene regions are unclear. For 
example, some imprinted genes considered by one research group as parts of a 
separate imprinted regions are considered by other groups using different criteria as 
just border genes of an adjacent region. Thus, 25 to 30 imprinted gene regions in 
both mouse and human could be provisionally defined. 
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Figure 5. 8 out of 27 human imprinted gene regions express a macro ncRNA. Human 
imprinted gene regions are located on 14 out of 22 autosomes. Red filled boxes; locations of 
imprinted gene regions, Bold black letters; human imprinted gene regions named according to 
the gene with “central” position in the cluster, Blue; paternally methylated, Red; maternally 
methylated, Black non-filled boxes; Known macro ncRNAs. 
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1. 2. 5. 1. Six well-studied imprinted gene regions in human and mouse 
Six imprinted gene regions (e.g. mouse Igf2r, Igf2, Kcnq1, Dlk1, Gnas and Pws/As) 
have been well-studied in mouse and human and are used as valuable models for 
macro ncRNA research since each of them contain at least one macro ncRNA 
(Koerner et al., 2009). Table 3 shows a comparison between known gametic 
methylation marks that are imprint control elements (ICEs) in six well-studied 
imprinted gene regions in mouse and human. Gametic DMR locations in these 
regions are conserved, as well as, the pattern of parental specific methylation. 
Gametic DMRs found to be paternally methylated typically lie upstream of ncRNAs 
promoters, while maternally methylated DMRs contain macro ncRNAs promoters.  
 
Imprinted gene region 
(chromosome positon) Gametic DMR (gDMR) 
Mouse Human Mouse Human 
Gnas (chr2) GNAS (chr20) 
GNAS-
DMR(Williamson et al., 
2004) 
 
*EXON1A-DMR(Liu et 
al., 2000) 
 
Pws/As (chr7) PWS/AS (chr15) PWS-IC(Yang et al., 1998) 
Bipartite IC: PWS-
SRO(Sutcliffe et al., 
1994; Zeschnigk et al., 
1997), AS-SRO(Buiting 
et al., 1999) 
Igf2 (chr7) IGF2 (chr11) H19 DMD(Tremblay et al., 1997) 
ICR1(Jinno et al., 
1996) 
Kcnq1 (chr7) KCNQ1 (chr11) KvDMR1(Fitzpatrick et al., 2002) 
ICR2(Beatty et al., 
2006) 
Dlk1 (chr12) DLK1 (chr14) IG-DMR(Lin et al., 2003) 
IG-DMR(Geuns et al., 
2007) 
Igf2r (chr17) IGF2R (chr6) DMR2(Sleutels et al., 2002) 
*CGI-2 (Smrzka et al., 
1995) 
Table 3. Gametic DMRs and parental origin of methylation are conserved between 
mouse and human. Names of the imprinted gene regions and chromosome positions have 
been shown. Gametic DMRs (gDMRs) residing in well-studied imprinted regions, designated 
with the common literature name are presented. Green; paternally methylated, Orange, 
maternally methylated, * DMRs not tested if gametic or somatic but predicted from mouse 
data to be gametic 
 
Our survey of genes showing imprinted expression in mouse and human well-studied 
imprinted gene regions shows global conservation of imprinted expression in these 
regions (Table 4). Each well-studied imprinted gene region contains at least one 
macro ncRNA. Some of these ncRNAs are hosts for small RNAs e.g. miRNAs and 
snoRNAs, which if tested show the same parental imprinted expression as their 
precursor macro RNAs. 
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Imprinted gene region 
(chromosome position) 
Imprinted 
protein coding genes Imprinted macro ncRNAs 
Small ncRNA 
host 
Mouse Human Mouse Human Mouse Human Mouse Human 
Gnas 
(chr2) 
GNAS 
(chr20) 
Nesp(Peters et al., 
1999) 
Gnasxl(Peters et al., 
1999) 
Gnas(Williamson et 
al., 1996) 
XLαS(Hayward et 
al., 1998a) 
NESP55(Hayward 
et al., 1998b) 
GS-α(Hayward et 
al., 2001) 
Nespas(Wroe et 
al., 2000) 
Exon1A 
(Li et al., 2000) 
SANG 
(Hayward and 
Bonthron, 2000) 
EXON1A 
(Liu et al., 2000) 
- hsa-mir-296, hsa-mir-298 
Pws/As 
(chr7) 
PWS/ 
AS 
(chr15) 
Atp10a∗ 
(Kashiwagi et al., 
2003; Kayashima et 
al., 2003a) 
Ube3a(Albrecht et al., 
1997) 
Snrpn(Leff et al., 
1992) 
Snurf(Gray et al., 
1999) 
Ndn(MacDonald and 
Wevrick, 1997; 
Watrin et al., 1997) 
Magel2(Boccaccio et 
al., 1999) 
Mkrn3(Jong et al., 
1999a) 
Peg12 
(Chai et al., 2001; 
Kobayashi et al., 
2002) 
ZNF127(Jong et al., 
1999b) 
NDN(MacDonald 
and Wevrick, 1997) 
MAGEL2(Boccaccio 
et al., 1999) 
SNURF(Gray et al., 
1999) 
SNRPN(Glenn et 
al., 1993) 
UBE3A(Rougeulle 
et al., 1998) 
ATP10A(Meguro et 
al., 2001) 
GABRG3∗ 
(Hogart et al., 2007; 
Meguro et al., 1997) 
GABRG5∗ 
(Hogart et al., 2007; 
Meguro et al., 1997) 
Zfp127as 
(Jong et al., 
1999b) 
AK014392 
(Nikaido et al., 
2003) 
[Lncat 
(Landers et al., 
2004; Le Meur et 
al., 2005) 
Ipw(Wevrick and 
Francke, 1997) 
Ube3a-
as(Chamberlain 
and Brannan, 
2001) 
Pec2(Buettner et 
al., 2005) 
Pec3 
(Buettner et al., 
2005)]*** 
 
ZNF127AS 
(Jong et al., 
1999b) 
[UBE3A-
AS(Rougeulle et 
al., 1998) 
PWCR1 
(de los Santos et 
al., 2000) 
IPW(Wevrick et 
al., 1994) 
PAR1(Sutcliffe et 
al., 1994) 
PAR5(Sutcliffe et 
al., 1994) 
PAR-SN(Ning et 
al., 1996))]*** 
 
Snord6 
(MBII-
13)(Cavaill
e et al., 
2000) 
Snord115(
MBII-
52)(Cavaill
e et al., 
2000) 
Snord116 
(MBII-85) 
 
HBII-85 
(Cavaille et 
al., 2000) 
HBII-52 
(Cavaille et 
al., 2000) 
Igf2 
(chr7) 
IGF2 
(chr11) 
Igf2(DeChiara et al., 
1991) 
Ins(Deltour et al., 
1995; Giddings et al., 
1994) 
 
IGF2(Giannoukakis 
et al., 1993) 
INS(Moore et al., 
2001) 
 
H19(Bartolomei 
et al., 1991) 
91H(Berteaux et 
al., 2008) 
Igf2as(Moore et 
al., 1997) 
H19(Zhang and 
Tycko, 1992) 
91H(Berteaux et 
al., 2008) 
IGF2AS 
(Okutsu et al., 
2000) 
- 
miR-675 
(Cai and 
Cullen, 
2007) 
Kcnq1 
(chr7) 
KCNQ1 
(chr11) 
Th(Schulz et al., 
2006) 
Ascl2(Guillemot et al., 
1995) 
Tspan32(Umlauf et 
al., 2004) 
Cd81(Umlauf et al., 
2004) 
Tssc4(Paulsen et al., 
2000) 
Kcnq1(Gould and 
Pfeifer, 1998; 
Paulsen et al., 1998) 
Cdkn1c(Hatada and 
Mukai, 1995) 
Msuit1(Onyango et 
al., 2000) 
Slc22a18(Dao et al., 
1998) 
Phlda2(Qian et al., 
1997) 
Nap1l4(Engemann et 
al., 2000) 
Tnfrsf23(Clark et al., 
2002) 
Osbpl15(Engemann 
et al., 2000) 
Dhcr7(Schulz et al., 
2006) 
KCNQ1(Lee et al., 
1997) 
KCNQ1DN 
(Xin et al., 2000) 
CDKN1C(Matsuoka 
et al., 1996) 
SLC22A18AS 
(Bajaj et al., 2004) 
SLC22A18 
(Dao et al., 1998) 
PHLDA2(Qian et al., 
1997) 
OSBPL5(Higashimo
to et al., 2002) 
TRPM5(Prawitt et 
al., 2000) 
Kcnq1ot1 
(Lee et al., 1999; 
Smilinich et al., 
1999) 
KCNQ1OT1 
(Smilinich et al., 
1999) 
- - 
Dlk1 
(chr12) 
DLK1 
(chr14) 
Begain(Tierling et al., 
2009) 
Dlk1(Schmidt et al., 
2000) 
Mico1(Labialle et al., 
2008) 
Mico1os(Labialle et 
al., 2008) 
Rtl1(Seitz et al., 
2003) 
Dio3(Tsai et al., 
2002) 
DLK1(Wylie et al., 
2000) 
[Gtl2(Miyoshi et 
al., 2000) 
Rtl1as(Seitz et 
al., 2003) 
Rian(Hatada et 
al., 2001) 
AK050713 
(Hagan et al., 
2009) 
AK053394 
(Hagan et al., 
2009)]*** 
GTL2(Miyoshi et 
al., 2000) 
C/D 
snoRNAs(C
availle et 
al., 2002) 
Mirg 
(Seitz et al., 
2004) 
miRNAs(Se
itz et al., 
2004; Seitz 
et al., 2003) 
has 
mir-
154(William
s et al., 
2007) 
hsa-mir-335 
SNORD 
113, 
SNORD 
114 
Igf2r 
(chr17) 
IGF2R 
(chr6) 
Igf2r(Barlow et al., 
1991) 
Slc22a2(Zwart et al., 
2001) 
Slc22a3(Zwart et al., 
2001) 
IGF2R∗∗(Xu et al., 
1993) 
SLC22A2(Monk et 
al., 2006) 
SLC22A3(Monk et 
al., 2006) 
Airn 
(Lyle et al., 
2000; Wutz et 
al., 1997) 
AIRN(Yotova et 
al., 2008) - - 
Table 4. Each well-studied imprinted gene region expresses at least one macro ncRNA 
in mouse and human. Imprinted expression of both protein coding genes and ncRNAs is 
globally conserved. Blue; paternally expressed genes, Red; maternally expressed genes, 
Black; genes showing imprinted expression in one of the species but not tested in another, ∗; 
Conflicting data, ∗∗; Polymorphic imprinting; [ ]***; Suggested to represent one long macro 
ncRNA. 
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Although most imprinted genes show conserved imprinted expression, the Igf2r 
imprinted gene region is an example that shows differences between human and 
mouse. In mouse, ubiquitous imprinted expression has been found for both Igf2r and 
Airn ncRNA in fetal, extra-embryonic and adult tissues (with the exception of neurons 
and ES cells), while the Slc22a2 and Slc22a3 genes have placental specific 
imprinted expression (Monk et al., 2006; Yamasaki et al., 2005). In human, the 
IGF2R, SLC22A2 and SLC22a3 genes are largely biallelically expressed, but show 
polymorphic imprinted expression in placenta, early fetal tissue, lymphoblastoid cells, 
cultured amniotic cells and Wilms’ tumors (Monk et al., 2006; Oudejans et al., 2001; 
Smrzka et al., 1995; Xu et al., 1993). Interestingly, the human IGF2R intron 2 CpG 
island (CGI-2) is maternally methylated, in the same position as the mouse gDMR 
(gDMR2, Table 3), in all tested fetal and adult tissues (Smrzka et al., 1995). Human 
AIRN ncRNA is expressed from the CGI-2 promoter in Wilms’ tumor cell line and 16-
40% of Wilms’ tumor patients, but has not been tested for imprinted expression 
(Yotova et al., 2008).  
 
The genomic organization of six well-studied human imprinted gene regions is shown 
in Figure 6. Differentially methylated regions (DMRs) are present in each region. 11 
DMRs including 7 maternally methylated and 4 paternally methylated are shown. 5 
are gametic DMRs (including 2 that are the parts of the bipartite IC in the PWS 
imprinted gene region), 2 are somatic, while for 4 it is still not tested if are gametic or 
somatic. Each of 6 well-studied imprinted gene regions has at least one macro 
ncRNA. 5 of these macro ncRNA are paternally expressed, 2 are maternally 
expressed while for AIRN imprinted status is not known.  
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Figure 6. Six well-studied human imprinted gene clusters. Each cluster expresses a 
macro ncRNA. Differentially methylated regions (DMRs) are present in each cluster. Red; 
transcription from mothers’ chromosome, Blue; transcription from fathers’ chromosome, Grey; 
parental origin not tested, Black arrow; transcription direction of protein coding gene, Wavy 
orange line; macro ncRNA expression, Pale orange box; small ncRNA (snoRNAs, miRNAs) 
clusters, Yelow circle; maternally specific methylation, Green circle; paternally specific 
methylation, gDMR; gametic DMR, sDMR; somatic DMR, *DMR; not tested if DMR is gametic 
or somatic 
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1. 2. 5. 2. Less-studied imprinted gene regions in human and mouse 
A survey of the literature for gametic DMRs (Table 5) and imprinted gene expression 
(Table 6A, Table 6B) in less-studied mouse and human imprinted gene regions 
shows that further study of these regions is necessary in order to understand the 
mechanisms of genomic imprinting in these regions.  While most of less-studied 
imprinted regions are conserved between mouse and human, some are not or still 
lack examination to the same extent in both species. In mouse 24 less-studied 
imprinted gene regions, 9 maternally methylated and 1 paternally methylated DMRs 
have been previously found and shown to be gametic, while in 21 human regions 8 
maternally methylated DMRs have been found (1/8 located in GRB10 region has 
been shown as gametic while 7 were not tested).  
 
Imprinted gene region 
(chromosome position) Gametic DMR (gDMR) 
Mouse Human Mouse Human 
Zdbf2 (chr1) ZDBF2 (chr2) DMR 10kb upstream Zdbf2(Kobayashi et al., 2009) - 
Sfmbt2 (chr2) - - - 
Gatm (chr2) - - - 
HM13 (chr2) HM13 (chr20) Mcts2 DMR(Wood et al., 2007b; Wood et al., 2008) - 
Nnat (chr2) NNAT (chr20) Nnat DMR(Kikyo et al., 1997) Nnat DMR not tested for gametic(Evans et al., 2001) 
Mkrn1-ps1 (chr5) - - - 
Calcr-Dlx5 (chr6) CALCR-DLX5 (chr7) 
Exon1 Peg10/SGCE DMR(Ono et al., 
2003) 
Exon1 SGCE DMR not tested for 
gametic(Grabowski et al., 2003) 
Mest (chr6) MEST (chr7) Mest promoter DMR(Lucifero et al., 2002) 
5’ of MEST DMR not tested for 
gametic(Riesewijk et al., 1997) 
Nap1l5 (chr6) NAP1L5 (chr4) Nap1l5 promoter DMR(Smith et al., 2003; Wood et al., 2007b) - 
Zim2 (chr7) ZIM2 (chr19) - - 
Ampd3 (chr7) - - - 
Inpp5f (chr7) INPP5F (chr10) CpG 5’Inpp5f_v2 DMR(Wood et al., 2007b) - 
Rasgrf1 (chr9) - 30kb 5’Rasgrf1(Pearsall et al., 1999) - 
Plagl1 (chr10) PLAGL1 (chr6) Hymai DMR(Arima and Wake, 2006) HYMAI DMR not tested for gametic(Arima et al., 2001) 
Dcn (chr10) - - - 
Grb10 (chr11) GRB10 (chr7) Grb10 DMR(Arnaud et al., 2003) CGI2 DMR(Arnaud et al., 2003) 
Commd1 (chr11) - - - 
Pde4d (chr13) - - - 
Htr2a (chr14) HTR2A (chr13) - - 
Kcnk9 (chr15) KCNK9 (chr8) Peg13 DMR(Ruf et al., 2007) - 
Slc38a4 (chr15) - - - 
Impact (chr18) - - - 
Tbc1d12 (chr19) - - - 
Xist (chrX) - - - 
- TP73 (chr1) - - 
- DIRAS3 (chr1) - 
DMRs CpGI,II,III in DIRAS3 gene not tested 
for gametic(Yu et al., 1999; Yuan et al., 2003) 
- PRIM2 (chr6) - - 
- ZNF215 (chr11) - - 
- WT1 (chr11) - WT1 ARR DMR not tested for gametic(Dallosso et al., 2004) 
- SDHD (chr11) - - 
- ZNF597 (chr16) - - 
- ZNF331 (chr19) - - 
- L3MBTL (chr20) - CPG 3, 4 promoter 2 L3MBTL DMR not tested for gametic(Li et al., 2004) 
Table 5. Methylation status of gametic DMRs in 24 mouse and 21 human less-studied 
imprinted gene regions is mostly conserved. Imprinted gene regions are named according 
to the gene located on the “central” position in the region. Parental methylation status is 
coserved between mouse and human but human typically lacks the test if observed 
methylation is set in gametes due to problems in obtaining human oocytes. 10 gametic DMRs 
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are listed for mouse imprinted gene regions (9 maternally methylated and 1 paternally 
methylated) while one gametic maternally methylated DMR is confirmed in human GRB10 
region and 7 more are found to be maternally expressed. Green; paternally methylated, 
Orange; maternally methylated, -; not tested. 
 
Imprinted gene region 
(chromosome position) 
Imprinted 
protein coding genes 
Imprinted macro 
ncRNAs 
Imprinted expression 
of  
small ncRNAs 
Mouse Human Mouse Human Mouse Human Mouse Human 
Zdbf2 
(chr1) 
ZDBF2 
(chr2) 
Gpr1(Mishima et al., 1990) 
Zdbf2(Kobayashi et al., 2009) 
ZDBF2(Kobayashi et al., 
2009) - - - - 
Sfmbt2 
(chr2) - Sfmbt2(Kuzmin et al., 2008) - - - - - 
Gatm 
(chr2) - Gatm(Sandell et al., 2003) 
No imprinted 
expression(Monk et al., 
2006) 
- - - - 
HM13 
(chr2) 
HM13 
(chr20) 
HM13a, b, c(Wood et al., 2007b; 
Wood et al., 2008) 
HM13d, e(Wood et al., 2008) 
Mcts2(Wood et al., 2007b) 
MCTS2(Wood et al., 
2007b) - - - - 
Nnat 
(chr2) 
NNAT 
(chr20) 
Nnat(Kagitani et al., 1997) 
Blcap_v1a(Schulz et al., 2009) 
Blcap_v2a(Schulz et al., 2009) 
NNAT(Evans et al., 2001) 
BLCAP_V1a,b,c 
(Schulz et al., 2009) 
BLCAP_V2a(Schulz et al., 
2009) 
- - - - 
Mkrn1-
ps1 
(chr5) 
- 
Mkrn1-ps1∗ 
(Gray et al., 2006; Hirotsune et 
al., 2003) 
- - - - - 
Calcr-
Dlx5 
(chr6) 
CALCR-
DLX5 
(chr7) 
Calcr(Hoshiya et al., 2003) 
Tfpi2(Monk et al., 2008) 
Casd1(Babak et al., 2008) 
Sgce(Monk et al., 2008) 
Peg10(Ono et al., 2001) 
Neurabin(Monk et al., 2008; Ono 
et al., 2001) 
Pon3(Ono et al., 2001) 
Pon2(Ono et al., 2001) 
Asb4(Mizuno et al., 2002) 
Dlx5∗(Horike et al., 2005; Schule 
et al., 2007) 
PEG10(Ono et al., 2001) 
GNGT1(Okita et al., 2003) 
CALCR(Okita et al., 2003) 
SGCE(Grabowski et al., 
2003) 
PPP1R9A(Nakabayashi et 
al., 2004) 
PON1(Okita et al., 2003) 
DLX5∗(Okita et al., 2003; 
Schule et al., 2007) 
APS(Okita et al., 2003) 
- - - - 
Mest 
(chr6) 
MEST 
(chr7) 
Mest(Kaneko-Ishino et al., 1995) 
Copg2(Lee et al., 2000) 
Klf14(Parker-Katiraee et al., 
2007) 
MEST(Kobayashi et al., 
1997) 
COPG2*(Blagitko et al., 
1999; Yamasaki et al., 
2000) 
CPA4(Kayashima et al., 
2003b) 
KLF14(Parker-Katiraee et 
al., 2007) 
Copg2as1 
(Lee et al., 
2000) 
Copg2as2 
(Lee et al., 
2000) 
MESTIT
1(Li et 
al., 
2002) 
MIT1 
(Yamasa
ki et al., 
2000) 
Mirn-
335(Royo 
and 
Cavaille, 
2008) 
- 
Nap1l5 
(chr6) 
NAP1L5 
(chr4) 
Nap1l5(Smith et al., 2003; Wood 
et al., 2007b) 
NAP1L5(Wood et al., 
2007b) - - - - 
Zim2 
(chr7) 
ZIM2 
(chr19) 
Zim2(Kim et al., 2004) 
Zim1(Kim et al., 1999) 
Apeg3(Choo et al., 2008) 
Peg3(Kaneko-Ishino et al., 1995) 
Usp29(Kim et al., 2000) 
Zim3(Kim et al., 2001) 
Zfp264(Kim et al., 2001) 
ZIM2(Kim et al., 2004) 
ITUP1(Maegawa et al., 
2004) 
PEG3(Murphy et al., 2001) 
- - - - 
Ampd3 
(chr7) - Ampd3(Schulz et al., 2006) - - - - - 
Inpp5f 
(chr7) 
INPP5F 
(chr10) 
Inpp5f_v2(Choi et al., 2005) 
Inpp5f_v3(Wood et al., 2007a)  
INPP5F_V2(Wood et al., 
2007b) - - - - 
Rasgrf1 
(chr9) - 
Rasgrf1(Plass et al., 1996) 
As4(Nomura et al., 2008) - 
A19(de la 
Puente et 
al., 2002) 
- 
Mir184 
(Nomura et 
al., 2008) 
- 
Plagl1 
(chr10) 
PLAGL1 
(chr6) 
Plagl1(Piras et al., 2000; Smith 
et al., 2002) 
PLAGL1(Kamiya et al., 
2000) 
Hymai(Arim
a and 
Wake, 
2006) 
HYMAI 
(Inoue et 
al., 
2001) 
- - 
Dcn 
(chr10) - Dcn(Mizuno et al., 2002) 
No imprinted 
expression(Monk et al., 
2006) 
- - - - 
Grb10 
(chr11) 
GRB10 
(chr7) 
Ddc_exon1a(Menheniott et al., 
2008) 
Grb10as(Babak et al., 2008) 
Grb10α,δ(Miyoshi et al., 1998) 
Grb10β1,β2 
(Arnaud et al., 2003; Hikichi et 
al., 2003) 
Cobl(Shiura et al., 2009) 
GRB10β,γ1,γ5,γ6,ε,δ(Blagit
ko et al., 2000) 
GRB10γ1,γ2 
(Blagitko et al., 2000; 
McCann et al., 2001) 
- - - - 
Commd1 
(chr11) - 
U2af1-rs1(Hatada et al., 1993; 
Zhang et al., 2006) 
Commd1(Zhang et al., 2006) 
- - - - - 
Pde4d 
(chr13) - Pde4d(Babak et al., 2008) - - - - - 
Htr2a 
(chr14) 
HTR2A 
(chr13) Htr2a(Kato et al., 1998) 
HTR2A∗(Kato et al., 1996; 
Pastinen et al., 2004) - - - - 
Kcnk9 
(chr15) 
KCNK9 
(chr8) 
Kcnk9(Ruf et al., 2007) 
Trappc9(Wang et al., 2008b) KCNK9(Ruf et al., 2007) 
Peg13(Smit
h et al., 
2003) 
- - - 
Slc38a4 
(chr15) - 
Slc38a4(Mizuno et al., 2002; 
Smith et al., 2003) - - - - - 
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Table 6A. Imprinted expression of protein-coding genes and macro ncRNAs is mostly 
conserved between human and mouse in less-studied imprinted gene regions. 9 mouse 
imprinted gene regions express imprinted genes while homologous human regions  are not 
tested or if in two cases tested did not express imprinted genes. Blue; paternally expressed 
genes, Red; maternally expressed genes, -; not tested, ∗; conflicting data. 
 
Imprinted gene region 
(chromosome position) 
Imprinted 
protein coding genes Imprinted macro ncRNAs 
Imprinted expression 
of  
small ncRNAs 
Mouse Human Mouse Human Mouse Human Mouse Human 
Impact 
(chr18) - 
Impact(Hagiwara et 
al., 1997) - - - - - 
Tbc1d12 
(chr19) - 
Tbc1d12(Babak et 
al., 2008) 
Ins1∗(Deltour et al., 
1995; Giddings et 
al., 1994) 
- - - - - 
Xist 
(chrX) - 
Fthl17(Kobayashi 
et al., 2010) 
Xlr3b(Raefski and 
O'Neill, 2005) 
Xlr4b(Raefski and 
O'Neill, 2005) 
Xlr4c(Raefski and 
O'Neill, 2005) 
Rhox5(Kobayashi 
et al., 2006) 
- 
Xist(Kay et al., 
1994) 
Tsix(Lee, 2000) 
No imprinted 
expression(Migeon 
et al., 2002) 
- - 
- TP73 (chr1) - TP73(Kaghad et al., 1997) - - - - 
- DIRAS3 (chr1) - DIRAS3(Yu et al., 1999) - - - - 
- PRIM2 (chr6) - PRIM2(Pant et al., 2006)  - - - 
- ZNF215 (chr11) - ZNF215(Alders et al., 2000) - - - - 
- WT1 (chr11) - 
WT1∗(Mitsuya et 
al., 1997) 
AWT1(Dallosso 
et al., 2004) 
WT1∗(Jinno et 
al., 1994) 
No imprinted 
expression(Dallosso 
et al., 2007) 
WT1-AS(Dallosso 
et al., 2004) - - 
- SDHD (chr11) - SDHD(Badenhop et al., 2001) - - - - 
- ZNF597 (chr16) - ZNF597(Pant et al., 2006) - - - - 
- ZNF331 (chr19) - 
ZNF331(Pant et 
al., 2006) - - - - 
- L3MBTL (chr20) 
No imprinted 
expression(Li et al., 
2005) 
L3MBTL(Li et al., 
2004) - - - - 
Table 6B. Genes from imprinted gene regions (3 mouse and 9 human) show imprinted 
expression in mouse or human. 7 more mouse regions that also show imprinted expression 
in mouse, but not in human (mostly not tested in human) were already shown in Table 6A. For 
two paternally expressed human genes (L3MBTL and WT1-AS) no imprinted expression has 
been found in mouse, while imprinted mouse Xist and Tsix ncRNAs do not show imprinted 
expression in human. Blue; paternally expressed genes, Red; maternally expressed genes, 
Black; genes showing imprinted expression in one of the species, but not tested in another, ∗; 
conflicting data, -; not tested. 
 
A census of mammalian imprinting has been published in 2005 by Morison et al. 
(Morison et al., 2005) when 112 imprinted “functional components” were found (53 
human and 96 in mice with 37 overlapping). They found a number of discordances 
between human and mouse imprinting data. Interestingly a recent review by Frost 
and Moore (Frost and Moore, 2010) examined conservation of mouse genes 
imprinted in placenta and found that up to date most of the genes showing imprinted 
expression in mouse, but not in human are exactly those that are imprinted just in the 
mouse placenta.   
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By literature search I found 126 mouse and 88 human imprinted genes or gene 
variants (Table 4, Table 6A, B). I also observed certain number of discordances, but 
similarly to the conclusion from Morison et al. (Morison et al., 2005), most of them are 
due to lack of data in one of the species or a missing the orthologous gene. ZIM2 is 
an example of the gene that shows different parental expression in human and 
mouse. Interestingly, the basis for this difference has been found: the insertion of 
Zim1 between Peg3 and Zim2 in mouse lead to the different imprinted expression of 
these genes between the species (Kim et al., 2004). 
 
By looking into parental expression of human imprinted genes I observed that a large 
majority of genes that are found to be imprinted in both mouse and human show 
expression from the same parental allele in both species. Thus, human and mouse 
imprinted genes are mostly conserved considering parental expression status, but 
still with some exceptions and the necessity for further investigation in number of 
cases where expression has not been tested in one of the species. Interestingly, a 
number of human and mouse imprinted gene regions express imprinted macro 
ncRNAs. Functions of imprinted protein coding genes and imprinted macro ncRNAs 
will be further described. 
 
1. 2. 6. Imprinted protein coding genes have diverse functions 
The evidence for the functions of imprinted genes is gained from knockouts or rare 
random mutations in mice, while natural deletions and mutations are the basis for 
finding the function of imprinted genes in human. Imprinted protein coding genes 
have diverse functions but they can be grouped into genes that affect growth, those 
with no obvious role in development and those affecting behavior through their role in 
the nervous system (mouse imprinted genes and their functions are listed on the 
Harwell web site 
http://www.har.mrc.ac.uk/research/genomic_imprinting/function.html). Numerous 
imprinted genes have a function in development by acting as a growth regulators 
among which those paternally expressed promote growth and those maternally 
expressed act as growth repressors (e.g. Igf2 and Igf2r respectively) (Barlow, 2007). 
These genes are in agreement with the “parental conflict” theory of evolution of 
genomic imprinting (described in 1.2.3.). The group of by-stander genes (genes with 
no obvious role in development) remain to be understood since they cannot be easily 
explained by any of the theories about evolution of imprinting (introduced in 1.2.3.). A 
number of imprinted genes are expressed in brain and associated with cognitive, 
behavioral and neurological disorders (lists of these genes are available at Cardiff 
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University web site http://www.bgg.cardiff.ac.uk/imprinted_tables/index.html). 
Evolution of genomic imprinting, for some genes that affect maternal care 
(nourishment and protection of a newborn) also could be explained by “parental 
conflict” theory. An example of an imprinted gene associated with a neurological 
disorder is Ub3a, the maternally expressed gene involved in Angelman syndrome 
recently found to be required for experience-dependent synapse plasticity in the 
mouse visual cortex (Sato and Stryker, 2010). 
 
1. 2. 7. Atypical biology of imprinted macro ncRNAs? 
Imprinted macro ncRNAs show parent-of-origin specific expression, are unusually 
large (defined as more than 200bp in length, but typically several hundred thousand 
nucleotides long) and do not have a continuous open reading frame (ORF). In a few 
cases it has been showed that macro ncRNAs have a methyl-7-guanosine cap 
(7mGcap) and that are RNA Polymerase (RNAP) II transcripts with polyA-tail similar 
to RNAP II mRNA transcripts. Atypical features of macro ncRNAs e.g. reduced 
splicing potential, relative unstability and nuclear retention are overviewed for mouse 
macro ncRNAs in a Table 7. In human imprinted macro RNA research, the biology of 
the majority of ncRNA transcripts remains to be tested.  
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Nespas 
Unspliced >3.35 
Spliced 1.4-15.8 
Genomic size: 
>30 
Yes Yes - - - S and U - - 
Exon1A 
Unspliced 
>1.1kb 
Spliced 
>1.4 
Genomic size: 
19  
Yes Yes - - - S and U - - 
Lncat ∼1000 No Yes 
Yes 
(Paoloni-
Giacobino et 
al., 2007) 
- - S - 
C 
(Le Meur et 
al., 2005) 
H19 2.2, Genomic size: 2.5 No - - 
Yes 
(Brannan et 
al., 1990) 
Yes 
(Pachnis et 
al., 1988) 
S (low 
I/E)  - 
N, C 
(Brannan et 
al., 1990) 
Igf2as 4.8, Genomic size: 10.7 Yes - - - - S - - 
Kcnq1ot1 ∼90 Yes Yes 
Yes 
(Paoloni-
Giacobino et 
al., 2007) 
Yes 
(Redrup et 
al., 2009) 
- U 
Moderately 
stable 
(3.4h)(Redr
up et al., 
2009) 
N 
(Redrup et al., 
2009) 
Gtl2 
1.9-7 
Genomic size: 
30.7 
No - 
Yes 
(Dindot et al., 
2009) 
- - U - - 
Airn 108 Yes Yes 
Yes 
(Neumann et 
al., 1995) 
Yes 
(Seidl et al., 
2006) 
Yes 
(Seidl et al., 
2006) 
U 
95% 
Low S 
5% 
Unstable 
(1.6-
2.1h)(Seidl 
et al., 2006) 
N 
(Seidl et al., 
2006) 
Table 7. Macro ncRNAs may have atypical biology. Mouse macro ncRNAs from six well-
studied clusters are overwieved. -; Not tested, S; spliced, U; unspliced, I/E; intron/exon ratio, 
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C; cytoplasmic localization, N; nuclear localization. Length and splicing of macro ncRNAs 
were reviewed in (Koerner et al., 2009). 
 
The largest gene in the human genome, DYSTROPHIN has a genomic size of 
2.22Mb, but only 14.069kb is transcribed as a mRNA. The reason for this difference 
is the very high intronic content of most messenger RNAs (mRNAs), leading to the 
high intron/exon ratio of these transcripts. In comparison, macro ncRNAs are mostly 
unspliced or with a low intronic content that leads to the unusual length of their 
mature transcripts. For example, mouse Airn ncRNA is 108kb long while Lncat could 
be the longest mature transcript known to date at around 1000kb in length. Since 
their mature transcripts are covering large genomic regions macro ncRNAs are rich 
in transposons that are normally depleted from mature mRNAs (Latos and Barlow, 
2009). Unspliced forms of mouse Airn and Xist imprinted macro ncRNAs are found to 
be relatively unstable. Seidl et al. (Seidl et al., 2006) for example used Actinomycin D 
in order to determine the stability of mouse Airn ncRNA and Igf2r mRNA and found 
that unspliced Airn had a 2.1h half-life while spliced Airn had a 15-17h half-life and 
Igf2r mRNA 14.3h half-life. Furthermore, some of these ncRNA transcripts (especially 
those found to be unspliced) are nuclear localized since they escape nuclear export 
by still unclear mechanism (Redrup et al., 2009; Seidl et al., 2006). Human 
KCNQ1OT1 is similarly to mouse Kcnq1ot1 found to be unspliced and nuclear 
localized transcript (Murakami et al., 2007).  
 
Interestingly, mouse Airn and Kcnq1ot1 imprinted macro ncRNAs that are long; 
transposon rich, unspliced and nuclear localized transcripts have a function in gene 
regulation. The roles of macro ncRNAs will be the focus of the next section. 
 
1. 2. 8. Imprinted macro ncRNAs are transcriptional regulators 
Studies of imprinted macro ncRNAs function have been performed on mouse 
embryonal stem (mES) cells and knockout mice models. Three types of experiments 
involving deletions of ICEs, replacements of ncRNAs promoters and deletions or 
truncations of ncRNA genes have been done for a restricted number of imprinted 
macro ncRNAs. Those experiments showed clearly in cis silencing of protein coding 
genes by two tested imprinted macro ncRNAs (Airn and Kcnq1ot1) and in one case 
(H19), in trans regulation of at least 16 co-expressed imprinted genes belonging to a 
recently defined “imprinted gene network” (Gabory et al., 2009; Mancini-Dinardo et 
al., 2006; Sleutels et al., 2002).  
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Lost of macro ncRNA expression and de-repression of imprinted protein coding 
genes in their clusters are found after deletions of the unmethylated ICE containing 
the promoters of Airn, Kcnq1ot1 and Nespas ncRNAs (Fitzpatrick et al., 2002; Shin et 
al., 2008; Williamson et al., 2006; Wutz et al., 1997). For example, a 3.7kb deletion of 
the unmethylated ICE expressing Airn ncRNA led to loss of imprinted expression of 
Igf2, Slc22a2 and Slc22a3 genes (Wutz et al., 2001; Zwart et al., 2001). These 
experiments show the ICE is important, but they do not distinguish between the role 
of the ICE as a ncRNA promoter (e.g. KvDMR1 for Kcnq1ot1 ncRNA) or regulator 
(e.g. IG-DMR for GTL2 ncRNA) and other possible functions of the ICE.  
 
The second group of experiments involving promoter replacements showed that high 
ncRNA expression is necessary for silencing. For example, when the Airn promoter 
was replaced with a strong PGK promoter, these cells gained Igf2r promoter DNA 
methylation in differentiated ES cells and silenced Igf2r in cis, while cells where the 
Airn promoter was replaced with a weak TET promoter resulting in low Airn 
expression failed to establish Igf2r methylation and silence Igf2r (Stricker et al., 
2008). These experiments showed that the Airn promoter itself has no role in 
silencing, while the expression level of Airn macro ncRNA is a key factor in silencing.  
 
Truncations are the third group of experiments that further examined the function of 
ncRNAs in silencing. Airn ncRNA has been truncated from 108kb to 3kb length by 
inserting 1.2kb long polyadenylation cassette without changing the ICE. 3kb Airn 
remained paternally expressed and the promoter maternally methylated, while loss of 
imprinted expression was observed again for all three genes in the Igf2r cluster 
(Sleutels et al., 2002). Similarly, Kcnq1ot1 ncRNA truncated on the paternal 
chromosome from about 90kb to 1.5kb led to a derepression of the seven genes 
(located over 775kb of DNA sequence) from the Kcnq1 region in ES cells (Mancini-
Dinardo et al., 2006). These kinds of experiments showed that the initiation of 
ncRNAs transcription is not critical for silencing, while transcriptional elongation or 
the transcript itself are the critical factors for silencing in cis. 
 
Interestingly, deletion of H19 ncRNA gene in the Igf2 locus showed that this macro 
ncRNA does not have a role in imprinted gene regulation in cis in liver, while it 
showed small effect in skeletal muscle (Schmidt et al., 1999). Instead this locus is an 
example of the insulator model of cis-acting silencing in imprinted clusters. Deletion 
of the paternally methylated DMR 2kb upstream from H19 led to loss of imprinted 
expression of both H19 and Igf2 (Thorvaldsen et al., 1998). This experiment showed 
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that this gametic DMR is the ICE, which has been further shown to have insulator 
function. The unmethylated ICE located on the maternal chromosome binds CTCF 
and enhancers located downstream of H19 activate expression of this ncRNA, while 
their interaction with Igf2 and Ins is blocked. In contrast, methylation of ICE on the 
paternal chromosome does not allow binding of CTCF allowing the enhancers 
activate Igf2 and Ins expression (Bell and Felsenfeld, 2000; Hark et al., 2000).  
 
Models of cis-mediated ncRNA imprinted silencing are the Igf2r and Kcnq1 clusters 
where truncations of macro ncRNAs led to loss of imprinted expression of protein 
coding genes in the cluster. The exact mechanism how cis-mediated ncRNA 
silencing takes place is still under debate and number of hypothesis that are less or 
more supported by current evidence are present in the literature (reviewed in (Pauler 
et al., 2007)). Two main types of hypotheses are that the ncRNA product or ncRNA 
transcription per se, leads to cis-imprinted silencing. Recent evidence provide 
support for the ncRNA itself recruiting Polycomb group (PcG) and G9a (functions as 
H3K9me2 histone methyltransferase) proteins and targeting them to silence 
imprinted genes in placenta. For example, interaction of G9a with Kcnq1ot1 and Airn 
macro ncRNAs has been found and in the case of Airn it has been shown that this 
macro ncRNA targets G9a to chromatin of Slc22a3 promoter in placenta suggesting 
this may epigenetically silence transcription of the genes that show imprinted 
expression only in placenta (genes like Igf2r that shows ubiquitous imprinted 
expression were not affected) (Nagano et al., 2008; Pandey et al., 2008). Further 
careful examinations of all epigenetic players in imprinting gene regions will be 
necessary for further understanding of the mechanism how macro ncRNAs silence 
imprinted genes.  
 
Insulator model and RNA-mediated silencing model showed that macro ncRNAs 
present in imprinted regions could have role in silencing in cis (macro ncRNAs like 
Airn, Kcnq1ot1) or do not have this role (macro ncRNAs like H19). Interestingly, a 
role for H19 regulation of imprinted gene network in trans has been found in mice. 
After deletion of H19 macro ncRNA in two knock out models, upregulation of five 
imprinted genes located on different chromosomes was shown (Gabory et al., 2009). 
The role of macro ncRNAs in regulation of imprinting are clear, but the exact 
mechanisms of ncRNA mediated epigenetic regulation remain to be fully understood. 
Important functions of imprinted protein coding genes and imprinted macro ncRNAs 
imply that if disrupted they may be involved in disease and next section will focus on 
this subject. 
 
Irena Vlatkovic PhD Thesis   38 
1. 2. 9. Human genomic imprinting and disease 
Disruption of genomic imprinting by diverse genetic and epigenetic causes leads to 
human disease. Uniparental disomies (UPDs), deletions, translocations and point 
mutations are genetic causes affecting imprinted genes or ICEs in diverse imprinted 
gene clusters found to be involved in imprinting disorder syndromes. Epigenetic 
causes leading to disease are found to involve changes in DNA methylation. 
Interestingly, genetic and epigenetic causes leading to disease can be combined, 
such as genetic mutations in MeCP2 (methyl CpG binding protein 2) gene, that lead 
to a failure to read the DNA methylation imprint and cause changes in histone 
modifications in Rett syndrome (reviewed in (Arnaud and Feil, 2005)). 
 
Involvement of genomic imprinting in about ten human syndromes and cancer is well 
documented (e.g. Beckwith Wiedmann, Prader-Willi (PWS), Angelman, Silver-
Russel, Transient Neonatal Diabetes Mellitus (TNDM), McCune-Albright syndrome 
(MAS), Albrights hereditary osteodystrophy (AHO), pseudohypothyroidism type 1a 
and 1b (PHP1a and PHP1b), reviewed in (Murrell, 2006; Robertson, 2005)). 
Numerous complex genetic diseases e.g. autism, diabetes, Alzheimer disease and 
schizophrenia are showing parent-of-origin effects by linkage studies (reviewed in 
(Das et al., 2009)). The potential role of imprinting in these kinds of genetic disorders 
remains to be elucidated. There is a controversy in the field about the association 
between diseases caused by perturbations in imprinting and assisted reproductive 
technologies (AST). A number of papers showed that there is an increased risk of 
different imprinting diseases in babies born after AST (reviewed in (Laprise, 2009)), 
however other studies, like Danish large study involving around 450,000 babies born 
naturally or by AST, found no risk (Lidegaard et al., 2005). 
 
1. 2. 9. 1. Selected human disorders of genomic imprinting 
Human syndromes involving genomic imprinting could be grouped into three main 
types: those that affect growth and development, neurological and 
hormonal/metabolic disorders (Arnaud and Feil, 2005). Here I describe three well-
studied imprinted clusters (PWS, IGF2 and KCNQ1) where disturbances are 
documented to cause Prader-Willi (PWS), Angelman (AS) and Beckwith-Wiedemann 
(BWS) syndrom. 
 
Prader-Willi (PWS) is a neuro-developmental disorder with an incidence of about one 
in 10,000-20,000 individuals (Butler, 1990) (reviewed in (Horsthemke and Wagstaff, 
2008)). The clinical presentation includes infantile hypotonia, childhood obesity, small 
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hands and feet, hypogonadism, behavior problems and mental retardation. Genetic 
defects like deletion of 15q11-q13 on the paternal chromosome (70% cases) and 
maternal UPD of chromosome 15 (29% cases) are involved in PWS. An imprinting 
defect involving DNA methylation change on the ICE in the PWS imprinted cluster is 
found in ∼1% of PWS patients. Interestingly, there is an increased risk for myeloid 
leukemia in PWS patients (Davies et al., 2003).  
 
Angelman (AS) syndrome is a neurological disorder that also involves the 15q11-q13 
chromosome region including the PWS imprinted cluster, and occurs with the same 
frequency as PWS (reviewed in (Horsthemke and Wagstaff, 2008; Van Buggenhout 
and Fryns, 2009). This disorder is characterized by mental retardation, microcephaly, 
ataxia, behavioral problems including hyperactivity, a happy personality, and sleeping 
problems. Approximately 60-75% of AS patients show maternal deletion or re-
arrangement on 15q11-q13; 2-5% show paternal UPD, while around 10% shows 
mutation in the UBE3A imprinted gene. An imprinting centre (IC) defect is found in 3-
5% of AS where both alleles show unmethylated SNRPN, NDN and MKRN3 
imprinted genes promoter regions (Horsthemke and Wagstaff, 2008).  
 
Beckwith-Wiedmann (BWS) is a growth disorder with an incidence of one in 13,700 
(Weksberg et al., 2010). Major clinical findings of BWS involve e.g. macroglossia, 
visceromegaly, renal abnormalities and abdominal wall defects. The molecular basis 
of 75-80% of BWS involves changes to the 11p15.5 chromosome region including 
IGF2 and KCNQ1 imprinted clusters. Uniparental disomies, parent-of-origin specific 
duplications, translocations/inversions, microdeletions and mutations in the CDKN1C 
imprinted gene are genetic alterations found in BWS patients (Weksberg et al., 
2010). Epigenetic alterations involve the loss of methylation on ICR2, that involves 
promoter of KCNQ1OT1 ncRNA (Table 3, Figure 6, section 1.2.5) in 50% of BWS 
cases and gain of methylation on ICR1 in 2-7% of cases, while loss of ICR2 
methylation happens in 95% of BWS patients born following assisted reproduction. 
Interestingly, BWS patients have 7.5-9% overall risk for developing embryonic tumors 
within 5-8 years of age (Murrell, 2006). 
 
Imprinted non-protein coding RNAs, linked with human syndromes involving 
imprinting, are overviewed in Table 8. Different molecular mechanisms might disturb 
macro ncRNAs in disease, for example there are some cases of BWS where a 
microdeletion of the KCNQ1OT1 ncRNA gene is found (Niemitz et al., 2004) while in 
other cases KCNQ1OT1 shows biallelic expression (Lee et al., 1999). 
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Imprinted macro ncRNA Imprinting disorder Reference 
H19 Beckwith-Wiedemann Syndrome (Sparago et al., 2004) 
KCNQ1OT1 Beckwith-Wiedemann Syndrome (Niemitz et al., 2004) 
MESTIT1 Russell-Silver syndrome (Nakabayashi et al., 2002) 
MIT1 Russell-Silver syndrome (Yamasaki et al., 2000) 
UBE3A-AS Angelman syndrome (Chamberlain and Brannan, 2001) 
IPW Prader-Willi syndrome (Wevrick et al., 1994) 
Table 8. Imprinted macro ncRNAs are involved in human imprinting disorders.  
 
1. 2. 9. 2. Human genomic imprinting and cancer 
Loss of imprinted expression (LOI), based on the changes in parent-of-origin specific 
DNA methylation leading to gain of biallelic expression, is common in cancer. 
Demethylated mouse ES cells and chimeric mice derived from these ES cells 
showed that LOI may lead to widespread tumorigenesis (Holm et al., 2005). In 
humans, complete hydatiform moles that are mostly androgenetic (two fathers’ 
chromosome sets) and partial moles that are triploid (usually two paternal and one 
maternal chromosome sets) have predominant paternal imprints and show the 
potential to develop into malignant choriocarcinomas. Gynogenotes, on the other 
hand (two mothers’ chromosome sets) form benign ovarian teratomas (reviewed in 
(Murrell, 2006; Paoloni-Giacobino, 2007)). Interestingly, some imprinting disorders 
predispose suffers to cancers, e.g. BWS patients are most commonly predisposed to 
Wilms’ tumor and hepatoblastoma.  
 
LOI of several studied genes occurs in high frequency in spontaneous tumors that 
commonly include the activation of a normally silent growth-promoting gene or 
silencing of a normally active growth-inhibitory gene. The most common gene 
exhibiting LOI is the IGF2 gene coding for growth a factor, that has been found in 
100% of chronic myeloid leukemia, 66% of colorectal cancer and 70% of Wilms’ 
tumors (reviewed in (Jelinic and Shaw, 2007)). It has been shown that LOI of IGF2 
occurs in the nephrogenic embryonic cells (potentially stem cells) in Wilms’ tumors 
and that LOI is an early event in cancer progression (Yuan et al., 2005). Interestingly, 
LOI also shows an increased occurrence in normal tissue surrounding the Wilms’ 
tumor and colorectal cancers (Kaneda and Feinberg, 2005; Nakagawa et al., 2001). 
These studies support the epigenetic origin of cancer hypothesis according to which 
epigenetic disruption of progenitor cells is the first step in the cancer progression 
(Feinberg et al., 2006). The question if LOI has the causal role in cancer progression 
is still open, but it is clear that understanding how disruptions of genomic imprinting 
occur will have a further impact on cancer research. Except for the IGF2 gene, LOI of 
the human protein coding genes has been suggested for PLAGL1 in ovarian cancer 
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(Abdollahi et al., 2003; Kamikihara et al., 2005) and MEST in lung, colon and breast 
cancers (Kohda et al., 2001; Nakanishi et al., 2004; Pedersen et al., 2002; Pedersen 
et al., 1999). 
 
Certain imprinted macro ncRNAs that show altered expression in cancer suggest a 
link between aberrant genomic imprinting and cancer. For example, KCNQ1OT1 
ncRNA shows LOI in 40% of colorectal cancer patients (Tanaka et al., 2001) while 
WT1-AS ncRNA disply biallelic expression in Wilms’ tumors, but monoallelic 
expression in normal kidney also suggesting LOI (Malik et al., 2000). Furthermore, 
overexpression of the imprinted IGF2AS macro ncRNA is found in Wilms’ tumors 
(Okutsu et al., 2000), while the imprinted H19 macro ncRNA is upregulated in 
carcinogenesis and found to be an oncogene in hepatocellular and bladder 
carcinoma (Matouk et al., 2007). 
 
1. 3. Human transcriptome research and ncRNAs 
 
1. 3. 1. New high-throughput technologies and surprises from transcriptomics 
The human transcriptome (complete set of transcripts of cell under a specific 
physiological condition) is much more complex than estimated ten years ago. The 
encyclopedia of DNA Elements (ENCODE) pilot project examined 1% of human 
genome by three high-throughput approaches: tilling arrays hybridizations, tag 
sequencing of cap-selected RNAs (CAGE) and integrated annotation of cDNAs and 
ESTs. ENCODE showed that less than 2% of the genome codes for proteins but 
more than 90% is transcribed (Birney et al., 2007). The first surprise of human 
transcriptomics data was the unexpectedly low number of protein coding genes 
(previously estimated to be 30-70,000 (Harrison et al., 2002) and by this research to 
be 20,000-25,000) and the high overall transcription with more than 88% of genome 
transcribed into unannotated transcripts named by ENCODE as ‘transcripts of 
unknown function’ (TUF), today recognized as putative ncRNAs with a possible 
regulatory function (Birney et al., 2007).  
 
Large intervening non-coding RNAs (lincRNAs) have been recently identified 
genome-wide using a combination of chromatin maps (overlapping H3K4me3 and 
H3K36me3 domains) and a tiling array approach. In mouse ~1600 lincRNAs have 
been mapped across 4 cell types with more than 95% of them beeing evolutionarily 
conserved (Guttman et al., 2009), while in human the same group found ~3300 
highly conserved lincRNAs across 6 cell types (Khalil et al., 2009). 
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By using next generation mRNA-seq by Illumina technology 66% of polyadenylated 
human transcriptome has been mapped to annotated genes and 34% to unannotated 
regions, where these unannotated regions again have the potential of representing 
regulatory ncRNAs (Sultan et al., 2008). The second surprise of the transcriptomics 
data came with the discovered complexity of both the coding and non-coding portion 
of the transcriptome. Even less abundant than thought, the protein-coding 
transcriptome is highly diverse through alternative splicing, alternative initiation of 
transcription and alternative polyadenylation. For example, by combining mRNA-Seq 
and EST sequence data it has been estimated that ∼95% of multiexon genes in 
human undergo alternative splicing (Pan et al., 2008) and two or more alternative 
promoters are used by ∼58% of mouse protein coding transcripts (Carninci et al., 
2006).  
 
Furthermore, complexity is found in the abundance of overlapping transcripts where it 
has been estimated for the mouse that an average 7.6 transcripts are overlapping 
from the same strand and could be grouped into one transcription unit (Carninci et 
al., 2005), while overlapping antisense transcription has been found in mouse for 
72% of all transcriptional units (Katayama et al., 2005). Overlapping transcription is a 
feature of both coding and non-coding regions and supports a new model of genomic 
organization in higher Eukaryotes as discussed by Kapranov et al. (2007). They 
suggest the old ‘collinear’ model based on Jacob and Monod description of lac 
operon in Bacteria (Jacob and Monod, 1961) needs to be replaced by an ‘interleaved’ 
model where: “multiple functional elements can overlap in the same genomic space” 
(Kapranov et al., 2007b). Underestimated complexity has been found also in the non-
protein coding transcriptome (Kapranov et al., 2007a). This complexity is not 
completely understood or defined and challenges in defining this portion of 
transcriptome will be further described.  
 
1. 3. 2. Challenges in defining the non-protein coding transcriptome 
Next generation RNA Sequencing, tiling arrays and full-length cDNA sequencing 
projects together with bioinformatics has shown that the greatest portion of the 
mammalian genome is non-protein coding. When the majority of the transcription 
was revealed to map outside of annotated regions the first question was if all new 
transcriptional units are novel protein coding genes or if they are non-coding. 
Transcripts that did not have open reading frame (ORF)>300bp have been classified 
as non-coding. For example, in one of the first large studies of full-length cDNAs in 
the mouse genome it was found that 35% of 33,400 of clustered ‘transcriptional units’ 
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were new non-coding transcripts on the basis of the ORF criteria (Okazaki et al., 
2002), while even ∼70% of 7500 full-length human cDNA sequences were shown to 
be non-coding by another group (Ota et al., 2004).  
 
The ORF criterion has been useful but there could still be problems with this 
approach. For example, the SRA gene was first characterized as a ncRNA on the 
basis of ORF criteria, while later it was found that this transcript has multiple isoforms 
including some protein coding. Today we know that SRA has in the same RNA both 
regulatory and the protein coding functions (Chooniedass-Kothari et al., 2004). The 
second possible weakness of the ORF definition of ncRNA is based on the finding 
that in Drosophila transcripts with an ORF of 33bp could be translated, so it is not 
clear if 300bp is a valid number for the cut off of the ORF length for all cases. A third 
potential obstacle with the ORF criteria is possibility that ORF>300bp present in a 
transcript could be spurious (ORF that occur just by chance), something that could 
only be examined further by mutational analysis. Evolution favors synonymous over 
non-synonymous mutations in protein-coding genes and on that basis true ORF 
(protein coding gene) can be distinguished from spurious (non-coding RNA) (Lin et 
al., 2007).  
 
Conservation is a second often used criteria for ncRNA mapping from any kind of the 
transcription data. NcRNAs are generally not conserved as highly as protein coding 
genes, although ncRNAs often have shorter stretches of sequence conserved, while 
whole ORF need to be conserved in protein coding genes (reviewed in (Mercer et al., 
2009)). One of the explanations for these different conservation patterns is the 
finding that ncRNAs evolution is less restricted than for protein coding genes (Pang 
et al., 2006). The conservation approach in defining ncRNAs can be based on two 
measurements: reading frame conservation (RFC) and codon substitution frequency 
(CSF) (Clamp et al., 2007). RFC shows what is the percentage of nucleotides of an 
open reading frame that is conserved among species, while CSF score shows 
different patterns in nucleotide substitutions between protein coding genes and non-
protein coding genes. For example, mouse linc (long intervening non-coding) RNAs 
have CSF<0 while known protein coding genes are showing CSF>0 scores (Guttman 
et al., 2009).  
 
Guttman et al. (2009) developed a method that combines the rate of mutations with 
the level of constraint, where the calculated Pi LOD (logarithm of the odds) score 
represents the comparison of sequence evolution to neutrally evolving sequence. By 
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using this method they found that lincRNA sequence conservation score is in the 
middle between lowly conserved introns and highly conserved protein-coding genes 
for both mouse (Guttman et al., 2009) and human (Khalil et al., 2009) lincRNAs.  
 
The PhastCons score from the UCSC annotation is another measure of the 
sequence conservation where number of phastCons elements is counted across 
each ncRNA candidate region and compared with random regions scores. 
PhastCons scores>0.8 were used in a computational pipeline where non-coding 
RNAs were mapped from human low abundance expressed sequence tags (EST) 
(Xue and Li, 2008).  
 
One group used secondary structure prediction criteria in combination with 
conservation to identify small ncRNAs (Weile et al., 2007). They used the RNAz 
program to filter out conserved secondary structured RNAs from multispecies 
conserved sequences and further they combined these data with their tiling array 
expression data from human neuroblastoma cell line. By this approach novel non-
coding, structured and conserved RNA genes have been found, but what needs to be 
considered is that this kind of approach is optimized for detecting small ncRNAs (e.g. 
miRNAs and snoRNAs), while previous “ORF” and conservation approaches have 
been used also for macro ncRNA prediction. The ideal approach to computationally 
define a portion of the transcriptome as non-coding is still not available since all 
mentioned approaches are predictions with possible exceptions and need further 
experimental validation. Still, these approaches are highly valuable since they have 
increased our understanding of the transcriptome. 
 
Wide-spread transcription outside of annotated regions has been named pervasive 
transcription, and if this transcription is functional (reviewed in (Mercer et al., 2009)) 
or represents transcriptional ‘noise’ (Ebisuya et al., 2008; Struhl, 2007) has been the 
focus of debates in the field. Today, research of many groups is showing supporting 
evidence towards functionality of the biggest part of ncRNA transcriptome. 
Developmental regulation, specific localization in the cell, evolutionary selection and 
the association with disease of many ncRNAs are supporting a functional role 
(Wilusz et al., 2009). Roles of the non-coding portion of the genome in disease will 
be further described. 
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1. 3. 3. Non-protein coding RNAs and disease 
Non-protein coding RNAs have numerous regulatory roles in the cell and have been 
linked with diseases. The roles of micro ncRNAs in diverse human diseases from 
cardiovascular and muscular diseases to cancer are well established. Numerous 
micro ncRNAs are regulating cell growth and differentiation and are specifically 
involved in cancer where some of them are acting as oncogenes, while some are 
found to have tumor suppressor roles (reviewed in (Trang et al., 2008)). Involvement 
of imprinted macro ncRNAs in human syndromes and cancers has been discussed 
already in sections: 1.2.9.1 and 1.2.9.2, while in this section the main focus will 
consider non-imprinted macro ncRNAs and their role in disease.  
 
The involvement of macro ncRNAs in disease is mainly based on correlative data 
showing deregulation of ncRNA expression in numerous diseases and cancer. 
Examples of macro ncRNAs altered in disease are reviewed in (Prasanth and 
Spector, 2007). Still, there are just few reports showing a causative role of ncRNA in 
disease. An interesting example is a report of an individual with α-thalassemia where 
deletion of HBA1 and HBQ1 genes juxtaposes a region normally located 18kb 
downstream from α-globin (HBA2) gene, next to the HBA2 gene, leading to 
expression of a newly formed ncRNA transcript. This novel ncRNA formed by this 
deletion is antisense to HBA2 and has been shown to cause de novo DNA 
methylation on the CpG island promoter of HBA2 and silencing of the HBA2 gene 
that further cause the disease (Tufarelli et al., 2003). A second interesting example 
has been found in Lynch syndrome patients where germline deletion of the 3’ exons 
of the EPCAM gene cause transcriptional read through that leads to promoter DNA 
methylation and silencing of the MSH2 gene (Ligtenberg et al., 2009; Niessen et al., 
2009). Germline inactivation of one of the mismatch repair genes (MLH1, MSH2, 
MSH6 and PMS2) is the known cause of Lynch syndrome, therefore the newly 
formed EPCAM-MSH2 fusion ncRNA that silence MSH2 has a causative role in 
Lynch syndrome (Ligtenberg et al., 2009; Niessen et al., 2009). In the past few years, 
there is more and more evidence supporting the roles of macro ncRNAs in disease 
and the possibilities of their use in medicine as biomarkers and potentially drug 
targets will be further described. 
 
1. 3. 4. Non-protein coding RNAs as biomarkers and drug targets 
There is evidence about the involvement of different classes of ncRNAs in human 
disease and especially in cancer. An emerging question is the possibility of their use 
as diagnostic or prognostic markers. The micro ncRNA field already widely 
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recognized the potential for the use of these small ncRNAs as biomarkers and 
companies like Rosetta Genomics and Exiquon are focused on revealing novel 
miRNA biomarkers for various cancers. Macro ncRNAs are emerging as new 
molecules with a potential in prognostics. Numerous macro ncRNAs have been 
found up or downregulated in various multigenic diseases and cancer and just some 
of them will be discussed here.  
 
The DD3 macro ncRNA is expressed specifically in prostate and over-expressed in 
prostate cancer (Bussemakers et al., 1999). DD3 was found to be a sensitive and 
specific marker for early detection of prostate cancer (de Kok et al., 2002). aHIF is a 
ncRNA found after exposure of cells to hypoxia and over-expressed in renal (Thrash-
Bingham and Tartof, 1999) and breast cancer where is established as a strong 
predictor for poor breast cancer prognosis (Cayre et al., 2003). MALAT-1 ncRNA is 
significantly associated with metastasis in non-small cell lung cancer (NSCLC) and 
has prognostic potential for the survivals of patients in stage I of NSCLC (Ji et al., 
2003). The same ncRNA has been found to be over-expressed in endometrial 
sarcoma (Yamada et al., 2006) and in hepatocellular carcinomas (HCCs) where the 
possibility of using MALAT-1 as a marker of neoplastic cells has been proposed (Lin 
et al., 2007). P15AS macro ncRNA is overexpressed in two forms of leukemia where 
it correlates with antisense silencing, and heterochromatization of the p15 tumor 
suppressor gene showing the potential role of this macro ncRNA in cancerogenesis 
and potential use as a biomarker (Yu et al., 2008). Interestingly, fragments of 
ncRNAs can be detected from human blood by two approaches used by Semenov et 
al., which supports the possibility of biomarker ncRNAs usage in medical practice 
(Semenov et al., 2008).  
 
The growing evidence of the role of macro ncRNAs in gene regulation suggests they 
could be potential molecular targets for epigenetic therapy. In the past, most of the 
drugs were directed towards proteins and delivering drugs to target ncRNAs will be a 
completely new challenge. Macro ncRNAs deregulated in disease have a potential to 
be targeted by siRNAs, antisense oligonucleotides, ribozymes or small molecules, 
but still there are many shortcomings in usage of these approaches, especially in 
patients. β-secretase-1 antisense (BACE1-AS) is a ∼2kb long macro ncRNA involved 
in Alzheimer’s disease that has the potential to be used as drug target. This ncRNA 
is upregulated in Alzheimer’s patients and importantly its’ function in regulating the 
BACE1 enzyme crucial for cleavage of amyloid precursor protein (APP) is 
established (Faghihi et al., 2008). This ncRNA is directly implicated in increased 
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abundance of plaque formation, one of the key features of Alzheimers’ disease 
(Faghihi et al., 2008). A company named CuRNA was founded in 2008 with the goal 
of identifying of new biomarkers and drugs based on macro ncRNAs deregulated in 
disease (http://www.curna.com/). Further development of new technologies like tiling 
arrays and RNA Sequencing will lead to the identification of novel macro ncRNAs 
deregulated in disease e.g. cancer, potentially resulting in numerous benefits for 
medicine, in diagnostics, prognostics, and development of new drugs. 
 
1. 4. Aims of the study 
Recent development of new technologies: next generation RNA Sequencing and 
Tilling arrays hybridizations, led to a break through in the transcriptomics field and 
changed our perception of the complexity of genome. The majority of the transcripts 
in the human genome are non-protein coding, but still little is known about the 
diversity and functional potential of these transcripts. In order to give my contribution 
to the understanding of that diversity, I focused on the identification and 
characterization of one of the ncRNAs classes: macro ncRNAs. Mapping of macro 
ncRNAs by new technologies has been in itself the challenge since at the time I 
started this project the exact methodology for this kind of transcriptome research was 
not fully established.  
 
My first goal was to establish methodologies and data analysis procedures based on 
Tiling array and RNA sequencing in order to reliably map novel macro ncRNAs and 
this part of project has been done in collaboration with Ru Huang and Florian Pauler 
in the lab. Focus on this specific ncRNAs class came from ten years expertise of our 
lab in the field of imprinted macro ncRNAs. In this thesis I use genomic imprinting as 
a model for macro ncRNA research based on the fact that well-studied imprinted 
gene regions express macro ncRNAs and that for two of these ncRNAs a direct role 
in gene regulation has been shown. Current understanding of the imprinting 
phenomenon and the role of macro ncRNAs in imprinted gene regulation is mainly 
based on 6 out of about 30 imprinted gene clusters. Thus, my second goal was to 
analyze transciption of all human imprinted gene clusters in different tissues and 
developmental stages and map and characterize novel macro ncRNA transcripts in 
these regions in order to address the question if macro ncRNAs are a universal 
feature of imprinted gene regions in human. Characterization of novel imprinted 
macro ncRNAs is valuable in broadening our knowledge about the biology of these 
transcripts and could be helpful in predicting their functions. With the recent 
development of ncRNA field it became clear that macro ncRNA transcripts are 
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associated with a spectrum of human diseases and in a few cases a causative role of 
a macro ncRNA in disease development has been found. Numerous macro ncRNAs 
are biomarkers for different cancer types and some of them are proposed as 
potential drug targets. Thus, my third goal was to investigate deregulation of novel 
macro ncRNAs found in imprinted gene regions in different types of cancer. In 
conclusion, this PhD thesis aims to broaden our knowledge of macro ncRNAs from 
imprinted gene regions in both normal and disease conditions and will be a valuable 
resource for further functional studies of human macro ncRNAs. 
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2. Results 
 
2. 1. HIRTA (Human Imprinted Region Tiling Array) technology successfully 
detects macro ncRNAs 
 
2. 1. 1. Selection of regions of interest and design of HIRTA  
The Human Imprinted Region Tiling Array (HIRTA) was designed with the aim of 
mapping novel macro ncRNAs in human regions containing imprinted genes. HIRTA 
is a NimbleGen custom tiling array with one 50bp oligonucleotide (further referred as 
a tile) per 100bp of single copy sequence from selected gene regions (Figure 7A). 
HIRTA covers around 2% of the human genome. 4% of all HIRTA probes cover 
exons of annotated genes, 3% cover intron-exon junctions, 49% cover intronic 
regions while 43% of the HIRTA cover intergenic regions (Figure 7B). Note that 
interspersed repeats identified by Repeat Masker (http://www.repeatmasker.org/) 
were excluded from HIRTA (black bars in Figure 7A). 
 
 
Figure 7. HIRTA covers ~2% of the human genome. A. UCSC snapshot showing a 3kb 
region of human chromosome 6 and HIRTA oligonucleotide probes 50bp in length (short 
black bars) that cover each 100bp of a single copy sequence. RefSeq genes UCSC track 
shows part of SLC22A1 gene (dark blue) indicating that HIRTA oligonucleotide probes cover 
both genic and intergenic regions. Repeat Masker track shows that interspersed repeats 
(black bars) are not covered by HIRTA oligonucleotide probes. B. 49% of the sequence 
covered by HIRTA oligonucleotide probes are positioned in intronic regions, 43% in 
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intergenic, 4% in intron-exon junctions and 3% in exonic regions of annotated genes. HIRTA 
is a NimbleGen array that covers ∼2% of human genome. 
 
The 2% of human genome covered by HIRTA includes three types of regions 
containing imprinted genes: 1) well-studied regions containing genes imprinted in 
both human and mouse, 2) less-studied regions containing genes imprinted in 
mouse, human or both and 3) the XIST region that is well-studied but imprinted just 
in mouse extraembryonic tissues (Table 9; genes showing imprinted expression in 
these regions were described in section 1.2.5.). Regions contained on HIRTA map 
on 16 human chromosomes and range in length from 1-5Mb (Table 9). The HIRTA 
regions contain centrally positioned genes known to be imprinted in human and/or 
mouse and cover the known imprinted gene cluster plus flanking regions containing 
non-imprinted genes. 
 
HIRTA REGION Chr. REGION START REGION END LENGTH (Mb) 
REGION  
imprinting  
status 
TP73 1 2,900,000 3,900,000 1 L (H) 
DIRAS3 1 67,800,000 68,800,000 1 L (H) 
COMMD1 2 61,500,000 62,500,000 1 L (M) 
NAP1L5 4 89,300,000 90,300,000 1 L (M, H) 
PLAGL1 6 143,830,000 144,830,000 1 L (M, H) 
IGF2R 6 160,000,000 161,000,000 1 W (M, H) 
GRB10 7 50,200,000 51,200,000 1 L (M, H) 
CALCR 7 92,400,000 97,400,000 5 L (M, H) 
MEST 7 129,500,000 130,500,000 1 L (M, H) 
KCNK9 8 139,600,000 142,600,000 3 L (M, H) 
SFMBT2 10 5,800,000 8,800,000 3 L (M) 
INPP5F 10 121,100,000 122,100,000 1 L (M, H) 
BAZ2 11 6,000,000 8,000,000 2 L (H) 
AMPD3 11 10,000,000 11,000,000 1 L (M) 
IGF2, KCNQ1 11 1,700,000 3,700,000 2 W (M, H) 
WT1 11 31,830,000 32,830,000 1 L (H) 
SDHD 11 110,800,000 111,800,000 1 L (H) 
SLC38A4 12 45,000,000 46,000,000 1 L (M) 
DCN 12 89,600,000 90,600,000 1 L (M) 
HTR2A 13 45,800,000 46,800,000 1 L (M, H) 
DLK1 14 99,600,000 101,600,000 2 W (M, H) 
PWS 15 20,170,000 25,170,000 5 W (M, H) 
GATM 15 42,900,000 43,900,000 1 L (M) 
RASGRF1 15 76,600,000 77,600,000 1 L (M) 
IMPACT 18 19,900,000 20,900,000 1 L (M) 
ZIM2 19 61,600,000 62,600,000 1 L (M, H) 
HM13 20 29,200,000 30,200,000 1 L (M, H) 
NNAT 20 35,080,000 36,080,000 1 L (M, H) 
GNAS 20 56,500,000 57,500,000 1 W (M, H) 
L3MBTL 20 41,100,000 42,100,000 1 L (H) 
XIST X 70,700,000 75,700,000 5 X (M) 
 
Table 9. HIRTA oligonucleotide probes are covering 32 genomic regions with at least 
one gene having imprinted expression in human or mouse. Names of the HIRTA regions 
(given according to the RefSeq name of the gene that shows imprinted expression and is 
centrally positioned within the region), positions on human chromosomes (Chr.) in the human 
build NCBI36/hg18, starts and ends of the regions, their length (in mega bases) and grouping 
according to the imprinting status in human and mouse (into well-studied imprinted (W), less-
studied imprinted (L) and XIST (X) region) is shown. M; region cointains genes showing 
imprinted expression in mouse, H; region contains genes showing imprinted expession in 
human. 
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2. 1. 2. Normal and cancer samples were hybridized on HIRTA 
HIRTA was hybridized with cDNA from 43 normal or cancer human samples 
including cells, tissues and patient tissue samples (Figure 8).  
                                   
Figure 8. 43 human samples were hybridized to HIRTA. cDNA from three types of 
samples: cultured cells, tissues and patient samples were hybridized to HIRTA.  
 
The 20 normal cells/tissues hybridized to the HIRTA array are described in Table 10. 
Undifferentiated human embryonic stem cells (HES2d0) and day 7 differentiated 
human embryonic stem cells (HES2d7) were hybridized to HIRTA in order to test the 
developmental regulation of known and novel macro ncRNAs. Normal human 
fibroblast cell line, samples from 3 fetal human tissues, placenta (extraembryonic 
tissue) and 13 different adult tissues were hybridized to HIRTA with the aim of testing 
tissue specific expression of the macro ncRNAs (Table 10). RNA from human tissues 
was purchased from Clontech and in most cases only pooled tissues were available. 
While this does not allow individual variation to be assessed, it has the advantage of 
reducing effects of biological variation at the level of the gene expression that is 
relatively high in human (Cheung et al., 2003).  
 
NORMAL 
Cell line/tissue Description 
Hs27 Normal male human fibroblasts 
HES2d0 Undifferentiated female embryonic stem cells  
HES2d7 7 days differentiated female embryonic stem cells  
Fetal Brain 21 male/female: Caucasian fetuses, ages: 26-40 weeks 
Fetal Liver 63 male/female Caucasian fetuses, ages: 22-40 weeks 
Fetal Kidney 34 Caucasian male/female fetuses, ages: 12-31 weeks 
Placenta Obtained from 4 female Caucasians, ages: 21-39  
Adult Brain 2 male Caucasians, ages: 47-55 
Adult Lung 3 male/female Caucasians, ages: 32-61 
Adult Uterus 8 female Caucasians, ages: 23-63 
Adult Heart 10 male/female Caucasians, ages: 21-51 
Adult Kidney 14 male/female Caucasians, ages: 18-59 
Skeletal Muscle 7 male/female Caucasians, ages:20-68 
Bone Marrow 8 male/female Caucasians, ages: 18-56 
Colon 1 female Caucasian, age: 23 
Cervix 1 female African American, age: 40 
Mammary Gland 1 female Caucasian, age: 27 
Adult Liver 1 male Caucasian, age: 51 
Whole Blood 1 female Caucasian, age: 30 
Testis 39 male Caucasians, ages: 14-69 
Table 10. 20 normal human cells/tissues has been hybridized to HIRTA. Names of used 
samples and their description is presented. 
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Further, 17 cell lines from 6 different cancer types (cervical, breast, colon, 
teratocarcinoma, rhabdomyosarcoma and neuroblastoma) and 6 patient samples  (4 
acute myeloid leukemias and 2 myeloproliferative disorders) were hybridized to 
HIRTA in order to test regulation of macro ncRNAs in cancer (Table 11).  
 
CANCER 
Cell line/tissue Description 
HeLa Cervical cancer cell line, adenocarcinoma 
HT3 Cervical cancer cell line, carcinoma 
C4I Cervical cancer cell line, carcinoma 
C4II Cervical cancer cell line, carcinoma 
SiHa Cervical cancer cell line, squamous cell carcinoma, grade II 
C33A Cervical cancer cell line, carcinoma 
DoTc2 Cervical cancer cell line, carcinoma 
ME180 Cervical cancer cell line, epidermoid carcinoma 
SW756 Cervical cancer cell line, squamous cell carcinoma 
HCT116 Colon cancer cell line, colorectal adenocarcinoma 
Caco2 Colon cancer cell line, colorectal adenocarcinoma 
MCF7 Breast cancer cell line, adenocarcinoma 
CAMA-1 Breast cancer cell line, adenocarcinoma 
Tera2 Malignant embryonal carcinoma 
NCCIT Teratocarcinoma 
A201 Rhabdomyosarcoma 
SH-SY-5Y Neuroblastoma 
AML5_BMMC Acute myeloid leukemia patient, bone marrow mononuclear cells 
AML5_PBMC Acute myeloid leukemia patient, periferal blood mononuclear cells 
AML7 Acute myeloid leukemia patient, bone marrow mononuclear cells 
AML8 Acute myeloid leukemia patient, bone marrow mononuclear cells 
MP_0351B Myeloproliferative disorder patient, periferal blood  
MP_0363 Myeloproliferative disorder patient, periferal blood  
Table 11. 23 cancer samples including: cervical, colon, breast, teratocarcinoma, 
rhabdomyosarcoma, neuroblastoma, acute myeloid leukemia and myeloproliferative 
disorder cancer types have been hybridized to HIRTA. Names of the cell lines, patient 
tissue samples and short descriptions are shown. 
 
2. 1. 3. Reproducibility of HIRTA 
HIRTA reproducibility was tested by performing five replicates of HIRTA 
hybridizations. Three biological (Hs27, Adult uterus and HeLa) and 2 technical 
replicates (HES2d0 and HES2d7) were tested. Scatter plots of the replicates that 
showed near linear relationships between replicates and Pearson’s correlations 
ranging from r= 0.885 to 0.951 (where +1 is a perfect linear correlation) 
demonstrated that HIRTA is highly reproducible (Figure 9A). Looking at the single 
gene level, the Decorin (DCN) gene was showing no (HES2d0, HES2d7), low 
(HeLa), medium (Hs27) or high (Adult uterus) expression in both replicates of each of 
five tested samples (Figure 9B). High reproducibility of highly expressed and 
saturated DCN gene was indicated by its intronic signal that showed similar levels of 
expression in two biological replicates (DCN expression in Adult uterus, Figure 9B). 
As the HIRTA hybridization technique is highly reproducible for 5 examples, 
replicates were not performed for other tissues and cell lines. 
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Figure 9. HIRTA hybridizations show high reproducibility. A. Comparissons of log2 
expression signals from two replicates of Hs27, HES2d0, HES2d7, Adult uterus and HeLa are 
represented using scater plots. Each black dot represents log2 expression from one HIRTA 
tile. Scatter plots show a nearly linear relationship of two replicates for five HIRTA samples, r; 
Pearson’s correlations. B. Decorin (DCN) expression for five tested HIRTA samples in two 
replicate hybridizations. HIRTA hybridization results were loaded on the UCSC browser in the 
form of custom track where X-axis represents position in the genome (hg18), while Y-axis is a 
log2 ratio of cDNA normalized to genomic DNA. Name of the custom track is shown on the left 
side of the figure. Publicaly available UCSC track for RefSeq genes is shown, as well as scale 
and hg18 chromosome positions. 
 
 2. 1. 4. Dynamic range of HIRTA 
Tiling arrays have been shown to display limited dynamic range with signal saturation 
of highly expressed genes (Wang et al., 2009a). The dynamic range of HIRTA was 
tested by comparing expression of Decorin gene (DCN) from three different cell lines 
by HIRTA hybridization and RT-qPCR. DCN showed high expression in Hs27 (value 
of DCN gene expression in fibroblasts was 8.21, while maximal saturated value of 
HIRTA expression in fibroblasts was 8.38, observed for COL1A2 gene), medium 
expression in HeLa (value of 6.05) and no expression in HESd7 cells (values down to 
minus 6.14 over the exonic regions) by HIRTA hybridizations (Figure 10A). RT-qPCR 
data for the same gene using four exonic (DCNEx1-4) and four intronic primer pairs 
(DCNIn1-4) confirmed the relatively high expression in Hs27 cell line (set to 100) 
while expression in HeLa was about 50 fold less in exons and 100 fold less in introns. 
DCN was not expressed in HES2d7 by both RT-qPCR and the tiling array (Figure 
10B).  
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Figure 10. Tiling arrays can distinguish high, medium and no expression but has a low 
dynamic range and a saturation limit. A. Tissue specific expression of the Decorin in Hs27, 
HeLa and HES2d7 cells. Tracks are displayed on UCSC as on Figure 9. B. RT-qPCR primers 
positions are also shown.  B. RT-qPCR validation of tiling array data using the human Decorin 
(DCN) gene was done in cell lines with different expression levels. Expression is assayed by 
eight primer pairs, four of which were located in exons (blue) and four in introns (orange) of 
the Decorin gene. Negative exonic and intronic expression showed by these primer pairs are 
indicated using blue and orange arrows respectivelly. Each primer pair is set to 100 in Hs27 
cells and normalized to expression of the RPLPO gene. 
 
The dynamic range of HIRTA was ~250 fold expression difference (Table 12). DCN 
expression values in Hs27 and HeLa, obtained from HIRTA hybridizations, were 
about a 5 fold different, while RT-qPCR showed a 50 fold difference in DCN 
expression between the cell lines, indicating that DCN expression on HIRTA was 
saturated (Table 12).   
 
The dynamic range and saturation of HIRTA Chip based on RT-qPCR and HIRTA 
expression of Decorin gene 
 Hs27 expression  
values 
HeLa expression  
values 
Difference in expression 
values between the cell lines 
HIRTA Log2n=8.21  
n= 296.11 
Log2n=6.05 
n=66.26 
= ∼4.5 fold 
 
RT-qPCR  100  ∼2  = ∼50 fold  
If HIRTA data range from Log2n=0, n=1 to Log2n=8, n=256, than by HIRTA we are able to 
observe ~250 fold difference in expression (potential background not taken into account) 
Note that HIRTA hybridizations have different saturation limit but typically they have 
maximal observed log2 expression in range of 7.5 to 8.5.  
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Table 12. Comparisson of HIRTA data and RT-qPCR in different tissues shows that 
dynamic range of HIRTA is about 250 and that HIRTA has a saturation limit.  
 
2. 1. 5. Single cDNA hybridization on HIRTA 
Total RNA from cell lines, tissues or patient samples was converted to double 
stranded cDNA, labeled with a flourochrome Cy5 and co-hybridized with sonicated 
DNA from the Hs27 cell line, labeled with a fluorochrome Cy3 (Figure 9A). This type 
of hybridization was named “single cDNA hybridization”. The raw data was Tukey bi-
weight normalized and the HIRTA hybridization results are displayed on the UCSC 
(University of California Santa Cruz) genome browser using the human Mar. 2006 
(NCBI 36/hg18) assembly with the position in the genome on the X-axis and log2 
signal values from HIRTA hybridizations on Y-axis (Figure 9). HIRTA probe 
intensities were log2 transformed in order to enable visualization of lowly transcribed 
genes. Log2 signal values displayed in orange and positioned above the zero line 
represent enrichment of cDNA over genomic DNA and indicate RNA expression. The 
blue signal below the zero line shows that there is more genomic DNA than cDNA 
and that RNA is not expressed. Zero line represents equal amounts of cDNA and 
genomic DNA. The results of human fibroblasts hybridizations (Hs27) for a typical 
imprinted macro ncRNA and a typical protein coding gene show different tiling array 
patterns (Figure 11B). Protein coding genes (e.g. DCN) typically show high signals 
matching to exons and low to moderate signals over introns. The high exonic signals 
are often saturated, depending on the expression in examined tissue.  This observed 
signal pattern of protein coding genes is based on their high intron/exon ratio, typical 
of most mammalian genes. Macro ncRNAs (e.g. GTL2) are found to show a HIRTA 
pattern with most of the tiles strongly positive through whole body of macro ncRNA 
gene (they have low intron/exon ratio), with the HIRTA signal that is typically not 
saturated. On the basis of these distinct tilling array patterns macro ncRNA can be 
differentiated from protein coding genes by visual inspection of tiling array 
hybridization results displayed on the UCSC genome browser.  
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Figure 11. Single cDNA hybridizations on HIRTA can detect macro ncRNAs and 
distinguish them from protein coding genes. A. Short overview of the sample preparation 
using “single cDNA hybridization” on HIRTA. ds cDNA; double stranded cDNA B. The figure 
is displayed as in Figure 9B. In addition, publically available UCSC tracks for sno/miRNA and 
CpG islands are shown. Sno/miRNA UCSC track display miRNAs in red and snoRNAs in blue 
color. The upper panel shows a typical known macro ncRNA, the GTL2 transcript expressed 
from the DLK1 imprinted gene region that is also precursor to miRNAs and snoRNAs. The 
lower panel shows Decorin (DCN) as an example of typical protein coding gene showing high 
expression signals (orange focal peaks) matching the exons of DCN (shown as dark blue 
blocks on RefSeq gene track) and moderately expressed introns.  
 
The expression patterns of already known macro ncRNAs and their differences to 
annotated protein coding genes, that resulted from single cDNA hybridizations on 
HIRTA, were used to develop criteria for mapping novel variants of known or novel 
macro ncRNAs. HIRTA macro ncRNA mapping by visual inspection criteria include: 
1) high coverage of positive expressed probes through the body of the transcript 
(coverage was used as a relative measure of low intron/exon ratio with typical 
coverage >90%, and in the case of lowly transcribed transcripts >70% coverage); 2) 
absence of typical protein coding exons visualized as highly expressed focal signals, 
that typically consist of 1-2 tiles as the average human exon is <200bp in length, and 
are often positioned on the distances of about 2-8kb typically resembling introns 
(Lander et al., 2001; Sakharkar et al., 2004)); 3) more than 1kb in length; 4) 
Simultaneous analysis in 43 cells/tissues/patients. The first two criteria are based on 
the already shown difference between macro ncRNAs and protein-coding genes in 
the HIRTA expression pattern (Figure 11) while the third criteria limits the analysis to 
very long/macro ncRNAs; potential 200bp to 1kb long ncRNAs were not analysed 
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since transcription of these lengths are more difficult to distinguish from cross-
hybridizations, pseudogenes or background. Further, the fourth criteria requiring 
simultaneous detection from all HIRTA hybridizations resolves three potential 
problems: a) difficulties in distinguishing macro ncRNAs from protein coding genes 
showing high transcription rate, which can have introns expressed to the similar 
extent as exons, b) potential overlapping transcripts c) distinguishing between low 
transcription (less than log2=1) and tilling array background, if a transcript is highly 
expressed in one of the tissues and a low expression from another tissue maps to 
the same position, then this expression was recognized as a ncRNA. Positions of the 
first and the last HIRTA oligonucleotide probe giving high expression were defined as 
the start and the end of the macro ncRNA transcript. Positions of intergenic 
transcripts were reliably mapped while the positions of overlapping and very lowly 
expressed transcripts were given provisionally since exact mapping of these 
transcripts on the basis of tiling array data was not possible.  
 
2. 1. 6. Double cDNA hybridization on HIRTA 
In order to test the cellular localization of macro ncRNAs, double hybridizations on 
HIRTA were performed using two-color labeling of double stranded (ds) cDNA from 
nuclear and cytoplasm fractions of a normal human fibroblasts cell line (Hs27) 
(Figure 12A). The raw data was normalized by method implemented by Dr. Florian 
Pauler (unpublished data). The normalized hybridization results were loaded into 
UCSC genome browser as the custom track with black bars above the zero line 
indicating nuclear enriched RNA regions and grey bars below the zero line indicating 
the cytoplasmic enriched RNA. As expected, exons of protein coding genes were 
enriched in cytoplasmic fraction (e.g. DCN exons, gray bars below the zero line), 
while a known nuclear KCNQ1OT1 macro ncRNA (Murakami et al., 2007) was 
enriched in the nucleus (Figure 12B). Thus, we further used this technique for testing 
cellular localization of novel macro ncRNAs. 
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Figure 12. Double cDNA hybridization shows nuclear enrichment of the KCNQ1OT1 
macro ncRNA and cytoplasmatic enrichment of the Decorin protein coding gene. A. 
Short overview of the sample preparation using “double cDNA hybridization” on HIRTA. ds 
cDNA; double stranded cDNA B. The upper panel shows result of double cDNA hybridization 
on HIRTA for known nuclear localized KCNQ1OT1 imprinted macro ncRNA indicated with the 
black arrowed line. The lower panel shows example of cytoplasmic localization of typical 
protein coding gene. Black signals above the zero line represent nuclearly localized introns 
while gray signals below the zero line correspond to exons of the DCN gene indicated by the 
blue arrowed lines. Names of the double cDNA hybridization custom tracks are shown on left 
part of both panels as well as names of displayed UCSC custom tracks (RefSeq Genes, 
sno/miRNA, CpG islands). 
 
2. 2. Macro ncRNAs in six well-studied human imprinted gene regions  
 
2. 2. 1. Known human macro ncRNAs from the HIRTA well-studied regions 
 
2. 2. 1. 1. Mapping and tissue specific expression of known macro ncRNAs 
Six well-studied regions in mouse cointaining imprinted genes are: Igf2, Kcnq1ot1, 
Igf2r, Pws/As, Gnas and Dlk1 (Koerner et al., 2009). Analysis of the same regions in 
human, using HIRTA, showed that six known human imprinted macro ncRNAs (H19, 
KCNQ1OT1, GTL2, UBE3A-AS, NESPAS, EXON1A) were successfully detected in 
five of well-studied regions (Figure 13). No single tissue expressed all six well-
studied macro ncRNAs and the human AIRN macro ncRNA (that is described in 
section 2.6.3.) was not detected in any of tissues studied by HIRTA. The detected 
macro ncRNAs were used as positive controls for HIRTA and based on their 
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expression pattern, criteria for mapping novel macro ncRNAs were established 
(described in section 2.1.5.). 
 
 
Figure 13. Macro ncRNAs in well studied human imprinted gene regions.  Expression of 
H19, KCNQ1OT1, GTL2, UBE3A-AS, GNAS1-AS and EXON1A macro ncRNAs is shown by 
presentation of one HIRTA track from a cell line/tissue that highly expressed each ncRNA. 
Known macro ncRNAs orientation is depicted with black arrowed lines while their lengths in 
kilobases (kb) are shown in brackets. Names of HIRTA regions and screenshot positions in 
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hg18 are shown on the top of each box. Custom HIRTA tracks as well as RefSeq genes, 
sno/miRNA and CpG islands UCSC tracks are shown. 
 
H19, KCNQ1OT1, GNAS1-AS and EXON1A are macro ncRNAs annotated by 
RefSeq with gene lengths of 2.3kb, 59.5kb, 32kb and 22kb respectively and the 
relatively same lengths were mapped by HIRTA except in the case of the 
KCNQ1OT1 ncRNA when the repetitive region positioned downstream of ncRNA 
transcript was not spoted on the HIRTA Chip, therfore the exact end of this ncRNA 
could not be determined (Table 13).  
 
Mapping of the GTL2 and UBE3A-AS macro ncRNAs in the DLK1 and PWS HIRTA 
regions respectively showed a complex transcriptional pattern in different tissues that 
resulted in the mapping of 6 tissue specific transcripts that are novel variants of, or 
transcripts overlapping GTL2 (Figure 14), and 4 novel tissue specific transcripts that 
are variants of, or are overlapping with the UBE3A-AS macro ncRNA (Figure 16). 
GTL2 (MEG3) is by RefSeq Genes as a ∼35kb long transcript. GTL2var1 (Figure 13, 
14) was mapped using HIRTA as ∼250kb transcript, overlapping known miRNAs and 
snoRNA clusters. In diverse tissues, different novel variants were mapped using 
HIRTA: GTL2var2 overlapping both annotated MEG3 and miRNA cluster, GTL2var3 
that may be short variant of annotated MEG3, GTL2var4 coresponding to the second 
miRNA cluster in the region, GTL2var5 that is lowly expressed and corresponds to 
two known snoRNA clusters (14qI and 14qII) and GTL2var6 that is positioned next to 
the retrotransposon like-1 (RTL1) and may be overlapping this gene (Figure 14).  
Interestingly, GTL2 long and short variants may use different promoters in different 
tissues. The GTL2 long transcripts (GTL2var1 and GTL2var2) use one promoter in 
Hs27 and adult brain, while the GTL2var3 uses another promoter in adult lung and 
heart (Figure 15).  
 
HIRTA 
REGION 
 
Chr. NAME of macro 
ncRNA 
POSITION (hg18) Length 
(kb) 
COV 
(%) 
Position to 
annotated 
PC genes 
IGF2 11 H19 chr11:1972982-1975641 (RefSeq) 2.6 100 IG 
KCNQ1  KCNQ1OT1 chr11:2618344-2677804 (RefSeq) 59.5 99.7 IN 
DLK1 14 GTL2var1 chr14:100362198-100609108 246.9 99.3 IG 
  GTL2var2 chr14:100362198-100473308 111.1 93 IG 
  GTL2var3 chr14:100364721-100372481 7.7 98.4 IG 
  GTL2var4 chr14:100537556-100609108 71.5 74.9 IG 
  GTL2var5 chr14:100459386-100536578 77.2 72.3 IG 
  GTL2var6 chr14:100420937-100440719 19.8 85.5 IG 
PWS 15 UBE3A-ASvar1 chr15:22751163-23171714 420.5 97.3 OV 
  UBE3A-ASvar2 chr15:22751163-22960127 209 99.5 OV 
  UBE3A-ASvar3 chr15:22751163-22918716 167.5 98.3 OV 
  UBE3A-ASvar4 chr15:22954110-23050454 96.4 58.3 IG 
GNAS 20 GNASAS chr20:56827368-56859353 (RefSeq) 32 98.1 5’/OV 
  EXON1A chr20:56897575-56919642 (RefSeq) 22 98.5 OV 
 
Irena Vlatkovic PhD Thesis   62 
Table 13. Known macro ncRNAs in five well-studied imprinted gene regions. H19, 
KCNQ1OT1, GNASAS and EXON1A are mapped by HIRTA to positions annotated as 
RefSeq genes on UCSC. GTL2 and UBE3A-AS show a complex transcription patterns and 
number of tissue specific variants of these macro ncRNA are detected by HIRTA. The length 
of visualy mapped macro ncRNAs ranges between 2.6 and 420kb. HIRTA regions named in 
accordance to Table 9, chromosome positions according to hg18, name of macro ncRNAs 
and their length (in kilobases) were shown. Coverage (COV) represents % of positive probes 
in a tissue expressing high level of the macro ncRNA candidate. Macro ncRNAs were 
grouped according to their position in relation to annotated protein coding genes: intergenic 
(IG)= non-overlapping, 5’/OV= 5’ exons or overlapping, 3’/OV= 3’UTRs or overlapping, 
OV=overlapping, IN=inside of annotated protein-coding genes. PC; protein-coding gene 
 
 
Figure 14. Tissue specific expression of the GTL2 macro ncRNA complex transcription 
unit. GTL2 variants or overlapping macro ncRNA transcripts ranging in length from 7.5 to 
247kb (marked by the black boxes) show tissue specific expression. Note positions of miRNA 
(red) and snoRNA clusters (blue). Black lines show expressed macro ncRNAs. Custom 
HIRTA tracks as well as RefSeq genes, sno/miRNA and CpG islands UCSC tracks are 
shown. 
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Figure 15. GTL2 macro ncRNA long and short variants use different promoters. Long 
GTL2 variants are present in Hs27 and adult brain, while short lung and heart GTL2 variants 
use another promoter. Short GTL2 transcript partially map to the previously annotated MEG3 
(GTL2) ncRNA. Custom HIRTA tracks as well as RefSeq genes, sno/miRNA and CpG islands 
UCSC tracks are shown. 
 
Four variants or transcripts overlapping UBE3A-AS macro ncRNA were expressed in 
representative tissues in lengths ranging from 96 to 420kb (Figure 16). The existence 
of UBE3A-ASvar1 has been previously suggested in mouse where Ube3a-as has 
been mapped to ∼1000kb (Landers et al., 2004) and here in human was visualized 
using HIRTA as about 420kb long. Two imprinted snoRNA clusters (HBAII-85 or 
SNORD116 and HBAII-52 or SNORD115) have been mapped in this region 
previously (Cavaille et al., 2000). Interestingly, UBE3A-ASvar2 that overlaps the 
HBII-85 and the 40kb shorter UBE3A-ASvar3 RNAs, were ubiquitously expressed in 
all cells/tissues hybridized to HIRTA. The UBE3A-ASvar4 overlapping to HBAII-52 in 
contrast had tissue specific expression and showed developmental upregulation (it 
was not expressed in human undifferentiated embryonic stem cells while it was lowly 
expressed in day 7 differentiated ES cells). High expression of HBAII-52 was 
restricted to fetal and adult brains that were also the same two tissues uniquely 
expressing 420kb UBE3A-ASvar1.  
 
One of possible explanations for complexity of both GTL2 and UBE3A-AS macro 
ncRNA regions could be based on the presence of overlapping micro and snoRNA 
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clusters. Thus some of the mapped variants could represent primary miRNA or 
snoRNA transcripts.  
 
 
Figure 16. UBE3A-AS macro ncRNA tissue specific expression. Five cells/tissues 
(undifferentiated and differentiated embryonic stem cells, adult brain, uterus and cervix) were 
chosen in order to depict four different UBE3-AS variants or overlapping transcripts that range 
in length from 96 to 420kb (lengths depicted in brackets). The red line highlights 
developmental upregulation (in human ES cell system) of UBE3A-ASvar4 that is 
corresponding to HBII-52 snoRNA cluster. Black boxes highlight macro ncRNA variants while 
black lines show expressed macro ncRNAs. Custom HIRTA tracks as well as RefSeq genes, 
sno/miRNA and CpG islands UCSC tracks are shown. 
 
Tissue specific expression of 6 known and novel macro ncRNAs based on tiling array 
expression in 43 samples is depicted on Figure 17. Level of macro ncRNAs 
expression in different tissues was assessed by visual inspection of HIRTA 
hybridization profiles. Since tiling arrays have potential background and saturation 
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limitations, tissue specific expression of macro ncRNAs is shown as two clear 
expression states: ON and OFF, where ON represents low, medium or high 
expression whereas OFF means no expression. The exact level of ON expression of 
each transcript can be further assessed by loading available .wig tracks for specific 
tissues showing ON expression into hg18 of UCSC browser and by searching macro 
ncRNA position.  
 
 
Figure 17. Tissue specific expression of well-studied macro ncRNAs in normal and 
cancer cells. Expression of known and novel variants macro ncRNAs from well known 
imprinted regions in 20 normal and 23 cancer samples is shown. Names of the HIRTA 
regions and macro ncRNAs that are previously defined in Table 9 and Table 13, respectively 
are shown on the left. 20 normal and 23 cancer cells/tissues/ patients are named below and 
grouped with corresponding normal and cancer white boxes. Yellow boxes; transcript 
expressed, Red boxes; transcript is not expressed. 
 
The EXON1A, KCNQ1OT1 and H19 macro ncRNAs are largely ubiquitously 
expressed (exceptions: H19 is not expressed in fibroblasts and whole blood while 
KCNQ1OT1 is downregulated in two cervical cancers lines). GNAS1-AS and most 
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GTL2 and UBE3A-AS variants have diverse tissue specific patern. GTL2var6 is 
specific for neuroblastoma (SHSY5Y) while UBE3A-AS long variant (var1) is 
specifically expressed in brain (both fetal and adult) (Figure 17). 
 
2. 2. 1. 2. Nuclear versus cytoplasmic localization of known macro ncRNAs 
Nuclear versus cytoplasmic localization of six well-known macro ncRNAs was 
assessed by double cDNA hybridization on HIRTA in normal human fibroblasts cell 
line (Hs27)  (Figure 12, section 2.1.6). KCNQ1OT1 and GTL2var1 macro ncRNAs 
were highly expressed in fibroblasts and were clearly nuclearly enriched by double 
HIRTA hybridization (Figure 18). Nuclear localization of KCNQ1OT1 was also 
confirmed by RT-PCR and RT-qPCR and has been used as a positive control in 
further experiments testing localization of novel macro ncRNA candidates. GNASAS 
was lowly expressed and showed both nuclear and cytoplasmic localization while 
EXON1A localization was difficult to determine since this ncRNA differs just in the 
first exon (that corresponds to one HIRTA probe) from the overlapping protein coding 
gene GNAS. H19 and UBE3A-ASvar1 localizations could not be determined since 
they showed no expression in fibroblasts. Human tissues were not available for 
nuclear versus cytoplasmic study of macro ncRNA localization.  
 
 
Figure 18. KCNQ1OT1 and GTL2var1 macro ncRNAs are nuclear-enriched. A. 
Expression of KCNQ1OT1 ncRNA in fibroblasts is shown in orange while its nuclear 
enrichment is visible as black bars probe (enrichment in double nucleus and cytoplasmic 
hybridization) B. GTL2var1 ncRNA is nuclearly enriched in fibroblasts. Tracks are displayed 
on UCSC as on the Figure 12B, section 2.1.6.  
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2. 2. 1. 3.  5’-3’ slope as a feature of macro ncRNA expression by HIRTA 
HIRTA mapping of known macro ncRNAs led to the observation of that tile 
expression intensity decreases through the macro ncRNA body in a 5’ to 3’ direction. 
This feature was typically observed for highly expressed and very long macro 
ncRNAs like KCNQ1OT1, GNASAS, GTL2var1 and UBE3A-ASvar1 (Figure 19) in 
different tissues and cell lines. SLOPE function (that assess the slope of a linear 
regression line through the data points, where the slope is defined as vertical 
distance divided by horizontal distance between any two points on the line showing 
rate of the change along the regression line) was used to calculate decreases in tile 
expression intensities through macro ncRNA bodies. Interestingly, positive/negative 
value of the calculated slope and the known strand orientation of the transcript 
showed an opposite correlation. If the calculated slope was negative, transcript was 
expressed from plus (+) DNA strand (strand defined by UCSC) while positive slope 
indicated transcription from minus (-) DNA strand. Thus, the decrease in the HIRTA 
probes intensity has a 5’ to 3’ direction and this feature was named the 5’-3’ slope. 
This shows that the slope has potential in predicting macro ncRNAs transcription 
orientation and promoter location. Correlation between slope and strand was shown 
for four known macro ncRNAs showing low to moderate non-saturated expression, 
while H19 ncRNA was showing high, saturated level of expression and did not show 
the slope and EXON1A could not be tested since it highly overlaps with the GNAS 
protein coding gene. Wheather this correlation is a universal feature of long ncRNAs 
will be further tested in the section 2.5.3, where prediction of transcriptional 
orientation, based on 5’-3’ slope and other genetic/epigenetic features, for novel 
macro ncRNAs will be described.  
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Figure 19. Reverse correlation between 5’-3’ slope and transcriptional orientation. Log2 
tile expression intensities through the length of macro ncRNA from cells/tissues highly 
transcribing macro ncRNAs are ploted to the HIRTA probes (number of tiles through the 
macro ncRNA region) and shown in orange. Trendline corresponding to signal intensities is 
depicted in black. KCNQ1OT1 and GNASAS macro ncRNAs known to be transcribed from 
the - DNA strand show positive SLOPE values while GTL2var1 and UBE3A-ASvar1 macro 
ncRNas are known to be transcribed form the + DNA strand and show negative SLOPE 
values.  
 
2. 2. 2. Novel macro ncRNA candidates in well-known imprinted gene regions 
In addition to the six macro ncRNAs presented on Figure 13, in six well-studied 
imprinted clusters there is a number of less-studied macro ncRNAs (AIRN in IGF2R 
cluster, 91H and IGF2AS in IGF2 gene cluster, LOC650368 and LOC100133545 in 
KCNQ1OT1 cluster, NCRNA00239 in DLK1 and PWRN1 in PWS imprinted gene 
cluster (described in introduction or annotated by RefSeq genes)). HIRTA also 
detected expression of less-studied macro ncRNAs except for AIRN ncRNA, which 
was not detected in the tissues and cell lines that were used (data not shown).  
 
28 novel macro ncRNA candidates that range from 3.9 to 666kb in length (Table 14) 
were mapped in six well-known human imprinted gene regions based on criteria 
described in section 2.1.5. Positions of the candidate macro ncRNAs, their lengths, 
% of positive probes covered and their positions corresponding to annotated genes 
are shown.  
 
 
 
 
 
 
Irena Vlatkovic PhD Thesis   69 
HIRTA 
REGION 
 
 
Chr. NAME of macro 
ncRNA 
POSITION (hg18) Length 
(kb) 
COV (%) Position to  
annotated PC 
genes 
IGF2R 6 SLC22A2up chr6:160616598-160620501 3.9 100 IG 
  MAS1down chr6:160249097-160257182 8 95.9 3’/OV 
  MAS1ov chr6:160171198-160260777 89.6 89.9 OV 
IGF2 11 H19down chr11:1930616-1972982 42.4 94 3’/OV 
  H19up chr11:2019588-2048590 29 100 IG 
  ASCL2ov chr11:2167733-2255607 87.8 89.5 OV 
  ASCL2up chr11:2261646-2270383 8.7 100 3’/OV 
  TSPAN32down1 chr11:2296006-2355798 59.8 100 IG 
KCNQ1 11 ZNF195down1 chr11:3225444-3318834 93.4 87.6 IG 
  ZNF195down2 chr11:3321897-3329926 8 100 IG 
  ZNF195down3 chr11:3311198-3317597 6.4 92.3 IG 
  ZNF195down4 chr11:3303912-3308999 5 97 IG 
  ZNF195up1 chr11:3379056- 3421678 42.6 86.5 IG 
  ZNF195up2 chr11:3463567-3560541 97 89.1 IG 
DLK1 14 BEGAINup chr14:100105884-100123177 17.2 100 5’/OV 
  PPP2R5Cup1 chr14:101163838-101268901 105 86.6 OV 
  PPP2R5Cup2 chr14:101262293-101297952 35.6 100 OV 
PWS 15 NIPA1up1 chr15:20647107-20666695 19.5 92 IG 
  WHAMML1up chr15:20759798-20797989 38.2 94.7 5’/OV 
  WHAMML1up1 chr15:20800834-20804904 4 100 IG 
  SNRPNup1 chr15:21621941-21834998 213 87.6 IG 
  SNRPNup2 chr15:21887504-22553483 666 98.2 IG 
  GABRB3down1 chr15:24040777-24097047 56.3 75 IG 
  GABRB3down2 chr15:24191839-24252220 60.4 93 IG 
GNAS 20 APCDD1Lup1 chr20:56523841-56628352 104.5 84.3 OV 
  APCDD1Lup2 chr20:56633435-56655122 21.7 85.4 IG 
  ZNF831up1 chr20:57154647-57199470 44.8 99.3 5’/OV 
  ZNF831up2 chr20:57070823-57103486 32.6 91 IG 
Table 14. 28 novel macro ncRNA candidates are mapped in six well-known imprinted 
gene clusters in a total of 43 tissues/cell lines. The columns are as described in Table 13., 
section 2.2.1.1.  
 
To illustate these candidates, six examples of novel macro ncRNAs: MAS1down from 
the IGF2R imprinted gene region, H19up from the IGF2 imprinted gene region, 
ASCL2up from the KCNQ1 region, PPP2R5Cup2 from the DLK1 region, 
WHAMML1up from the PWS region and ZNF831up2 from GNAS region are shown 
(Figure 20). Relative to RefSeq and UCSC annotated genes, 17 macro ncRNAs do 
not overlap, 5 overlap with annotated genes, 3 are located next to the gene from its’ 
5’ end and 3 are located adjacent to the 3’end of a gene. Transcripts located next to 
the genes could be overlapping ncRNAs, novel 5’ exons or 3’UTRs. For example 
PPP2R5Cup2 and WHAMML1up could be novel 5’ exons or overlapping ncRNA 
while MAS1down and ASCL2up could be novel 3’UTRs or novel overlapping macro 
ncRNAs (Figure 20). From 28 mapped transcripts H19up is the only that showed very 
slight upregulation through human embryonic cell differentiation (log2=1.5 in HESd0 
and log2=2.1 in HES2d7). Eight novel macro ncRNA candidates have CpG islands 
that may be their promoters. Interestingly, five of the candidates are overlapping with 
annotated Expression Sequenced Tags (ESTs) that do not have coding potential in 
UCSC description while PPP2R5Cup2 that is exclusively expressed in testis partially 
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overlaps NCRNA00239 ncRNA. Thus, these evidences straighten the hypothesis that 
these transcripts are indeed non-protein coding RNAs.  
 
         
Figure 20. Typical examples of novel macro ncRNA candidates from 6 well-known 
imprinted gene regions. Diverse examples of macro ncRNA candidates expressed in 
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different cell lines/tissues from six well-known imprinted regions are noted by black boxes. 
PPP2R5Cup2 is an example of a group of macro ncRNA candidates rich in repetitive regions. 
Name of the HIRTA region and viewed UCSC screen position in hg18 is shown on the top of 
each gray box. The name and the lengths of the novel transcripts are showed below the 
boxes. Custom HIRTA tracks as well as RefSeq genes, sno/miRNA and CpG islands UCSC 
tracks are shown. 
 
Expression of novel candidate macro ncRNAs mapped by HIRTA in 6 well-known 
imprinted gene regions was analysed using the described ON/OFF system showing if 
ncRNA candidates are expressed or not expressed in normal and cancer cells or 
tissues (Figure 21). 
 
Among these 28 mapped novel ncRNAs there were no ubiquitously expressed 
transcripts. Five transcripts (MAS1ov, PPP2R5Cup2, GABRB3down1, 
GABRB3down2 and ZNF831up2) were expressed in a single cell line/tissue. 6 
transcripts were expressed exclusively from cancer cell lines/ tissues (MAS1ov, 
ZNF195down1, 2, 3, 4 and PPP2R5Cup1). Examples of cancer specific and cancer 
dowregulated transcripts will be further shown in section 2.6. Fetal liver and placenta 
do not express any of the 28 macro ncRNA candidates althow they do express other 
macro ncRNAs (Figure 17, section 2.2.1.1.), which is the same for two cervical 
cancer cell lines (DoTc2 and ME180).  
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Figure 21. Tissue specific expression of macro ncRNA candidates from the 6 well-
known imprinted gene regions. Expression of 28 macro ncRNA candidates in 43 normal 
and cancer cells/tissues. Description of the figure is as for Figure 17., section 2.2.1.1. Yellow; 
ON- expressed transcripts, Red; OFF-no expression. 
 
2. 3. Human XIST region  
The XIC (X Inactivation Centre) region is included here as an example of region 
containing a wel-studied Xist/XIST macro ncRNA. The XIC was genetically identified 
as a locus on the X chromosome that is required and sufficient for the X chromosome 
inactivation (Russell, 1963). However the human XIC has several differences 
compared to mouse XIC. The mouse XIC region contains Xist macro ncRNA that is 
expressed exclusively from inactivated X chromosome in female, shows imprinted 
expression in extraembryonic tissues and has silencing function in X-inactivation 
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(reviewed in (Wutz and Gribnau, 2007)). The human XIST ncRNA is also expressed 
exclusively from inactivated X chromosome in female cells containing at least two X 
chromosomes and has a silencing function in X-inactivation but it does not show 
imprinted expression in extraembryonic tissues (Brown et al., 1991; Migeon, 2002). 
Expression of the XIST macro ncRNA was shown by HIRTA single hybridizations in a 
number of human cells/tissues (one example of high XIST expression is shown on 
Figure 22A). The undifferentiated human embryonic stem cell line HES2 did not 
express XIST while after seven days of differentiation XIST was expressed in the 
same cell line (Figure 22B).  
 
 
Figure 22. Xist macro ncRNA is developmentally regulated in HES2 cell line. A. HIRTA 
expression of XIST macro ncRNA corresponds to the annotated gene. TSIX ncRNA is not 
expressed. B. XIST macro ncRNA was not expressed in HESd0 cells but showed expression 
after 7 days of differentiation in HES2d7 cell line. Custom HIRTA tracks as well as RefSeq 
genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
Mouse Tsix and human TSIX macro ncRNA show different expression patterns and 
possibly different roles between mouse and human (Chang and Brown, 2010; 
Migeon et al., 2002). The mouse Tsix is expressed early in development and 
silenced upon differentiation (Debrand et al., 1999; Lee and Lu, 1999). The Tsix 
completely overlaps Xist ncRNA, and was found to have a role in regulating Xist 
expression and in partitioning chromatin domains within the mouse Xic (Navarro et 
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al., 2009). The human TSIX macro ncRNA just partially overlapps XIST and is 
expressed in chorionic villus cells, embryonal bodies and the human embryonal 
carcinoma N-Tera2D1 cell line (Chow et al., 2003; Migeon et al., 2002). The role of 
human TSIX is not fully elucidated but it was proposed that the TSIX is not a 
regulator of XIST in humans (Chang and Brown, 2010). Using HIRTA analysis TSIX 
was not expressed in undifferentiated and differentiated HES2 cells (Figure 22B) or 
in two tested embryonal carcinoma cell lines (Tera2 and NCCIT) as well as any other 
tested cells/tissues (data not shown). Surprisingly, the N-Tera2D1 cell line that was 
previously found to express TSIX was derived by cloning the NTERA-2 cell line that 
was itself established from the nude mouse xenograft of Tera-2 
(http://www.lgcstandards-atcc.org/), the cell line that was hybridized to HIRTA and 
did not show TSIX expression. 
 
The Jpx that is also known as Enox ncRNA is the first gene expressed upstream of 
the Xist ncRNA and it was found to partially escape X-inactivation in mouse 
(Johnston et al., 2002). Similarly, human JPX/ENOX was also found to be expressed 
from both inactive and active X chromosomes (Chow et al., 2003). In the UCSC 
RefSeq genes JPX/ENOX ncRNA is annotated as NCRNA00182 that is located 
about 90kb upstream of XIST. NCRNA00183 ncRNA is another ncRNA that 
overlapps NCRNA00182 and was recently annotated by UCSC RefSeq genes. 
Ubiquitous expression in all tested normal and cancer tissues of both overlapping 
NCRNA00182 and NCRNA00183 macro ncRNAs, was found by HIRTA (typical 
expression pattern in one of the tissues is shown on Figure 23). These ncRNAs were 
not developmentaly regulated after seven days of differentiation in ES cell system 
(data not shown). Both NCRNA00182 and NCRNA00183 were rich in repeats and 
NCRNA00183 overlapped with three annotated miRNAs (Figure 23).  
 
 
Figure 23. NCRNA00138 and NCRNA00182 macro ncRNAs are expressed from XIC 
region. HIRTA detects two overlapping macro ncRNAs (NCRNA00182 and NCRNA00183) 
that are positioned more than 90kb upstream of XIST. Custom HIRTA tracks as well as 
RefSeq genes, sno/miRNA and CpG islands UCSC tracks are shown. 
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2. 4. Macro ncRNAs in 26 less-studied imprinted gene regions  
 
2. 4. 1. Mapping of known and novel macro ncRNAs in less-studied regions 
In the previous sections six well-studied imprinted gene clusters and the XIST 
genomic region were shown to express already known or novel macro ncRNAs 
(sections 2.2.; 2.3.). To examine whether all human imprinted gene clusters express 
macro ncRNAs, we analysed 26 less-well studied imprinted gene regions spotted on 
HIRTA (less-studied regions were defined in Table 9, section 2.1.1.). Mapping of 
novel macro ncRNAs in 43 cells/tissues/patients in 26 less-studied regions was done 
on the basis of the already presented criteria (section 2.1.5.). 11/26 tested regions 
had been shown previously to express macro ncRNAs (e.g. WT1 region: WIT1 
ncRNA, MEST region: MESTIT1 and MIT1 ncRNAs, PLAGL1: HYMAI ncRNA, 
CALCR region: DLX6AS ncRNA) (introduced in Table 6A and Table 6B, section 
1.2.5.2.).  
 
HIRTA Chip confirmed expression of the paternally expressed, 2.4kb long WIT1 
ncRNA although the size of this ncRNA could not be precisely mapped since a new 
∼39kb long transcript overlapping WIT1 or presenting novel variant of WIT1, was 
found (WIT1down). This new 39kb transcript showed specifically high expression in 
fetal kidney, similar to WIT1 (Figure 24A).  
 
MESTIT1 ncRNA is 3.2kb long, paternally expressed and overlaps the MEST gene 
(Li et al., 2002). Expresion of this transcript was confirmed by HIRTA and showed 
tissue specific expression (Figure 24B). MIT1, from the same MEST imprinted gene 
region was previously identified as a ncRNA mapping to intron 20 of COPG2 and 
having an antisense orientation to this protein-coding gene (Yamasaki et al., 2000). 
Since the reference sequence, from the hg18 version of the UCSC human genome 
that was used for HIRTA design, has a gap of about 80kb including 10 previously 
mapped COPG2 exons, MIT1 expression could not be confirmed.  
 
HYMAI is a paternally expressed 5kb long ncRNA previously shown to overlap the 
PLAGL1 protein-coding gene in the sense orientation. HIRTA showed high 
expression signals over the known HYMAI region, but since the PLAGL1 gene is 
simultaneously highly expressed and shows high intronic signals in the region 
overlapping HYMAI, the expression of HYMAI itself could not be independently 
elucidated. 
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DLX6AS ncRNA expression was detected from the CALCR imprinted gene region by 
HIRTA. But simultaneously, two novel macro ncRNA candidates could be mapped in 
the DLX6AS region: the ∼11kb long DLX6up1 positioned upstream of DLXAS and the 
∼26kb long DLX6up2 ncRNA overlapping DLX6AS. These results indicate, DLX6 is a 
region with potentially highly complex overlapping transcriptional units that are still 
not fully elucidatet (Figure 24C).  
 
 
Figure 24. Examples of known macro ncRNAs from 26 less studied imprinted gene 
regions. A. 2.4kb long known WIT1 macro ncRNA positioned downstream of WT1 protein-
coding gene is expressed in fetal kidney. WIT1down is a 39kb long macro ncRNA candidate. 
B. In the MEST region the MESTIT1 macro ncRNA is expressed in undifferentiated ES cells. 
C. The DLX6 region is part of the CALCR imprinted gene region and may contain a number of 
overlapping transcripts (e.g. DLX6up1, DLX6AS, DLX6up2, DLX6). Custom HIRTA tracks as 
well as RefSeq genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
Mapping of novel macro ncRNAs in 26 less-studied regions revealed 73 novel macro 
ncRNA candidates in 43 tested cell lines/tissues (Table 15). Overall positions in the 
human genome, lengths, coverage and positions in accordance to protein coding 
genes were mapped. Novel macro ncRNA transcripts that were identified from were 
in between 6 and 460kb in length. Five of these candidates are found to be between 
1kb and 10kb, 51 between 10 and 100kb and 17 more than 100kb in length. 19 of 
 
Irena Vlatkovic PhD Thesis   77 
these transcripts have potential CpG island promoters on one of the mapped ends, 
and 13 of them are partially overlapped with ESTs annotated with RefSeq genes 
where 10 of these ESTs are showing non-protein coding potential according to the 
UCSC description.  
HIRTA REGION 
 
Chr. NAME of macro 
 ncRNA 
POSITION (hg18) Length 
(kb) 
COV 
(%) 
Position to 
annotated PC 
genes 
TRP73 1 LRRC47down chr1:3679188- 3686484 7.1 99 IG 
DIRAS3 1 GADD45Aup chr1:67842948-67867981 25 92.4 IG 
  GPR177up chr1:68530492-68571923 41.4 97.4 IG 
  RPE65ov chr1:68626430-68712423 85.9 100 OV 
  RPE65down1 chr1:68484480-68624258 139.7 96.9 3’/OV 
  RPE65down2 chr1:68530492-68571923 41.4 89.6 IG 
COMMD1 2 B3GNT2down1 chr2:62376964-62498341 121.3 99.2 IG 
  B3GNT2down2 chr2:62305370-62373270 67.9 93 3’/OV 
  FAM161Adown chr2:61794031-61845495 51.4 83.1 IG 
NAP1L5 4 TIGD2down chr4:90255075-90296601 41.5 91.9 3’/OV 
PLAGL1 6 PHACTR2ov chr6:143899928-144040795 140.8 98 OV 
GRB10 7 COBLdown1 chr7:50948084-51023474 75.4 87.9 IG 
  COBLdown2 chr7:50902101-50930499 28.4 98.7 IG 
CALCR 7 DLX6up1 chr7:96422607-96434058 11.4 100 IG 
  DLX6up2 chr7:96446866-96472851 25.9 97.8 IG 
  COL1A2up chr7:93758984-93858857 99.8 97.7 IG 
MEST 7 KLF14up1 chr7:130121904-130170014 41.8 89.7 IG 
  KLF14up2 chr7:130186541-130248421 61.8 99.7 IG 
  KLF14up3 chr7:130248421-130279459 31 100 IG 
KCNK9 8 PEG13 chr8:141173723-141180357 6.6 100 IN 
  PTK2up chr8:142107593-142163814 56.2 92 IG 
  KIAA1126up chr8:142333407-142388337 54.9 99.2 5’/OV 
SFMBT2 10 PFKFB3down chr10:6317511-6509111 191.6 99.9 3’/OV 
  SFMBT2down1 chr10:6866778-6926405 59.6 99.6 IG 
  SFMBT2down2 chr10:6820088-6866778 46.7 99.3 IG 
  SFMBT2down3 chr10:7185016-7201477 16.5 87.6 IG 
  SFMBT2down4 chr10:6915718-7015793 100 95.9 IG 
  SFMBT2down5 chr10:6929387-6964245 34.8 99.4 IG 
  GATA3down chr10:8452227-8487562 35.3 73.8 IG 
INPP5F 10 BAG3down chr10:121427002-121475599 48.6 92.6 3’/OV 
  SEC23IPdown1 chr10:121922168-122083651 161.5 90.7 IG 
  SEC23IPdown2 chr10:122068853-122096845 28 99.3 IG 
  SEC23IPdown3 chr10:121922168-122085936 163.8 90.6 IG 
BAZ2 11 OR556B4up1 chr11:6000641-6087607 87 98.5 OV 
  OR56A1down chr11:6020186-6041034 20.8 99.3 IG 
  PRKCDBPup chr11:6298316-6323682 25.4 100 5’/OV 
  PRKCDBPdown chr11:6272107-6296751 24.6 93.9 3’/OV 
  HPXdown chr11:6400477-6409017 8.5 100 3’/OV 
  ZNF215up chr11:6724246-6904230 180 95.3 OV 
  RBMXL2down chr11:7068955-7116437 47.5 93 3’/OV 
  OR5P2ov chr11:7684517-7876797 192.3 99 OV 
AMPD3 11 AMPD3up chr11:10325169-10428800 103.6 78.5 5’/OV 
  LYVE1ov chr11:10519395-10551214 16.6 98.8 OV 
  MRVI1up chr11:10672111-10707462 35.5 83.8 5’/OV 
WT1 11 WIT1down chr11:32418196-32457422 39.2 96.3 3’/OV 
SDHD 11 SDHDdown chr11:111471727-111514225 42.5 97.9 3’/OV 
  PTSdown chr11:111645888-111756700 120 97.4 3’/OV 
SLC38A4 12 SLC38A4down1 chr12:45063900-45174483 110.6 83.52 IG 
  SLC38A4down2 chr12:45063900-45527065 463.2 94.3 OV 
  SLC38A4up chr12:45563328-45661331 98 98 IG 
DCN 12 EPYCov chr12:89855372-89888024 32.6 83.8 OV 
  DCNup1 chr12:90400030-90416192 16.1 87.1 IG 
  DCNup2 chr12:90469318-90484664 15.3 93.2 IG 
  DCNup3 chr12:90538500-90546595 8 92.7 IG 
HTR2A 13 LRCH1up1 chr13:45925127-45939792 14.6 92.7 IG 
  LRCH1up2 chr13:45947398-46015616 68.2 87.6 5’/OV 
  HTR2Aup1 chr13:46364433-46472289 107.8 85.5 5’/OV 
  HTR2Aup2 chr13:46364433-46405913 41.4 90.8 OV 
  HTR2Ain chr13:46317545-46333910 16.4 94.1 IN 
GATM 15 SQRDLdown chr15:43784646-43889432 104.8 74.4 IG 
  C15orf43up chr15:42962890-42998200 35.3 93.4 IG 
RASGRF1 15 ADAMTS7down chr15:76830029-76836494 6.4 96.7 IG 
  TMED3down chr15:77402383-77490747 88.4 98.5 3’/OV 
  KIAA1024up chr15:77492611-77511913 19.3 89 5’/OV 
  CHRNB4up chr15:76739929-76826996 87 88.6 5’/OV 
IMPACT 18 ZNF521up chr18:20555579-20779652 224 94.4 IG 
ZIM 19 ZNF71down1 chr19:61824857-61835672 10.8 100 3’/OV 
  ZNF71down2 chr19:61835974-61866765 30.8 91.3 3’/OV 
HM13 20 ID1up1 chr20:29623883-29635995 12.1 91.7 IG 
  ID1up2 chr20:29639171-29654648 15.4 95.6 5’/OV 
NNAT 20 BLCAPov chr20:35547467-35583161 35.7 99.5 3’/OV 
L3MBTL 20 L3MBTLup chr20:41552855-41572354 19.5 100 IG 
  TOX2up chr20:41817556-41913383 95.8 72.7 IG 
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Table 15. 73 novel macro ncRNA candidates have been mapped in 26 less-well studied 
imprinted gene regions in 43 cells/tissues/patients by HIRTA. The columns are as 
described in Table 13., section 2.2.1.1. 
 
2. 4. 2. Developmental regulation of macro ncRNAs in less-studied regions 
We tested developmental regulation of macro ncRNA candidates by differentiating 
human ES cells and testing candidate gene expression using HIRTA single 
hybridizations before and after differentiation. Among 73 mapped macro ncRNA 
candidates in 26 less-well studied imprinted gene regions, 6/22 that were expressed 
in ES cells showed some degree of developmental regulation.  
 
The OR56B4up1 ncRNA candidate was expressed from the BAZ2 region in 
undifferentiated ES cells while after seven days of differentiation expression of this 
gene was not detected (Figure 25A). Interestingly, another macro ncRNA candidate 
that also overlaps olfactory receptor genes, OR5P2ov was upregulated after seven 
days of ES cells differentiation (Figure 25B). SLC38A4down2 is ∼463kb long ncRNA 
expressed from SLC38A4 region and was downregulated to a lesser extent during 
ES cells differentiation. Three other candidates (PKCDBPup, ZNF521up, ID1up1) 
that show downregulation during HES2 differentiation were lowly expressed in 
undifferentiated ES cells and by day 7 of differentiation of HES2 they did not show 
expression (data not shown). 
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Figure 25. Comparison of novel macro ncRNAs expression before and after day 7 of 
human embryonal stem cells differentiation. A. The OR56B4up1 macro ncRNA expressed 
from the BAZ2 imprinted gene region is downregulated upon differentiation of HES2 cell line. 
B. OR5P2ov shows upregulation upon ES cells differentiation. Both OR56B4up1 and 
OR5P2ov are overlapping olfactory receptor genes. Custom HIRTA tracks as well as RefSeq 
genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
2. 4. 3. Nuclear versus cytoplasmic localization of novel macro ncRNAs in less-
studied regions 
Nuclear versus cytoplasmic localization of macro ncRNA candidates in less-studied 
imprinted gene regions was first tested by the double cDNA hybridization procedure 
in normal human fibroblasts cell line (Hs27) (section 2.1.6). 14 out of 73 transcripts 
showed expression in Hs27 cell line. For 5 macro ncRNAs  (KLF14up2, KLF14up3, 
OR5P2ov, ADAMTS7down, TMED3down) double HIRTA hybridization showed 
nuclear enrichment, 7 (TIGD2down, PEG13, KIAA1126ov, PRKCDBPup, PTSdown, 
KIAA1024up, BLCAPov) were found to be both nuclear and cytoplasmic and one 
appeared to be cytoplasmic enriched (LRRC47down). To illustrate these findings, 
examples of double cDNA hybridizations on HIRTA for novel macro ncRNAs will be 
shown under section 2.4.5., where ten novel macro ncRNAs will be characterized 
using different techniques. 
 
Further, SLC38A4down2 and ADAMTS7down macro ncRNAs nuclear enrichment 
relative to the RPLPO housekeeping gene was shown using quantitative RT-PCR 
(qRT-PCR) (Figure 25). RNA from nuclear (N) and cytoplasmic (C) fractions of the 
Hs27 cell line and total Hs27 RNA (T) were tested by primers specific for these 
macro ncRNA candidates. The H19 macro ncRNA was used as a control as it was 
previously found in both nucleus and cytoplasm (Brannan et al., 1990). H19 
expression showed a N/C ratio of 1.5/1 as expected. Similarly, the GAPDH 
housekeeping gene N/C ratio was 0.8/1. Two primer pairs were used to test 
localization of KCNQ1OT1, which was used as a positive control known to be nuclear 
enriched (Murakami et al., 2007). KCNQ1OT1 was entirely found in nuclear fraction 
of the Hs27 fibroblast cell line (with ratios N/C=208/1 and N/C=142/1 depending of 
the primer pair), while SLC38A4down2 and ADAMTS7down were present in both the 
nuclear and cytoplasmic fractions, but enriched in nucleus with N/C ratios of 5:1 and 
11:1 respectively. Still, it cannot be excluded that cytoplasmic aboundance was 
under estimated due to presence of rRNA. 
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Figure 26. qRT-PCR showed nuclear enrichment of the ADAMTS7down and 
SLC38A4down2 macro ncRNAs relative to the RPLPO housekeeping gene. Hs27 cells 
were fractionated to nuclear (N) and cytoplasmic (C) fractions. Total (T) RNA from the same 
cell line was set to 1 and used for comparisson. The H19 macro ncRNA was found to be 
partially exported to the cytoplasm as previously published. The GAPDH housekeeping gene 
(GAPDH primer pair) showed the same kind of distribution showing both nuclear and 
cytoplasmic localization. KCNQ1OT1 ncRNA was tested by two primer pairs (KCNQ1OT1q1 
and KCNQ1OT1q2) and found to be nuclearly localized. ADAMTS7down macro ncRNA 
candidate has been tested with ADAMTS7Cq3 primer pair and found to be nuclearly enriched 
same as SLC38A4down2 macro ncRNA tested with SLC38A4Cq1 primer pair. Standard 
deviation bars represent three technical replicates.  
 
2. 4. 4. Tissue specific expression of macro ncRNAs from less-studied regions 
Tissue specific expession of 73 novel macro ncRNA candidates in 43 tested 
cells/tissues/patients was examined from HIRTA single hybridization data by the 
ON/OFF system where ON means expressed at any level and OFF no expression of 
a ncRNA candidate (Figure 27). 2/73 transcripts (ADAMTS7down and KLF14up3) 
showed ubiquitous expression in all tested samples, while two other macro ncRNA 
candidates: KIAA1126ov and BLCAPov were expressed in most of the cells/tissues. 
The SEC23IPdown3 expression was restricted to fetal and adult kidney and 
L3MBTLup restricted to fetal and adult brain tissue. 13/73 transcripts showed 
expression detected just in one of the 43 tested cells/tissues/patients, and 7 out of 
these 13 transcripts were testis specific. 56 transcripts showed different levels of 
expression or lack of expression in different tissues. 16 macro ncRNA candidates 
were found to be cancer specific (not expressed in any of tested normal tissues). 
From these candidates 9 were found exclusively in one cancer cell line; for example 
SFMBT2down5 was cervical cancer specific and OR56A1down was AML5 patient 
specific. Examples of cancer specific expression of these transcripts will be shown in 
the section focused on macro ncRNA expression changes in cancer (2.6). 
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Figure 27. Tissue specific expression of novel macro ncRNAs in normal and cancer 
cells. Tissue specific expression of 73 macro ncRNA candidates from 26 less-known 
imprinted gene regions is shown for 43 tested cells/tissues. Description of the figure is as for 
Figure 17, section 2.2.1.1. Yellow; ON- expressed transcripts, Red; OFF-no expression. 
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2. 4. 5. Examples of characterization of novel macro ncRNAs  
Ten novel macro ncRNA candidates expressed from less-studied imprinted gene 
regions were selected for further characterization. Characterization included 
assessment of: 1) Length of macro ncRNA, 2) Tissue specific expression and 
subcellular localization, 3) Annotation, 4) CpG island features, 5) 
Monoallelic/Imprinted expression of macro ncRNA. 
 
Length of macro ncRNA transcripts as well as tissue specific expression was 
assessed by analyzing HIRTA hybridization data, or by Northern blots using diverse 
cells/tissues and probes specific for macro ncRNA of interest (for details about the 
method see section 5.8.6.). Mouse Airn and Kcnq1ot1 ncRNAs that have function in 
gene silencing in cis are both nuclearly localized (Redrup et al., 2009; Seidl et al., 
2006). Thus, characterization of transcripts included the test of subcellular 
localization for transcripts expressed in normal human fibroblasts using double cDNA 
hybridization (section 2.1.6.) and RT-PCRs on nuclear, cytoplasmic and total RNA.  
 
Annotation of transcripts orientation was done using 5’-3’ slope feature, CpG islands, 
H3K4me3, RNAP II. CpG islands, visualized using CpG island track available on 
UCSC browser (Gardiner-Garden and Frommer, 1987), overlapping one of the 
transcript ends are potential promoters of the transcripts. CpG islands and/or borders 
of macro ncRNA candidate transcription were compared with maps of H3K4me3 
histone modification peaks from 9 cell lines (GM12878, H1-hESC, HepG2, HMEC, 
HSMM, HUVEC, K562, NHEK and NHLF) and with maps of RNAP II peaks from 3 
cell lines (HUVEC, K562 and NHEK), visualized using ENCODE Histone 
Modifications by Broad Institute ChIP-seq track available on UCSC browser, 
http://genome.ucsc.edu/cgibin/hgTrackUi?hgsid=168678869&c=chr1&g=wgEncodeB
roadChipSeq, (Bernstein et al., 2005; Bernstein et al., 2006). The large intergenic 
non-coding (linc) RNAs (Khalil et al., 2009) were compared with HIRTA mapped 
transcripts expressed from Hs27 and HeLa cell lines. Since Khalil et al. data also 
include tracks of lincRNA association with Polycomb repressive complex (PRC)2 and 
chromatin-modifying protein CoREST complexes, indication of this association was 
also investigated for three novel HIRTA mapped macro ncRNAs overlapping with linc 
ncRNAs.  
 
The assessed CpG island features were: test of CpG island promoter methylation 
status (if the CpG island is a DMR), test for presence of Differential Histone 
Modifications (DHM) and test for presence of tandem direct repeats in the CpG 
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island. A number of imprinted macro ncRNA (e.g. KCNQ1OT1) have promoter CpG 
islands that are also Differentially Methylated Regions (DMRs) with one 
unmethylated and one methylated allele depending of parent-of-origin. Methylation 
status of CpG islands mapping to ends of novel macro ncRNAs was tested using 
methylation sensitive enzymes in Southern blot method and the Southern probe 
specific for tested macro ncRNA (for details about the method see section 5.5.). 
Deletions of DMRs showed previously that they could function as Imprint Control 
Elements (ICEs), controlling imprinted expression in the entire gene cluster 
(introduced in section 1.2.4.). Two known features of ICEs are: 1) presence of 
Differential Histone Modifications (DHM) including both activation H3K4me3 and 
repressive H3K9me3 chromatin modifications, 2) often direct repeats are present. 
Presence of DHM was tested comparing HIRTA expression profiles with ChIP-Seq 
profiles, published for both H3K4me3 and H3K9me3 in T cells by Barski (Barski et 
al., 2007). Presence of tandem direct repeats in the CpG island promoters of novel 
macro ncRNAs was assessed using dotmatcher program (EMBOSS).  
 
The imprinted gene expression was assessed by a combination of PCR/Proofreading 
RT-PCR and sequencing. In the first step, DNA from the cell lines that express genes 
of interest, was amplified using PCR with primers overlapping with known SNPs from 
the dbSNP build 129 database (Sherry et al., 2001) and sequenced on the Applied 
Biosystems 3730xl DNA Analyzer. Results of sequencing were analyzed using 
Sequencher 4.7. The heterozygous SNPs were visualized as two sequencing peaks 
at one base pair (bp) position and the same primer pairs were further used in the 
proofreading RT-PCR reaction using cDNA as a template. If two peaks were 
overlapping on Sequencher tracks gained from both DNA and cDNA sequencing 
than biallelic, and if one peak was present on the cDNA than monoallelic expression 
was found. The blood from one family and three lymphoblastoid cell lines that 
originated from families genotyped from the international HapMap project 
(http://hapmap.ncbi.nlm.nih.gov/) were assessed using the same method (for details 
see section 5.8.5). Macro ncRNA candidates that were assessed for listed 
characteristics and that will be presented through the section are: LRRC47down, 
KLF14up3, PEG13, KIAA1126up, PRKCDBPup, SLC38A4down2, ADAMTS7down, 
TMED3down, KIAA1024up and BLCAPov. 
 
2. 4. 5. 1. HIRTA REG TP73 (chr1): LRRC47down macro ncRNA characterization 
TP73 is expressed from human chromosome 1 and encodes the p73 transcription 
factor involved in cellular response to stress and development (Dickman, 1997). 
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TP73 is the only known imprinted gene in the HIRTA TP73 region and shows 
expression from maternal chromosome in neuroblastoma cells (Kaghad et al., 1997). 
No macro ncRNAs and DMRs have been mapped previously to this region.  
 
1) Length of macro ncRNA 
The LRRC47down macro ncRNA candidate is ∼7kb long. It is positioned ∼ 40kb 
downstream of the TP73 gene and immediately downstream from LRRC47 (Leucine-
rich repeat containing protein 47). LRRC47down partially overlaps the hypothetical 
protein LOC388588 (Figure 28A).  
 
2) Tissue specific expression and subcellular localization 
LRRC47down macro ncRNA candidate was expressed in 16/20 normal cells/tissues 
while in cancer downregulation was apparent since just 2/23 cancer samples 
expressed LRRC47down (Figure 27, section 2.4.4). Double cDNA hybridization in 
Hs27 fibroblast cell line indicated potential cytoplasmic enrichment for this candidate 
(Figure 28A). 
 
3) Annotation 
The LRRC47down macro ncRNA candidate did not show clear presence of 5’-3’ 
slope, but it had CpG island 92 located at one of the ends of the transcript that could 
be a potential promoter of this macro ncRNA candidate, as well as H3K4me3 in 9/9 
(shown for H1-hESC) and RNAP II in 1/3 (shown in K562) Broad Histone cell lines 
(Figure 28A).  
 
4) CpG island features 
The CpG island 92 was shown to be unmethylated in fibroblasts (Hs27) and HeLa 
cells using three methylation sensitive enzymes (BstUI, BssHII and EglI) in Southern 
blot hybridization with LRRC47SBP probe (Figure 28C). Presence of DHM could not 
be observed on this CpG island (data not shown). Direct repeats were present in the 
CpG island 92 (Figure 28D). 
 
5) Monoallelic/Imprinted expression of macro ncRNA 
One heterozygous SNP (rs12061931, C/T) was found in fibroblast, Hs27 DNA using 
sequencing of PCR products from LRRC47CIE1 and LRRC47CIE2 primer pairs. 
Sequencing of RT-PCR band containing heterozygous SNP showed that 
LRRC47down macro ncRNA candidate was bialelically expressed in fibroblasts Hs27 
cell line (Figure 28B).  
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Figure 28. LRRC47down macro ncRNA candidate characterization. A. Expression of 
LRRC47down ncRNA candidate from normal fibroblasts (Hs27) and fetal liver is shown. This 
candidate is ∼7kb in length and has a potential CpG island promoter (CpG 92) overlapped 
with H3K4me3 in H1-hESC cell line and RNAP II in K562 cell line. This candidate is 
potentially cytoplasmically enriched since gray cytoplasm signals could be observed in the 
Hs27, N/C track. Positions of the Southern blot probe LRRC47SBP and heterozygous SNP 
(rs12061931) are shown in the hg18 build on UCSC browser by loading the custom .wig 
track. UCSC browser position is shown on the top. Tracks presented as on Figure 11B, 
section 2.1.5. and Figure 12B., section 2.1.6. B. Primer pair used for PCRs and RT-PCRs is 
shown on the top. Products were sequenced and sequencing tracks from Hs27 DNA and 
RNA showing five nucleotides from both sides of heterozygous SNP are shown.  rs12061931 
express both C and T alleles in the Hs27 cell line. *; heterozygous SNP, blue box; position of 
the SNP. C. Map of the genomic region surrounding CpG island 92 is shown. Positions where 
enzymes cut are shown using vertical gray lines while numbers on the left side from vertical 
lines represent expected lengths (in kilobases) of the DNA fragments digested with 
corresponding enzymes and recognized with the probe that is shown in red. Southern blot 
using three methylation sensitive enzymes (BstUI, BssHII and EglI) in combination with EcoRI 
and LRRC47SBP probe showed that both alleles of CpG 92 are unmethylated in HeLa and 
Hs27 cell lines, since three methylation senzytive enzymes cutted DNA producing 2.4kb, 
1.8kb, 1.7kb and 1.3kb bands while 4.7kb band expected from digestion of EcoRI enzyme 
alone was not present (indicated with arrow). D. CpG island 92 shows presence of direct 
repeats using dotmatcher program (EMBOSS) with following criteria, window size: 30 and 
treshold: 65. 
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In summary, LRRC47down was shown to be ~7kb long transcript expressed in most 
of the tested normal tissues (16/19) and not expressed in most of the tested cancer 
cell lines (21/23) that had unmethylated CpG island promoter and was biallelically 
expressed in fibroblasts. 
 
2. 4. 5. 2. HIRTA REG MEST (chr7): KLF14up3 macro ncRNA characterization 
The HIRTA MEST region is positioned on human chromosome 7 and includes four 
known protein coding genes showing imprinted expression (MEST and COPG2 that 
are paternally expressed and CPA4 and KLF14 that are maternally expressed) and 
two macro ncRNAs: MESTIT1 and MIT1, both previously found to be paternally 
expressed imprinted genes (introduced in Table 6A, section 1.2.5.2.).  
 
1) Length of macro ncRNA 
The KLF14up3 macro ncRNA candidate was a part of complex transcription unit 
potentially containing numerous overlapping transcripts expressed in both 
transcriptional orientations. The KLF14up3  (∼30kb long) alone was located directly 
upstream of Homo sapiens hypotetical LOC378805 (FLJ43663), transcript variant 1, 
ncRNA (RefSeq genes, UCSC) and could be part of this transcript (Figure 29A).  
 
2) Tissue specific expression and subcellular localization 
KLF14up3 was ubiquitously expressed in all 43 tested cells/tissues (Figure 27, 
section 2.4.4). HIRTA double cDNA hybridization (Figure 29A) and RT-PCRs on 
nuclear and cytoplasmic fractions of normal human fibroblasts (Figure 29B) both 
showed nuclear enrichment of KLF14up3 macro ncRNA candidate. 
 
3) Annotation 
The presence of H3K4me3 in GM12878 lymphoblastoid cell line (and in 7 more cell 
lines mapped by Broad Histone, UCSC track, section 2.4.5.) at the distal end of the 
KLF14up3 transcript, argues for plus (+) strand transcription that is opposite to 
transcription orientation of FLJ43663 ncRNA transcript. KLF14up3 has been 
previously mapped as linc ncRNA, associated with PRC2 and CoREST complexes 
(Figure 29A). 
 
4) CpG island features 
KLF14up3 did not show presence of a CpG island promoter (Figure 29A). 
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5) Monoallelic/Imprinted expression of macro ncRNA 
Despite the nuclear localization and genome position close to known imprinted 
genes, KLF14up3 was biallelically expressed in fibroblasts on the basis of three 
heterozygous SNPs (rs17165272, rs205712 and rs13230391) (data shown for 
rs17165272, Figure 29B).  
 
 
Figure 29. KLF14up3 (~31kb) is nuclear enriched biallelic macro ncRNA. A. Expression 
of KLF14up2 (~52kb) and KLFup3 (~31kb) in Hs27 cells and bone marrow from single HIRTA 
hybridizations is shown. This macro ncRNA is enriched in nucleus by double cDNA 
hybridization and overlapps to previousy found linc RNAs that are associated with PRC2 and 
CoREST complexes. Positions of heterozygous SNP (rs17165272) and PCR product 
(KLF14CIE3) used for sequencing of SNPs and for testing cellular localization are shown in 
the hg18 build on UCSC browser by loading the custom .wig track. Tracks presented as on 
Figure 11B, section 2.1.5. and Figure 12B., section 2.1.6. B. KLF13up3 nuclear localization 
has been confirmed using RT-PCR on nuclear (N), cytoplasmic (C) and total (T) fibroblasts 
RNA. GAPDH is used as a loading control. +; +RT reaction, -; -RT reaction, NT; no template 
C. KLF14up3 is biallelically expressed in fibroblasts based on rs17165272 SNP. For detailed 
description look at the Figure 28B, section 2.4.5.1. 
 
In summary, KLF14up3 was ∼30kb long, ubiquitous, nuclear, biallelically expressed 
macro ncRNA that is associated with PRC2 and CoREST complexes. 
 
2. 4. 5. 3. HIRTA REG KCNK9 (chr8): PEG13 and KIAA1126up ncRNA 
characterization 
KCNK9 (potassium chanel, subfamily K, member 9) is the only known gene showing 
imprinted expression (maternally expressed (Ruf et al., 2007)) in HIRTA region 
KCNK9. In mouse this imprinted gene region contains two imprinted protein coding: 
maternally expressed genes Kcnk9 and Trappc9 (Ruf et al., 2007; Wang et al., 
2008b) and one paternally expressed non-protein coding RNA, Peg13 (Smith et al., 
2003). The CpG island promoter of mouse Peg13 is a gametic DMR (Ruf et al., 
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2007). Previously human PEG13 was not identified, despite the in silico mapping of 
the orthologous human region of the Peg13 DMR, to intron 17 of the TRAPPC9 gene 
(Ruf et al., 2007).  
 
1) Length of macro ncRNAs 
HIRTA single hybridizations showed expression of the human ∼ 6.6kb long transcript 
from intron 17 of TRAPPC9, overlapping the CpG island corresponding to mouse 
Peg13 DMR and with specifically high expression in fetal and adult brain (Figure 
30A). Thus, I named this transcript PEG13. The second macro ncRNA candidate 
identified in the KCNK9 region, KIAA1128up was ∼55kb long macro ncRNA, located 
upstream of KIAA1126, a putative uncharacterized protein (that is annotated by 
UCSC gene track with eight annotated exons, but not present in RefSeq genes) with 
no reports about its imprinted expression in both human or mouse (Figure 31A). 
 
2) Tissue specific expression and subcellular localization 
Normal human fibroblasts (Hs27) showed low expression of PEG13. In the same cell 
line this ncRNA candidate was present in both nuclear and cytoplasm fractions by the 
double cDNA hybridization (Figure 30A). Except from fibroblasts, PEG13 was 
expressed from the whole blood, and it showed especially high expression from fetal 
and adult brain (Figure 27, 2.4.4.). The KIAA1126up, candidate was highly expressed 
from the whole blood, while fibroblasts showed low expression (Figure 31A). The 
KIAA1126up was expressed from 15/20 of normal and from 14/23 cancer cell lines 
(Figure 27, section 2.4.4.). This macro ncRNA candidate was present in both nuclear 
and cytoplasm fractions of fibroblasts, based on the double cDNA HIRTA 
hybridizations (Figure 31A).  
 
3) Annotation 
The CpG island that overlapps PEG13 (CpG: 210, UCSC) showed presence of 
H3K4me3 in 7/9 Broad Histone Modification tracks (presence of H3K4me3 in H1-
ESC is shown on Figure 30A). The KIAA1026up had a potential CpG island promoter 
(CpG: 77, UCSC) that was overlapped by H3K4me3 in 8/9 cell lines on the Broad 
UCSC track.  
 
4) CpG island features 
A Southern blot using methylation sensitive enzyme BssHII in combination with 
EcoRI or EcoRI alone as a control, and specific probe (PEG13SBP) revealed that the 
CpG island 210 is a DMR in the Hs27 cell line where the methylated and 
 
Irena Vlatkovic PhD Thesis   89 
unmethylated alleles respectively were visually present as bands of similar intensities 
indicating a 50%: 50% ratio (feature of a DMR) (Figure 30C). In the same time this 
CpG island shows hypermethylation in HeLa cells (Figure 30C). A dotplot of CpG 210 
showed the presence of numerous direct repeats (Figure 30D). KIAA1026up CpG 
island was not tested for presence of methylation.  
 
5) Monoallelic/Imprinted expression of macro ncRNA 
To test potential monoallelic expression of PEG13, I used 4 primer pairs (P13CIE1-4) 
and were able to map one known heterozygous SNP (rs35257944) (dbSNP build 
130, UCSC) and one novel heterozygous SNP on position chr8: 141176581-
141176581 in Hs27 DNA by sequencing PCR products with both forward and reverse 
primers. Both SNPs showed a strong bias towards one allele (preferential monoallelic 
expression) being expressed in the fibroblast cell line (Figure 30B, rs35257944 
presented). To test allelic expression of KIAA1126up transcript, I used five primer 
pairs (KIAA1126CIE1-5) positioned through the body of the KIAA1126up gene and 
mapped three heterozygous SNPs in the Hs27 cell line (rs62524186, rs67307958 
and rs72681595). rs62524186 was heterozygous in Hs27 and had A nucleotide 
present on one parental chromosome (allele) and G nucleotide present on the same 
position on another parental chromosome. By using the KIAA1126CIE4 primer pair 
and sequencing RT-PCR products, biallelic expression of KIAA1126up was shown 
since both A and G alleles were expressed at the rs62524186 SNP  (Figure 31B).  
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Figure 30. PEG13 is a human homolog of mouse Peg13 gene that shows preferential 
expression from one allele and the presence of Differentially Methylated Region (DMR) 
in normal human fibroblasts. A. Expression and nucleus vs. cytoplasmic localization of 
PEG13 (∼6.6kb long transcript) in fibroblasts (Hs27) and expression in adult brain is shown. 
CpG island 210 (UCSC, CpG island track) position and H3K4me3 presence in H1-ESC is 
shown (UCSC, Broad Histone Modifications). Positions of heterozygous SNP (rs35257944) 
and Southern blot probe (PEG13SBP) are presented using orange and brown boxes. Tracks 
presented as on Figure 11B, section 2.1.5. and Figure 12B., section 2.1.6. B. CpG 210 is a 
DMR in Hs27 fibroblasts while in HeLa cells this CpG island is hypermethylated. Methylation 
was tested by Southern blot using BssHII methylation sensitive enzyme in combination with 
EcoRI and EcoRI alone as a control while hybridization was done with specific probe 
(PEG13SBP). 10kb and 3.3kb bands represent methylated and unmethylated alleles 
respectively. D. Preferential monoallelic expression of PEG13 ncRNA was found in Hs27 
fibroblasts using the P13CIE4 primer pair flanking the rs35257944 SNP. For detailed 
description look at the Figure 28B, section 2.4.5.1. C. Numerous direct repeats are present in 
CpG 210 using Dotmatcher with criteria: window size=30 and threshold=65. 
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Figure 31. KIAA1126up macro ncRNA candidate is ∼55kb long, both nuclear and 
cytoplasmic biallelically expressed transcript. A. Expresssion profiles in Hs27 and whole 
blood, double cDNA hybridization (Hs27, N/C) and presence of CpG: 77 island mapping to 
the distal end of the candidate and marked with H3K4me3 from H1-hESC CHIP-seq is shown. 
Tracks presented as on Figure 11B, section 2.1.5. and Figure 12B., section 2.1.6. B. 
KIAA1126up is biallelically expressed from Hs27 cell line. For detailed description look at the 
Figure 28 B, section 2.4.5.1. 
 
In sumary, PEG13 was a novel ~6.6kb long, nuclear macro ncRNA that was highly 
expressed from brain, showed biased expression towards one parental allele in 
fibroblasts and had CpG island that was a DMR. The KIAA1126up was a novel 
~55kb long ncRNA candidate that is expressed in most of the tested tissues and cell 
lines, had both nuclear and cytoplasmic localization, had a CpG island promoter and 
was biallelically expressed in fibroblasts. 
 
2. 4. 5. 4. HIRTA REG BAZ2 (chr11): PRKCDBPup macro ncRNA 
characterization 
The HIRTA region named BAZ2 contains the ZNF215 gene showing maternal 
imprinted expression in human while in the same region there is no known imprinted 
genes in mouse (Alders et al., 2000). Eight novel macro ncRNA candidates were 
mapped in this region. Macro ncRNA candidate PRKCDBPup will be presented in 
this section.  
 
1) Length of macro ncRNA 
PRKCDBPup was ∼25kb in length and could represent novel 5’ exons of PRKCDBP 
protein coding gene or macro ncRNA that overlapps this gene in the same direction.  
 
2) Tissue specific expression and subcellular localization 
The PRKCDBPup showed tissue specific expression and was expressed in 9/20 
normal cells/tissues and 5/23 cancer samples (Figure 27, section 2.4.4.). The 
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transcript showed high expression in adult uterus and it was very lowly expressed in 
fibroblasts where it showed both nuclear and cytoplasmic localization (data not 
shown). 
 
3) Annotation 
The CpG island 108 island could be a bidirectional promoter for both PRKCDBPup 
and PRKCDBP (Protein kinase C, delta binding protein). This CpG island was 
marked with H3K4me3 in 7/9 Broad Histone Modifications tracks with the example of 
H1-hESC shown in Figure 32A.  
 
4) CpG island features 
A Southern blot using BssHII methylation sensitive enzyme in combination with 
EcoRI and HindIII enzymes and the PRKCDBPSBP probe showed that CpG 101 is 
unmethylated in both the HeLa and Hs27 cell lines (Figure 32D), and therefore is not 
a DMR, since 14.8kb band and 4.3kb bands predicted to be observed from the 
methylated allele were not observed. The CpG island 108 showed presence of a low 
number of direct repeats using previously described criteria for the dotmatcher 
program (Figure 32E).  
 
5) Monoallelic/Imprinted expression of macro ncRNA 
By using both forward and reverse sequencing of PCR bands with two primer pairs 
(PRKCDBPCIE1 and 2) one known heterozygous SNP (C/T, rs12807110)(dbSNP 
build 130, UCSC) and one novel heterozygous SNP (T/A, chr11: 6314801- 6314801) 
were mapped in HeLa cells.  Interestingly, these two SNPs were positioned with 
three base pairs in between. Both SNPs showed slight bias towards one allele in 
HeLa cells (Figure 31B). In order to test if these two SNPs are showing imprinted 
expression (both are expressed always from one parental allele) or they show 
random monoallelic expression (situation when some cells in the population 
transcribe one allele while other cells transcribe other allele, thus expression of two 
SNPs could be: both from the first allele, both from the second allele or one from the 
first and another SNP from the second allele (Krueger and Morison, 2008)), RT-PCR 
bands from HeLa cells using the PRKCDBPCIE2 primer pair were isolated and 
cloned into pGEM-T-Easy vector and sequenced from the T7 promoter. If candidate 
macro ncRNA shows expression from one allele uniformly (and thus could be 
imprinted) linkage of C and A alleles and linkage of T and T alleles (CA/TT SNPs 
combination) or linkage of C and T alleles and linkage of T and A alleles (CT/TA 
SNPs combination) would be expected in each tested case, while if the macro 
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ncRNA has random monoallelic expression mixture of possible SNPs combinations  
(CT/TA and CA/TT SNPs combinations) would be expected (Figure 32C). Nine 
tested clones all showed CA/TT SNPs combinations, showing that these two SNPs 
are linked and thus indicating imprinted expression of PRKCDBPup (Figure 32C).  
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Figure 32. PRKCDBPup is a ∼25kb long macro ncRNA candidate showing slight biased, 
but non-random expression towards one allele. A. Expression of PRKCDBPup in the adult 
uterus and in HeLa cells. CpG island 108 is marked with H3K4me3 in H1-hESC (Broad, 
UCSC). Positions of the Southern probe PRKCDBPSBP and rs12807110 SNP are shown as 
previously described. B. C/T known SNP and novel T/A SNP are mapped in HeLa DNA. Both 
SNPs show slight biased expression towards one allele in HeLa cells. C. On the left side 
possible combinations of expression from two close SNPs are shown. Sequencing from T7 
promoter is shown. Nine clones show that two heterozygous SNPs are linked on the same 
chromosome (CA/TT SNPs combination) and argue against random expression of 
PRKCDBPup ncRNA candidate. D. Southern blot using BssHII methylation sensitive enzyme 
in combination with EcoRI and HindIII enzymes and PRKCDBPSBP probe in Hs27 and Hela 
cells.  E. Dotplot of CpG island 108 is shown as previously. 
 
In summary, PRKCDBPup was ∼25kb long macro ncRNA candidate showing biased 
imprinted expression in HeLa cells and potentially having unmethylated bidirectional 
CpG island promoter.  
 
2. 4. 5. 5. HIRTA REG SLC38A4 (chr12): SLC38A4down2 macro ncRNA 
characterization 
Imprinted expression of human genes residing in the SLC38A4 HIRTA region is 
unknown while mouse Slc38a4 (Solute carrier family 38, member 4) has paternal 
imprinted expression (Smith et al., 2003).  
 
1) Length of macro ncRNA 
The SLC38A4down2 macro ncRNA candidate was ∼463kb long and the candidate 
was located about 10kb downstream of the human SLC38A4 gene (Figure 33A).  
 
2) Tissue specific expression and subcellular localization 
The SLC38A4down2 transcript was expressed in 14/20 HIRTA hybridizations of 
normal cells/tissues and in 19/23 cancer cells/patients (Figure 27, section 2.4.4.). 
Relative high expression of SLC38A4down2 in HES2d0 was shown by both HIRTA 
single hybridizations and by qRT-PCR (normalized to RPLPO gene) using two primer 
pairs, SLC38A4Cq1 and SLC38A4Cq3 (Figure 33A). Fetal liver and Hs27 showed 
very low but no negative expression signals (blue signals) by HIRTA. This was in 
agreement with qRT-PCR that also showed low expression in both tissues. The 
SLC38A4down2 showed 5:1 nuclear enrichment in Hs27 cells using qRT-PCR 
(shown on Figure 26, section 2.4.3.) 
 
3) Annotation 
Part of SLC38A4down2 transcript was a lincRNA associated with PRC2 and 
CoREST complexes (Figure 33A). Since both lincRNA data and HIRTA data did not 
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show strand specific information the strand of SLC38A4down2 candidate was 
predicted as plus (+) since a CpG island 106 was observed on one end of the 
mapped transcript and the slope of the HIRTA expression through the body of the 
novel ncRNA was negative (reverse correlation between slope and transcriptional 
orientation was shown previously on Figure 19, section 2.2.1.) (Figure 33B). In order 
to further check the reliability of the predicted transcript strand I looked into published 
chromatin modification maps and RNAP II maps at the CpG island 106 (Figure 34A). 
In both examples shown in Figure 34A: T cells (examined by Chip-seq method 
(Barski et al., 2007)) and Normal Human Keratinocytes (NHEK) cell line from Broad 
Histone track (UCSC), enrichment of H3K4me3 and RNAP II was found on the CpG 
island 106 position supporting its function as a promoter of SLC38A4down2. Similar 
H3K4me3 methylation enrichment of the CpG island position was present in a range 
of cell lines on the Broad Histone track, UCSC.  
 
4) CpG island features 
The CpG island 106 adjacent to SLC38A4down2 does not show the features of a 
DHM since no H3K9me3 was present on this island (Figure 34A), but this CpG island 
showed presence of direct repeats when dotmatcher program using following criteria: 
window=30 and threshold=65, was used. In order to experimentally test if CpG island 
106 is a DMR, Southern blot using two methylation sensitive enzymes (BstUI and 
BssHII) and specific probe (SLC38A4SBP) located upstream of CpG island was 
performed in two cell lines (Hs27 and HeLa). Methylation sensitive enzymes were 
used in combination with the EcoRI enzyme where a 15kb band recognized with 
specific probe would be expected if allele is methylated (when BstUI and BssHII can 
not cut) while 3.1 or 3.3kb bands would be expected from unmethylated alleles (when 
BstUI and BssHII are able to cut DNA). If a DMR is present both 15kb and 3.1kb 
bands or 15kb and 3.3kb bands are expected showing presence of unmethylated and 
methylated allele. Both alleles of the CpG island promoter of SLC38A4down2 were 
unmethylated by two methylation senzytive enzymes in both Hs27 and HeLa cell 
lines (Figure 34C). Thus, CpG island promoter of SLC38A4 down2 is not a DMR and 
cannot have a function as an ICE in this region.  
 
5) Monoallelic/Imprinted expression of macro ncRNA 
In order to test if SLC38A4down2 macro ncRNA is biallelic or shows imprinted 
expression 23 primer pairs for PCR/RT-PCR were designed. By doing PCRs with 
these primers on Hs27 cell line DNA and sequencing products, I was not able to map 
any heterozygous Single Nucleotide Polymorphism (SNP) in those tested 23 regions 
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that range in length from 130 to 990bp, of the SLC38A4down2 gene body. Therefore, 
I further tested these primers on the blood from a volunteer whose mother also 
volunteered blood. After sequencing, 7 heterozygous SNPs from 4 primer pairs were 
found. Expression of 4 heterozygous SNPs (rs12814298, rs11183486, rs2131371, 
rs2408497) was further tested using forvard plus reverse primers (SLC38A4CIE1 and 
SLC38A4CIE12) to sequence the SNPs and in all eight cases preferential expression 
of one allele was found (Figure 33D). In order to reveal parent-of-origin of 
SLC38A4down2 expression we tested the Mothers’ blood and on the basis of 
rs2408497 SNP, a bias towards the Fathers’ G allele was found. Thus, preferential 
paternal expression of SLC38A4down2 was detected. 
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Figure 33. SLC38A4down2 is macro ncRNA candidate predicted to be expressed in 
plus (+) transcriptional orientation and showing preferentially paternal imprinted 
expression. A. Expression of SLC38A4down2 (~463kb long) macro ncRNA candidate is 
shown using HIRTA and qRT-PCR (primer pairs: SLC38A4Cq1 and SLC38A4Cq3) in 
fibroblasts, HES2, d0 cells and fetal liver. qRT-PCR expression relative to RPLPO gene. Linc 
RNAs exons, Hs27/HeLa expression, PRC2 and CoREST association tracks as well as 
custom SNP and qPCR primers tracks are shown. Tracks presented as on Figure 11B, 
section 2.1.5. B. Slope of SLC38A4down2 in HES, d0 cells predicts + strand expression of 
this candidate. Details as on Figure 19, section 2.2.1. C. SLC38A4down2 contains SNP 
(rs2408497) showing bias towards paternal allele in one family whole blood. For detailed 
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description look at the Figure 28B, section 2.4.5.1. D. Forward and reverse sequencing from 
SLC38A4CIE1 and SLC38A4CIE12 primers revealed 4 heterozygous SNPs (rs12814298, 
rs11183486, rs2131371 and rs2408497) in blood DNA and showed biased expression from 
blood RNA. 
 
 
Figure 34. The CpG island 106 matches to the proximal end of SLC38A4down2 HIRTA 
expression, is enriched for H3K4me3 and RNAP II, direct repeats and is unmethylated. 
A. CpG island 106 region on chromosome 12 shows enrichment of H3K4me3 in T cells and 
NHEK cells and RNAP II peaks over the same region. Peak of H3K9me3 repressive mark is 
found upstream, but not matching the CpG island. B. Dotplot of CpG island 106 is shown as 
previously. C. Southern blot using BstUI and BssHII in combination with EcoRI and 
SLC38A4SBP in HeLa and Hs27 cells.  
 
In sumary, SLC38A4down2 was ~463kb long macro ncRNA that was predicted to 
have plus (+) strand transcriptional orientation, partially overlapped to lincRNAs 
associated with PRC2 and CoREST complexes, showed paternal biased imprinted 
expression and had unmethylated CpG island promoter. 
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2. 4. 5. 6. HIRTA REG RASGRF1 (chr15): ADAMTS7down, TMED3down and 
KIAA1024up macro ncRNA characterization 
Rasgrf1 and RASGRF1 regions are located on mouse chromosome 9 and human 
chromosome 15 respectively. Previous studies showed that mouse Rasgrf1 region 
contains four genes showing paternal imprinted expression: Rasgrf1, As4, A19 and 
miR-184 (de la Puente et al., 2002; Nomura et al., 2008; Plass et al., 1996). 
Imprinting status of genes residing in human RASGRF1 region is not known. I 
characterized three macro ncRNA candidates (ADAMTS7down, TMED3down and 
KIAA1024up), found in the human RASGRF1 region by HIRTA single cDNA 
hybridizations.  
 
1) Length of macro ncRNA 
ADAMTS7down macro ncRNA was ∼6kb long and located downstream of ADAMTS7 
protein coding gene (ADAM metallopeptidase with thrombospondin type 1, motif, 7) 
(Figure 35A). The length of the candidate mapped from the HIRTA hybridization data, 
was further confirmed in fibroblasts using Northern blot with a specific 
ADAMTS7downNOR probe. ß-Actin was used as a loading control for the Northern 
blot (Figure 35C). The Northern blot was repeated using fibroblasts and HeLa and 
same ~6kb band was found in both Hs27 and HeLa (data not shown). In addition to 
ADAMTS7down, I mapped two more candidates in human RASGRF1 region: 
TMED3down  (~88kb in length) and KIAA1024up (~19kb in length) (Figure 39A). 
 
2) Tissue specific expression and subcellular localization 
The ADAMTS7down was ubiquitously expressed in all cells/tissues hybridized to 
HIRTA, including skeletal muscle that was the only tissue showing very low 
expression of this candidate (Figure 27, section 2.4.4. and Figure 35A). Expression 
of ADAMTS7down was also assessed by qRT-PCR using the ADAMTS7Cq3 primer 
pair in three different tissues and showed the expected profile matching to HIRTA 
hybridizations of the same tissues (Figure 35A, B). Cellular localization of 
ADAMTS7down was tested and its preferential nuclear localization using double 
HIRTA hybridization (Figure 35A), RT-PCR (Figure 35D) and qRT-PCR (11:1 ratio of 
nuclear to cytoplasmic) (Figure 25, section 2.4.1.) was shown.  
 
TMED3down and KIAA1024up candidates were expressed in fibroblasts, blood and 
human embryonic stem cells but were not expressed in any other tested normal 
cells/tissues (Figure 27, 2.4.1). Both candidates showed upregulation in different 
cancer types (Figure 27, 2.4.1). To test nuclear versus cytoplasmic localization of 
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these candidates double cDNA hybridization and RT-PCRs were used. TMED3down 
was enriched in the nuclear compartment by both techniques. KIAA1024up also 
showed nuclear enrichment, but in this case I was also able to detect substantial 
amount of this transcript in cytoplasmic fraction by RT-PCR, showing both nuclear 
and cytoplasmic localizations (Figure 39B).  
 
3) Annotation 
The CpG island 17 maps to the ADAMTS7down proximal position. The same CpG 
island was marked with the H3K4me3 histone in 6/9 cell lines from the Broad Histone 
track (Figure 36A). However, the H3K4me3 activation mark of promoters was not 
only found on the CpG island 17 position in ADAMTS7down region, but also on a 
distal position where 3/9 cell lines mapped by Broad Histone track showed its 
presence (Figure 36A). TMED3down and KIAA1026up showed no presence of CpG 
island. H3K4me3 were not found in any of 9 Broad cell lines on both ends of 
TMED3down while 7/9 cell lines showed peaks of H3K4me3 coresponding to the 
minus (-) strand transcriptional orientation of KIAA1026up. 
 
4) CpG island features 
In mouse, the 252bp long DMR located about 30kb upstream of Rasgrf1 is paternally 
methylated in both monoallelic and biallelic tissues while in human there is no data 
about the presence of a DMR in the RASGRF1 gene region that contains ADAMTS7 
and the novel ADAMTS7down transcripts. To test the methylation status of CpG 
island 17, which is potential promoter of ADAMTS7down, Southern blot with the 
BstUI methylation sensitive enzyme in combination with EcoRI and specific 
ADAMTS7downSBP probe, was used. The CpG 17 island was a DMR in both 
fibroblasts and HeLa cells since from BstUI/EcoRI digestion were gained both a 
10.6kb band representing the methylated allele and a 1.6kb band representing the 
unmethylated allele (Figure 36B). By using EcoRI alone as a control, a 10.6kb band 
coming from the methylated allele and a 1.9kb band originating from the 
unmethylated allele were observed (Figure 36B). The CpG island 17 did not show 
any existence of direct repeats using dotmatcher program with standard criteria (data 
not shown). 
 
5) Monoallelic/Imprinted expression of macro ncRNA 
To determine if ADAMTS7down macro ncRNA candidate shows monoallelic 
expression I tested 11 primer pairs (ADAMTS7CIE1-11) on DNA from the Hs27 cell 
line and found two heterozygous SNPs (rs7174572 and rs34019568). Both SNPs 
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showed monoallelic expression of ADAMTS7down in fibroblasts (Figure 37B). To see 
whether ADAMTS7down shows imprinted expression, same 11 primer pairs were 
tested on DNA from whole blood of one family consisting of the child and its mother 
(family described in section 2.4.5.5.). Two heterozygous SNPs were found in the 
child’s DNA (rs71211234 and rs12908299) and after testing its RNA I observed 
monoallelic expression of ADAMTS7down in blood. The child’s RNA showed 
expression of the G allele in both SNPs and the mothers DNA showed a bias towards 
the expression of A allele in both cases, indicating paternal expression of 
ADAMTS7down candidate on the basis of these two SNPs in blood (Figure 37C). To 
confirm imprinted expression of this candidate two more families were tested using 
RNA from lymphoblastoid cell lines (GM108054 and GM108046). Genotypes of the 
Utah families (father, mother and children) have been published by the international 
Haplotype Map of the Human Genome (HapMap) project (http://snp.cshl.org/) (Frazer 
et al., 2007). Two heterozygous SNPs in HapMap data from the children  (SNP_A-
8391868 and SNP_A-8407002) were found and RNA from lymphoblastoid cells 
originated from the same children was tested. Sequencing from both the forward and 
reverse primers ADAMTS7CIE11 in the GM108054 cell line showed C allele 
expressed on the position of SNP_A-8391868. This expression confirmed 
monoallelic expression of ADAMTS7down in lymphoblastoid cells and by assessing 
HapMap genotyping data of parents, paternal expression of ADAMTS7down was 
found.  
 
However, in contrast to this, sequencing from both forward and reverse primers 
ADAMTS7CIE10 showed only the A allele expressed on the position of SNP_A-
8407002, which according to the HapMap genotyping data indicated maternal 
expression of ADAMTS7down (Figure 37D). The same heterozygous SNPs were 
tested on RNA from the second lymphoblastoid cell line (GM108046) originating from 
another family. In this case SNP_A-8391868 showed maternal while SNP_A-
8407002 showed paternal expression of ADAMTS7down (Figure 37E). In summary 
my results show clear monoallelic expression of ADAMTS7down from fibroblasts, 
blood and lymphoblastoid cell lines. Concerning the imprinted expression we tested 
three families and found paternal expression on the basis of four SNPs and maternal 
expression on the basis of two SNPs. Possible expleantions for these findings could 
be monoallelic random expression of ADAMTS7down macro ncRNA or potential 
artefacts in HapMap whole genome genotyping data (discussed in section 3.6.1.). 
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To test if the ADAMTS7 protein coding gene positioned ~2kb from ADAMTS7down 
also shows monoallelic expression four primer pairs (ADAMTS7GIE1-4) were tested 
and one heterozygous SNP (rs7173267) positioned in exon2 of ADAMTS7 protein 
coding gene in fibroblasts (Hs27) was found. The ADAMTS7 protein-coding gene 
was biallelically expressed in fibroblasts (Figure 38).  
 
To examine monoallelic expression of TMED3down and KIAA1024up ncRNA 
candidates I tested seven primer pairs (TMED3CIE1-7) and six primer pairs 
(KIAA1024CIE1-6) on normal fibroblasts cell lines, respectively. By using 
TMED3CIE4 primer pair on Hs27 DNA the rs1532968 heterozygous SNP (T/G) that 
showed preferential expression of one allele (T bias) in fibroblasts was mapped 
(Figure 39C). Further, by using the KIAA1024CIE3 primer pair the heterozygous 
rs769770 (A/G) SNP that also showed preferential expression from one allele (G 
bias) in fibroblasts was mapped (Figure 39C). In summary, both TMED3down and 
KIAA1024up were expressed preferentially from one allele in fibroblasts and 
therefore may show imprinted gene expression.  
 
 
Figure 35. ADAMTS7down is a ~6kb long preferentially nuclearly localized macro 
ncRNA candidate.  A. ADAMTS7down expression is high in fibroblasts (Hs27), medium in 
HeLa cells and low in skeletal muscle by HIRTA single cDNA hybridizations. Double cDNA 
hybridization of nuclear versus cytoplasmic fractions of Hs27 (Hs27, N/C) shows preferential 
nuclear localization. Positions of the Northern blot probe (ADAMTS7downNOR), qPCR 
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primers (ADAMTS7Cq3) and CpG island 17 and 24 are shown together with the RefSeq 
genes UCSC track in hg18 human build. B. qRT-PCR using ADAMTS7Cq3 primer pair and 
normalized to the RPLPO gene in three tissues confirmed findings from HIRTA single 
hybridizations. C. Northern blot on fibroblasts (Hs27), bone marrow (BM) and skeletal muscle 
(SM) RNA using ADAMTS7downNOR probe, detects a strong band ~6kb in length in 
fibroblasts and very faint (*) ~4kb long band that is likely an artefact of 28S rRNA. Northern 
blot using a ß-Actin specific probe was used as a loading control. D. RT-PCR of nuclear, 
cytoplasmic and total fibroblasts RNA using ADAMTS7downNOR primer pair (967bp band) 
showed nuclear enrichment of ADAMTS7down macro ncRNA candidate. GAPDH was used 
as a loading control (176bp band). 
 
 
 
Figure 36. CpG island promoter of ADAMTS7down is a differentially methylated region 
(DMR) in fibroblasts and HeLa cells. A. HIRTA expression of ADAMTS7down in fibroblasts 
and HeLa cells. The proximal end of ADAMTS7down expression overlaps with CpG island 17 
and H3K4me3 from 6/9 cell lines displayed by Broad Histone, UCSC track. The distal-end of 
ADAMTS7down HIRTA expression overlaps with H3K4me3 in 3/9 cases. Tracks presented 
as on Figure 11B, section 2.1.5. B. Southern blot using BstUI methylation sensitive enzyme in 
combination with EcoRI and EcoRI alone as a control and ADAMTS7CSBP specific probe, 
showed that CpG island 17 is a DMR in Hs27 and HeLa cells. The 10.6kb band represents 
the methylated allele, the 1.6kb band the unmethylated allele and a 1.9kb band is a result of 
an unusual EcoRI digestion: when G is present after GAATTC EcoRI cutting site this enzyme 
is methylation sensitive and cuts just the unmethylated allele. 
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Figure 37. The ADAMTS7down macro ncRNA candidate region is monoallelically 
expressed in all tested cells/tissues. A. Positions of 6 heterozygous SNPs in hg18 
assembly coresponding to HIRTA expression of ADAMTS7down in fibroblasts (Hs27). B. 
Sequencing tracks showed as previously. Monoallelic expression in normal human fibroblasts 
shown using two SNPs (rs7174572 and rs34019). C. ADAMTS7down mapped region shows 
paternal expression based on two SNPs (rs71211234 and rs12908299) from the whole blood 
of one family. D. ADAMTS7down mapped region shows paternal expression based on 
SNP_A-8391868 when lymphoblastoid cell GM108054 RNA from the child was sequenced  
and compared to the parents’ genotypes from the HapMap project. The same region shows 
maternal expressin based on SNP_A-8407002. E. ADAMTS7down mapped region shows 
maternal expression based on SNP_A-8391868 when lymphoblastoid cell GM108046 RNA 
from the child was tested and compared to the parents’ genotypes from published the 
HapMap consortium. The same region shows paternal expression based on SNP_A-
8407002. 
 
 
Figure 38. ADAMTS7 protein coding gene is biallelically expressed in fibroblasts. A. 
HIRTA expression in fibroblasts in ADAMTS7 gene region. The position of ADAMTS7down is 
marked by gray box. The positions of four ADAMTS7GIE primers are shown by orange 
boxes. Position of heterozygous rs7173267 SNP is marked by a star. B. Sequencing of PCR 
and RT-PCR products from primer ADAMTS7GIE3F showed biallelic expression of 
ADAMTS7 in fibroblasts on the basis of rs7173267 SNP.  
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Figure 39. TMED3down and KIAA1024up are nuclearly enriched macro ncRNA 
candidates that show preferential expression from one allele in fibroblasts. A. 
Expression of TMED3down (~88kb in length) and KIAA1024up (~19kb in length) in fibroblasts 
and two cervical cancer cell lines and nuclear enrichment using double HIRTA hybridization is 
shown. Positions of mapped heterozygous SNPs and PCR products of primer pairs used for 
testing nuclear vs. cytoplasmic fractionations are shown. Tracks presented as on Figure 11B, 
section 2.1.5. and Figure 12B., section 2.1.6.B. RT-PCR with primer pairs TMED3CIE1 and 
KIAA1024CIE3 on nuclear, cytoplasmic and total RNA from fibroblasts shows nuclear 
enrichment of TMED3down, while KIAA1024up is both nuclear and cytoplasm enriched. 
GAPDH has been used as a loading control. *; Spill over. C. TMED3down shows expression 
bias towards one allele in fibroblasts using the rs1532958 heterozygous SNP. For detailed 
description look at the Figure 28B, section 2.4.5.1. D. KIAA1024up is preferentially expressed 
from one allele in fibroblasts using the rs769770 heterozygous SNP. 
 
2. 4. 5. 7. HIRTA REG NNAT (chr20): BLCAPov macro ncRNA characterization 
Human HIRTA region NNAT, paternally expresses NNAT (Neuronatin) and BLCAP 
v2a (Bladder cancer-associated) protein-coding genes while other variants of 
BLCAP: v1a, b and c are maternally expressed (Evans et al., 2001; Schulz et al., 
2009).  
 
1) Length of macro ncRNA 
The only macro ncRNA candidate I mapped in the NNAT region was the ∼36kb long 
BLCAPov transcript that was potentially overlapping and mapping also downstream 
of BLCAP protein coding gene. 
 
2) Tissue specific expression and subcellular localization 
The BLCAPov was expressed in 40/43 tested samples (Figure 27, 2.4.1). Double 
cDNA hybridization of nuclear versus cytoplasmic Hs27 RNA together with RT-PCR 
(using primer pair BLCAPCIE3) on fractionated fibroblasts cells showed both nuclear 
and cytoplasmic localization of BLCAPov (Figure 40A, B). Double cDNA hybridization 
showed cytoplasmic enrichment of three consecutive probes (typical for exons), thus 
we cannot exclude that BLCAPov represents part of the BLCAP gene.  
 
3) Annotation 
Taking into consideration the 5’-3’ slope through its’ gene body and 6/9 cell Broad 
lines that showed enrichment of H3K4me3, BLCAPov was predicted to be 
transcribed from minus (-) strand (same as BLCAP) (Figure 40A). However, a linc 
RNA expressed in Hs27 and HeLa partially maped to BLCAPov and indicated that 
this region is a complex transcriptional unit consisting of a number of overlapping 
protein coding and non-coding transcripts (Figure 40A).  
 
4) CpG island features 
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BLCAPov did not show presence of potential CpG island promoter (Figure 40A). 
 
5) Monoallelic/Imprinted expression of macro ncRNA 
10 tested primer pairs (BLCAPCIE1-10) failed to identify a heterozygous SNP in the 
Hs27 fibroblasts cell line. Thus, I used the HapMap data (Frazer et al., 2007) from 
GM108046 lymphoblastoid cell line where the authors found both the A and G alleles 
present in DNA at the position of the A-2275664 SNP. I used primer pair 
BLCAPCIE11 covering this SNP and by sequencing of the RT-PCR product from 
both forward and reverse primers I showed BLCAPov biallelic expression in the 
lymphoblastoid cell line. 
 
In summary, BLCAPov was ∼36kb long, both nuclear and cytoplasm enriched 
transcript showing biallelic expression in a lymphoblastoid cell line. 
 
 
Figure 40. BLCAPov is a nuclear localized biallelic macro ncRNA candidate. A. 
Expression of BLCAPov in fibroblasts and whole blood using single HIRTA hybridizations and 
enrichment in fibroblasts nuclear fraction using double HIRTA hybridization is shown. 
BLCAPov partially overlaps a lincRNA expressed in Hs27 and HeLa (blue colored linc Hs27, 
HeLa track). H3K4me3 and RNAP II enrichments from HUVEC cell line (Broad Histoane 
modifications, UCSC track) in this region are shown. Positions of a SNP (A-2275664) 
heterozygous in GM108046 lymphoblastoid cell line and PCR primer product used for testing 
of nuclear versus cytoplasmic localization (BLCAPCIE3) are shown. Tracks presented as on 
Figure 11B, section 2.1.5. and Figure 12B., section 2.1.6. B. RT-PCR confirms nuclear 
enrichment of BLCAPov already shown using HIRTA double cDNA hybridization. 819bp 
product from primer pair BLCAPCIE3 shows nuclear enrichment while very faint band (*) 
could also be detected in cytoplasm. GAPDH has been used as a loading control where the 
expected 176bp band was observed in both fractions and total RNA from Hs27. C. BLCAPov 
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is biallelic since A and G alleles are both present in heterozygous SNP (A-2275664) from the 
HapMap data of Child DNA (NA10846) and in RNA from lymphoblastoid cell line originating 
from the same Child (GM108046). Sequencing from both forward and reverse primer 
BLCAPCIE11 is shown. 
 
2. 4. 5. 8. Summary of characteristics for ten examined macro ncRNAs 
Ten macro ncRNAs from 7 gene regions containing imprinted genes were 
characterized. These transcripts had lengths in a range from 6 to 463kb. 2/10 
samples showed ubiquitous expression in all 43 tested cells/tissues while 8 were 
tissue specifically expressed. From 10 tested candidates that were all expressed in 
Hs27, 4 were enriched in the nuclear fraction, 5 were present in both nuclear and 
cytoplasmic and one was cytoplasmically localized by RT-PCRs or HIRTA double 
nuclear versus cytoplasm cDNA hybridizations. Three out of ten selected macro 
ncRNA candidates were mapping to previously published linc (large intergenic non-
coding) RNAs (Khalil et al., 2009).  
 
6/10 candidates had CpG islands, while 9/10 showed presence of H3K4me3 peaks 
on one of the transcript ends. The methylation of CpG islands promoters was tested 
on 5 candidates and 3 CpG island promoters were found to be unmethylated while 
two (PEG13 and ADAMTS7down) showed the presence of Differentially Methylated 
Region (DMR) in tested cell lines. Direct repeats were present in 4/5 tested CpG 
island promoters of macro ncRNA candidates. 
 
Characterization of 10 macro ncRNA candidates showed that ADAMTS7down was 
exclusively monoallelically expressed while 5 other candidates showed biased 
expression and 4 were found to be biallelically expressed from tested cells and/or 
tissues. SLC38A4down2 macro ncRNA candidate was found to be paternally 
expressed from the blood.  
 
2. 5. Each human imprinted gene region express macro ncRNA 
 
2. 5. 1. Overview of macro ncRNAs in human imprinted gene regions 
 
Previous studies have shown that all human well-studied imprinted gene regions 
contain macro ncRNAs (Table 4 and Figure 6, section 1.2.5.1.). To see whether 
macro ncRNAs could be a universal feature of all human imprinted gene regions 43 
different cells/tissues/patients were hybridized and novel macro ncRNAs in 32 HIRTA 
regions were mapped. I showed that each of the 32 studied HIRTA regions contains 
at least one known or candidate macro ncRNA in human normal and cancer tissues 
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(Figure 41). 18/32 HIRTA regions that were previously shown to contain a macro 
ncRNAs were grouped into well-studied (H19, KCNQ1OT1, GTL2, UBE3A-AS, 
GNASAS, EXON1A, XIST and TSIX) and other known (HYMAI, AIRN, 
LOC100129427, DLX6AS, MIT1, MESTIT1, FLJ4663, 91H, IGF2AS, LOC650368, 
LOC100133545, WT1AS, LOC100233209, NCRNA00239, PWRN1, LOC145663, 
PEG3AS, NCRNA00028, NCRNA00182 and NCRNA00183) macro ncRNAs. GTL2 
and UBE3A-AS are highly complex transcriptional units that contain a number of 
known overlapping ncRNAs of different length that were previously extensively 
studied and were not considered separately in this analysis. 27/30 known macro 
ncRNAs were detected by HIRTA while 3 were not (TSIX, HYMAI and AIRN). 101 
novel macro ncRNA candidates in 32 HIRTA regions from 43 tested 
cells/tissues/patients were mapped. The results illustrate that regions with a high 
number of macro ncRNAs are: KCNQ1 and PWS with 9 macro ncRNAs each, and 
SFMBT2, BAZ2 and IGF2, with 8 ncRNAs each. Regions with only one mapped 
macro ncRNA candidate were: TRP73, NAP1L5, IMPACT and NNAT. In total, 131 
known or candidate macro ncRNAs were expressed from 32 HIRTA regions. 
 
Figure 41. Distribution of known and novel macro ncRNAs from 32 HIRTA regions. 
Number of novel macro ncRNA candidates per HIRTA region (TRP73 to XIC region) is shown 
in orange (101 candidates), while we grouped known macro ncRNAs in two groups (well-
studied; red color (8), and known; green color (22)).  
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Novel macro ncRNA candidates were grouped according to their position in 
accordance with RefSeq and UCSC annotated genes. 55/101 novel transcripts were 
positioned intergenically which means they did not overlap any annotated gene, 
12/101 were positioned 5’ to an annotated gene and had the potential to be novel 
5’exons of annotated genes or distinct upstream ncRNAs that are overlapping these 
transcripts, 18/101 were mapped 3’ to annotated transcripts and could represent 
novel 3’UTRs or macro ncRNAs that overlaped these transcripts. Further, 2/101 were 
positioned inside of an intron of an annotated gene, while 14/101 overlapped one or 
more short genes, for example long transcripts overlapping olfactory receptor genes 
(Figure 42).  
 
 
 
Figure 42. Grouping of novel macro ncRNA candidates in accordance with positions of 
annotated genes. 5 groups of positioning could be distinguished with a certain number of 
candidates mapping to these categories: non-overlapping (55/101), 5’exons or overlapping 
(12/101), 3’UTR or overlapping (18/101), inside of annotated genes (2/101) and overlapping 
annotated genes (14/101). 
 
The GNASAS macro ncRNA expressed from the GNAS region, GTL2var1 from the 
DLK1 region and UBE3A-ASvar1 from PWS imprinted gene regions were overlapped 
by a large intergenic noncoding (linc) RNA published by Khalil et al. (Khalil et al., 
2009). Comparison of 101 macro ncRNA candidates mapped from HIRTA 
hybridizations with large intergenic noncoding (linc) RNA showed that 9/101 
transcripts were previously mapped in fibroblasts and HeLa cells. From these 
transcripts, two were fully overlapped with linc RNAs while 7 others were partially 
overlapped. 5/9 transcripts that overlap between our study and previously published 
linc RNAs were associated with PRC2 and CoREST complexes (Khalil et al., 2009).  
 
2. 5. 2. Overview of tissue specific expression of macro ncRNA candidates 
20 normal cells/tissues were hybridized to the HIRTA Chip using the single cDNA 
hybridization technique. These samples included undifferentiated and differentiated 
embryonic stem cells (HES2), 3 fetal tissues, placenta as extra embryonic tissue and 
13 adult tissues. With 29 novel mapped macro ncRNAs in 32 HIRTA regions, testis 
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was a tissue with the highest number of macro ncRNA candidates (Figure 43A). 
Further, undifferentiated ES cells had 28 and adult uterus, 27 candidates. Tissues 
showing 10 or less macro ncRNA candidates were: fetal liver, placenta, adult lung 
and adult heart.  
 
HIRTA was hybridized with 23 cancer samples including 9 cervical, 2 colon, 2 breast, 
1 teratocarcinoma, 1 rhabdomyosarcoma, 1 neuroblastoma cell line and 6 patients (4 
AML (Acute lymphoid leukemia) and 2 MPD (Myeloproliferative disorder)). Overall, 
20/23 samples expressed more than 15 novel macro ncRNA candidates with the 
highest number in C4II, one of the cervical cancer cell lines (25) (Figure 43B). On 
average, 18.65 candidates were expressed per normal and 19 candidates per tested 
cancer sample showing no overall difference in number of expressed macro ncRNA 
candidates in imprinted gene regions in human between normal and cancer samples.  
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Figure 43. Distribution of novel macro ncRNAs in normal and cancer cells/tissues. A. 
Number of macro ncRNA candidates in 20 normal human cells/tissues are shown. NC; 
normal cell line, ES; embryonic stem cells, EE; extraembryonic tissue B. Number of macro 
ncRNA candidates in 23 human cancer cells/patients is presented.  
 
 
2. 5. 3. Strand prediction of macro ncRNA candidates 
To determine the expression of known and novel transcripts from imprinted gene 
regions I used single cDNA hybridizations to the HIRTA tiling array. We co-hybridized 
double-stranded cDNA and sonicated DNA, to the HIRTA Chips and mapped 101 
novel macro ncRNA candidates in 43 tested samples. As this approach did not allow 
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the orientation of transcription to be determined for these candidates I developed a 
novel approach in order to predict the strand of the novel macro ncRNA candidates. 
This approach was based on the usage of 4 features (Tabe 16). The CpG islands 
(CpG island track, UCSC (Gardiner-Garden and Frommer, 1987)), H3K4me3 and 
RNAP II enrichments (Broad Histone tracks, UCSC; ENCODE Histone Modifications 
by Broad Institute ChIP-Seq, Peaks from 9 cell lines for H3K4me3 and 3 cell lines for 
RNAP II) were used as indicating of promoters.  To these three criteria feature based 
on the reverse correlation between the SLOPE and the strand, was added (Figure 
19, 2.2.1.) and to each criteria a relative value was assigned (Table 16).  
 
Presence of Overlapping Feature  Given Value (Sum= -4 to +4) 
CpG island inside of +/- 1kb from transcript 
start or end +1 or -1 
SLOPE value negative or positive +1 or -1 
H3K4me3 peak inside of +/- 1kb from 
transcript start or end (9 cell lines) 
+1 (for each cell line positive on the start add +0.11)  
or -1 (for each cell line positive on the end add –0.11) 
RNAP II peak inside of +/- 1kb from 
transcript start or end  
(3 cell lines) 
+1 (for each cell line positive on the start add +0.33)  
or -1 (for each cell line positive on the end add –0.33) 
Table 16. Four criteria used in prediction of macro ncRNA candidates orientation and 
their assigned values. Each feature has value +1 if present on proximal or -1 if present on 
distal end of the novel transcript.  
 
The starting hypothesis was that each criterion has the same value (+1 if present on 
the position +/- 1kb from the proximal end of the transcript and -1 if present on the 
position +/- 1kb from the distal end of the transcript) and thus showed equal 
prediction importance. Thus, the maximal sum from the criteria values was +4 if the 
transcript showed plus (+) strand orientation or -4 if the transcript showed minus (-) 
strand orientation. In order to calculate the Score depicting likelihood of the transcript 
orientation prediction I used the value of: (sum of criteria values)/4. Thus +1 was the 
score showing highest probability that transcript is plus (+) strand while -1 is the 
highest probability that the transcript had minus (-) strand orientation based on used 
criteria. Further, the scores were grouped into: high probability score (+/- 0.5 to +/- 1), 
medium probability (+/- 0.25 to +/- 0.5) and low probability (- 0.25 to + 0.25). This 
approach does not allow potential novel overlapping transcripts transcribed in the 
opposite directions to be distinguished since for these transcripts low probability for 
each strand is expected. Thus, a separate group of transcripts was formed (marked 
with *) that were showing a low/medium probability prediction for certain transcription 
orientation, but at the same time were overlapping at least one tested feature on 
each end. I first tested this approach on 6 well-studied macro ncRNAs from imprinted 
gene regions and found that prediction based on the four used criteria’s matched the 
known strands of all these transcripts (Table 17).  
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H19 -1 -1 0.11 0 -0.33 0 -2.22 -0.555 - - 
KCNQ1OT1 -1 -1 0 0 -0.99 -0.66 -3.65 -0.912 - - 
GTL2var1 1 1 0.55 0.33 -0.11 -0.33 2.44 0.61 + + 
UBE3A-
ASvar1 1 1 0.88 0.66 0 0 3.54 0.885 + + 
GNASAS -1 -1 0 0 -0.77 0 -2.77 -0.692 - - 
EXON1A 1 -1 0.99 0.99 0 -0.99 0.99 0.247 + + 
Table 17. Predicted orientations of 6 well-known macro ncRNA are matching to known 
orientations using approach based on four epigenetic/genomic features that associate 
with promoters. Calculations are done according to the scheme described in Table 16. 
 
Interestingly, a low probability prediction also matched to the known transcription 
orientation as shown on the example of the well-known EXON1A macro ncRNA. 
Further, we predicted the strands for 101 novel macro ncRNA candidates (Table 18) 
where distribution of candidates in each category is shown on Figure 44.  
 
 
Figure 44. Orientation is confidently predicted for 43 macro ncRNA candidates. Number 
of candidates per each of three prediction categories is shown. Nine candidates that are 
predicted to represent overlapping transcripts of opposite orientations are marked with star 
(*).  
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Macro ncRNA 
candidate 
Score C P.
S. 
Macro ncRNA 
candidate 
Score C P.
S. 
Macro ncRNA 
candidate 
Score C P.
S. 
 
SLC22A2up 0.222 L + B3GNT2down1 0.387 M + OR5P2ov -0.25 L - 
MAS1down 0.25 L + B3GNT2down2 0.195 L + AMPD3up -0.302 M - 
MAS1ov 0.222 L + FAM161Adown -0.995 H - LYVE1ov 0.495 M + 
H19down 0.582 H + TIGD2down 0.305 M + MRVI1up -0.5 M - 
H19up 0.25 L + PHACTR2ov -0.025 L -* WIT1down 0.555 H + 
ASCL2ov -0.25 L - COBLdown1 0.25 L + SDHDdown -0.167 L - 
ASCL2up -0.222 L - COBLdown2 -0.25 L - PTSdown 0.36 M + 
TSPAN32down1 -0.385 M - DLX6up1 -0.25 L - SLC38A4down1 0.385 M + 
ZNF195down1 0.222 L + DLX6up2 -0.692 H - SLC38A4down2 0.995 H + 
ZNF195down2 -0.222 L - COL1A2up -0.305 M - SLC38A4up -0.25 L - 
ZNF195down3 0.222 L + KLF14up1 0.25 L + EPYCov 0.277 M + 
ZNF195down4 0.25 L + KLF14up2 -0.607 H - DCNup1 0.25 L + 
ZNF195up1 -0.167 L - KLF14up3 -0.222 L -* DCNup2 0.25 L + 
ZNF195up2 0.14 L + PEG13 -0.082 L - DCNup3 -0.222 L - 
BEGAINup 0.085 L +* PTK2up 0.332 M + LRCH1up1 -0.25 L - 
PPP2R5Cup1 -0.275 M -* KIAA1126ov -0.08 L -* LRCH1up2 0.25 L + 
PPP2R5Cup2 -0.967 H - PFKFB3down 0.332 M + HTR2Aup1 0.387 M + 
NIPA1up1 -0.137 L -* SFMBT2down1 0.222 L + HTR2Aup2 0.387 M + 
WHAMML1up 0.995 H + SFMBT2down2 0.415 M + HTR2Ain 0.25 L + 
WHAMML1up1 0.25 L + SFMBT2down3 -0.277 M - SQRDLdown 0.912 H + 
SNRPNup1 -0.25 L - SFMBT2down4 -0.25 L - C15orf43up -0.14 L - 
SNRPNup2 0.25 L + SFMBT2down5 0.25 L + ADAMTS7down 0.472 M +* 
GABRB3down1 -0.25 L - GATA3down 0.222 L + TMED3down 0.332 M + 
GABRB3down2 -0.25 L - BAG3down -0.72 H - KIAA1024up -0.22 L -* 
APCDD1Lup1 0.39 M + SEC23IPdown1 -0.25 L - CHRNB4up 0.25 L + 
APCDD1Lup2 0.25 L + SEC23IPdown2 0.25 L + ZNF521up 0.332 M + 
ZNF831up1 -0.582 H - SEC23IPdown3 -0.25 L - ZNF71down1 0.5 M + 
ZNF831up2 -0.14 L - OR556B4up1 0.25 L + ZNF71down2 0 - No 
LRRC47down 0.247 L +* OR56A1down 0.25 L + ID1up1 0.967 H +* 
GADD45Aup 0.222 L + PKCDBPup 0.885 H + ID1up2 -0.247 L - 
GPR177up -0.112 L - PKCDBPdown -0.885 H - BLCAPov -0.747 H - 
RPE65ov 0.277 M + HPXdown -0.167 L - L3MBTLup 0.305 M + 
RPE65down1 -0.497 M - ZNF215up -0.692 H - TOX2up -0.277 M - 
RPE65down2 0.387 M + RBMXL2down 0.25 L +     
Table 18. Strand of 100 macro ncRNA candidates is predicted based on four 
epigenetic/genomic features. Score for each candidate and predicted strand (P. S.) is 
shown. Strand of ZNF1down2 could not be predicted since the score was equal to zero. 
Candidates that could represent two overlapping transcripts expressed in opposite directions 
are marked by *. C; confidence, H; High, M; Medium, L; Low. 
 
2. 5. 4. Non-coding potential of macro ncRNA candidates 
To further examine the non-coding potential of macro ncRNA candidates we used 
RNAcode (Washietl et al., 2010, unpublished data) that predicts protein-coding 
regions based on evolutionary signatures. Jan Engelhart, a visiting MSc student from 
Peter Stadlers’ laboratory, Institut für Informatik, Universität Leipzig, conducted 
RNAcode over 44 vertebrate species using Multiz Align from UCSC and obtained 
whole genome predictions of protein-coding regions. RNAcode was found to be 
highly reliable in mapping known protein coding exons, while there was no RNA code 
predictions mapping through the body of known macro ncRNAs from imprinted gene 
regions in human (in some cases 1-2 “orphan” RNAcode predicted exons were 
found). The “orphan” RNAcode predictions were short, positioned centrally in the 
body of ncRNA, alone or paired with one more exon (Lander et al., 2001). The 
“orphan” prediction could represent exon of overlapping protein-coding gene (this 
exon could splice to another distant exon, if non-annotated gene has introns longer 
than average), but it is unlikely to represent exons of tested macro ncRNA candidate. 
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Examples of typical protein coding genes: DCN and KCNQ1 (Figure 45A, B), and 
typical macro ncRNAs: KCNQ1OT1 and H19, are shown (Figure 45B, C).  
 
 
Figure 45. RNAcode protein-coding predictions match to exons of known protein 
coding genes and do not find any protein coding potential in known non-coding RNAs. 
A. RNAcode mapped 7/9 known DCN exons. B. RNA code mapped 10/10 known and two 
novel exons for the KCNQ1 protein-coding gene, while no exons mapping to the start and end 
of the KCNQ1OT1 ncRNA were mapped. C. RNAcode did not find any protein-coding region 
in H19 and LOC100133545 ncRNAs. RNA code predictions are presented as black filled 
boxes and are highlited with light brown boxes. 
 
I further analyzed results of the RNAcode predictions over 101 macro ncRNA 
candidates from imprinted gene regions in human. I found that 89/101 macro ncRNA 
transcripts mapped from HIRTA expression data were predicted to be non-protein 
coding since no RNAcode output could be found through the body of mapped genes. 
From these candidates 63 had no overlap with any of RNA code predictions (group 
1) while for 27 others, part overlapped RNAcode exons matching known overlapping 
protein coding genes (group 2- macro ncRNA candidates overlapping annotated 
genes, Figure 42, 2.5.1) or 1-2 short exons (“orphans”) were detected located in the 
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central part of a mapped ncRNA gene (group 3) (examples of each of the three 
groups are shown in Figure 46).  
 
 
Figure 46. Examples of HIRTA macro ncRNA candidates confirmed to be non- protein 
coding using RNAcode. A. TMED3down and KIAA1024 are 2/63 macro ncRNAs that do not 
overlap any RNAcode protein-coding region. B. RNAcode finds exons of annotated RPE65 
protein-coding gene while does not find any other region mapping to RNA65ov macro ncRNA. 
C. ZNF521up  is an example of ncRNA that overlaps with 1 “orphan” RNAcode region.  
 
The 12 macro ncRNAs that were found to have protein-coding potential could be also 
further subgrouped. The first subgroup included those where potentially both a non-
protein coding and coding RNA could be present in the same time in the mapped 
HIRTA region (7 candidates: OR556B4up1, OR56A1down, OR5P2ov, AMPD3up, 
SLC38A4down2, SQRDLdown, CHRNB4up). The second subgroup of 5 candidates: 
ZNF195up1 (RNAcode=9), ZNF195up2 (RNAcode=4), SNRPNup2 (RNAcode=7), 
RPE65down1 (RNAcode=5) and SLC38A4up (RNAcode=3) had protein-coding 
potential with RNAcode regions positioned at distances resembling typical introns 
(Lander et al., 2001) and could potentially present novel exons of novel genes 
(number of RNAcode regions mapping to candidates shown in brackets) (examples 
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are shown on Figure 47). In summary, 96/101 mapped HIRTA candidates are macro 
ncRNAs that are intergenic or overlap known or potentially novel protein-coding 
genes, while 5/101 candidates have protein-coding potential. Thus, RNAcode 
indicated that the HIRTA expression macro ncRNA mapping approach had 4.5% 
false positives while 95.5% of the HIRTA mapped macro ncRNAs were predicted to 
be non-coding. 
 
 
Figure 47. Examples of 3/12 HIRTA candidates with both non-coding and coding, or 
protein-coding potential alone. A. RNAcode predicts two known olfactory genes and three 
new protein-coding regions that could to also represent olfactory receptor genes, while 
ORF56B4up1 macro ncRNA positioned in this region could be a precursor or it may overlap 
short olfactory receptor genes. B. RNAcode finds known exons of SLC38A4 and SLC38A2 
protein-coding genes and 4 regions overlapping SLC38A4down2 showing that part of this 
macro ncRNA could be overlapped with a novel protein coding gene. C. RNAcode regions are 
potential novel exons of ZNF195up2 transcript showing the protein-coding potential of this 
transcript. 
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2. 6. Macro ncRNAs from imprinted regions are deregulated in cancer 
Macro ncRNA expression can be deregulated in cancer through genetic and 
epigenetic mechanisms as introduced in sections 1.2.9.2 and 1.3.3. Macro ncRNA 
deregulation in cancer could be valuable for prognostics since macro ncRNAs have 
the potential to be used as biomarkers (introduced in section 1.3.4). Among 20 
normal and 23 tumor samples, cancer cell lines/patients matching normal tissues 
(from which the cancer originated), were distinguished. Thus, it was possible to 
correlate expression in mammary gland and two breast cancer cell lines (MCF7 and 
Cama1), cervix and 9 cervical cancer cell lines, colon and two colon cancer lines 
(HCT116 and Caco2), skeletal muscle and rhabdomyosarcoma (A201) line, and 
whole blood or bone marrow and 6 AML/MPD patients.  
 
2. 6. 1. Well-studied macro ncRNAs are deregulated in cancer  
Imprinted macro ncRNAs can be deregulated in cancer through loss of imprinted 
expression (LOI). Examples of H19 upregulation in bladder and hepatocellular 
carcinoma and IGF2AS overexpression in Wilms’ tumor were introduced in section 
1.2.9.2. Analysis of expression of 6 well-known macro ncRNAs (H19, KCNQ1OT1, 
GTL2, UBE3A-AS, GNAS and EXON1A) in pairs of normal and the corresponding 
cancer cell lines/patients was performed.  
 
An overview of expression of 6 well-known macro ncRNAs is shown in the Figure 17, 
section 2.2.1.1. and here details of the observed deregulation of the ncRNAs are 
presented.  In the IGF2 imprinted gene region, the H19 macro ncRNA was expressed 
in cervix, colon and mammary gland while 3/9 cervical cancer cell lines, 1/2 colon 
cancer and 1/2 breast cancer cell lines did not show expression of H19. We found 
KCNQ1OT1 macro ncRNA to be a widely expressed ncRNA that was downregulated 
in 2/9 cervical cancer cell lines (Figure 48).  
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Figure 48. KCNQ1OT1 ncRNA is downregulated in HeLa and the C4I cervical cancer 
cell line and expressed from normal cervix. HT3 and 6 more cervical cancer cell lines that 
are not shown express KCNQ1OT1. UCSC position shown on the top. Custom HIRTA tracks 
as well as RefSeq genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
In the DLK1 HIRTA region, the GTL2var1 macro ncRNA is expressed from cervix 
and mammary gland while in 9/9 cervical cancer cell lines and 2/2 breast cancer cell 
lines hybridized to HIRTA this macro ncRNA was fully downregulated (examples in 
Figure 49A). Interestingly, the same ncRNA was not expressed in skeletal muscle, 
but expressed in a A201 cell line (Figure 49B). One of the GTL2 variants (GTL2var6) 
was characteristic for neuroblastoma cell line (Figure 17, section 2.2.1.1.).  
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Figure 49. GTL2var1 macro ncRNA is deregulated in cancer. A. GTL2var1 expressed in 
normal cervix and mammary gland tissues is downregulated in cervical and breast cancers. 
B. GTL2var1 shows upregulation in rhabdomyosarcoma (A201) compared to the skeletal 
muscle sample. UCSC position shown on the top. Custom HIRTA tracks as well as RefSeq 
genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
UBE3-ASvar4 ncRNA from PWS imprinted gene region was expressed in diverse 
normal tissues, but not expressed in any of tested cancer cells. In the GNAS 
imprinted gene region, GNASAS ncRNA was not expressed in cervix but showed 
upregulation in 6/9 cervical cancer cell lines (Figure 50A). The same ncRNA was 
expressed in normal colon, but showed downregulation in 2/2 colon cancer cell lines 
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(Figure 50B).  EXON1A ncRNA was ubiquitously expressed in all tested normal and 
cancer samples and did not show cancer deregulation. In summary, 5/6 well-known 
macro ncRNAs were deregulated in cancer. 
 
 
Figure 50. GNASAS ncRNA is deregulated in cervical and colon cancers. A. GNASAS is 
not expressed in cervix but it is upregulated in HeLa and HT3 (and 4 more cervical not shown 
cancer cell lines). B. GNASAS is expressed from colon and downregulated in 2/2 colon 
cancer cell lines hybridized to HIRTA. UCSC position is shown on the top. Tracks presented 
as on Figure 11B, section 2.1.5.  
 
2. 6. 2. Novel macro ncRNAs are deregulated in cancer   
101 novel macro ncRNA candidates were found to be expressed using HIRTA in 43 
cell lines/tissues/patients. I showed previously that there was no overall difference in 
number of macro ncRNAs in imprinted gene regions between normal and cancer 
samples since on average ~19 novel macro ncRNA candidates are expressed per 
both normal or cancer sample (section 2.5.2.), but I found a number of samples 
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expressed exclusively in cancer cells or in normal cells as well as candidates 
showing different levels of expression between a normal tissue and the 
corresponding cancer of that tissue.   
 
22 macro ncRNAs were expressed exclusively in cancers (Table 19). From these 
macro ncRNAs 10 were expressed in only one tested cancer cell line. 16 of these 
transcripts were characteristic for one type of cancer while 6 others were expressed 
from more than one type of cancer but not expressed from any normal tissue. In 
11/22 cases macro ncRNAs were not expressed in normal cervix (or any other tested 
normal tissue), but expressed from 1-3 cervical cancer cell lines. Cancer deregulation 
of RPE56ov and RPE65down1 is presented on Figure 51. OR56A1down and 
PPP2R5Cup1 (low expression) were expressed in acute myeloid leukemia patients, 
but not expressed in whole blood and bone marrow.  
 
Cancer specific 
macro ncRNA 
candidates  
 
Cell line expressing macro ncRNA 
 
Cancer type 
GPR177up C33A, Tera2, A201 cervical, teratocarcinoma, rhabdomyosarcoma 
RPE65ov C4I, C33A, DoTc2, HCT116, A201 cervical, colon, rhabdomyosarcoma 
RPE65down1 C33A, A201 cervical, rhabdomyosarcoma 
RPE65down2 Tera2 teratocarcinoma 
MAS1ov NCCIT teratocarcinoma 
PTK2up DoTc2 cervical 
SFMBT2down5 HeLa, C4I, C4II cervical 
GATA3down Cama1 breast 
SEC23IPdown2 SHSY5Y neuroblastoma 
OR56A1down AML5_BMMC, AML5_PBMC, AML7 acute lymphoid leukemia 
PKCDBPdown A201 rhabdomyosarcoma 
ZNF195down1 C4I, C4II cervical 
ZNF195down2 HCT116, C33A colon, cervical 
ZNF195down3 C4I, C4II, C33A, HCT116 cervical, colon 
ZNF195down4 C4I, C4II cervical 
SLC38A4down1 Hela, SW756 cervical 
EPYCov DoTc2 cervical 
DCNup3 MCF7 breast 
LRCH1up2 Tera2 teratocarcinoma 
PPP2R5Cup1 AML7, MP_0351B, MP_0363 acute lymphoid leukemia, myeloproliferative 
disorder 
ZNF831up2 A201 rhabdomyosarcoma 
TOX2up Cama1 breast 
Table 19. 22 novel macro ncRNAs are cancer specific. Cancer specific macro ncRNAs are 
not expressed in any of 20 tested normal tissues, but are expressed in presented cell lines or 
patients of a specific cancer type.  
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Figure 51. RPE65ov and RPE65down1 macro ncRNAs are not expressed in any of 20 
tested normal tissues, but show cancer specific expression. RPE65ov is a ~86kb long 
macro ncRNA not expressed in normal cervix, colon and skeletal muscle, but expressed in 
corresponding cancers (3/9 cervical, 1/2 colon and 1/1 rhabdomyosarcoma cell lines). 
RPE65down1 is specifically expressed in C33A and A201 cell lines. Predicted orientation of 
macro ncRNAs is shown with black arrows. UCSC position is shown on the top. Custom 
HIRTA tracks as well as RefSeq genes, sno/miRNA and CpG islands UCSC tracks are 
shown. 
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Figure 52. OR56A1down macro ncRNA lacks expression in normal blood and bone 
marrow (as well as any of tested 20 normal tissues), but shows upregulation in 3/4 
acute myeloid leukemia patient samples. This ncRNA is ~20kb in length, predicted to be 
expressed from + strand (black arrow) and expressed from ZNF215 HIRTA region on 
chromosome 11. UCSC position is shown on the top. Custom HIRTA tracks as well as 
RefSeq genes, sno/miRNA and CpG islands UCSC tracks are shown. 
 
A number of macro ncRNAs were expressed in both normal and cancer samples, but 
showed deregulation in cancer. For example, SFMBT2down1 was not expressed in 
cervix, but expressed in 4/9 cervical cancer cell lines, or B3GNT2down2 was not 
expressed in colon, but showed upregulation in 1/2 colon cancer cell lines. Further, 
SLC38A4up was not expressed in cervix, mammary gland and colon but is 
upregulated in 2/9 cervical cancer cell lines, 1/2 breast and 1/2 colon cancer cell 
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lines. In contrast, LRCH1up macro ncRNA was expressed in 9/20 normal samples, 
but not expressed in any of examined cancers while C15orf43up showed expression 
in normal blood, but was downregulated in 1/3 AML and 2/2 MPD patients. Since 
tiling arrays have limitations (in background and dynamic range) numerous subtle 
changes in expression were not examined but rather I focused on candidates fully 
silenced or fully upregulated in cancers. Therefore, I expect that the expression 
change of presented transcripts is at least equal to the dynamic range of HIRTA and 
possibly higher, meaning that the expected fold difference in transcript expression 
between normal and corresponding cancer tissue was <= 200 fold (based on 
previous RT-qPCR experiments, Table 10, section 2.1.4.) 
 
2. 6. 3. Identification of the human homolog of the mouse Airn ncRNA in Wilms’ 
tumors 
Previously it was shown that the CpG island in intron 2 of IGF2R (CGI-2), similar to 
the mouse CpG island located on the same position of Igf2r, carries a maternal-
specific DNA methylation imprint (Smrzka et al., 1995). Since this CpG island is 
associated with the transcription start site of paternally expressed Airn ncRNA in 
mouse we tested if the human CpG island could also act as a promoter for a macro 
ncRNA (Figure 53A). While mouse Igf2r shows ubiquitous imprinted expression in 
fetal, extra-embryonic and adult tissues (except post-mitotic neurons) (Yamasaki et 
al., 2005), human IGF2R shows polymorphic imprinted expression in early fetal 
tissue, amniotic and lymphoblastoid cells, placenta and Wilms’ tumors (Oudejans et 
al., 2001; Smrzka et al., 1995; Xu et al., 1993; Xu et al., 1997). No evidence of a 
human AIRN has been previously found in placenta (Oudejans et al., 2001). I 
focused on Wilms’ tumors that were not previously tested for AIRN expression, but 
had polymorphic imprinted expression of human IGF2R gene.  
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Figure 53. AIRN is expressed from a Wilms’ tumor. A. Map of human chromosome 6q27 
region showing IGF2R and flanking genes. Transcription orientation of protein coding genes 
and predicted AIRN transcripts is indicated by arrows. Exons of IGF2R are marked by 
numbers (1-3) and position of CGI-2 is marked by an asterisk. Positions of RT-PCR (pp9) and 
qRT-PCR assays (IGF2R QPCR and AIRN QPCR1 and 2) are indicated underneath. B. 
Expression of spliced AIRN in Wilms’ tumor cell lines using primer pair pp9 amplifying a 
160bp product (1: Sk-Nep1, 2: G-401, 3: STA-WT3ab). The Hs27 normal human fibroblasts 
cell line (4) was used as a negative control and plasmid SV1 containing the spliced human 
AIRN product from mouse transgenes known to express AIRN as a positive control. Human 
GAPDH was used as a loading control (178bp band). NT; no template control. C. Summary of 
expression of AIRN by RT-PCR using pp9 in 120 Wilms’ tumor samples from the German 
SIOP/GPOH 93-01 study (see Figure 54). D. Quantitative RT-PCR of unspliced AIRN (AIRN 
QPCR1 assay) and IGF2R (IGF2R QPCR assay) expression in human cell lines (1: Sk-Nep1, 
2: G-401, 3: STA-WT3ab, 4: Hs27) using assays shown in A. Values average three technical 
replicates normalized to GAPDH. (Modified from Yotova IY, Vlatkovic IM et al., 2008 (Yotova 
et al., 2008)) 
 
AIRN was expressed from 1 in 3 tested Wilms’ tumor cell lines (Figure 53B) by using 
RT-PCR and primer pair pp9 that amplified the expected 160bp band. Further, using 
same assay I tested 120 Wilms’ tumor samples and found that 42.5% Wilms’ tumor 
patients expressed spliced AIRN (Figure 53C, Figure 54A). pp9 assay examining 
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spliced AIRN expression in these samples was used since 65% of the samples were 
DNA contaminated (data not shown) and thus could not be tested for unspliced AIRN 
expression (to examine DNA contamination, primer pair CON located intergenically 
between IGF2R and SLC22A1 and amplifying 509bp band by RT-PCR was used). 
 
Quantitative RT-PCR in cell lines confirmed AIRN expression from the STA-WT3ab 
Wilms’ tumor cell line using the AIRN QPCR1 assay for unspliced AIRN (Figure 
53D). Since expression of mouse Airn correlates with silencing of Igf2r on one 
parental allele I further tested if in human similar correlation was observed. qRT-PCR 
using IGF2R QPCR primer pair showed the lowest expression of IGF2R in the STA-
WT3ab cell line that expressed AIRN compared with other 3 tested cell lines that did 
not express AIRN (Figure 53D). When we applied the AIRN QPCR2 assay 
(corresponding to pp9 primer pair) for spliced AIRN and the IGF2R QPCR assay, on 
20 Wilms’ tumor patient samples and the Hs27 cell line that expressed no AIRN or 
showed medium or high AIRN expression from RT-PCR data, no correlation between 
no or medium expressed AIRN and IGF2R in same samples was found, while 3/6 
samples with high AIRN showed reduced IGF2R (Figure 54B). The data did not show 
a clear correlation between human AIRN and IGF2R, however, since Wilms’ tumor 
patient samples most likely contain mixtures of cells expressing, or not expressing 
AIRN the data does not exclude a correlation and thus potential silencing of IGF2R 
by AIRN in cis.  
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Figure 54. AIRN expressed in Wilms tumor patients do not show clear correlation to 
IGF2R in same patients. A. RT-PCR assay of spliced AIRN in 123 human Wilms' tumor 
samples using primer pp9. GAPDH was used as a loading control. M: Size markers, C; the 
plasmid pSpIF containing the SV1 AIRN spliced variant was used a positive control for the 
pp9 primers and HS27 cDNA used as the GAPDH primer control. 51 out of 120 samples 
(excluding 3 samples negative for both GAPDH and AIRN) were positive for spliced AIRN 
(black type). X, insufficient material to assay GAPDH, *spill over from control lane. B. 
Quantitative RT-PCR assay for human IGF2R and AIRN in 20 Wilms' tumor samples selected 
for no, medium or high AIRN expression. AIRN QPCR2 assay amplified spliced AIRN from 
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exons 1-2 (these AIRN exons were also amplified by the primer pair pp9 shown above), and 
assay IGF2R QPCR amplified IGF2R from exons 1-2. Hs27 cells were used as a negative 
control for AIRN expression. qRT-PCR data was normalized to 18S rRNA. Sample 43 with 
maximal IGF2R expression and sample 48 with maximal AIRN expression, were each set to 
100 (*). Error bars indicate the standard deviation of three technical replicates. Three 
independent experiments (each with 3 technical replicates) were performed with the same 
sample set. The measurements of AIRN abundance from the non-quantitative and 
quantitative assays were in general agreement with some exceptions (e.g. sample 38). 
(Modified from Yotova IY, Vlatkovic IM et al., 2008 (Yotova et al., 2008)) 
 
Normal human tissues showed the presence of maternally methylated CGI-2 that we 
found to be the promoter for human AIRN macro ncRNA in all tested fetal and adult 
tissues (Riesewijk et al., 1996; Smrzka et al., 1995). To determine if AIRN expression 
is specific for Wilms’ tumors or could be also found in normal tissues, I tested 20 
normal human tissues (placenta; fetal brain and liver; adult: brain, liver, heart, lung, 
uterus, thyreoidea, bone marrow, skeletal muscle, salivary gland, adrenal gland, 
prostate, testis, spinal cord, trachea, thymus, kidney and cerebellum) using the pp9 
primer pair for spliced AIRN. I could not detect expression of AIRN in any of 20 
tested normal tissues (data not shown). Further, I tested both undifferentiated (d0) 
and differentiated (d7) human embryonic stem cells (HES2) for expression of spliced 
AIRN and found that spliced AIRN was not expressed in these cells (data not 
shown).  
 
To determine if AIRN could be present in other cancers we focused on embryonic 
cancers expected to show polymorphic expression of IGF2R. I tested four cancer cell 
lines: Tera2, NCCIT, PA1 and A201, for the presence of differentially methylated 
region on the CpG island in intron 2 of IGF2R (CGI-2) shown to be the promoter of 
AIRN in Wilms’ tumors. By using Southern blot with methylation sensitive enzyme 
Not1 combined with EcoRI digestion and the specific Bx probe, both alleles of the 
CpG island were methylated in the four tested cell lines (Figure 55). The CpG island 
in intron 2 of IGF2R in Tera2 cell line was confirmed to be methylated using three 
more methylation sensitive enzymes (BstUI, XhoI and HpaII) in Southern blot with the 
same Bx probe. Additionally I confirmed existence of both methylated alleles of the 
same CpG island in the A201 cell line, using BstUI, HpaII, Eco52I and PauI 
methylation sensitive enzymes (data not shown). It was previously shown that DNA 
methylation is a repressor of transcription if found on promoter regions (reviewed in 
(Koerner and Barlow, 2010)) , thus it is expected that AIRN would not be expressed 
from tested cancer cell lines. In summary, AIRN could be a cancer and particularly 
Wilms’ tumor specific macro ncRNA. Partially this work has been published in Yotova 
IY, Vlatkovic IM et al., 2008 (Yotova et al., 2008). 
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Figure 55. Lack of DMR2 in four teratocarcinoma and rhabdomyosarcoma cell lines. 
Southern blot analysis using NotI methylation sensitive enzyme in combination with EcoRI 
using specific Bx probe showed the methylation of both alleles (presence of 5.7kb band) of 
CpG island in intron 2 of IGF2R in four tested cancer cell lines. Hs27 normal human 
fibroblasts cell line was used as a positive control and showed a 5.7kb methylated and 3.3kb 
unmethylated bands (presence of CGI-2 DMR) as expected.  
 
2. 7. Ribosomal RNA-depleted RNA-sequencing detects macro ncRNAs in 
human fibroblasts 
Transcriptome sequencing (RNA-seq) using next-generation technologies e.g. 
illumina has a great potential in whole genome research. I examined part of the 
human RNA-seq data from diverse tissues published during 2008, in order to 
compare them to our HIRTA tiling arrays expression results. First I examined if 
published RNA-seq data could detect known imprinted macro ncRNAs. Interestingly, 
published RNA-seq data poorly detected expression of well-known macro ncRNAs 
(shown in Figure 56) even in tissues and cells that are known to express these 
transcripts. For example in Pan et al. (Pan et al., 2008) where a mRNA-seq dataset 
consisting of 17-32 million 32bp reads that examined whole brain, cerebral cortex, 
liver, lung, skeletal muscle and heart was published, I was not able to detect known 
macro ncRNAs. For example, expression of KCNQ1OT1 and UBE3A-AS macro 
ncRNAs was clearly detectable by HIRTA, but poorly detectable using RNA-seq 
(Figure 56A, B). The only known imprinted macro ncRNA that could be clearly 
detected in Pan et al., 2008, was the 2.6kb H19 macro ncRNA that differs from 
KCNQ1OT1 in that it has small introns and a cytoplasm localization. Similarly, I found 
almost no expression of known imprinted macro ncRNAs in RNA-seq data from 
Sultan et al. (Sultan et al., 2008) where poly (A) RNA was extracted from human 
embryonic kidney (HEK cell line) 293T and B cells (RAMOS cell line) and produced 
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8.6 million and 7.6 million of 27bp sequencing reads respectively. This analysis of 
public data indicated that RNA-seq using poly A selected RNA does not allow optimal 
macro ncRNA detection and I tested if total RNA could potentially improve macro 
ncRNA detection using normal human fibroblasts, a cell line that express most of the 
known macro ncRNAs. Ru Huang, a PhD student in the lab developed a protocol for 
RNA-seq of the mouse cells using total RNA depleted of ribosomal RNA (rRNA) and 
hydrolyzed prior to double stranded (ds) cDNA preparation. I performed the rRNA 
depletion RNA-seq protocol, on normal Hs27 human fibroblast sample and 
performed double stranded (ds) cDNA. The sample was further processed (see 
section 5.8.8.5.) by Andy Sommer, GENAU consortium, applied on 4 flowcells and 
runned on Illumina Genome Analyser obtaining in total 58.8 milion 36bp sequence 
reads (13.1-15.5 million reads per flowcell). 
 
 
Figure 56. Imprinted macro ncRNAs were not detectable in mRNA-Seq data published 
prior to our RNA-Seq experiment. A. KCNQ1OT1 macro ncRNA is clearly expressed from 
adult brain hybridization on HIRTA while it is poorly detected from the same tissue in mRNA-
Seq from Pan et al., 2008 data. B. UBE3A-AS is highly expressed in adult brain by HIRTA, 
but shows very low, not continuous expression in mRNA-seq data from Pan et al., 2008. 
UCSC view of RNA-seq (black) and HIRTA (orange) expression data on specified UCSC 
position (hg18). HIRTA tracks are presented as previously (Figure 11B, section 2.1.5.). Black: 
RNA-seq track; RNA-seq with cut off of 25 reads. 
 
2. 7. 1. Statistics of rRNA depleted RNA-seq reads in fibroblasts 
From 58.8 milion reads, 44.6% (26.2 million reads) were uniquely mapped on the 
NCBI36/hg18 using the Bowtie alignment program (the alignment was done by Ido 
Tamir, GENAU consortium). Further, 49.95% of unique mapped reads were mapping 
to rRNA genes after the depletion. This showed that depletion was not complete, but 
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considering that rRNA consists ~95% of the cell RNA, depletion was enriched for 
non-rRNA. 
 
To examine the distribution of the reads through different categories of genomic 
regions the TopHat (Trapnell et al., 2009) program that aligns reads from the RNA-
Seq to the reference genome (hg18) without relying on known splice sites, was used. 
This program finds potential exons in Bowtie aligned data and further it builds a 
database of possible splice junctions that the program further confirms by mapping 
the experimentally gained reads to the junctions. This program was used to find 
known and novel splice junctions (across “GT-AG” introns) and to determine the 
distribution of the spliced and by extracting from the starting Bowtie data, the 
unspliced portion of the human genome.  
 
The TopHat algorithm aligned ∼11 million reads to the hg18, consisting of reads that 
are complete  (they contiguously align to the hg18) and that are spliced 
(discontinuous alignment). Approximately 8.3 million complete reads and 0.5 million 
of spliced reads that map to genic regions (annotated exons and introns of the 
RefSeq genes), and 2.1 million of complete and 0.13 million of spliced reads that 
map to intergenic regions (Figure 57A), were found. As expected, most of spliced 
reads partially map to exons and introns. Reads found to map to intergenic regions 
represented potential novel spliced transcripts in the human genome. This analysis 
showed that there are about 20% more spliced transcripts than annotated by RefSeq 
genes genes, and about 25% of novel exons mapping to introns (new spliced 
variants of known genes).  
 
The results of RNA-Seq were visualized on the UCSC browser (NCBI36/hg18) with 
the X-axis representing position in the genome and Y-axes representing number of 
reads. Representation of the Bowtie and the TopHat outputs are shown with the 
example of the DCN protein coding gene where 7/9 known exons have been found 
using exon-exon mapping (Figure 57B). As expected, the number of reads matching 
to exons of protein coding genes was very high in the RNA-Seq data, for example for 
DCN, 553 reads were mapped to the exon 5 showing highest expression (note that 
on Figure 57B a cut off of 25 reads was used). 
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Figure 57. TopHat alignment of fibroblasts RNA-seq finds novel splice-junctions in 
intergenic and intronic regions. A. Comparison of TopHat complete and spliced reads with 
RefSeq genes (reads that are completely or partially within exons, introns, genic and 
intergenic regions are shown). B. UCSC screenshot of Bowtie and TopHat aligned RNA-seq 
fibroblasts data. TopHat alignment is shown in the form of splice junctions where exons are 
represented as vertical lines. 7/9 exons of DCN were found using TopHat. Black RNA-seq 
track; RNA-seq reads with cut off of 25 reads. 
 
To examine the number of Hs27 RNA-seq reads that are represented in the 
unspliced fraction of the genome, I extracted the TopHat spliced fraction (based on 
Bowtie alignment) from uniquely mapped reads mapped with Bowtie and found that 
57.4% (~15 millions) of reads were unspliced (Figure 58). This rather large fraction 
potentially contains exons that are spliced in the tested cell line, but were not 
detected by TopHat (false negative rate), known unspliced transcripts (e.g. Kcnq1ot1 
macro ncRNA lacks any spliced products (Pandey et al., 2008)) and novel unspliced 
transcripts e.g. macro ncRNAs.  
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Figure 58. Using different aligners mapping spliced and total unique reads, 42.6% of 
the fibroblasts transcriptome has been found to be spliced while 57.4% is unspliced. 
Note that unspliced fraction contains TopHat false negatives, but also novel macro ncRNAs. 
 
2. 7. 2. Known macro ncRNAs by RNA-seq 
I further examined expression of known imprinted macro ncRNAs by RNA-seq and 
found that KCNQ1OT1, GTL2var1, UBE3A-ASvar2 and EXON1A that were 
expressed in fibroblasts by HIRTA hybridization, also showed expression in the Hs27 
RNA-seq data (examples in Figure 59). Previously, exact mapping of KCNQ1OT1 
was not possible with HIRTA mapping since the end of KCNQ1OT1 macro ncRNA is 
highly repetitive and was not spotted on the Chip. Using RNA-seq, I found the end of 
the human KCNQ1OT1, that is annotated RefSeq transcript of 59.5kb, and mapped 
the KCNQ1OT1 transcript as a 100kb long. The H19 and GNASAS macro ncRNAs 
that were very lowly expressed in fibroblasts using HIRTA compared to other 
cells/tissues e.g. liver for H19 and fetal kidney for GNASAS, could not be mapped 
using RNA-seq (these macro ncRNAs were covered with a very low number of 
reads). Interestingly, I observed that using RNA-seq, all known imprinted macro 
ncRNAs were lowly expressed (below 20 uniquely mapped reads) compared to 
protein coding genes. 
 
Further, expression of known non-imprinted macro ncRNAs expressed from 
fibroblasts was analysed and it was found that RNA-seq clearly detected the HOTAIR 
and MALAT1 macro ncRNAs (Figure 60A, B). Interestingly, MALAT1 was among the 
most highly expressed genes excluding rRNA genes, having the expression 
maximum of 5052 mapped reads (Figure 60B).  
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Figure 59. Known imprinted macro ncRNAs are detected by rRNA depleted RNA-seq. A. 
Both RNA-seq and HIRTA detect expression of KCNQ1OT1 with RNA-seq mapping a longer, 
100kb KCNQ1OT1 variant. B. GTL2var1 ncRNA is detected using RNA-seq. C. UBE3A-
ASvar2 is expressed in Hs27 using HIRTA and RNA-seq. UCSC view of RNA-seq (black) and 
HIRTA (orange) expression data on specified UCSC position (hg18). HIRTA tracks are 
presented as previously (Figure 11B, section 2.1.5.) Black: RNA-seq track; RNA-seq reads 
with cut off of 25 reads.  
 
 
 
Figure 60. rRNA depleted RNA-seq in normal human fibroblasts detects known non-
imprinted macro ncRNAs. A. HOTAIR macro ncRNA maps to annotated RefSeq genes 
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track. B. MALAT1 macro ncRNA maps to annotated ncRNA gene and shows very high 
expression with maximum of 5052 uniquely mapped reads. UCSC view of RNA-seq (black) 
expression data on specified UCSC position (hg18). Black RNA-seq track; RNA-seq reads  
 
2. 7. 3. Novel HIRTA macro ncRNAs validation by RNA-seq  
24 novel macro ncRNAs that were found by HIRTA in the fibroblast cell line were 
compared to rRNA depleted RNA-seq of the same cell line (Table 20). 6/24 
transcripts found by HIRTA were also clearly expressed by RNA-seq, 16 were very 
lowly expressed (with few sequencing reads mapping to regions annotated by HIRTA 
expression) and expression of two macro ncRNA was not found using RNA 
sequencing (Table 20). Three examples of novel macro ncRNA transcripts RNA-seq 
expression are shown in Figure 61, where KLF14up2 and KLF14up3 (Figure 61A) 
were clearly expressed and SLC38A4down2 example of lowly expressed transcript 
(Figure 61B).  
 
Since previously published RNA-seq data (shown in 2.7) could not detect expression 
from known imprinted macro ncRNAs, I looked into RNA-seq data recently integrated 
by UCSC (Burge RNA-seq (Wang et al., 2008a), CSHL Long RNA-seq, GIS RNA-
seq, Caltech RNA-seq and Helicos RNA-seq). These RNA-seq data examined 
expression in brain, breast, heart, lymph node, lymphoblastoid cells and K562 
myelogenous leukemia cell line, but there were no available fibroblasts sequencing 
data to which I could compare our Hs27 RNA-seq. Therefore, RNA-seq was 
compared to global run-on sequencing (GRO-seq) data (Core et al., 2008) which 
shows the positions of transcriptionally-engaged RNA polymerases in IMR90 lung 
fibroblasts. In total, 18/24 macro ncRNAs expressed from HIRTA were also 
transcribed by GRO-seq and similarly to RNA-seq of Hs27, they showed very low 
transcription of macro ncRNAs. GRO-seq data are strand specific and I found that 
7/18 GRO-seq transcripts showed transcription from both plus (+) and minus (-) 
UCSC strands indicating transcriptional orientation of probably overlapping 
transcripts, while 11 were transcribed from one of the UCSC strands (Table 20). 
When GRO-seq expression data was compared with the strand prediction data 
(section 2.5.3), overall agreement between these datasets was found, with exception 
of SDHDdown transcript that was predicted as expressed from - strand (with low 
probability score of -0.167), but found by GRO-seq data to be lowly expressed from + 
strand. Three more examples: PHACTR2ov, KIAA1024up and ADAMTS7down were 
similarly predicted as one strand transcripts and found as opposite strand by GRO-
seq, but they were all in the group of transcripts marked with a star (Table 18, section 
2.5.3.) representing probable overlapping transcripts of opposite orientations.  
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Macro ncRNAs expressed 
in fibroblasts (Hs27) by 
HIRTA  
RNA-seq in fibroblasts 
(Hs27) 
GRO-seq + 
(Core et al., 2008) in 
fibroblasts (IMR90) 
GRO-seq - 
(Core et al., 2008) in 
fibroblasts (IMR90) 
H19down + (low) + (low) - 
TSPAN32down1 + (low) - - 
ZNF195up1 + (low) - - 
ZNF195up2 + (low) - - 
SNRPNup2 + (low) - - 
APCDD1Lup1 + (low) + (low) + (low) 
 LRRC47down + (low) + (low) + (low) 
TIGD2down + (low) + (low) - 
PHACTR2ov + (low) + (low) - 
COL1A2up + (low) + (low) + (low) 
KLF14up2 + - + 
KLF14up3 + + + (low) 
PEG13 + (low) - + (low) 
KIAA1126up - - + (low) 
ZNF215up + (low) - - 
OR5P2ov + - - 
SDHDdown + (low) + (low) - 
PTSdown + (low) + (low) + (low) 
SLC38A4down1 + (low) + (low) + (low) 
SLC38A4down2 + (low) + (low) + (low) 
ADAMTS7down - - + (low) 
TMED3down +  + (low) - 
KIAA1024up +  + (low) - 
BLCAPov + - + 
Table 20. RNA-seq in fibroblasts validated 22/24 macro ncRNAs mapped by HIRTA. 16 
transcripts show low expression (<= 5 reads and usually low coverage that could not allow us 
mapping of transcript borders) while 6 show low expression, but with >5 reads and coverage 
that could be visually distinguished as a transcript. GRO-seq data confirmed 18/24 transcripts 
in IMR90. GRO-seq shows that most of the transcripts are lowly transcribed (<= 5 reads and 
usually low coverage). Transcriptional orientation of 9 transcripts could be determined from 
GRO-seq data. RNAs that are transcribed from both strands (columns GRO-seq + and GRO-
seq -) represent probably overlapping transcripts of opposite transcriptional orientation. 
 
 
Figure 61. Novel macro ncRNAs are detected by RNA-seq. A. Region upstream of KLF14 
protein coding gene is complex transcriptional unit consisting of annotated FLJ43663 ncRNA 
and KLF14up2 and KLFup3 macro ncRNAs expression detected by both HIRTA and RNA-
seq. RNA-seq expression is shown in black while tiling array expression is orange. B. 
SLC38A4down2 is a macro ncRNA expressed between SLC38A2 and SLC38A4 protein 
coding genes. This ncRNA shows low expression using HIRTA, but is still found to be 
expressed using RNA-seq with 26.2 millions of uniquely mapped reads. UCSC view of RNA-
seq (black) and HIRTA (orange) expression data on specified UCSC position (hg18). HIRTA 
tracks are presented as previously (Figure 11B, section 2.1.5.) Black: RNA-seq track; RNA-
seq reads with cut off of 25 reads.  
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I analyzed 24 macro ncRNA candidates expressed in fibroblasts by HIRTA with 
TopHat alignment in order to test if this program could find exon-exon junctions in our 
candidates directly from our experimental RNA-seq fibroblasts data. 23/24 
candidates did not show any presence of the splice junctions while the only exception 
was found in the complex transcription unit on chromosome 7 where 2 splice 
junctions were found in the KLF14up3 macro ncRNA. These splice junctions were 
just partially overlapping KLFup3 and thus potentially represent a novel overlapping 
protein-coding gene in this region. 
 
2. 7. 4. Novel primary small ncRNA transcripts in the human fibroblasts 
Macro ncRNAs can be precursors for different classes of small RNAs. Among six 
well-known imprinted macro ncRNAs four are known precursors of small ncRNAs, for 
example: H19 hosts hsa-mir675, GNASAS hosts hsa-mir296, hsa-mir298, GTL2var1 
hosts a cluster of miRNA and the 14I and 14II snoRNAs, and, UBE3A-ASvar1 hosts 
clusters of SNORD115 and SNORD116 snoRNAs. RNA preparation used for the 
RNA-Seq did not allow detection of RNAs smaller than 200bp, but the precursors of 
small RNAs should be detectable. To find novel primary micro (pri-mi) and primary 
snoRNA (pre-sno) transcripts I used miRBase Release 13 (March 2009) and mapped 
transcription overlapping these micro and snoRNAs on ten human chromosomes 
(chr1- chr10) in normal human fibroblasts from RNA-seq data. 
 
282 miRNAs and 121 snoRNAs have been annotated from miRBase on the first 10 
human chromosomes and I found 26 transcripts overlapping these small RNAs on 
the first 9 human chromosomes while chromosome 10 was negative (Table 21; 
names of transcripts will be shown as chromosome number, number of candidate 
from proximal end of chromosome). 25 were novel while one (chr 9-3) was 
overlapping the recently validated RefSeq gene LOC554202 ncRNA. 25 were miRNA 
precursors (overlapping 1-3 miRNAs) and one pre-snoRNA was also mapped. 
Lengths of these transcripts were 0.5 to 884kb (for those that are lowly expressed the 
exact positions of start and end was only provisionally determined). 16/26 transcripts 
had a CpG island on one of their ends. I used RNAcode prediction to determine non-
coding versus coding status of these transcripts and found 20 to be non-coding, 4 
protein coding and 2 possibly overlapping both coding and non-coding transcripts. 
According to the position of novel transcripts to the annotated genes (RefSeq) in the 
region 16 were intergenic, 5 potential novel 5’exons or overlapping, 3 potential 
3’UTRs or overlapping transcripts and 2 intronic transcripts.  
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1 46, 40 6 1 chr1:9131097-9185835 54.7 hsa-mir-34a yes IG NC 
   2 chr1:65271069-65305978 34.9 has-mir-101-1 yes IG NC 
   3 chr1:206037598-
206108847 
71.2 hsa-mir-29c,  
hsa-mir-29b-2 
yes IG NC 
   4 chr1:197084516-
197173082 
88.6 hsa-mir-181a-1,  
hsa-mir-181b-1 
no IG NC 
   5 chr1:170374221-
170380725 
6.5 hsa-mir-214, 
hsa-mir-199a-2 
no IN NC 
   6 chr1:98159044-98283926 124.9 hsa-mir-137 yes 5’/OV NC (1) 
2 24, 14 1 1 chr2:132727100-
132755758 
28.6 hsa-mir-663b yes 5’/OV PC 
(11) 
3 31, 15 3 1 chr3:44016047- 44141886 125.8 hsa-mir-138-1 yes IG NC (1) 
   2 chr3:115516049-
115540802 
24.7 has-mir-568 no 3’/OV NC 
   3 chr3:196898055-
196932703 
34.6 has-mir-570 no 5’/OV NC (1) 
4 25, 5 1 1 chr4:24118111-24138849 20.7 hsa-mir-573 no 3’/OV NC 
5 30, 9 1 1 chr5:148766576- 
148793784 
27.2 hsa-mir-143, 
hsa-mir-145 
no IG NC 
6 15, 13 4 1 chr6:72136483- 72187456 51 hsa-mir-30c-2, 
hsa-mir-30a 
yes IG NC (1) 
   2 chr6:126753203-
127481933 
728.3 hsa-mir-588 yes IG PC 
(12) 
   3 chr6:155876033-
156759776 
883.7 hsa-mir-1202 yes IG NC/PC 
(2) 
   4 chr6:18636712-18860589 223.9 hsa-mir-548a-1 no IG NC (1) 
7 34, 8 4 1 chr7:22859996-22876600 16.6 HBII-336 yes IG PC (3) 
   2 chr7:27176401-27173373 3 hsa-mir-196b yes IG NC 
   3 chr7:32733372- 32851180 117.8 hsa-mir-550-2 yes IG PC (8) 
   4 chr7:130207753-
130252350 
44.6 hsa-mir-29a, 
hsa-mir-29b-1 
no IG NC/PC 
(2) 
8 29, 4 4 1 chr8:135866372-
135914313 
47.9 hsa-mir-30b,  
hsa-mir-30d 
yes IG NC 
   2 chr8:105552966-
105570604 
17.6 hsa-mir-548a-3 no 3’/OV NC 
   3 chr8:22158068- 22158541 0.5 hsa-mir-320a yes 5’/OV NC 
9 26, 11 3 1 chr9: 95968398- 96001224 32.8 hsa-let-7a-1,  
hsa-let-7f-1,  
hsa-let-7d 
yes IG NC 
   2 chr9:130045825-
130047020 
1.2 hsa-mir-199b no IN NC 
   3* chr9:21444267-21549697 105.43 hsa-mir-31 yes 5’/OV NC (1) 
10 22, 3 - - - - - - - - 
Table 21. 26 novel primary mi/sno transcripts are mapped on first 10 human 
chromosomes in normal human fibroblasts. Total number of mi/snoRNAs per human 
chromosome is shown (using miRBase, Release13, March 2009). Positions (in hg18) and 
lengths (in kb) of novel transcripts named according to number starting from proximal end of 
the chromosome they are transcribed from are shown. Overlapping small RNAs, CpG island 
located on one of the end of the mapped transcript, position according to annotated genes 
(RefSeq) and RNAcode prediction for these transcripts is presented. * LOC554202 ncRNA 
 
The example of the novel LET-7-pri-miRNA (chr 9-1) overlapping three miRNA (hsa-
let-7a-1, hsa-let-7f-1, hsa-let-7d) and of novel SNORD93-pre-snoRNA (chr 7-1) 
overlapping HBII-336 are showed on Figure 62A, B. Both of those have a CpG island 
at one end putatively identifying the transcriptional start site. Positions of 26 mapped 
transcripts on 10 human chromosomes are depicted on Figure 62C.  
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Figure 62. Positions of novel primary small RNA transcripts on 10 human 
chromosomes and examples of SNORD93pre-snoRNA (chr 7-1) and LET-7-pri-miRNA 
(chr 9-1). A. LET-7-pri-miRNA in length of 38.7kb is found by RNA-seq in Hs27, maps to 
three miRNAs and has a CpG island positioned on the proximal end of the transcript. B. RNA-
seq in fibroblast cell line shows 16.6kb transcription overlapping SNORD93. Novel transcript 
has a CpG island promoter (green). C. Positions of novel transcripts expressed in fibroblasts 
that map to ten human chromosomes (transcripts are numbered from the proximal end of the 
chromosome). 
 
2. 7. 5. Novel SHOX protein coding gene variants 
The SHOX gene consists of 7 exons. This gene is located on the pseudoautosomal 
region 1 on chromosomes X and Y and encodes a transcription factor. In 
collaboration with Claudia Durand from the lab of Gudrun Rappold (Heidelberg, 
Germany) who had performed a systematic screen of 41 human tissues and 
identified novel SHOX gene variants including four exon variants named 2a, 7-1, 7-2 
and 7-3, I verified these findings using RNA-seq. Since the Hs27 normal human 
fibroblasts cell line expressed some novel SHOX variants in levels detectable by RT-
PCR, I analyzed rRNA depleted RNA-seq whole genome data from Hs27. I 
confirmed novel SHOX exons in the SHOX gene region on chromosome X in Hs27 
cell line by RNA-seq (Figure 63A). Applying a cut-off of 5 unique mapped reads, 
expression of novel SHOX exon 2a and variants of the known exon 7:  7-1, 7-2 and 
7-3, were detected by RNA-seq (Figure 63B). In summary, novel SHOX exon 2a and 
three variants of exon 7 were validated by RNA-seq technique in the Hs27 cell line. 
This work has been submitted as: Durand C, Roth R, Vlatkovic I, Dweeph H, Decker 
E, Schneider K, Rappold G, Alternative splicing and nonsense-mediated RNA decay 
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contribute to the regulation of SHOX expression. The analysis shows usefulness of 
RNA-seq to identify novel spliced variants. 
 
Figure 63. RNA-seq of diploid human fibroblasts (Hs27) confirms novel 2a, 7-1, 7-2 and 7-3 
exons of SHOX gene. A. UCSC browser screenshot of Hs27 RNA-seq on the chromosome X 
genomic region covering SHOXa and SHOXb genes (RefSeq UCSC track) shows expression 
of known and novel SHOX exons. The X-axis represents the number of mapped reads; the Y-
axis shows the position in the NCBI36/hg18 release of the human genome. Known and novel 
exons of SHOX variants are numbered below. B. UCSC browser screenshot focused on 
novel exons 2a and 7-1, 7-2 and 7-3, shows that more than 5 unique reads could be mapped 
on the genome positions of these exons confirming their expression in the Hs27 cell line.  
(Modified from Durand C, Roth R, Vlatkovic I, et al., submitted) 
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3. Discussion  
 
3. 1. Summary of results 
I successfully used tilling array (HIRTA) and RNA-seq approaches to map novel 
macro ncRNAs in human imprinted gene regions. From 20 normal and 23 cancer 
human samples hybridized to HIRTA, tissue specific profiles of human imprinted 
gene regions were obtained and 101 novel macro ncRNA candidates were identified. 
Furthermore, rRNA depleted RNA-seq of a fibroblast cell line validated the 
expression of 22/24 transcripts detected by HIRTA in fibroblasts. 7 novel macro 
ncRNAs were developmentally regulated in a human embryonic stem cell 
differentiation system. Characterization of 10 novel macro ncRNAs showed that 6 
had preferentially or exclusively monoallelic expression, 5 were exclusively nuclear 
localized indicating their potential role in gene silencing and 2 (ADAMTS7down and 
PEG13) had CpG island promoters that were found to be differentially methylated 
regions (DMRs). Furthermore, 22 out of 101 mapped transcripts were cancer 
specific. These results indicate that macro ncRNAs could be a universal feature of 
human imprinted gene regions since each human imprinted gene region analyzed 
expressed at least one macro ncRNA. 
 
3. 2. HIRTA and RNA-Seq successfully detects macro ncRNAs 
 
3. 2. 1. Macro ncRNAs could be mapped from their expression features on the 
tiling array 
Tiling arrays have been used for obtaining expression profiles of limited number of 
cell lines from selected genomic regions (e.g. Cheng (Cheng et al., 2005)) or in 
whole genome expression studies (e.g. Bertone and colleagues used liver polyA 
RNA (Bertone et al., 2004) and Kapranov polyA RNA from HeLa and HepG2 cell 
lines (Kapranov et al., 2007a)). These studies with some exceptions utilized 
Affymetrix technology and polyA RNA cell fractions and showed that the non-
annotated portion of the human genome is still substantial and that high proportion of 
transcription consists of non-protein coding RNAs. These studies found numerous 
novel non-annotated transcripts from a small number of tested cell lines, but they did 
not examine if any novel transcripts were macro ncRNAs of the type found in 
imprinted gene clusters.  
 
In this thesis, I applied total RNA to a custom NimbleGen tilling array (HIRTA) and 
showed that known imprinted macro ncRNAs are successfully detected using “single 
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cDNA hybridization on HIRTA”. Focusing on imprinted gene regions (HIRTA contains 
2% of the human genome) allowed a higher probability of finding novel imprinted 
macro ncRNAs and also lowered the cost of applying higher number of samples than 
if the whole genome tiling arrays were used. The expression profile of macro ncRNAs 
from HIRTA hybridizations showed specific characteristics: a continuous high signal 
through the whole ncRNA gene body, a 5’-3’ slope and a non-saturated transcription 
level. These features distinguish macro ncRNAs from protein-coding mRNA genes 
that typically showed a peaked pattern with a high, saturated signal over exons and a 
low non-saturated signal over introns. I discuss below how these features of macro 
ncRNA and protein coding mRNA genes may originate from differences in macro 
ncRNA and pre-mRNA biology and how they were used to develop a strategy for 
mapping novel macro ncRNAs.  
 
3. 2. 1. 1. “Continuous high HIRTA signal” over macro ncRNA body may 
originate from differences in splicing  
The first macro ncRNA feature observed from the six well-studied imprinted gene 
clusters were continuous non-saturated signals from typically more than 90% of 
HIRTA tiles, through the whole length of macro ncRNA gene. In contrast, most pre-
mRNAs showed focal saturated signals matching exons and typically low to 
moderate non-saturated intronic signals. Continuous high signals from macro 
ncRNAs most probably results from their low level of splicing (e.g. Airn is mostly 
unspliced and Kcnq1ot1 lacks any spliced products (Pandey et al., 2008; Seidl et al., 
2006)).  
 
Nonsense-mediated decay (NMD) is the mechanism that selectively eliminates 
aberrant RNAs that have premature transcription termination codons in eukaryotic 
cells. Splicing is coupled with NMD since specific protein complexes that mark 
premature codon deposited to the RNA during splicing had been found (reviewed in 
(Chang et al., 2007)). Thus, previously it was proposed that macro ncRNAs could 
loose their capacity to be spliced during evolution, to escape the nonsense mediated 
decay pathway (Ponting et al., 2009). 
 
Continuous high signals may also originate from the low intron/exon ratio that had 
been previously shown to characterize some known macro ncRNAs, e.g. H19 and 
Xist are spliced but have short introns relative to exon length (Brannan et al., 1990; 
Brown et al., 1991). These short introns were more difficult to visualize in comparison 
to the typical long protein-coding introns (protein coding genes are showing high 
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intron/exon ratio (Lander et al., 2001)). Thus when expressed, short introns could not 
be distinguished from “continuous high signals” appearance of macro ncRNAs, while 
protein-coding genes that typically splice out long introns had a clearly different high-
exonic/low-intronic HIRTA expression pattern.  
 
Potential obstacles in differentiating between ncRNAs and protein coding genes 
based on the “continuous high signal” criterion were: 1) protein coding genes that 
consist of one exon (12% of human annotated genes are single-exon genes 
(Sakharkar et al., 2005), e.g. NDN located on chr15) and 2), protein coding genes 
that show high intronic signals. Based on the HIRTA profile alone I could not exclude 
that some of the novel mapped transcripts are single-exon protein coding genes and 
thus I used the RNAcode algorithm (Washietl et al., unpublished data) that predicts 
exons based on evolutionary signatures, to show that no single-exon genes were 
among novel mapped transcripts. Protein coding genes that show high intronic 
expression on the tiling array may represent transcripts with a high transcriptional 
rate (Ebisuya et al., 2008). I excluded these potential false positives from the mapped 
macro ncRNA candidates since I compared all 43 hybridized samples 
simultaneously. This approach maximizes possibility to exclude protein-coding genes 
with high transcriptional rate since these genes are expected not to have high intronic 
expression, but typical high-exonic/low-intronic HIRTA expression pattern in most of 
the tissues. 
 
3. 2. 1. 2. 5’-3’ slope macro ncRNA feature may originate in alternative 
polyadenylation 
By visual examination of the HIRTA macro ncRNA expression profiles, as a second 
feature, the decreases of the HIRTA expression through the body of known macro 
ncRNAs were observed. These decreases showed opposite correlation with the 
transcription orientations of the known ncRNA transcripts and thus were named as 
5’-3’ slope. In this section I will discuss how 5’-3’ slope macro ncRNA feature may 
originate in alternative polyadenilation. 
 
The biology of macro ncRNAs is still poorly characterized. For a few tested imprinted 
macro ncRNAs it has been shown that they are RNA Polymerase (RNAP) II 
transcripts (e.g. mouse H19, Airn, Kcnq1ot1 (Brannan et al., 1990; Redrup et al., 
2009; Seidl et al., 2006)) and that have low level of splicing (e.g. Airn) or that they are 
unspliced (e.g. Kcnq1ot1) (Pandey et al., 2008; Seidl et al., 2006).  
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Mammalian pre-mRNA transcription termination is directed by sequence elements on 
the pre-mRNA (Mandel et al., 2008). Primary sequence elements consist of 
polyadenylation signal sequence, the cleavage site and the G/U rich downstream 
element (Zhao et al., 1999). The auxiliary elements were found downstream of the 
RNAP II cleavage site or upstream of the polyadenylation sequence (Zhao et al., 
1999). Downstream auxiliary elements are generally G-rich while upstream auxiliary 
elements are usually U-rich (UUUU, UGUA or UAUA) (Bagga et al., 1995; Hu et al., 
2005). Interestingly upstream auxiliary elements that enhance efficiency of cleavage 
and polyadenilation of primary transcript RNAs by binding auxiliary polyadenylation 
factors are mostly found together with enhanced transcription of intronless genes (Le 
Hir et al., 2003; Moreira et al., 1995). Thus, we speculate that auxiliary elements may 
be potentially more often found in intronless macro ncRNAs than in pre-mRNAs 
containing long introns, enhancing their transcription and promoting their 
polyadenylation.  
 
If macro ncRNAs are RNA polymerase (RNAP) II transcripts, three non-mutually 
exclusive hypothesis could explain the 5’-3’ slope of macro ncRNAs: 1) very long, 
macro ncRNAs may have a number of polyA signals that are usually not functional 
through the genomic region, but could potentially be more often used by RNAP II 
when the coupling with the splicing machinery does not take place, 2) macro ncRNAs 
may have a higher number of additional termination elements (auxiliary elements) in 
3’ regions that will advance RNAP II termination on different polyA sites comparing to 
pre-mRNAs 3), macro ncRNAs may be characterized by a higher level of alternative 
polyadenylation than pre-mRNAs and thus different cells will produce macro ncRNA 
transcripts of different lengths that could be seen as 5’-3’ slope in the RNA pool 
detected by the HIRTA array (Figure 64).  
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Figure 64. Model showing how 5’-3’ HIRTA feature of macro ncRNAs may originate in 
macro ncRNA biology. A number of macro ncRNA variants may be transcribed from one cell 
by RNAP II, when different polyadenylation sites are more efficiently recognized with the help 
of auxiliary factors and in the potential absence of splicing machinery each cell of the 
population may transcribe macro ncRNA variant of different length by using different 
polyadenylation and cleavage site for transcription termination. TSS; transcriptional start site, 
pA; polyadenylation site. See key for further details. 
 
These hypothesis remain to be tested, for example by using RNA FISH with different 
probes for potential diverse 3’ ends, it could be tested if each cell transcribe just one 
alternatively polyadenylated macro ncRNA transcript or each cell transcribes a pool 
of macro ncRNA transcripts of different lengths. Further, sequences of high number 
of macro ncRNAs and pre-mRNAs could be tested for statistical difference in number 
of G-rich and U-rich auxiliary elements. 
 
3. 2. 1. 3. 5’-3’ slope macro ncRNA feature as a criteria for the transcript 
orientation prediction 
HIRTA hybridizations did not allow strand specific information to be obtained, since 
double stranded cDNAs were applied to the HIRTA chips. In order to indirectly gain 
this information, I used 5’-3’ slope expression feature as one of the criteria in 
prediction of the macro ncRNA strand. In addition to the slope criteria, I based 
prediction of the transcript orientation on three more published genomic/epigenomic 
features: CpG island, H3K4me3 enrichment and RNAP II binding site. I used these 
features since they are known marks of promoters (described in section 1.) and thus 
could predict the 5’ ends of the transcripts. I found overall agreement between 
transcript orientation predictions of the novel macro ncRNAs based on these four 
features and the GRO-Seq data that mapped the amount, position and orientation of 
transcriptionally engaged RNA polymerases in the IMR90 fibroblast cell line (Core et 
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al., 2008). Further, I found that around 50% of the macro ncRNAs that were 
overlapping with GRO-seq data showed presence of RNA polymerases in both 
directions. Thus, a certain percentage of novel macro ncRNAs that I mapped may 
represent overlapping transcripts supporting the “interleaved” model (extensive 
overlap of transcriptional units and regulatory regions on the same genomic space) 
proposed by Kapranov and colleagues (Kapranov et al., 2007b).  
 
3. 2. 1. 4. Differences in HIRTA mapping for macro ncRNAs having diverse 
positions to the annotated genes 
101 novel macro ncRNAs that were grouped as: 1) intergenic, 2) intronic, 3) adjacent 
to the 5’ end of annotated genes (5’/OV), and 4) adjacent to the 3’ end of annotated 
genes (3’/OV), were mapped using the described strategy (section 2.1.5.) based on 
the HIRTA expression patterns. The intergenic transcripts were mapped reliably 
since borders of these transcripts could be easily visualized. The borders of potential 
intronic transcripts could not be assigned in most of the cases when high expression 
was observed through the whole length of the host gene intronic regions. The intronic 
macro ncRNAs I was able to distinguish from the host gene expression were PEG13 
where I knew the orthologous position from the mouse, and HTR2Ain where the 
HTR2A host protein-coding gene was not expressed in number of tissues. Human 
introns have been found as a source of regulatory RNAs (Mattick and Gagen, 2001), 
and among imprinted macro ncRNAs some are intronic e.g. MESTIT1 macro ncRNA 
(Figure 24, section 2.4.1.). Thus, there is a high potential for existence of a more 
intronic macro ncRNAs than already known or mapped by HIRTA in imprinted 
regions and for study of these transcripts strand specific mapping technology in 
numerous tissues would be necessary.  
 
Many known macro ncRNAs overlap protein-coding genes (e.g. KCNQ1OT1, 
UBE3A-AS, GNAS1-AS, EXON1A), thus I also mapped transcription longer than 1kb 
positioned adjacent to 5’ and 3’ ends of known genes. This transcription could 
represent macro ncRNAs that overlap annotated genes or alternatively novel 5’UTRs 
or 3’ UTRs of annotated genes. Further examination of each specific example would 
be necessary to reveal the origin of mapped transcription. However, I showed that 29 
transcripts that are positioned 5’ and 3’ to the known protein-coding gene are 
predicted to be non-coding by using the RNAcode algorithm (Washietl et al., 
unpublished data) where no protein coding potential could be found in these regions 
based on evolutionary signatures in 44 species.  
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3. 2. 2. Ribosomal RNA depleted RNA-seq successfully maps macro ncRNAs 
Previous RNA-seq studies from poly (A) selected RNAs have been focused on 
alternative splicing of protein coding genes while the macro non-protein coding 
portion of the genome was not directly assessed (Pan et al., 2008; Sultan et al., 
2008). Visual inspection of mRNA-seq data from these studies showed that imprinted 
macro ncRNAs were poorly detected showing the necessity for employment of 
modified RNA-seq sample preparation in order to improve the macro ncRNAs 
detection. Thus, RNA-seq using the Illumina/Solexa technology on total rRNA 
depleted RNA from fibroblasts was performed, and successfully detected the known 
macro ncRNAs such as KCNQ1OT1, GTL2var1, UBE3A-ASvar2, HOTAIR and 
MALAT1 and 22/24 of the novel macro ncRNAs that I detected by tiling array.  
 
With some exceptions, most of the known and novel macro ncRNAs were relatively 
lowly expressed in comparison to annotated protein coding genes by rRNA depleted 
RNA-seq. Low expression of macro ncRNAs was also shown by HIRTA 
hybridizations indicating that low macro ncRNA expression reflects their biology and 
not technical problems. Both HIRTA and RNA-seq detect the steady-state level of 
gene expression. The steady-state level is expected to be a result of the combined 
rate of transcription and degradation (stability) of the transcript. The low expression 
of macro ncRNAs could be based on the low stability of macro ncRNAs measured by 
their relatively short half-life (e.g. mouse unspliced Airn half-life was 2.1h, whereas 
Igf2r mRNA had half-life of 14.3h (Seidl et al., 2006)), while in the same time macro 
ncRNA transcription may be high. To examine if low expression of novel mapped 
macro ncRNAs results from combined rate of transcription and degradation, measure 
of transcription rate using nuclear-run on assays in diverse cells/tissues and measure 
of macro ncRNA stability for example by using actinomicin D for each novel lowly 
expressed macro ncRNA would be necessary. 
 
In the RNA-seq data, the read coverage of the 16/24 lowly expressed novel macro 
ncRNAs was also often low. Due to this low coverage in 66% of the novel transcripts, 
if HIRTA mapping data would not be available, RNA-seq alone would not allow us to 
map 5’ and 3’ macro ncRNA boundaries. This indicates that the 26.2 million of 
uniquely mapped reads provided by the RNA-seq data was not deep enough to 
completely cover lowly expressed macro ncRNAs and this could be further improved 
by more efficient rRNA depletion of total RNA prior to the RNA-seq procedure.   
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The ∼45% of the total read number was uniquely mapped in the Hs27 cell line by 
rRNA depleted RNA-seq. This number was in overall agreement with other RNA-seq 
data. For example Sultan et al. (Sultan et al., 2008) had 50% uniquely mapped reads 
using mRNA-seq. In the rRNA depleted RNA-seq from the Hs27 cell line, 20% more 
spliced transcripts than annotated by RefSeq genes and 25% novel exons mapping 
to introns of known genes, were found by TopHat alignment. This result was in 
concordance with previous findings that alternative splicing is one of the key factors 
on which complexity of higher eukaryotes is based (Matlin et al., 2005). For example, 
Pan et al. detected novel splice junctions in about 20% of multiexon genes from six 
human tissues (Pan et al., 2008). Novel spliced transcripts and exons that were 
detected in Hs27 cells and described in section 2.7.1., further add to the human 
alternative splicing complexity. 
 
The ∼60% of the unspliced reads found in Hs27 cell line after extracting TopHat 
spliced transcripts from Bowtie aligned uniquely mapped reads, contained known 
unspliced transcripts, potentially TopHat false negative transcripts, but also showed 
that high percentage of uniquely mapped reads may represent novel unspliced 
macro ncRNAs. The finding of a high proportion of unspliced transcripts in the human 
genome from RNA-seq data, was in the overall agreement with HIRTA study based 
on 2% of the genome, where 101 novel transcripts, that showed “continuous high 
signal” patterns and thus were potentially unspliced macro ncRNAs, were mapped. 
RNA-seq using rRNA depleted total RNA successfully detected macro ncRNAs but 
further advancement in detection is expected from more efficient rRNA depletion, 
paired-end sequencing, strand-specific sequencing and from further development of 
technology towards the longer reads lengths.  
 
3. 3. Pervasive transcription or functional ncRNAs? 
Rapid development of technologies such as tiling arrays and next-generation RNA-
sequencing in the last years led to novel insights into the genome complexity. These 
findings led to the use of the term “pervasive transcription” that refers to widespread 
unannotated transcription arising over most of the human genome (reviewed in 
(Kapranov et al., 2007b)). In the literature the term “pervasive transcription” was not 
uniquely defined and fully understood and become a matter of debate in the field (for 
publications see: http://pervasivetranscription.com/). For example, Jacquier et al., 
(Jacquier, 2009) referred to pervasive transcription as transcription not restricted to 
well-defined functional features, such as genes, and Ponting et al. (Ponting et al., 
2009) noted that pervasive transcription does not necessarily imply an abundance of 
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functional RNAs. Oppositely, Beretta and Morillon predicted a crucial role of 
pervasive transcription in controlling gene expression and genomic plasticity while 
Mattick also suggests a functionality of transcripts (ncRNAs), derived from pervasive 
transcription (Berretta and Morillon, 2009; Dinger et al., 2009; Mattick and Makunin, 
2006). The overall picture is that there are different possibilities of what pervasive 
transcription could represent: novel transcripts (coding or non-coding) that have 
currently unknown functional roles, spurious products of transcription (junk RNAs) 
that do not have a function and represent side products of functional processes in the 
cell, novel 5’ and 3’ UTRs of annotated genes, transcriptional read through or even 
experimental artifacts (reviewed in (Huttenhofer et al., 2005; Johnson et al., 2005; 
Mendes Soares and Valcarcel, 2006; Wilusz et al., 2009)).  
 
Global transcription resembling pervasive transcription, but found specifically in 
undifferentiated mouse ES cells on the whole genome level, was proposed to be the 
key mechanism that could keep the pluripotent state of the cells. The same authors 
found that after 7 days of ES cell differentiation total and mRNA levels were ∼2 fold 
lower compared to undifferentiated ES cells (Efroni et al., 2008). Global transcription 
of undifferentiated human ES cells in imprinted gene regions was not observed in my 
HIRTA studies since transcribed and silenced genomic regions were present at 
similar level to the differentiated ES cells.   
 
In this study 101 unannotated transcripts were mapped in cell lines and tissues with 
95% of them showing non protein coding potential as assessed by RNAcode 
(Washietl et al., unpublished data). It could not be fully excluded that some of these 
transcripts are UTRs of annotated genes, transcriptional read through, junk RNAs or 
experimental artifacts (originating from cross-hybridization on the tiling arrays or 
being background signals). However, newly mapped macro ncRNA transcripts were 
found in gene regions containing imprinted genes, with a number of them showing 
different indices of functionality that will be discussed through this section. 
 
3. 3. 1. Novel macro ncRNAs that show tissue specific expression and 
subcellular localization may be functional 
Tissue specific expression and a specific subcellular localization of macro ncRNAs 
are indices of functionality of macro ncRNAs (reviewed in (Mattick, 2009)). I tested 
expression of 20 normal and 23 cancer cells/tissues on HIRTA and found differential 
tissue specific expression of 99/101 novel macro ncRNA candidates in imprinted 
gene regions. Most of the macro ncRNAs (29%) were expressed in testis. This 
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observation was in agreement with work of Sasaki where they found that 29% of their 
tested mRNA-like ncRNAs were expressed in testis where the testis macro ncRNA 
fraction was the largest among 11 human tissues. Together with similar mouse data 
this implies that macro ncRNAs could potentially have specific roles in complex 
regulatory mechanisms in testis (Ravasi et al., 2006; Sasaki et al., 2007).  
 
I used a “double cDNA HIRTA hybridization” (section 2.1.6.) approach to identify 
nuclear-enriched macro ncRNAs. I confirmed the subcellular localization of the 
KCNQ1OT1 macro ncRNA and identified the subcellular localizations of 15 other 
known and novel macro ncRNAs using this technique. I observed a limitation in the 
reliable interpretation of subcellular localization for very lowly expressed transcripts 
since correct interpretation highly depends on the position of the base line and the 
used normalization, however those with higher expression macro ncRNAs were 
reliably assigned to the nuclear or cytoplasmic compartment. A second difficulty was 
the reliable interpretation of cytoplasm (grey) signals that only spanned one tile and 
were located in non-annotated regions. These signals may represent novel exons of 
cytoplasm-enriched transcripts. Additionally, it cannot be excluded that one tile 
cytoplasmic signals observed by double cDNA HIRTA hybridization may originate 
from cross-hybridizations with partially complementary transcripts mapping to other 
genomic regions. Overcoming the limitations in the data interpretation, double cDNA 
HIRTA hybridization reliably detected that 8/15 transcripts were localized in both 
cytoplasm and nucleus of the Hs27 cells while 6 transcripts were exclusively nuclear 
indicating their potential role in gene regulation. 
 
3. 3. 2. Developmentally regulated macro ncRNAs overlapping olfactory 
receptor genes may be functional 
HIRTA expression profiling of undifferentiated and day 7 differentiated human ES 
cells showed that 7 novel transcripts were developmentally regulated and thus may 
have regulatory functions. Two of these transcripts (OR56B4up1 and OR5P2ov) 
overlapped olfactory receptor genes (Figure 25, section 2.4.2.). Olfactory receptor 
genes are known as typical example of randomly monoallelically expressed genes 
and in mouse it has been previously shown that monoallelic expression of olfactory 
receptors is regulated by enhancer element H that is methylated on one chromosome 
and that can act in cis or in trans (Chess et al., 1994; Lomvardas et al., 2006). 
Further it was proposed that in mouse this enhancer element interacts just with one 
olfactory receptor (OR) gene per nucleus leading to expression of just this one OR 
gene out of 1300 OR genes, in one olfactory neuron (Serizawa et al., 2003). The 
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mapping of two macro ncRNAs that overlap a number of OR genes raises the 
question if these macro ncRNAs contribute to random monoallelic expression in a 
similar manner as found for imprinted macro ncRNA in inducing imprinted monoallelic 
expression? It would be interesting to test if the macro ncRNAs overlapping OR 
genes expressed in human ES cells are also present in olfactory neurons, and if they 
have the same transcription profiles in olfactory neurons expressing different 
olfactory genes. One of the possibilities how macro ncRNAs may regulate OR gene 
monoallelic expression is by transcription through enhancer elements where macro 
ncRNAs could potentially set a methylation mark on enhancer of one parental 
chromosome, that would further activate OR gene by known mechanism involving 
intra or interchromosomal interaction with promoter of OR gene. 
 
3. 3. 3. A small number of HIRTA mapped macro ncRNAs overlap with 
lincRNAs associated with PRC2 and CoREST complexes 
Large intergenic transcripts (lincRNAs) have been mapped in human fibroblasts and 
HeLa cells by approach based on finding of evolutionary conserved domains where 
H3K4me3 and H3K36me3 overlap (Khalil et al., 2009). Only 9 out of the 101 HIRTA 
mapped transcripts overlapped with lincRNAs. Interestingly, 5 out of these 9 
transcripts have been found to associate with PRC2 and CoREST complexes in the 
lincRNA study (Khalil et al., 2009). PRC2 is a methyltransferase that trimethylates 
H3K27 and has a function in repressing transcription of specific genes (Bracken et 
al., 2006). Recently, it has been shown that PRC2 interacts in mouse placenta with 
the imprinted Kcnq1ot1 ncRNA (Pandey et al., 2008) that is known to have a function 
in silencing imprinted genes in the Kcnq1 mouse imprinted cluster (described in 
section 1). The HOTAIR macro ncRNA that is transcribed from the HOXC cluster has 
been shown to bind PRC2 and to repress genes in trans in the HOXD cluster (Rinn et 
al., 2007). The CoREST complex is another chromatin-modifying complex known as 
a repressor of neuronal genes (Andres et al., 1999). The 5 transcripts found by both 
HIRTA and lincRNAs study that are physically associated with PRC2 and CoREST 
complexes may have a function as epigenetic initiators and target histone 
methylation at specific genomic location (epigenetic pathway model was described in 
1.1.2. (Berger et al., 2009)). 
 
3. 3. 4. Macro ncRNAs may function independently and as precursors for small 
ncRNAs 
Macro ncRNAs have different roles in the cell, but one function is to act as precursors 
for different classes of small ncRNAs, since macro ncRNAs as well as protein-coding 
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genes (especially their introns) can be post-transcriptionally processed into small 
RNAs (Fejes-Toth, 2009). Imprinted macro ncRNAs are known precursors for 
miRNAs and snoRNAs (e.g H19, GNASAS, UBE3A-AS, GTL2, described in section 
2.7.4.), as well as some non-imprinted macro ncRNAs e.g. MALAT1, ∼7kb nuclear 
macro ncRNA known to generate mascRNAs (MALAT1 associated small cytoplasmic 
RNA). It is becoming apparent that macro ncRNAs and their processed small 
ncRNAs can have different biology (e.g. cellular localization, half-life) and possibly 
different functions (Wilusz et al., 2008; Wilusz et al., 2009). 
 
The only large snoRNA clusters found in the human genome up to now are those 
embedded into the imprinted UBE3A-AS and GTL2 macro ncRNAs. The UBE3A-AS 
macro ncRNA that is expressed from PWS imprinted gene cluster contains two large 
snoRNA clusters: HBAII-85 and HBAII-52. The HBAII-85 has a significant role in the 
Prader-willi Syndrome (PWS) (Duker et al., 2010) and the HBAII-52 could be 
involved in the editing and/or alternative splicing of the pre-mRNA of 5-
hydroxytryptamine 2C (5-HT2C) receptor that plays a role in serotonergic signal 
transduction (such a regulatory role has been found for corresponding mouse MBAII-
52 snoRNA cluster) (Kishore and Stamm, 2006; Nicholls and Knepper, 2001). In this 
thesis UBE3A-ASvar4 macro ncRNA overlapping exclusively HBAII-52 snoRNA 
cluster (Figure 16, section 2.2.1.1.) that could be a potential precursor for HBAII-52 
was found in a small number of tissues including fetal and adult brain and 
developmentally upregulated in hES cell system correlating with a previously shown 
functional role in brain. 
 
In the DLK1 imprinted gene region, GTL2var5 overlapping the 14qI and 14qII 
snoRNA clusters (Figure 14, section 2.2.1.1.) was expressed only in adult heart and 
uterus and could also represent precursor for those snoRNA clusters. The question 
for the future work is if these macro ncRNAs that overlap small RNAs function 
exclusively as a precursors of small RNAs or they could have in the same time other 
roles in the cell, presumably in gene regulation in cis (Figure 65).  
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Figure 65. Macro ncRNAs can be precursors of small RNAs. Macro ncRNAs could 
function as small ncRNA precursors but may also have independent functions.  
 
The methodology of sample preparation for rRNA depleted RNA-seq did not preserve 
small RNA species (less than 200bp long), but by examining 10 human 
chromosomes (chr1 to chr10), 25 potential primary miRNAs transcripts (novel 
transcripts found to overlap known miRNAs) and 1 potential precursor for snoRNA 
(novel transcript that overlaps known snoRNA) were mapped, of which 20 were 
predicted to be macro ncRNAs, 4 predicted to be novel protein-coding genes and 2 
possibly overlapping both non-coding and coding transcripts. 
 
The number of novel precursors for small RNAs that were mapped was dependent 
on already known small RNAs from the miRBase, thus it could be predicted that 
more unknown precursors and small ncRNAs may be mapped in normal human 
fibroblasts. An interesting question will be if these precursors always have the same 
expression profiles as the small RNAs processed from them in different tissues, or 
they could be also transcribed in the tissue specific manner without processing into 
the small ncRNAs. For resolving of this question RNA-seq expression profiles of both 
small and precursor RNAs in number of tissues should be compared. 
 
Mapping of novel macro ncRNAs in human and indirect evidence implying their 
function are a valuable resource and the beginning point for direct testing of function 
of mapped macro ncRNAs, that is certainly the important challenge of future work 
(further discussed in section 3.8.). 
 
3. 4. Developmental upregulation of XIST macro ncRNA in HES2 cells 
X-chromosome inactivation takes place in female mammals and requires the X 
Inactive Specific Transcript (Xist/XIST) (Lee et al., 1996; Penny et al., 1996). Not all 
human ES cell lines have the ability to show developmental regulation of XIST 
ncRNA and to recapitulate X-inactivation in an in vitro system (Silva et al., 2008). The 
human XIST macro ncRNA was not expressed in the female undifferentiated human 
embryonic stem HES2 cell line by HIRTA, while was developmentally upregulated 
and showed relatively low expression after 7 days of HES2 differentiation (section 
2.3.). Interestingly, Silva et al. could not detect any expression of the XIST in the 
same HES2 cell line in any time point before or after differentiation, using the RNA 
FISH technique (Silva et al., 2008). The same study classified HES2 cells to be 
“class III” human embryonic cell lines that have lost the capacity to express XIST and 
that do not have a counterpart in mouse ES cells (all mouse ES cells express Xist 
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after differentiation). Silva et al., hypothesized that class III cells are prone to lose 
XIST expression once X inactivation is initiated in the culture, since they found that 
class III cells even if Xist was lost, still showed inactivation of X chromosome. A 
possible explanation for the differences in XIST expression through HES2 
differentiation observed between HIRTA and Silva et al. studies is that RNA FISH 
technique used in the Silva study was not sensitive enough to detect the low levels of 
XIST expression in differentiated HES2 cells. Thus, other human embryonic stem cell 
lines that were explored for the XIST expression by the Silva study and grouped as 
class III cell lines, should be also examined by techniques that detect RNA 
expression other than RNA FISH. This could potentially show that all human 
embryonic cell lines have a property to show developmental regulation of XIST 
ncRNA as found for mouse ES cells (Chaumeil et al., 2002). Potentially, human 
HES2 cells showing upregulation of XIST and X-inactivation may provide a model for 
in vitro studies of epigenetic changes during early human development. 
 
3. 5. Further support to the lack of conservation between mouse and human 
Tsix/TSIX function 
In the mouse the Tsix macro ncRNA is transcribed antisense to and regulates Xist 
macro ncRNA during both random and imprinted X-inactivation (Lee, 2000; Sado et 
al., 2001). Human TSIX transcripts have been found to be co-expressed with XIST 
only from the inactive X-chromosome in human fetal cells using RNA FISH technique 
indicating that TSIX does not have the same function as mouse Tsix in repressing 
Xist (Migeon et al., 2002). Further, Chang and Brown found lack of conservation of 
regulatory elements for human TSIX and thus also showed that TSIX is most 
probably not a regulator of XIST in humans (Chang and Brown, 2010). Previously 
TSIX was found expressed from small number of cells types: chorionic villus cells, 
embryonal bodies and one human embryonal carcinoma cell line (Chow et al., 2003; 
Migeon et al., 2002). In this thesis TSIX was found not to be expressed in 
undifferentiated and differentiated human embryonic stem cells (HES2), in three fetal 
tissues and in all other tested cancer cell lines including teratocarcinoma and 
malignant embryonal carcinoma. This finding further suggests that human TSIX lacks 
a conserved function as a regulator of XIST macro ncRNA and if functional, TSIX 
may have function specific for the cell type where it is expressed. 
 
3. 6. Are macro ncRNAs one of the key features in genomic imprinting? 
Genomic imprinting is an epigenetic phenomenon that utilizes different mechanisms 
of gene regulation and thus represents a valuable model system enabling deeper 
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understanding of how genes and genomic regions may be regulated. Genome 
regions that contain imprinted genes also contain different numbers of usually 
clustered imprinted genes, and show certain key features. The well-established key 
features of imprinted gene regions in human and mouse are: the presence of a short 
element known as the Imprint Control Element (ICE) that carries a parental specific 
methylation mark set in the germline (gametic Differentialy Methylated Region 
(DMR)) and cis-regulation over long distances that leads to monoallelic expression of 
clusters of flanking imprinted genes. In last years, it has been hypothesized that 
macro ncRNAs could be one of the key features of imprinted gene regions since they 
are expressed from the six-well characterized imprinted gene clusters and two, the 
mouse Airn and Kcnq1ot1 have been shown to play a role in silencing of protein 
coding genes in cis (introduced in section 1.2.5.1. and 1.2.8.). Thus, we tested known 
human gene regions containing imprinted genes, by using tiling array (HIRTA) and 
found that each of the 32 tested regions containing imprinted genes also contain 
macro ncRNAs. Since it was previously shown that non-coding portion of the human 
genome is substantial (introduced in section 1.3.) it could be that macro ncRNAs are 
not specifically enriched in the imprinted gene regions when compared to other 
randomly selected genomic regions. This could be directly tested by statistically 
comparing macro ncRNAs expression in 32 imprinted and the same number of 
randomly selected genomic regions of the same length. The question that remains is 
if at least one of the mapped macro ncRNAs per imprinted gene region shows 
imprinted expression. Thus, while HIRTA mapping of macro ncRNAs that showed 
that macro ncRNAs are expressed from each of 32 tested imprinted gene regions to 
some extent supports the idea that imprinted macro ncRNAs may be universal, key 
feature of imprinted gene regions in human, the additional evidence will come from 
further testing of imprinting expression status of novel macro ncRNAs that were 
mapped in human regions containing imprinted genes (Figure 66). 
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Figure 66. Macro ncRNAs may be a universal feature of human imprinted gene regions. 
Hypothetical imprinted gene region contains ICE that carries parental specific methylation 
mark set in the germline and monoallelically expressed clustered imprinted genes of which at 
least one could be a macro ncRNA. Black box points ICE. See key for further details.  
 
The two novel Differentially Methylated Regions (DMRs) corresponding to 
ADAMTS7down2 and PEG13 macro ncRNA CpG island promoters were found and 
could represent ICEs or somatic DMRs in corresponding RASGRF1 and KCNK9 
regions. For testing if this DNA methylation has germline origin and was set in 
mother’s or father’s germ lines, analysis of oocytes and sperm cells would be 
necessary.  
 
Monoallelic expression has been found in X-inactivation, genomic imprinting and as 
random monoallelic expression (reviewed in (Krueger and Morison, 2008)). 
Monoallelic imprinted expression that originates from a maternal or a paternal allele 
is one of the key features of imprinted genes. Imprinted genes can show ubiquitous 
or tissue specific monoallelic expression. In humans, monoallelic gene expression is 
usually tested from blood samples from families while testing of other tissues is 
highly restricted by the availability of the human samples. 6 out of 10 tested HIRTA 
mapped macro ncRNAs were found to show monoallelic or biased expression 
towards one allele based on expression of one to six Single Nucleotide 
Polymorphisms (SNPs), in fibroblasts and/or blood samples (section 2.4.5.). Further 
testing using higher number of SNPs, in more families and in other diverse tissues 
would further clarify imprinted status of novel HIRTA mapped macro ncRNAs. Two 
examples of human regions that may possess all the key features of imprinted gene 
regions will be further discussed below. 
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3. 6. 1. RASGRF1 may be novel human imprinted gene region 
The Mouse Rasgrf1 imprinted gene region (chr9) contains four paternally expressed 
imprinted genes: Rasgrf1 (monoallelic in brain and liver and biallelically in lung, 
thymus, kidney and stomach), As4, A19 ncRNA (that is monoallelically expressed in 
brain but biallelic in testis) and miRNA184 (described in section 2.4.5.6.). A paternally 
methylated DMR located 30kb upstream of Rasgrf1 that was shown to binds CTCF 
when unmethylated, functions in cis to silence maternal Rasgrf1 allele by blocking 
enhancers located further upstream from the DMR (section 2.4.5.6., (Yoon et al., 
2005)). Human genes from syntenic RASGRF1 region on chromosome 15 were not 
previously tested for imprinted expression and in this thesis no orthologous A19 
ncRNA expression could be seen in any of the 43 tested human samples (section 
2.4.1.). However, I could detect biased expressed of the TMED3down and 
KIAA1024up macro ncRNAs, monoallelic expression of the ADAMTS7down macro 
ncRNA and finally, I identified a DMR located on the ADAMTS7 down CpG island. 
Thus I show, for the first time that the human RASGRF1 region is an imprinted gene 
region (a comparison of mouse and human Rasgrf1/RASGRF1 imprinted gene 
regions is shown in Figure 67).  
 
 
Figure 67. Mouse Rasgrf1 and human RASGRF1 region both contain imprinted macro 
ncRNAs. In mouse brain Rasgrf1, A19 ncRNA and Mir184 show paternal expression while in 
human fibroblasts ADAMTS7down, TMED3down and KIAA1024up show biased or 
monoallelic expression. Paternally methylated DMR has been found in mouse about 30kb 
upstream of Rasgrf1 gene while in human CpG island promoter of ADAMTS7down ncRNA is 
a DMR. This DMR is positioned 500bp downstream of a chromosome break point in the 
 
Irena Vlatkovic PhD Thesis   160 
mouse syntenic region. Both mouse and human chromosomes are presented as on UCSC, 
placing chromosomal centromere always on the right side of the figure and thus inversion in 
the gene positions could be seen between mouse and human. Black boxes show differentially 
methylated region. See key for further details. 
 
Surprisingly, expression of the ADAMTS7down macro ncRNA showed clear 
monoallelic expression in fibroblasts and blood, but paternal expression was seen 
based on 4 SNPs and maternal expression was seen based on 2 SNPs, by testing 
cells and blood of 3 families. The first possibility that could explain these findings, 
was random monoallelic expression combined with clonal expansion from a single 
cell (Krueger and Morison, 2008). Since we used polyclonal lymphoblastoid cells for 
RNA isolation but exclusively found monoallelic expression, this disagreement of 
parental origin is not expected to be due to the random monoallelic expression. The 
second possibility that could explain finding of both maternal and paternal imprinted 
expression could be due to the technical artifacts originating from the whole genome 
HapMap genotyping data (described in 2.4.5.6.). While finding that 4 SNPs mapping 
to ADAMTSdown were paternally expressed based on both direct examining DNA 
and RNA from blood of one family and from examination of HapMap data, the finding 
that 2 SNPs were maternally expressed came solely from examination of parental 
genotypes available from the HapMap data. Thus, there may be a possibility that 
HapMap data could misinterpret small percentage of genotypes and thus also by 
chance these 2 maternally expressed SNPs even if it was shown that HapMap 
genotyping data had been passed very strict quality control filters (2005; Frazer et al., 
2007). The quality score of the each nucleotide assignment by the HapMap data to 
ADAMTS7down SNP positions could be further assessed by reanalyzing the 
HapMap raw data using the Genome Console, Affymetrix.   
 
When comparing mouse and human Rasgrf1/RASGRF1 regions, it can be observed 
that mouse syntenic region of chromosome 15 RASGRF1 human imprinted gene 
region, consists mostly of chromosome 9 where mouse Rasgrf1 imprinted gene 
region maps, but have a break point where 25kb of the chromosome 2 was inserted 
(Figure 67). Similar break point was observed through other mammalian genomes 
(data not shown) but was not present in Primates. This break point maps to the very 
distal end of human ADAMTS7down macro RNA and thus there is the possibility that 
this transcript and/or its regulation could be exclusively feature of Primates. Further 
testing of imprinted expression of genes from this region in human brain and in 
mouse fibroblasts could show if this imprinted gene region is conserved between 
human and mouse. 
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3. 6. 2. Identification of PEG13, the human homologue of the mouse Peg13  
ncRNA 
The mouse Kcnk9 imprinted gene region contains the maternally expressed Kcnk9, 
Trappc9 genes and the paternally expressed Peg13 ncRNA found to be ∼4kb long, 
highly expressed in brain and unspliced (section 1.2.5.2., (Smith et al., 2003)). In 
human, KCNK9 imprinted gene region contains the maternally expressed KCNK9 
(Ruf et al., 2007). In the study of Ruf et al., methylation from both parental alleles has 
been detected in human blood and brain on the CpG island orthologous to the mouse 
germline maternally methylated Peg13 DMR (Ruf et al., 2007).  
 
In this thesis, for the first time a PEG13 macro ncRNA of ∼6.6kb in length, consistent 
with mouse Peg13, expressed highly in brain, but also highly expressed in blood and 
fibroblasts, was found. In human fibroblasts, the DMR corresponding to the mouse 
Peg13-DMR was found while in HeLa cells only a methylated allele was detected 
(Figure 30, section 2.4.5.3.). Finding of only a methylated allele in HeLa may be due 
to Uniparental disomy (UPD) that could retain two copies of the chromosome 
carrying methylated allele. Mapping of UPDs in HeLa cells would be necessary to 
further investigate the origin of both chromosome methylation on the examined 
PEG13 CpG island.  
 
The PEG13 CpG island promoter was differentially methylated in a ratio that 
indicated allele specific methylation in fibroblasts and the same cell line also showed 
biased monoallelic expression of PEG13. Expression of PEG13 in blood from 
families and human brain needs to be examined to test if the parental origin of 
human PEG13 expression is same as found for mouse and to address if PEG13 
macro ncRNA has ubiquitous or a tissue-specific imprinted expression.  
 
In summary, I show that macro ncRNAs are expressed from all tested human regions 
containing imprinted genes and suggest this may represent one of the key features of 
imprinted gene regions. Further testing of the imprinted expression and methylation 
status and direct testing of macro ncRNA function will lead to a better understanding 
of the imprinting process and its role in mammalian biology. 
 
3. 7. Conservation of imprinted gene regions between human and mouse? 
The question of conservation of imprinted gene regions in mammals is still the matter 
of debate in the field since it is necessarily based on provisionally set cut off of how 
many of genes could show differences in imprinting status between the species. 
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Different laboratories have different opinions if these differences indicate a general 
lack of conservation or just sporadic exceptions from the overall conservation of 
imprinted gene regions (Frost and Moore, 2010; Luedi et al., 2007; Morison et al., 
2005). An interesting recent suggestion is that most of the differences between 
imprinted genes in mouse and human may have their origin in differences in their 
reproductive biology, e.g. multiple offspring compared to single offspring, that leads 
to a larger number of genes with imprinted expression in mouse placenta compared 
to human placenta (Frost and Moore, 2010). The question of conservation further 
gains on complexity when not only imprinted expression but also differential 
methylation is taken into account when comparing species. It is evident that there are 
differences between human and mouse in imprinted expression of certain genes but 
as an overall picture imprinted expression of these species may be conserved 
(introduced in section 1.2.5.1. and 1.2.5.2.), especially since the human imprinting 
field still suffers from the lack of tissue specific imprinted expression reports due to 
the difficulties in obtaining normal tissues from families. Thus, regions selected for 
the HIRTA array were not just those containing known human imprinted genes but 
also those whose imprinted status was only known in mouse. The identification here 
of novel human PEG13 ncRNA homologue that is expressed preferentially from one 
allele and has a DMR, also supports the conservation between mouse and human 
imprinted regions.  
 
3. 8. Macro ncRNAs from imprinted regions are deregulated in cancer 
The role of macro ncRNAs in disease started to come into view with findings of a few 
macro ncRNAs that showed deregulation correlating with disease (introduced in 
section 1.3.3.). Deregulation of macro ncRNAs were usually reported as sporadic 
cases but few studies showed this process on the large scale. For example one 
study showed that number of non-coding ultraconserved expressed regions that were 
longer than 200bp (UCRs) were deregulated in chronic lymphocytic leukemia’s, 
colorectal and hepatocellular carcinomas when compared with their normal 
counterparts, indicating their possible involvement in tumorigenesis (Calin et al., 
2007). Perez et al. also showed that 15 ncRNAs that were >400bp in length, were 
deregulated in breast and ovarian cancers (Perez et al., 2008). In this thesis (in 
section 2.6.) finding of 22 macro ncRNAs expressed exclusively in cancers and a 
number of known and novel ncRNAs showing complete upregulation or 
downregulation when normal and cancer tissues were compared, provided additional 
evidences that macro ncRNAs may be involved in tumorigenesis of tested 
rhabdomyosarcoma, AML, MPD, cervical, breast and colon cancers.  
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The observed lack of expression of macro ncRNAs in cancer compared to normal 
counterpart tissues could be caused by both genetic (e.g. Uniparental disomies, 
deletions) and epigenetic (e.g. DNA methylation/ repressive histone modifications on 
regulatory regions) changes. For example my results show the imprinted GTL2var1 
macro ncRNA was not expressed in 9/9 cervical cancer and 2/2 breast cancer lines, 
but was expressed in normal colon and breast tissues. This raises the possibility that 
GTL2var1 expression or the genomic region, from which it was expressed, may be 
changed in cancers comparing to the tested normal tissues. Further, this change 
could happen early in tumorigenesis since all tested cancer cell lines resembling 
different stages and/or cell types of the cervical and breast cancers showed lack of 
GTL2var1 expression. In order to resolve the potential cause of observed lack of 
macro ncRNA expression further genetic and methylation tests of the examined cell 
lines and patients would be necessary. In particular since GTL2var1 is only 
expressed from the maternal chromosome it would be necessary to investigate if 
cells still retained this parental chromosome.  
 
Macro ncRNAs from imprinted gene regions found to be upregulated in cancers by 
HIRTA are valuable resource for further examination involving patients having 
different stages of disease, in order to study their potential usage as biomarkers for 
specific grades of different cancer types. Most valuable candidates for this type of 
research are the 16 macro ncRNAs that were found to be upregulated uniquely in 
specific cancer types.  
 
AIRN macro ncRNA was shown to be expressed in the STA-WT3ab Wilms’ tumor 
cell line and in 42.5% of Wilms’ tumor patient samples, but it was not expressed in 
two other cancer cell lines nor in 20 tested normal tissues. Mouse Airn has a function 
in silencing of Igf2r in cis leading to its' imprinted expression. IGF2R loss of function 
genetic mutations accompanied by loss of heterozygosity are often seen in human 
tumors, suggesting its role as a tumor suppressor gene (De Souza et al., 1997; 
Sleutels et al., 2002). However, no clear correlation between high AIRN and low 
IGF2R expression in Wilms’ tumors could be seen (Figure 54, section 2.6.3., (Yotova 
et al., 2008)) and, to date there is no evidence that IGF2R could undergo epigenetic 
inactivation during tumorigenesis.   
 
Expression changes in cancer of 5/6 well-studied imprinted macro ncRNAs were 
identified. Imprinted macro ncRNAs could be also subjected to loss of imprinted 
expression (LOI) (introduced in section 1.2.9.2.). Imprinted macro ncRNAs that show 
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LOI have biallelic expression and thus their expression is expected to be two-fold 
upregulated in comparison to their monoallelic imprinted expression. Macro ncRNAs 
expression detected by HIRTA showed numerous subtle changes between normal 
and cancer cells but these changes remain to be quantified using for example qRT-
PCR that can reliably detect the two fold changes. In order to examine if LOI and not 
upregulation from the same allele that monoallelically express macro ncRNA 
occurred RNA FISH could be used.  
 
Myeloproliferative disease (MPD) can evolve into acute myeloid leukemia (AML). The 
higher number of macro ncRNAs found in all AML samples comparing to all MPD 
samples may indicate a globally upregulation during progression of MPD towards 
AML. Since only 6 patient samples were tested, number of the patients should be 
expanded to gain further evidence for potential global upregulation of macro ncRNAs 
through leukemia development. The OR56A1down macro ncRNA that was found 
exclusively in 2 AML patients and the PPP2R5Cup1 macro ncRNA found in 1/3 AML 
and 2/2 MPD patients could be potential biomarkers of these diseases since they 
were not found in any of normal and cancer tissues. Further investigation of these 
macro ncRNA would be necessary to reveal more about their potential function in 
tumorigenesis.  
 
Further detailed examination of each of 22 specific macro ncRNAs candidates, using 
a number of cancer patients as well as over-expression studies and testing their 
potential function in proliferation and/or apoptosis cell-based assays, may enlarge 
our knowledge about the role of macro ncRNAs in gene regulation and disease and 
show if these macro ncRNAs may have potential as novel biomarkers or drug 
targets. 
 
3. 9. Finding function of macro ncRNAs in development and disease 
In this thesis 101 novel macro ncRNAs were mapped in 43 tested cells/tissues and a 
number of them showed indices of functionality that were discussed through section 
3.3. These findings are a valuable resource for further functional tests of mapped 
macro ncRNAs. Functional tests could involve the macro ncRNA knock down. RNA 
interference (RNAi) knock down of macro ncRNAs using small interfering RNAs 
(siRNAs) has been found restricted to cytoplasm in human cells and thus not useful 
in degradation of nuclear macro ncRNAs (Zeng and Cullen, 2002). One of the recent 
possibilities for targeting macro ncRNA in human cells involves custom designed 
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zinc-finger nucleases, but still this method is not widely used because of high costs 
(Hockemeyer et al., 2009). A second possibility for the knock down of macro ncRNAs 
and examination of their function may be chemically modified chimeric antisense 
oligonucleotides (ASO) that have been found efficient in degradation of nuclear 
ncRNAs in mammalian cells in culture (Ideue et al., 2009).  
 
Some of the novel mapped macro ncRNAs identified in this thesis may be involved in 
imprinting where they could silence genes in cis as shown for the mouse Airn and 
Kcnq1ot1 ncRNAs, by mechanisms such as transcriptional interference (TI) or RNA-
mediated targeting (reviewed in (Koerner et al., 2009; Pauler et al., 2007)). Although 
expressed from regions containing imprinted genes, macro ncRNAs may also have 
functions independent to imprinting. Examples of roles played by non-coding RNAs 
include: 1) as regulatory RNAs regulating gene expression in trans through 
mechanisms as targeting proteins to specific genomic loci to control transcription, 2) 
modulating activity of proteins that are bound to macro ncRNA, 3) modulating 
alternative splicing, 4) altering protein localization, 5) novel housekeeping RNAs 
fulfilling structural roles (reviewed in (Wilusz et al., 2009)). In numerous human 
imprinted gene regions more than one macro ncRNA was mapped per cluster and 
thus it may be possible that while one of the mapped macro ncRNA has a function in 
silencing in cis (on the parental chromosome from which the macro ncRNA is 
expressed) leading to imprinted expression of all protein coding genes in the 
imprinted gene cluster, other macro ncRNAs from the same cluster may have diverse 
other functions that are independent of imprinting (Figure 68).  
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Figure 68. Models showing how macro ncRNAs from imprinted gene regions may 
function in or independently of imprinting. Transcriptional interference and RNA-mediated 
silencing are shown as most common models for macro ncRNA imprinted gene silencing in 
cis. In transcriptional interference transcription of a macro ncRNA through the promoter or an 
enhancer leads to the silencing of a protein coding gene by interfering with binding of 
necessary transcription factors. In RNA-mediated silencing the macro ncRNA acts as a locus 
specific epigenetic initiator inducing recruitment of repressive proteins and inducing chromatin 
remodeling and histone modifications. Some of the potential macro ncRNA functions 
independent of imprinting induced by hybridization to complementary RNA or binding to 
specific proteins are shown. Further, macro ncRNAs may regulate gene expression on both 
parental chromosomes in cis, but also on other chromosomes in trans. See key for further 
details. 
 
Mechanisms how and when during cancer progression macro ncRNAs may be 
involved in tumorigenesis are still far from understood, and different models could be 
proposed how these transcripts may have a role in cancer progression (Figure 69). 
Imprinted macro ncRNAs can lose their imprinted expression (LOI) and become 
biallelic in cancer (e.g. KCNQ1OT1 in colorectal cancer and WT1-AS in Wilms’ tumor 
(Malik et al., 2000; Tanaka et al., 2001)) while in normal tissues biallelic macro 
ncRNAs potentially could gain imprinted expression (GIE) in cancer, further adding to 
the complexity of potential roles of macro ncRNAs in cancer (Figure 69). Cancer is a 
genetic disease generally based on the changes involving tumor suppressors and 
oncogenes. Up to date two examples of a macro ncRNAs correlating with silencing of 
tumor suppressor genes were found: P15AS that silence P15 in leukemia (Yu et al., 
2008) and EPCAM-MSH2 fusion ncRNA that silence MSH2 in Lynch syndrome 
(Ligtenberg et al., 2009; Niessen et al., 2009), while no example of activation of 
oncogenes by macro ncRNAs was found even if macro ncRNAs may act as 
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transcriptional activators, as shown for mouse Evf-2 macro ncRNA (Feng et al., 
2006). Further investigation of novel macro ncRNAs expressed form human gene 
regions containing imprinted genes, that were deregulated in cancer may provide 
novel biomarkers and/or potential drug targets (see section 1.3.4.). 
 
 
Figure 69. Macro ncRNAs are deregulated in cancer and their role in cancer 
progression remains to be tested. Genetic and methylation changes, loss or gain of 
imprinted expression (LOI or GIE) may deregulate macro ncRNA expression and in 
combination with other genetic and epigenetic factors lead to silencing of tumor suppressor 
genes or potentially activation of oncogenes. Deregulated macro ncRNAs may potentially be 
used as biomarkers and/or drug targets. 
 
4. Conclusion 
In this thesis I showed that novel macro ncRNAs could be successfully mapped from 
their expression features on a tiling array and by using rRNA depleted RNA-seq 
technology. Mapping of 101 novel macro ncRNAs that showed different indications of 
functionality and were located in human regions containing imprinted genes further 
supports the idea that imprinted macro ncRNAs may be a universal feature of 
imprinted gene regions in human. The 22 novel macro ncRNAs that were expressed 
exclusively in cancer cells/tissues may provide the starting point for biomarker 
research. The data presented in this thesis overall broadens the knowledge about 
macro ncRNAs from human imprinted gene regions in both normal and disease 
conditions and will be an valuable resource for further studies of the function of 
macro ncRNAs in regulating imprinting and potentially in other cellular processes. 
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5. Materials and methods  
The overview of used chemicals, other materials and kits, with information about 
manufacturers, is shown in Appendix table I. Primers used for the allelic expression 
tests are listed in the Appendix table II, at the end of the section. 
 
5. 1. Human samples 
 
5. 1. 1. Cell lines 
Cell lines were purchased from the ATCC, http://www.lgcstandards-atcc.org/ (Table 
22), Coriell Cell Repositories, http://ccr.coriell.org (Table 23), or obtained from Peter 
Ambros’s laboratory, St. Anna Kinderspital, Vienna (STA-WT3ab human Wilms’ 
tumor cell line). The ATCC purchased cell lines were grown as adherent cultures 
under cell culture conditions using media, 10%-15% FBS, gentamicine (50µg/ml) and 
supplements recommended by repository (used media are listed in Tables 22 and 
23). The adherent STA-WT3ab cells were cultured in RPMI-1640, 25ml FBS (12.5%), 
supplemented with 5ml of HEPES (25mM) and 2.5ml of sodium pyruvate (1mM) per 
200ml of media.  Cells were subcultured by trypsinization before they reach a 80% to 
90% confluence and media was renewed twice a week.  
 
ATCC purchased 
Designations ATCC Number Media Designations ATCC Number Media 
Hs27 CRL-1634 DMEM HT-3* HTB-32 McCoy’s 5a 
HeLa CCL-2 DMEM C-4 I* CRL-1594 Waymouth’s 752/1 
HCT116 CCL-247 McCoy’s 5a C-4 II* CRL-1595 Waymouth’s 752/1 
Caco-2 HTB-37 MEM SiHa* HTB-35 MEM 
MCF7 HTB-22 MEM C-33 A* HTB-31 MEM 
CAMA-1 HTB-21 MEM DoTc2* CRL-7920 MEM 
Tera2 HTB-106 McCoy’s 5a ME-180* HTB-33 McCoy’s 5a 
NCCIT CRL-2073 RPMI-1640 SW756* CRL-10302 Leibovitz’s L15 
A-204 HTB-82 McCoy’s 5a SK-NEP1* HTB-48 McCoy’s 5a 
SH-SY5Y CRL-2266 MEM G-401* CRL-1441 McCoy’s 5a 
PA-1 CRL-1572 MEM    
 Table 22. Designations and ATCC number of 21 ATCC purchased cell lines are shown.   
* Cell lines that were grown by Dr. Iveta Yotova, Medical University Vienna 
 
The Corriel purchased lymphoblastoid cell lines were grown as suspension cultures 
in RPMI-1640, 15%FBS media. Cultures were typically seeded at a concentration of 
about 250,000 viable cells/ml (concentration of viable cells was measured using 
Casy Cell Counter, Scharfe System) and split after 2-4 days before the cultures 
reached confluence. 
 
Coriel purchased 
Designations Catalog ID CEPH/UTAH pedigree Media 
Lymphoblastoid GM12878 1463 RPMI-1640 
Lymphoblastoid GM10854 1349 RPMI-1640 
Lymphoblastoid GM10846 1334 RPMI-1640 
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Table 23. Lymphoblastoid cell lines were purchased from the Coriell Cell Repositories. 
Listed cell lines originated from the three pedigrees of the CEPH/UTAH collection used in the 
international HapMap project. 
 
5. 1. 2.  Differentiation of the human embryonic stem cells 
Human embryonic stem cells HES-2 (NIH code ESO2) were grown as 
undifferentiated for one day on ES cell media supplemented with basic fibroblast 
growth factor (bFGF). Further, cells were differentiated on gelatinized dishes in ES 
cell media without bFGF. Human embryonic stem cells were differentiated by Dr. 
Helia Berrit Schonthaler from laboratory of Erwin Wagner, IMP, Vienna (present 
address: CNIO, Madrid).  
 
5. 1. 3. Collection of human normal and patient tissue samples 
Whole blood was obtained from two healthy volunteers (mother and child) in the 
AKH, Vienna. Blood was collected in EDTA anticoagulant tubes to prevent clotting 
and processed for DNA and RNA isolation on the same day. The 24 normal tissue 
RNAs used for preparation of samples for HIRTA hybridizations and RT-PCR testing 
of AIRN expression were obtained from Clontech as a Human Total RNA Master 
Panel II or as separate Total RNAs. 
 
The peripheral blood and bone marrow tissue samples from Acute Myeloid Leukemia 
patients and Myeloproliferative disorder patients (see description in Table 11, section 
2.1.2.) were obtained from the Robert Kralovics laboratory, CeMM, Vienna and 
further processed for RNA isolation.  
 
The 123 Wilms’ tumor patient cDNA samples that were screened for the expression 
of AIRN ncRNA, were obtained from the laboratory of Prof. Martin Gessler, TBI, 
Wuerzburg. The Wilms’ tumor samples were part of the German SIOP/GPOH 93-01 
study and the patients were predominantly with preoperative chemotherapy as 
mandated by the European protocol.  
 
5. 2. DNA isolation  
 
5. 2. 1. DNA isolation from the cell lines 
The cells (presented in sections 5.1.1. and 5.1.2.) were washed twice with 1XPBS 
and lysed using 1ml of DNA Lysis buffer per T75 flask. Lysates were incubated 
overnight at 55ºC. 300µl of saturated (>5M) NaCl was added per 700µl of the lysed 
cells and mixed by inversion. The samples were spun for 10min using 14000rpm at 
 
Irena Vlatkovic PhD Thesis   170 
room temperature. The supernatant was added to 0.6V of 4ºC isopropanol and 
shaker by inverting to precipitate the DNA. The sample was spun 10min using 
14000rpm at 4ºC and the supernatant was discarded. In order to free the pellet of 
salt, samples were washed with 1ml of 70% ethanol for 15min at room temperature. 
The sample was spun for 10min using 14000rpm at 4ºC, the supernatant was 
removed, and the spin was repeated for 1min. After complete removal of the 
supernatant, the sample was resuspended in 200µl of TE buffer and further 
incubated overnight at 55ºC to dissolve the DNA. Concentration of the samples was 
measured using the NanoDrop ND-1000 Spectrophotometer, Peqlab. 
 
Solutions:  
DNA Lysis buffer 
1xTEN pH 9.0 (50mM Tris pH 9.0, 20mM EDTA pH8.0, 40mM NaCl in MQ H20) 
1% SDS 
0.5mg/ml Proteinase K 
 
TE buffer 
10mM Tris-Cl pH8.0 
1mM EDTA 
 
5. 2. 2.  DNA isolation from blood  
DNA was isolated from blood samples according to the manufacturer instructions 
using Wizard Genomic DNA Purification Kit, Promega. Briefly, 3ml of the blood from 
the anticoagulant EDTA tubes was mixed, red blood cells were lysed using 9ml of 
Cell Lysis Solution for 10min at room temperature and samples were centrifuged 
using 2000g for 10min at room temperature. For the RNA isolation the white pellet 
was resuspended in TRI Reagent (further processed as in the section 5.6.1.). For the 
DNA isolation, the white pellet, consisting mostly of the white blood cells, was 
resuspended in 3ml of the Nuclei Lysis solution supplemented with RNase Solution 
(15µl per 3ml sample volume) and the sample was incubated for 15min at 37ºC. After 
incubation, Protein Precipitation Solution was added (1ml per 3ml sample volume), 
vortexed for 20sec and centrifuged using 2000g for 10min at room temperature. RNA 
was further extracted using isopropanol (3ml of isopropanol per 3ml of the sample 
volume) and washed with 75% ethanol. DNA was dissolved in DNA Rehydratation 
Solution (250µl per 3ml sample volume) according to the manufacturer 
recommendations. DNA was stored at 4ºC. 
 
5. 3. Non-quantitative polymerase chain reaction (PCR) 
DNA isolated from fibroblasts was used as a template in Polymerase Chain Reaction 
(PCR). Non-quantitative PCR was used for the preparation of Southern blot probes 
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for testing methylation status of CpG island promoters of macro ncRNAs. Primers 
were designed using Primer3 (http://frodo.wi.mit.edu/primer3/) or using Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and synthesized by VBC-
Biotech Service GmbH (http://www.vbc-biotech.at/) by Standard DNA-
Oligonucleotide Synthesis protocol. Primers for the Southern probes were specifically 
placed in the genomic region of interest with the goal to amplify single copy 
sequences in length from 300bp to 1kb (probes and primers listed in Table 24). In a 
typical PCR reaction: 5µl 5X GoTaqPol buffer, 1µl 25mM MgCl2, 0.5µl 10mM dNTP, 
1µl 10pmol/µl forward primer, 1µl 10pmol/µl reverse primer, 2µl 5M Betaine, 0.125µl 
5U/µl GoTaqPol and H2O, were used in a 25µl reaction. The PCR cycle conditions 
were: 95ºC, 3min; 35 cycles of 95ºC, 30sec; 59ºC, 30sec; 72ºC, 45sec and final 
extension of 72ºC, 7min (with optimization of the annealling temperature and the 
extension time depending on the primer pair). PCR was performed using the Peltier 
Thermal Cycler PTC-200.  
 
Name of the 
probe 
Primer 
Name 
Sequence Length of the probe 
(bp) 
LRRC47SBP LRRC47SBPF AAGCCTCTCTGGAGGAGGAG 381 
 LRRC47SBPR AGAAAAAGGTGGGACAGTGC  
PEG13SBP P13SBP1F TGCATTCAGGCTCACGCGCT 451 
 P13SBP1R GCTGCCTGGCCAAAAGATGGCT  
PRKCDBPSBP PRKCDBPSBPF AGGCAGCGGCTGTATTAGAA 801 
 PRKCDBPSBPR CTTGCGCTCACCATCAATAA  
SLC38A4SBP SLC38ASBPF CCTTTTCATTTGACCCTGGA 865 
 SLC38ASBPR ACTCAAAGGGGGTTGTTGTG  
ADAMTS7CSBP ADAMTS7SBPF ATCCGTATATCCCCTGGACC 384 
 ADAMTS7SBPR CCCAGTACAGAACTGAGGGC  
Table 24. Primers for the Southern blot probes  
 
5. 3. 1. Dissolving the gel slice 
PCR reactions and marker (GeneRuler 100bp Plus DNA Ladder) were loaded into a 
2% agarose gel in 1xTAE, electrophoresed and stained using ethidium bromide 
solution (1mg/l). Fragments corresponding to expected probes lengths were excised 
from the gel under UV light and DNA was purified from the gel slice using Wizard SV 
Gel and PCR Clean-Up System, Promega according to manufacturers’ protocol.  
 
Solutions:  
TAE Buffer 
40mM Tris 
0.1142% glacial acetic acid 
1mM EDTA pH8.0 
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5. 4. Cloning 
Cloning of the Southern and Northern blot probes and of the PRKCDBPCIE2 band 
(section 2.4.5.4.) was done using the pGEM-T Easy Vector System I, Promega. In 
the first step, PCR products isolated from the agarose gel were ligated into the pGEM 
T-Easy vector as recommended by manufacturer. 1:1 and 1:3 ratios of vector to 
fragment were used, and 10µl ligation reactions were assembled using 2X Rapid 
Ligation buffer, T4 DNA Ligase, pGEM T-Easy vector and the fragment of interest. 
Ligation was performed at 16ºC overnight. 
 
In the second step, transformation of E.coli (JM109 competent cells) with ligated 
plasmid containing insert of interest, by heat shock, was performed. Bacteria were 
mixed with plasmids and incubated on ice for 30min. Heat shock was performed at 
42ºC for 1min. The reaction was placed on ice for 2min and 250µl of LB media per 
tube was added. Reactions were shaked at 37ºC for 1h. The reactions were plated 
on Ampicilin plates containing IPTG and X-Gal and growned on 37ºC overnight. 
Colonies containing inserts of interest were selected as white colored colonies, while 
negative colonies were blue colored. 
 
The positive white colonies were inoculated in 3ml LB with Ampicilin cultures and 
grown on 37ºC for 16h. The plasmid minipreps were prepared using Alkaline Lysis 
Protocol, Sambrook and Russel, Molecular Cloning, 2001. 1.5ml from each 3ml 
overnight culture were centrifuged using 14000rpm for 1min at room temperature. 
The supernatant was removed and the cells were resuspended on ice in 225µl of 
Alk-1, than 450µl of Alk-2 was added, mixed by inverting and after 5min 340µl of Alk-
3 was added. The reaction stayed 5min on ice prior to centrifugation at 14000rpm for 
7min at room temperature. The DNA pellet was washed in 1ml of 75% ethanol for 
5min at room temperature and centrifuged again using 14000rpm for 7min at room 
temperature. The plasmid DNA pellet was resuspended in 100µl of TE buffer and 
dissolved at 55ºC overnight. Concentrations were measured using the Nano Drop. 
Plasmids were sent to Agowa (http://www.agowa.de/) for sequencing from the T7 
promoter and the sequences of all DNA fragments that were further used as 
Southern blot probes, were confirmed. 
 
Solutions: 
 
Alk-1 
50mM glucose 
25mM Tris pH 8.0 
10mM EDTA pH 8.0 
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Alk-2 
0.2M NaOH 
1% SDS 
 
Alk-3 
3M KAc 
11.5% glacial acetic acid 
 
5. 5. DNA methylation analysis by the Southern blot 
 
5. 5. 1. DNA digestion for the Southern probe preparation 
The DNA fragments for the Southern probes were cloned into pGEM T-Easy vector 
(probes LRRC47SBP, PEG13SBP, PRKCDBPSBP, SLC38A4SBP and 
ADAMTS7CSBP), or were already available in the laboratory as a part of pE3Up 
vector (pBlueskript II SK with 5.7kb IGF2R region containing CGI2-DMR, X83701) 
(probe Bx). The probes were digested from the plasmids using the EcoRI enzyme for 
pGEM T-Easy cloned probes or the BstXI enzyme for excision of the 600bp long Bx 
probe from the pE3Up vector. Digestion reactions using recommended buffers 
(EcoRI buffer or O buffer for BstXI) in total volume of 20µl or 40µl were set up and 
digestion of DNA took place at 37ºC (with EcoRI) or 55ºC (with BstXI) overnight. DNA 
digestions were separated on 2% agarose gels together with a marker (GeneRuler 
100bp Plus DNA Ladder) and DNA probes were isolated from the bands of expected 
sizes (as described in the section 5.3.1.). 
 
5. 5. 2. Labeling, cleaning and assessing of Southern probes activity 
Labeling of the Southern probes was done using 32P radioactive isotope. 20ng of the 
DNA probe was made up to 14µl with MQ H2O, denatured for 5min at 100ºC and to 
the labeling reaction was added: 20µl LS, 6µl CTG mix, 1µl Klenow fragment and 2µl 
α32P dATP (total reaction volume=43µl). The labeling mixture was incubated 
overnight (not more than 18h) at room temperature. Cleaning of the probe to remove 
unincorporated nucleotides, salts and contaminants was done using G50-Sephadex 
columns prepared as 1ml syringes stuffed with glass wool and filled with Sephadex 
glass beads dissolved in TE by centrifugation using 3000rpm for 3min. Labeled 
probes were diluted with 60µl TE, loaded into the column and respun at 3000rpm for 
3min. A 1:100 dilution of the cleaned probe in TE was measured by Liquid 
Scintillation Analyzer 1600 TR and probes showing 20,000 to 100,000 cpm were 
further used. 
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Solutions: 
LS 
25ml 1M Hepes pH 6.6 
25ml of OL (25ml 1M Tris pH 8.0 + 10ml 25mM MgCl2+ 350µl ß-merkaptoethanol) 
1ml of TM (50units of pd(N)6 Random Hexamer Primer in 1.6ml TE, pH 8.0) 
 
CTG mix 
100µM dTTP 
100µM dCTP 
100µM dGTP 
2mg/ml BSA  
 
5. 5. 3. DNA digestion using the methylation sensitive enzymes 
DNA methylation analysis was done using methylation sensitive enzymes (BstUI, 
BssHII, EglI, NotI) and non-methylation sensitive enzymes (EcoRI, HindIII) in single 
or double enzyme digestions. The 20µg of genomic DNA from Hs27, HeLa, A-201, 
Tera2, NCCIT and PA-1 cells, were digested with 2µl of the enzyme in 40µl reaction 
using buffers recommended for single or double digestions with chosen enzymes 
(http://www.fermentas.com/en/tools/doubledigest). Each digestion reaction was 
separated on a 0.8% agarose gel in 1XTBE. The gels were stained using ethidium 
bromide and photographed with the ruler. DNA methylation assays are presented in 
Table 25. 
 
Region tested Enzymes Name of the probe Tested cell lines 
LRRC47down,  
CpG island: 92 
BstUI/EcoRI 
BssHII/EcoRI 
EglI/EcoRI 
LRRC47SBP Hs27, HeLa 
PEG13,  
CpG island: 210 
BssHII/EcoRI PEG13SBP Hs27, HeLa 
PRKCDBPup, 
CpG island: 108 
BssHII/EcoRI 
BssHII/HindIII 
PRKCDBPSBP Hs27, HeLa 
SLC38A4down2,  
CpG island: 106 
BstUI/EcoRI 
BssHII/EcoRI 
SLC38A4SBP Hs27, HeLa 
ADAMTS7down, 
CpG island: 17  
BstUI/EcoRI ADAMTS7CSBP Hs27, HeLa 
AIRN,  
CGI2-DMR 
NotI/EcoRI Bx A-201, Tera2, NCCIT, PA-1, 
Hs27 
Table 25. DNA methylation assays. CpG islands that are potential promoters of macro 
ncRNAs were tested for methylation status using double digestions with methylation sensitive 
and non-methylation sensitive enzymes. Names of the probes used for Southern blot and 
positions of the probes according to UCSC (hg18) are shown. 
 
Solutions: 
 
TBE buffer 
89.1 mM Tris 
89 mM Boric acid 
1mM EDTA pH8.0 
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5. 5. 4. DNA Blotting and hybridization with the probe 
The digested DNA from section 5.5.3. was electroforesed and photographed under 
UV light and the DNA were further denaturated into single stranded DNAs by shaking 
agarose gels twice for 30min covered with Denaturing solution. First three sheets of 
3MM Whatman paper pre-wet in Denaturing solution were placed on the glass plate 
with the overhanging ends dipped into the solution. Than the gel was placed upside 
down on the top of the Whatman papers and the edges of the gel were covered with 
plastic strips in order to prevent buffer short circuits. The Hybond XL membrane that 
was prewet in MQ H2O and than in denaturing solution was placed on the gel and 
two Whatman papers, a stack of the paper towels, glass plate and a weight were 
placed on the top. DNA was transferred from the gel to the membrane by capillary 
transfer that take place over at least 18h. 
 
The blots were disassembled and neutralized with 200ml of 20mM Na2HPO4 for 
2min. The blots were pre-hybridized with Church buffer for 1 to 3h at 65ºC in 
hybridization tubes. After removing the pre-hybridization solution, Hybridization buffer 
(Church buffer containing denatured, cleaned and labeled Southern blot probe) was 
placed into the hybridization tube containg the membrane, for at least 18h.  The 
membrane was washed twice with Wash buffer at 65ºC for 30min. The sealed 
membrane was exposed to the Phosphoimager screen overnight. The membrane 
was scanned using Typhoon Scanner 5600, Amersham.  
 
Solutions: 
 
Denaturing solution 
0.5M NaOH 
1.5M NaCl 
 
Church buffer 
500ml 0.5M Na2HPO4 
350ml 20% SDS 
2ml 0.5M EDTA  
Filled up to 1l with MQ H2O 
 
Wash buffer 
40ml 0.5M Na2HPO4 
50ml 20% SDS 
Filled up to 1l with MQ H2O 
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5. 6. RNA isolation  
 
5. 6. 1. RNA isolation using TRI Reagent 
RNA work was done under strict RNA-free conditions. RNA was isolated from 
samples listed in section 5.1, using TRI Reagent, according to the manufacturers’ 
protocol. Briefly, cells and tissues were lysed in TRI Reagent, for 5min on the room 
temperature. 1ml of TRI Reagent per 10cm2 of culture dish area for adherent or per 
5-10x106 viable cells for suspension cells was used. 0.1ml of 1-bromo-3-
chloropropane (BCP) was added per 1ml of TRI Reagent, shaked and left 15min at 
room temperature. The mixture was centrifuged at 12,000g for 15min at 4ºC and 
RNA was separated as colorless upper aqueous phase. The RNA was isolated from 
the aqueous phase using isopropanol (0.5ml per 1ml TRI Reagent), the vortexed 
sample was incubated for 10min at room temperature and than centrifuged using 
12,000g for 10min at 4ºC. The RNA pellet was washed using 75% ethanol, air dryed 
3-5min and dissolved in RNA Storage Solution. RNA was precipitated using 2.5X 
96% ethanol and 0.1 volumes 3M NaAc, and stored at -20ºC.  
 
5. 6. 2. RNA isolation from nuclear and cytoplasmic cell fractions 
Normal human fibroblast cells (Hs27) were cultured under the standard conditions. 
Nucleus versus cytoplasmic fractionation was adapted from Sambrook and Russel, 
Molecular Cloning, 2001. The cells (4x T75 flasks) were washed three times with ice 
cold PBS on ice and cell suspensions were centrifuged using 2,000g for 5min at 4ºC. 
The cells were lysed using N/C Lysis buffer, underlayed with an equal volume of the 
N/C Lysis Buffer containing sucrose (24% w/v) and NP-40 (1%) and centrifuged 
using 10,000g for 20min at 4ºC. 2xProteinase K Buffer and proteinase K (200µg/ml) 
was added to the cytoplasmic fraction that was recovered as upper turbid layer and 
incubated at 37ºC for 30min. The nuclear fraction that was in the form of the pellet 
was sheared by squirting through a needle and further proteinase K treated as 
above. Proteins were removed by phenol/chloroform extraction and further RNA was 
extracted using Acid Phenol/chloroform. Nucleus and cytoplasm RNA fractions were 
recovered as upper, aqueous phases after centrifugation using 13,000g for 10min at 
4ºC and were precipitated (by adding 2.5 volumes of 96% ethanol and 0.1 volumes 
of 3M NaAc pH 5.5). RNA was recovered by centrifugation, subject to a 75% ethanol 
wash and resuspended in RNA storage solution. RNA preparation from nuclear and 
cytoplasmic cell fractions was done two times, once by Federica Santoro, PhD 
student in the laboratory and once by myself. 
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Solutions: 
 
N/C Lysis Buffer 
0.14M NaCl 
1.5mM MgCl2 
10mM Tris HCl pH 8.6 
0.5% NP-40 
10mM Vanadyl-Ribonucleoside Complex 
 
Proteinase K Buffer 
0.2M Tris-HCl pH7.5 
25mM EDTA pH8.0 
0.3M NaCl 
2% SDS 
 
5. 7. DNaseI treatment 
DNaseI treatments were done for all RNAs prior to Reverse transcriptase (RT) 
reactions using the DNA-free Kit, Ambion. Typically DNAseI treatment was done in 
50µl or in 300µl reactions. For a routine 50µl reaction, 10µg of the RNA, 10X DNaseI 
Buffer and 1µl of DNaseI was incubated at 37º for 30min and a further 5µl of DNase 
Inactivation Reagent was added and mixed for 2min at room temperature. Reaction 
was centrifuged using 10,000g for 1.5min at room temperature. The supernatant 
containing RNA was precipitated and stored at -20ºC. In 300µl reactions rigorous 
DNaseI treatments were done, with 250µl of sample RNA, 30µl 10x Buffer, 10µl 
DNaseI and 10µl H2O. These reactions were inactivated using 60µl of DNase 
Inactivation Reagent. Specifically, nuclear fractions of Hs27 were DNaseI treated two 
times (the first time in a 50µl reaction with 1µl of DNaseI for 30min at 37ºC and the 
second time 1µl of DNaseI was again added to the same reaction and incubated for 
another 30 min at 37ºC). DNaseI treated RNAs were precipitated and recovered prior 
to reverse transcription reactions. 
 
5. 8. Expression analysis 
 
5. 8. 1. Reverse transcription (RT) reaction 
DNaseI treated RNAs were processed into cDNAs using the RevertAid First Strand 
cDNA Synthesis Kit, Fermentas. Reactions were performed according to the 
“Synthesis of First Strand cDNA Suitable for Second Strand Synthesis” protocol. 
Briefly, about 1µg of total RNA was mixed with 1µl of random hexamer primers 
(0.2µg/µl) and DEPC-treated H2O, in 12µl reactions, and incubated at 70ºC for 5min. 
The following components were added to the reaction: 4µl of 5x reaction buffer, 1µl 
of 20 u/µl of RiboLock Ribonuclease Inhibitor, 2µl of 10mM dNTP mix. Reactions 
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were incubated at 25ºC for 5min. 1µl of 200u/µl of RevertAid M-MuLV Reverse 
Transcriptase was added to +RT reactions while 1µl of DEPC-treated H2O was 
added to control –RT reactions and incubated on 25ºC for 10min, 42ºC for 60min and 
finally reaction was stopped by heating on 70ºC for 10min. Reactions were placed on 
ice and stored in -20ºC prior to RT-PCRs, proofreading RT-PCRs or qRT-PCRs. 
 
5. 8. 2. Non-quantitative RT-PCR 
Reverse transcription polymerase chain reactions (RT-PCRs) were done similarly as 
PCR reactions (section 5.3.), with the exception that as a template, cDNAs were 
used. These reactions were done to test expression of KLF14up3, ADAMTS7down, 
TMED3down, KIAA1024up and BLCAPov macro ncRNAs in nuclear and cytoplasmic 
fractions of Hs27 cell line, where GAPDH expression was used as a loading control 
and expression of KCNQ1OT1 macro ncRNA as a positive control (section 2.4.5.). 
Further, AIRN expression was tested by RT-PCRs in three Wilms’ tumor and Hs27 
cell lines and in 123 Wilms’ tumor patients (Figure 53 and 54 in section 2.6.3.). 
 
RT-PCR results were typically separated on 2% agarose gels in 1xTAE. An 
exception to this was for the 123 Wilms’ tumor samples, where a 160bp band was 
expected using the pp9 primer pair. There the separation was done using 12% 
polyacrylamide gel electrophoresis (PAGE) in 1xTAE. The RT-PCR results were 
visualized by ethidium bromide staining. 
 
5. 8. 3. Quantitative RT-PCR using SYBR and TaqMan Assays 
Quantitative RT-PCRs (qRT-PCR) were done using SYBR® Assays and TaqMan® 
Assays. Primer pairs were designed using PrimerExpress. The SYBR® Assays were 
performed with 100mM primers (listed in the Table 26) and MESA Green qPCR 
MasterMix Plus for SYBR Green assays. The reactions were amplified on the ABI 
PRISM 7000 Sequence Detection System, Applied Biosystems with cycling 
conditions: 95ºC for 5min, 40 cycles of 95ºC for 15sec, 60ºC for 1min. The standard 
curve method of analysis using serial dilutions of cDNA was used as a basis for the 
quantification of RNA. Data was normalized to RPLPO gene expression. 
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qRT-PCR Assay Primer Name Sequence  
DCNEx1 DCNEx1F CCACAGGAGCCCTCAAAG 
 DCNEx1R CTACCCCCTCCTCCTTTCCA 
DCNEx3 DCNEx2F GTCGCGGTCATCAGGAACTT 
 DCNEx2R ACAGAGAGGCTTATTTGACTTTATGCT 
DCNEx3 DCNEx3F CAGGTTCTTAAAGTCTCCATCTTTGA 
 DCNEx3R GGATCTTCCCCCTGACACAA 
DCNEx4 DCNEx4F TCGCACTTTGGTGATCTCATT 
 DCNEx4R GCCAGAAAAAATGCCCAAAA 
DCNIn1 DCNIn1F TGTATCTGTTTCCCATTAAAAATGCA 
 DCNIn1R GCAATGACTTTGCTTCATTTTTCTT 
DCNIn2 DCNIn2F TCTTCATCTGTTACTGCATATAATCATCA 
 DCNIn2R TCTTAGAAATCCTATTAATCGTGTGAGGTA 
DCNIn3 DCNIn3F AAAACTCCTTCCTCGCATATTCTC 
 DCNIn3R GTAGTGAGTGTTATGGACTTAAAGTAAAAGAAA 
DCNIn4 DCNIn4F GAAAAAGACTATTAGTGAAAGCAATACCAA 
 DCNIn4R AAGATGGGAATTGTAAACTTGCTTTAG 
GAPDH GAPDHF TGAAGGTCGGAGTCAACGG 
 GAPDHR ACCAGAGTTAAAAGCAGCCCT 
H19q1 H19q1F GTGTGACGGCGAGGACAGA 
 H19q1R TCCGTGGAGGAAGTAAAGAAACA 
KCNQ1OT1q1 KCNQ1OT1q1F ATTCCTCAAGTGTTGACCATTTTG 
 KCNQ1OT1q1R TGGTCCTGTGGGCTCCATT 
KCNQ1OT1q2 KCNQ1OT1q2F CTGCCTTCTCAGGTTATGGTCAT 
 KCNQ1OT1q2R GCTGGGCCTCCTTTGGA 
ADAMTS7q3 ADAMTS7Cq3F TGTTATGTGTGTGACTCCCTTGTG 
 ADAMTS7Cq3R GGGCCAGAGGGAAAAGCA 
SLC38A4q1 SLC38A4Cq1F AAGGCTCTAGGAGCTGTCAGATTAA 
 SLC38A4Cq1R CCACGCTCACCGAAGCTT 
SLC38A4q3 SLC38A4Cq3F TTTTCTATTCTCAGCCCCACTAAAG 
 SLC38A4Cq3R CTGAGATGAGCACTTGGATCCA 
RPLPO1 RPLPO1F CCACGCTGCTGAACATGCT 
 RPLPO1R TCGAACACCTGCTGGATGAC 
Table 26. Primers used in the SYBR® Assays. 
 
The TaqMan® Assays were performed using the primers and TaqMan probes listed 
in the Table 27. Primer pairs and TaqMan probes were designed using 
PrimerExpress. Primers were synthesized by VBC-Biotech Service GmbH, and 
TaqMan probes by Eurogentec (http://www.eurogentec.com/). The TaqMan qRT-
PCR reaction was set with 900mM primers and 200nM probe using qPCR MasterMix 
Plus, Eurogentec. The reaction was amplified on a ABI PRISM 7000 Sequence 
Detection System using following cycle conditions: 50ºC for 2min, 40 cycles of 95ºC 
for 15sec, 60ºC for 1min. Quantification was done using the standard curve method. 
RNA expression was normalized to GAPDH or 18S rRNA gene expression. To 
evaluate GAPDH expression the same primer pair as for the SYBR® Assay was 
used, with a GAPDH TaqMan probe (Table 27). For assessment of expression of 
18S rRNA, 18S rRNA Control kit (FAM-TAMRA), Eurogentec was used according to 
the manufacturers’ recommendations.  
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qRT-PCR Assay Primer/Probe Name Sequence 
AIRN QPCR1 H2354F TCAGATGCAGGAAGATTGGGT 
 H2354R AGGCTTGGCATCCAGGTG 
 H2354 CTCACAACAGGGCGGTGGTTGGA 
AIRN QPCR2 P4HuSplF GGCTCAGCCAAAAGGACACA 
 P4HuSplR TCGAACTGGGAGCCATGG 
 P4HuSpl AAGCCCTGCAGAGGCTCTGAAACCAA 
IGF2R QPCR P8HuF CACGCAGGCCCAGGC 
 P8HuR TGGTATCAACAGCTTCCCATGT 
 P8Hu CCCGTTCCCCGAGCTGTGCA 
Table 27. Primers and probes used in the TaqMan® Assays. 
 
5. 8. 4. Long range RT-PCR/ Proofreading RT-PCR  
Non-quantitative RT-PCRs and PCRs were done using the Long PCR enzyme Mix, 
Fermentas, when further allelic expression using Single Nucleotide Polymorphisms 
(SNPs) was tested. Long PCR enzyme Mix contains highly processive Taq DNA 
polymerase and second thermo stabile polymerase that exhibits 3’ to 5’ exonuclease 
activity. The proofreading activity was important to have greater protection against 
depurination and nicking and give good quality template for further sequencing 
through the genomic region containing SNPs. In the standard reaction: 5µl of 10x 
Long PCR Buffer with MgCl2, 1µl of 10mM dNTPs, 2.5µl of forward and reverse 
primers (10pmol/µl), 1µl DMSO, 0.25µl of Long PCR Enzyme Mix (1.25u) and 2µl of 
template cDNA were used per 50µl reaction. The reaction was amplified in the Peltier 
Thermal Cycler PTC-200, under the cycling conditions: initial denaturation on 94ºC 
for 1.5min, 35 cycles of 94ºC for 15sec, 59ºC for 30sec, 68ºC for 45sec and final 
elongation at 68ºC for 7min. Reactions were separated on a 2% agarose gel and 
stained using the ethidium bromide solution. The bands of expected size were further 
cleaned as in section 5.3.1.  
 
5. 8. 5. Allelic expression analysis using SNPs 
In order to test gene expression from parental alleles, a combination of 
PCR/Proofreading RT-PCR and sequencing was done. In the first step, specific 
primers for the known and novel macro ncRNAs and the ADAMTS7 protein coding 
gene were designed using Primer-BLAST on the genomic regions overlapping with 
known SNPs from the dbSNP build 129 database (Sherry et al., 2001) (primers are 
listed in Appendix Table II). In the second step, DNA from the cell lines (Hs27, HeLa) 
that were known to express genes of interest, were PCR amplified with specific 
primers; bands of expected size were cleaned (section 5.3.1.) and sent to the 
AGOWA, GmbH, for sequencing on the Applied Biosystems 3730xl DNA Analyzer. 
Results of the sequencing were further analyzed using Sequencher 4.7 
(http://www.genecodes.com/). The heterozygous SNPs were visualized as two 
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overlapping sequencing peaks at one base pair (bp) position. If a heterozygous SNP 
was observed for the tested genomic locus, the same primer pairs were used in the 
proofreading RT-PCR reaction (section 5.8.4) using cDNA as a template. 
Sequencing tracks were further visualized on Sequencher enabling analysis of 
expression at the genomic position where heterozygous SNP was previously 
detected in the DNA. If two peaks were overlapping on both Sequencher tracks 
gained from DNA and cDNA sequencing then biallelic expression was found. If one 
peak was present after cDNA sequencing on the position where two peaks were 
present in the DNA, monoallelic expression was observed. The same analysis was 
done in one family blood and in three lymphoblastoid cell lines that originated from 
families genotyped from the international HapMap project 
(http://hapmap.ncbi.nlm.nih.gov/). 
 
5. 8. 6. Northern blotting  
Northern blots were done on the Hs27, bone marrow, skeletal muscle and HeLa, 
cells and tissues using ADAMTS7downNOR and ß-Actin NOR probes (loading 
control). The probes were amplified using RT-PCR from Hs27 cDNA with specific 
primers (listed in Table 28). The probes were cloned into the pGEM T-Easy vector, 
confirmed by sequencing and excised from the plasmid by digestion prior to labeling 
with α32P dATP (as previously described in the sections 5.4. and 5.5.1).  
 
Name of the probe Primer 
Name 
Sequence Length of the 
probe (bp) 
ADAMTS7downNOR ADAMTSNORF1 GCCGCTGATTCTCTTGTCTC 967 
 ADAMTSNORR1 ACAGAGCAGCCCAGTGATCT  
ß-Actin NOR ß actinNORF CAGGCACCAGGGCGTGATGG 994 
 ß actinNORR GATGGAGGGGCCGGACTCGT  
Table 28. Primers for the Northern blot probes. 
 
The Northern blotting was done under strict RNase-free conditions. The agarose gel 
was prepared using 2g of Agarose-LE with 20ml of NorthernMax 10x Denaturing Gel 
Buffer and 180ml of DEPC-treated H20. 20µg of the RNA sample was dissolved in 
6µl of RNA Storage Solution and 3 volumes of Formaldehyde loading dye and 1µl of 
ethidium bromide were added to the mixture. Millennium marker RNA was similarly 
prepared. The RNA and marker samples were denatured for 15min at 65ºC and than 
put on ice briefly until loading. The denaturing gel was loaded with samples and 
electrophoresed at 100V for 2h, in MOPS 1xRunning Buffer. 
 
The northern blot was assembled similar as described for Southern blots in section 
5.5.4. with the exception that as the blotting buffer: 50mM Na2HP04 freshly treated 
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with DEPC (1:1000) was used. After the capillary transfer of RNA to the Hybond XL 
membrane took place, the membrane was dried for 15min in the 55ºC oven. The 
RNA was cross linked to the membrane by AUTO cross linking in the UV Stratalinker 
1800. The membrane was pre-hybridized with Church Buffer at 65ºC for 3h, 
hybridized at 65ºC for 18h with Church buffer containing the denatured labeled probe 
and washed using the Washing buffer (as described in section 5.5.4.). The 
membrane was exposed to the Phosphoimager screen and after 4 days scanned by 
the Typhoon Scanner 5600, Amersham. 
 
5. 8. 7. Sample preparation for the HIRTA hybridization 
The dscDNA samples used for the HIRTA hybridization, were prepared from the cell 
lines and tissues listed in Table 10 and Table 11 (section 2.1.2.) by first and second 
strand reverse transcription. The genomic DNA was sonicated and hybridized 
together with the dscDNA to HIRTA in order to enable normalization. 
 
5. 8. 7. 1. First strand reverse transcription using SuperScript II Reverse 
Transcriptase 
Typically 6µg of total DNaseI treated RNA was dissolved in 16µl of DEPC-treated 
H2O and incubated together with 2µl of pd(N)6 Random Hexamer 5’Phosphate, 
Sodium Salt prepared to 2.5µg/µl, at 70ºC for 10min. The mixture was placed on ice 
for 5min. To the mixture: 7µl of 5X First Strand cDNA Buffer, 3.5µl of 0.1M DTT, 3µl 
10mM dNTP, 1µl of 40u/µl RNase Inhibitor and 2µl of SuperScript II Reverse 
Transcriptase were added and filled with DEPC-treated H2O up to a total volume of 
35µl. The reaction was incubated at 42ºC for 1h and placed on ice prior to second 
strand synthesis. 
 
5. 8. 7. 2. Second strand reverse transcription 
20 µl of cDNA prepared using SuperScript II reverse Transcriptase was further mixed 
with: 30µl of 5X Second Strand Buffer, 10mM dNTP, 4µl DNA Polymerase I, 1µl 
E.coli DNA Ligase, 1µl RNase H and filled with DEPC-treated H2O up to a 150µl total 
reaction volume. The mixture was incubated at 16ºC for 2h. Further 2µl of 5u/µl T4 
DNA Polymerase was added and incubated at 16ºC for 10min and further on 70ºC 
for 10min to stop the reaction.  
 
The dscDNA was cleaned using QIAquick PCR Purification Kit, Qiagen using the 
procedure recommended by manufacturer. Briefly, 600µl of PBI Buffer was added 
per reaction, sample was applied onto QIAquick column and centrifuged using 
 
Irena Vlatkovic PhD Thesis   183 
13,000rpm for 1min. Reactions were washed for two times using 700µl of PE Buffer 
and centrifuged using 13,000rpm for 1min. Each sample was eluted with two times 
50µl of EB buffer and precipitated according to standard procedures. 
 
5. 8. 7. 3. Preparation of sonicated genomic DNA  
100µg of DNA isolated from Hs27 cells was first RNaseA treated (final concentration 
25µg/ml) and than incubated at 37ºC overnight. Further, the DNA was Proteinase K 
treated (to final concentration of 200µg/ml) at 55ºC for 3h and phenol-chloroform 
extracted by adding the same volume of phenol-chlorophorm to the sample and 
centrifuging at 14,000rpm for 15min at 4ºC. Collected supernatants were chloroform 
extracted, centrifuged 14,000rpm for 10min on 4ºC and filled with MQ H2O up to 1ml. 
Samples were sonicated on ice. 18 sonication cycles at 20sec “on”, 1min “off”; with 
the Power set on 40% and Cycle set at 90% were performed. Sonicated genomic 
DNA from the Hs27 cell line was cleaned according to standard procedures using 
QIAquick PCR Purification Kit, Qiagen, with 10µg of sonicated DNA per QIAquick 
column.  
 
5. 8. 7. 4. Quality control using Agilent DNA 7500 Bioanalyzer 
The quality of dscDNA and sonicated genomic DNA were tested using the Agilent 
DNA 7500 Kit, Agilent Technologies. Agilent DNA Chip 7500 was prepared according 
to the manufacturers recommendations and 1µl of the sample was loaded onto the 
Chip. The chip was run in the Agilent 2100 bioanalyzer and analyzed using 2100 
Expert Software for the DNA 7500 Assay. Sonicated genomic Hs27 DNA in a range 
from 100 to 800bp was used for the HIRTA hybridization. 
 
5. 8. 7. 5. Hybridization to the HIRTA chip 
The dscDNA samples and sonicated genomic DNA samples dissolved in nuclease 
free water with concentrations of 100 to 500ng/µl and OD260/280 ratios>= 1.7 
(measured using NanoDrop), that showed no signs of degradation through visual 
inspection of Agilent Bioanalyzer gel results and the 2% agarose gel electrophoresis 
of the sample, were send to ImaGenes (http://www.imagenes-bio.de). The dscDNA 
samples were labeled using Cy5 and genomic DNA using Cy3 fluorochromes. 
Samples were hybridized in Cy5/Cy3 pairs to HIRTA (as presented on Figure 11, 
section 2.1.5.). The HIRTA Chip was further washed and scanned by ImaGenes. 
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5. 8. 7. 6. Visualization of the HIRTA hybridization data 
The raw data from HIRTA hybridizations were normalized by Tuckey bi-weight 
normalization and prepared as .gff files by Ido Tamir, GENAU consortium. The data 
were further transformed into .wig files and visualized on the UCSC genome browser. 
 
5. 8. 7. 7. Bioinformatics analysis of the HIRTA reproducibility 
Assessment of HIRTA reproducibility was performed by comparison of HIRTA 
hybridization replicates, visualized by scatter plots of two numerical columns. Each 
column was a normalized biological or technical replicate HIRTA hybridization data. 
Pearsons’ correlation was the statistical test used to show correlation coefficients 
between the columns. Display of the data and statistics were done using Galaxy 
(http://main.g2.bx.psu.edu/). 
 
5. 8. 8. Sample preparation for the rRNA depleted total RNA Sequencing 
RNA was isolated from Hs27 fibroblasts using TRI Reagent. Quality of RNA was 
assessed using the Agilent RNA 6000 Nano Kit, Agilent Technologies, according to 
the manufacturers’ instructions. The Hs27 RNA sample had a RNA Integration 
Number (RIN)>9. The Hs27 RNA was DNaseI treated in a routine 50µl reaction and 
RNA quality was again assessed on the Agilent 2100 Bioanalyzer, showing RIN>9. 
DNaseI treated Hs27 RNA was than further depleted of ribosomal RNA. 
 
5. 8. 8. 1. Ribosomal RNA depletion  
Ribosomal RNA was depleted from the high quality Hs27 RNA sample using 
RiboMinus Transcriptome Isolation kit (Human/Mouse), Invitrogen according to the 
manufacturers’ recommendations. Briefly, 10µg of RNA was hybridized with the 
RiboMinus Human/Mouse Probe, RNA was denatured by heating at 70ºC for 5min 
and further cooled down to 37ºC during 30min in the water bath. The prepared 
RiboMinus Magnetic Beads were mixed with the RNA/RiboMinus probe sample and 
incubated at 37ºC for 15min. The supernatant containing RiboMinus RNA fraction 
was separated using a magnetic stand. The RiboMinus RNA fraction was 
concentrated using RiboMinus Concentration module, Invitrogen by a procedure 
recommended by manufacturer. Depletion efficiency was assessed using Agilent 
RNA 6000 Pico kit and Eukaryote Total RNA Pico Series II program on the 2100 
Agilent bioanalyzer.  
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5. 8. 8. 2. Hydrolysis of rRNA depleted total RNA 
100ng of the rRNA depleted Hs27 total RNA in nuclease free H20 was hydrolyzed 
using 5xHydrolysis buffer (200mM Tris pH8.2, 500mM KAc and 150mM MgAc2). The 
reaction mixture was heated at 94ºC for 3, 3.5 and 4min. The reaction was cleaned 
using RNasy MinElute Kit, Qiagen according to the manufacturers’ protocol. Cleaned 
RNA was diluted from the RNase Spin column in two times 50µl of nuclease free 
H20, precipitated according to standard procedures and further recovered in 10µl of 
nuclease free H20. The hydrolyses of rRNA depleted total Hs27 RNA was assessed 
using Agilent RNA 6000 Pico kit and the Eukaryote Total RNA Pico Series II program 
on the 2100 Agilent bioanalyzer. RNA that was hydrolyzed at 94ºC for 4min had the 
peak between 200 and 500bp and was further used for cDNA preparation. 
 
5. 8. 8. 3. First strand cDNA preparation for RNA Sequencing 
100ng of the hydrolyzed, rRNA depleted Hs27 sample was used in a 14µl reaction 
where 1.67µl of the pd(N)6 Random Hexamers 5’-Phosphate, Sodium Salt, dissolved 
to 3µg/µl and 1µl of 10mM dNTPs were added. The mixture was heated for 5min at 
65ºC. In the second step, 5µl of 5xFirst Strand Buffer, 2.5µl of 0.1M DTT, 1µl of 
40u/µl RNaseOUT and 1.5µl of nuclease free H20 were added and the mixture was 
heated for 2min on 25ºC. Finally, 1µl (200u) of SuperScript II Reverse Transcriptase 
was added and mixture was heated for 10min at 25ºC and further for 1h at 42ºC, to 
synthesize the Hs27 cDNA. 
 
5. 8. 8. 4.  Second strand cDNA preparation for RNA Sequencing 
To the first strand cDNA preparation, 90.5µl of nuclease free H20 was added 
together with: 1µl of DNA Polymerase I, 0.5µl of RNase H, 30µl of the 5xSecond 
strand buffer and 3µl of 10mM dNTPs, and than the mixture was heated for 2h at 
16ºC. 1µl of T4 DNA Polymerase was further added to the mixture. The mixture was 
heated for 10min at 16ºC and further for 10min at 70ºC. The dscDNA prepared from 
the hydrolyzed rRNA depleted Hs27 total RNA was cleaned using MinElute Reaction 
Cleanup kit, Qiagen according to the manufacturers’ protocol. The dscDNA was 
eluted from the MinElute column using two times 10µl of EB buffer.  
 
The concentration of the Hs27 dscDNA was examined using PicoGreen® Assay for 
dscDNA. The assay was performed according to the manufacturers’ protocol and 
analyzed on a NanoDrop ND-3300 Fluorospectrometer.  
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5. 8. 8. 5. Library preparation and Illumina/Solexa sequencing 
Library preparation and Illumina/Solexa RNA Sequencing were performed by 
Andreas Sommer, GENAU consortium. Library preparation was done using ChIP-
Seq DNA Sample Prep Kit, Illumina according to the manufacturers’ protocol. The 
library was loaded on four lines of the flowcell and RNA Sequencing was performed 
by the Illumina Genome Analyzer II. Image analysis and base calling were performed 
using Illumina Pipeline and 36bp single-reads were obtained.  
 
5. 8. 8. 6. Bioinformatics analysis of the RNA Sequencing data 
rRNA depleted total RNA Sequencing 36bp single-reads were aligned to the 
NCBI36/hg18 genome build using ELAND (http://bioit.dbi.udel.edu/howto/eland), 
Bowtie (http://bowtie-bio.sourceforge.net/) and TopHat (http://tophat.cbcb.umd.edu/) 
allowing two mismatches. Alignments were performed by Andreas Sommer and Ido 
Tamir from the GENAU Bioinformatics team. 
 
5. 9. Bioinformatics analysis of macro ncRNA potential 
The RNAcode, program that predicts regions with protein coding potential based on 
evolutionary signatures (Washietl et al., 2010, unpublished data) was performed over 
44 vertebrate species using Multiz Align from UCSC, by Jan Engelhart, a visiting 
MSc student from Peter Stadlers’ laboratory, Institut für Informatik, Leipzig. RNAcode 
predictions were in the form of a .wig track that was loaded into UCSC browser and 
compared with visually mapped macro ncRNAs expressed by HIRTA.  
 
5. 10. Bioinformatics analysis of direct repeats 
Presence of direct repeats in the CpG island promoters of macro ncRNAs was 
assessed using Dotmatcher program (http://emboss.bioinformatics.nl/cgi-
bin/emboss/dotmatcher). All CpG islands were tested using the same criteria: 
window size=30 and Threshold=65 and presented in the form of dotplots where dots 
from regions of similarity align to form diagonal lines and repeats are visualized as 
parallel diagonal lines. 
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5. 11. Appendix table I- Materials 
Chemicals, enzymes and other materials Company 
α 32PdATP PerkinElmer 
ß-merkaptoethanol Sigma 
Acid Phenol Chlorophorm Ambion 
Agar AppliChem 
Agarose  Biozym 
Agarose-LE Ambion 
Ampicilin Roche 
BCP MRC 
Betaine Fermentas 
Boric Acid  AppliChem 
Bovine Serum Albumine (BSA) Sigma 
BstXI Fermentas 
BstUI Fermentas 
BssHII Fermentas 
Chlorophorm Merck 
Diethyl pyrocarbonate (DEPC) Sigma 
Dimethyl sulfoxide (DMSO) Sigma 
Dithiothreitol (DTT) Invitrogen 
DNA polymerase I Invitrogen 
dCTP Bioron 
dGTP Bioron 
dNTP mix Fermentas 
dTTP Bioron 
Dulbecco’s Modified Eagle Medium (DMEM) Gibco 
E.coli DNA Ligase Invitrogen 
EcoRI Fermentas 
EglI Fermentas 
Ethanol Merck 
Ethidium Bromide Merck 
Ethylendiaminetetraacetic acid (EDTA) Merck 
Fetal bovine serum (FBS) Gibco 
First strand cDNA buffer, 5x Invitrogen 
Formaldehyde loading dye Ambion 
GeneRuler 100bp Plus DNA Ladder Fermentas 
Gentamicine Gibco 
Glacial Acetic Acid VWR 
Glucose Gibco 
GoTaq DNA Polymerase Promega 
HCl Merck 
Hepes Roth 
Hind III Fermentas 
Hybond XL Amersham 
Isopropanol Merck 
Isopropyl-ß-D-thiogalactopyraniside (IPTG) AppliChem 
KAc Sigma 
Klenow Fragment Fermentas 
L-Glutamin Gibco 
LB Medium Bio101 
McCoys’ media Gibco 
Minimum Essential Medium Eagle (MEM) Gibco 
Mesa Green qPCR MasterMix Plus Eurogentec 
MgAc2 Sigma 
MgCl2 Sigma 
MgCl2 (25mM) Fermentas 
NaAc, 3M, pH5.5 Ambion 
NaCl Neo Lab 
Na2HPO4 Sigma 
NaOH AppliChem 
NorthernMaxTM 10x Denaturing gel buffer Ambion 
NorthernMaxTM 10x MOPS gel running buffer Ambion 
NotI Fermentas 
NP-40 Calbiochem 
Nuclease free wather Ambion 
pd(N)6 Random Hexamer 5’ Phosphate, Sodium salt GE Healthcare 
Phosphate buffered saline (PBS) Qbiogene 
Proteinase K Qbiogene 
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qPCR MasterMix Plus Eurogentec 
Random hexamer primers (for RT-PCR) Invitrogen 
Random hexamer primers (for radioactive probe labeling) Pharmacia 
RiboLockTM RNase Inhibitor Fermentas 
Ribonucleoside Vanadyl Complex New England Biolabs 
RNA Millenium Marker Ambion 
RNA Storage Solution Ambion 
Rotiphorese Gel 30 Roth 
RNaseA Fermentas 
RNaseH Invitrogen 
RNaseOUT Invitrogen 
RPMI 1640 Media Gibco 
Second strand cDNA Buffer, 5x Invitrogen 
SephadexTM G-50 Amersham 
Sodium Dodecyl Sulfate (SDS) AppliChem 
Sodium Pyruvate Sigma 
SuperScript II Reverse Transcriptase Invitrogen 
TEMED Roth 
T4 DNA Ligase Fermentas 
T4 DNA Polymerase Invitrogen 
TRI Reagent Sigma 
Tris AppliChem 
Tris-Cl QBiogene 
Trypsin-EDTA Gibco 
X-Gal Roth 
 
Kits Company 
18S rRNA Control Kit (FAM-TAMRA) Eurogentec 
Agilent DNA 7500 Kit Agilent Technologies 
Agilent RNA 6000 Nano Kit Agilent Technologies 
Agilent RNA 6000 Pico Kit Agilent Technologies 
DNA-free Kit Ambion 
ChIP-Seq DNA Sample Preparation Kit Illumina 
Long PCR enzyme mix Fermentas 
MinElute Reaction Cleanup Kit Qiagen 
pGEM T-Easy Vector System I Promega 
PicoGreen Assay NanoDrop technologies 
RevertAid First Strand cDNA Synthesis Kit Fermentas 
RiboMinus Concentration Module Invitrogen 
RiboMinus Transcriptome Isolation Kit (Human/Mouse) Invitrogen 
RNasy MinElute Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
Wizard Genomic DNA Purification Kit Promega 
Wizard SV Gel and PCR Clean-Up System Promega 
 
5. 12. Appendix table II- Primers for testing allelic expression 
Candidate 
ncRNA 
F_Primer_Name F_Primer_Sequence R_Primer _Name R_Primer_Sequence Product 
Length (bp) 
Product 
position (hg18) 
LRRC47down LRRC47CIE1F CACCCAGATCGTAAGGCAGT LRRC47CIE1R CATATCATGCCAGGATGCAG 634 chr1 3685834 
3686467 
 LRRC47CIE2F ATCTGTCTGGCTGCATCTGG LRRC47CIE2R GTTCGTGAGTCTCTGGGAGG 341 chr1 3684319 
3684659 
KLF14up3 KLF14CIE1F GACGTGCGCAGACACAGGCT KLF14CIE1R TCATGGGGCCCGAGCTCTCC 743 chr7 130232070 
130232812 
 KLF14CIE2F GGTAGAGCACCTCCGGGCCA KLF14CIE2R GCCTCACTCCTGGGCAGCCT 473 chr7 130239881 
130240353 
 KLF14CIE3F CGCCTGGGTCCCGACCTGTA KLF14CIE3R CAGTGGGCCCCCAGCAAAGG 623 chr7 130262960 
130263582 
KIAA11264up 
(SLC45A4down) 
SLC45A4CIE1F ACGCCTGCTTTTGGGGTCCT SLC45A4CIE1R ATGCGTGCTGCAGCTTTGGC 849 chr8 142384577 
142385425 
 SLC45A4CIE2F TGCCACTTGCCGCCTGGTAA SLC45A4CIE2R ACAGTGAACTGCTGGCGTGC 429 chr8 142371976 
142372404 
 SLC45A4CIE3F AAACCAGCCAGGTGCGCGAT SLC45A4CIE3R AGTTGGCTCTTGGTGGGCTCCT 787 chr8 142368363 
142369148 
 SLC45A4CIE4F TGGCCAGCTGCTCTGAACGA SLC45A4CIE4R TGCAGCTTTGCCGCAGGTCT 641 chr8 142361627 
142362267 
 SLC45A4CIE5F GCACAGCACTGCACTCACAGGT SLC45A4CIE5R CGGCGTGTGTGGCTTTGCAT 529 chr8 142355919 
142356447 
PEG13 P13CIE1F TCAGCGCGCAGCTTCAGCAT P13CIE1R TTAGCGCTGACGCCTCCGAA 931 chr8 141179240 
141180170 
 P13CIE2F AGCTGCAGAATTGCCGCCGT P13CIE2R GCTGAAGCCGCGCTTGAAGA 534 chr8 141177184 
141177717 
 P13CIE3F GCACGGGGCAGGGCAAAGAT P13CIE3R GGCACAGCTGCGACTGCGTA 764 chr8 141176319 
141177082 
 P13CIE4F TAAACACGCCCACCGGGGTT P13CIE4R ATGCTGAAGCCGCGCACTGA 726 chr8 141178345 
141179070 
 P13CIE5F GGGAGGGCGCACATTCCACC P13CIE5R GCTGCAGGAGGAGCTGCGAG 908 chr8 141175322 
141176229 
 P13CIE6F CGGTGCCCTGGCAAGCAAGA P13CIE6R TCCCCTTCCTGCAGCCTCCC 827 chr8 141173975 
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141174801 
PRCDBPup PRKCDBPCIE1F TATCCCATTACCCAGGATGC PKCDBPCIE1R GTAGAGACAGAGGGCCACCC 395 chr11 6303553 
6303947 
 PRKCDBPCIE2F AGAGTATGTTCAGTGCGGAGC PKCDBPCIE2R CCAATTGACAGTGGATTTTTGA 330 chr11 6314515 
6314844 
SLC38A4down2 SLC38CIE1F GGCATGGCGTAGGTGTAGAT SLC38CIE1R CAACAGGTGGAGCCAGGTAT 708 chr12 45123429 
45124137 
 SLC38CIE2F ATCATTCCCTTGATGATGCC SLC38CIE2R CCCCAAAAATGACCATTCAC 714 chr12 45306921 
45307634 
 SLC38CIE3F TGGGAAGAGAAATTGAACGG SLC38CIE3R TTTCGTTTGTGCTGCACTTC 678 chr12 45141873 
45142551 
 SLC38AIE4F TACACCATTGCCAATTCCAG SLC38AIE4R ACATCGACGTTCTCCCTTGA 255 chr12 45292045 
45292299 
 SLC38AIE5F ATGGGGTACCAAAAAGGGAC SLC38AIE5R TTGCTAAACCCCAAAAGAACA 424 chr12 45198803 
45199226 
 SLC38AIE6F ACAGAAGGCCAGTGTTCAGG SLC38AIE6R AAGTCCCCCAGGGTTGTAAG 386 chr12 45339237 
45339622 
 SLC38AIE7F GGATTTTCCCCCTCGTTTTA SLC38AIE7R CCTGGAGGATTCACCATTTG 258 chr12 45065055 
45065312 
 SLC38AIE8F TTCAAATTGGAGGGAGCTTG SLC38AIE8R GGCTAAAGGCATAGCTGACG 312 chr12 45067607 
45067918 
 SLC38AIE9F GATGTGGCCTAAATTGGGAA SLC38AIE9R AGCTGGGGTTCAAGGTTCTC 230 chr12 45072960 
45073187 
 SLC38AIE10F TTACCCTGGCAACACCATTT SLC38AIE10R AGTGATGGGGACACAACCAT 433 chr12 45075519 
45075951 
 SLC38AIE11F TTCTGGGCTAATCCTCTCCA SLC38AIE11R TCCAAAAGGGAACAAAGCAG 196 chr12 45081679 
45081874 
 SLC38AIE12F ATGGGCTTGTTTGGAGACTG SLC38AIE12R ATGGTGTGGGGACTGTGTTT 491 chr12 45082671 
45083161 
 SLC38AIE13F TTCCCCCAGCACCTCCACCC SLC38AIE13R GGGTGGGGGCACGCATCTTC 678 chr12 45086582 
45087259 
 SLC38AIE14F TCCCTGCATCCTTCCTGGCT SLC38AIE14R TGTCGGAATGTGGCACTTGGCAG 850 chr12 45134077 
45134926 
 SLC38AIE15F ACAGCAGGTTTGCTGGCCCC SLC38AIE15R AGCCAGGACTGAGGGATGGCA 931 chr12 45253825 
45254755 
 SLC38ACIE16F TGTGCAATTCCCCACCCTGTGC SLC38ACIE16R ACCAGCTCAGGCTCCATGTTCCT 839 chr12 45091399 
45092237 
 SLC38ACIE17F GCCCGGGGAATTGCCTCTCC SLC38ACIE17R ACAGCACCATTGCTCCTGCGG 593 chr12 45153862 
45154454 
 SLC38ACIE18F AGGCAGGGTGTGGCTGGAGA SLC38ACIE18R CCATCACAGGGCACCGCAGG 864 chr12 45156579 
45157442 
 SLC38ACIE19F TCCCTTCCTTCCCTGCCTTGCT SLC38ACIE19R GGGGGTGAGAAGGGTGGTCCT 509 chr12 45172401 
45172906 
 SLC38ACIE20F CAGGAGGGCCTGTGGAGCCT SLC38ACIE20R CTGCCAGCAGCAGGGTGGTC 975 chr12 45203656 
45204630 
 SLC38ACIE21F TGGCAGGGTGGGAGGTGGAA SLC38ACIE21R TTGCCCTTTCTGGCTGGCCT 876 chr12 45226838 
45227713 
 SLC38ACIE22F ACCCTCCAGGCACTCCCACC SLC38ACIE22R TGCCGGTCCCTCTCTGCTGG 991 chr12 45332357 
45333347 
 SLC38A4CIE23F TGAGCAAAGGTTGCGGGCGT SLC38A4CIE23R GCCACCAGGGTCCACAGGTC 900 chr12 45216764 
45217663 
ADAMTS7down ADAMTS7CIE1F CCCTGCAGCTTGCTTTAGAA ADAMTS7CIE1R ATTTGGGAGACGATGCTCAG 325 chr15 76830664 
76830988 
 ADAMTS7CIE2F CACCAGCTGCCCTTAGGTT ADAMTS7CIE2R GAGGGAGGGGAAGTGTTAGC 419 chr15 76834538 
76834957 
 ADAMTS7IE3F TTGGGCGTTCTCTGTTCTCT ADAMTS7IE3R GACGTCTGTGTCCCAGGATT 723 chr15 76831349 
76832071 
 ADAMTS7IE4F CAGTGCTCCTGGTGTCTCCT ADAMTS7IE4R CTAAAGACACGAAGCCGGAG 549 chr15 76833701 
76834249 
 ADAMTS7IE5F CTGACCATGGGACACCTTCT ADAMTS7IE5R GCGTGTGGATTTCTCAGGTT 342 chr15 76830990 
76831347 
 ADAMTS7IE6F TCGTGGAAATCATTCACCAA ADAMTS7IE6R AGCTGTCCAAGACCGTTCAC 175 chr15 76833499 
76833673 
 ADAMTS7IE7F CTCCGGCTTCGTGTCTTTAG ADAMTS7IE7R AAAACCTAAGGGCAGCTGGT 329 chr15 76834230 
76834558 
 ADAMTS7IE8F CACCAGCTGCCCTTAGGTT ADAMTS7IE8R CTGAGGCTGGCACAGATACA 859 chr15 76834538 
76835396 
 ADAMTS7IE9F GGAGACGGTTCTGGTTTCAA ADAMTS7IE9R TCTGGGAATCCTTGATGGAG 885 chr15 76835542 
76836425 
 ADAMTS7IE10F AGGACTGCCTGGGCCTGTGT ADAMTS7IE10R TCAGCGGCGCTCCAGAGAGT 464 chr15 76832016 
76832479 
 ADAMTS7CIE11F CCTGCTGTGCCTGTGAGGGC ADAMTS7CIE11R AGGCAGCAACCCTCTGGCCT 743 chr15 76832429 
76833171 
TMED3down TMED3CIE1F CGCAGCCAGAACCCTCAGCC TMED3CIE1R TCGGCCTCCTGGGATTGGCA 327 chr15 77433842 
77434168 
 TMED3CIE2F CCCAGGCTGAGAGGGCAGGT TMED3CIE2R AGCCTGGGGAAGGCCAGAGG 992 chr15 77460995 
77461986 
 TMED3CIE3F AGTGGCTGTCAAATGCAGTG TMED3CIE3R CCGTGATCCTGGTCTTGAAT 443 chr15 77413645 
77414087 
 TMED3CIE4F TCGGCTTCTCTGTGAGCATA TMED3CIE4R TCACAGGGTTGTGAGACAGC 249 chr15 77437400 
77437648 
 TMED3CIE5F AAGCTAAGCTCGTGGTGGCAGC TMED3CIE5R AGCAGCTGGGGTCAGGAGAA 382 chr15 77446103 
77446484 
 TMED3CIE6F ATCCTGAGTCCCCCAGCCCC TMED3CIE6F AGGCCTCTGCACTGGGGACA 345 chr15 77397874 
77398218 
 TMED3CIE7F TGCCTGCTTGCAGTGGGACA TMED3CIE7R GGGCCTCAGCCACCAGGAGT 696 chr15 77412460 
77413155 
KIAA1024up KIA1024CIE1F GCAAACGCACACAGCAGGGC KIA1024CIE1R TGCCCCCAGCTTTTGCCACC 979 chr15 77497123 
77498101 
 KIA1024CIE2F GGGCTCTGTCCCTGGGGAGG KIA1024CIE2R AGGCCAGGGCCAAGTGGTCA 518 chr15 77510515 
77511032 
 KIA1024CIE3F TGTGCTGGGGTTTCCTGCCT KIA1024CIE3R AGGGTGCTGGTTTGTACCCGT 725 chr15 77493565 
77494289 
 KIA1024CIE4F AGGGTGCATTCAGGCCAGGT KIA1024CIE4R ACCAGCTGCCAATTCAGGGCT 657 chr15 77495061 
77495717 
 KIA1024CIE5F ACAGCTGCCAGGCGTCACAT KIA1024CIE5R TTGGCCCTGCTGTGTGCGTT 731 chr15 77496415 
77497145 
 KIAA10246F GGCTCCCTGGGACCAGCCTT KIAA10246R GCAGCCCAGTGCTCACAAAGGG 180 chr15 77506036 
77506215 
BLCAPov BLCAPCIE1F GGCCTTAGCACCTGCCTGCC BLCAPCIE1R CAGCGCTTACGCCCTGCCTT 836 chr20 35575145 
35575980 
 BLCAPCIE2F CAGGCAGCCCTCCACCTCCT BLCAPCIE2R TTGGGCCTCCCGATCCCTGG 960 chr20 35572583 
35573552 
 BLCAPCIE3F ACTGACAATGCAGGCCCCCT BLCAPCIE3R TCCTGTGGCGACACCTGGATGA 819 chr20 35577256 
35578074 
 BLCAPCIE4F TCAGCCAGCTCCTGCCAAGT BLCAPCIE4R AGGAAGGCCAGGAACCACCCTT 777 chr20 35570967 
35571743 
 BLCAPCIE5F AAAGGGCCTGCCGAGCATCT BLCAPCIE5R AGCATGGTGGCCCTGCTGAT 957 chr20 35563865 
35564821 
 BLCAPCIE6F ACTGGGTCATGGGAGCCCTCT BLCAPCIE6R TTTGGCCACCCACTGCCACC 549 chr20 35558111 
35558659 
 BLCAPCIE7F TCCTGCAAGCTCACCTGCCT BLCAPCIE7R TGGGCCCAATCCCTTGGCTT 576 chr20 35574201 
35574776 
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 BLCAPCIE8F TTGGGTGGGTGGGTCGTTGC BLCAPCIE8R AGGAGGTGGAGGGCTGCCTG 391 chr20 35572212 
35572602 
 BLCAPCIE9F TTGTTGCAGTAGCCGGGCTTT BLCAPCIE9R ACCACTGCCACTCCATTCTGCT 696 chr20 35554657 
35555352 
 BLCAPCIE10F TGGGCAGCACCAGCATTGGA BLCAPCIE10R ACATTTCCAGCCCTCCAGCCCT 786 chr20 35547819 
35548604 
 BLCAPCIE11F GCTGCTGCCACAGCGAGGAT BLCAPCIE11R CTCCAAGGAGGGGGCAGGCA 766 chr20 35574415 
35575180 
Protein coding 
gene 
F_Primer_Name F_Primer_Sequence R_Primer _Name R_Primer_Sequence Product 
Length (bp) 
Product 
position (hg18) 
ADAMTS7 
ADAMTS7GIE1F GACCGTCCCCACTGCACAGC ADAMTS7GIE1R TGCAGACACCTGCCACCCCT 984 
chr15 76844774 
76845757 
 
ADAMTS7GIE2F GGCTGTGCCTGCCCCACTTC ADAMTS7GIE2R CACATACGCACGCAGGGGCA 520 
chr15 76850535 
76851054 
 
ADAMTS7GIE3F AGGGTCCTGCACCTCGCCAA ADAMTS7GIE3R CTCTCCCTGCAGGACGTGCAAC 323 
chr15 76879634 
76879956 
 
ADAMTS7GIE4F CCTTGCTCAGGGTTCCGCCG ADAMTS7GIE4R GGCCAGTGAGCTTGCAGGGG 847 
chr15 76867241 
76868114 
 
 
5. 13. Abbreviations 
bp             basepairs 
cpm          counts per minute 
g               gram 
h               hour 
kb              kilobasepairs 
rpm           rounds per minute 
l                 litre 
mg            milligram 
min           minute 
ml             mililitre 
µg             microgram 
µl              microlitre 
MQ           milliq 
ng             nanogram 
u               units 
sec           seconds 
V              volts 
w/v           weight/volume percentage 
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